{"meta":{"query_hash":"2390c1d24952","filters":{"venue":"Antiviral Research"},"cohort_total":224,"direct_labels_cover":1,"predictions_cover":224,"exported":224,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2390c1d24952","api":"https://metacan.xera.ac/api/v1/cohort?venue=Antiviral+Research"},"results":[{"id":"W1141056041","doi":"10.1016/j.antiviral.2015.08.007","title":"Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"APOBEC3G; Derepression; Biology; Virology; Messenger RNA; Cytidine deaminase; Infectivity; RNA; Virus; Viral replication; Enzyme; Gene expression; Genetics; Gene; Biochemistry","score_opus":0.10949967002758479,"score_gpt":0.38996292176731107,"score_spread":0.2804632517397263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1141056041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836812,0.00020690668,0.00013474596,0.00016099378,0.00007653482,0.00083233777,0.00003402984,0.00008203725,0.014791201],"genre_scores_gemma":[0.9920842,0.000027198847,0.00028408627,0.0000061599603,0.00015132318,0.0000666061,0.000024979146,0.00004631573,0.0073091066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971645,0.00040334288,0.00038237803,0.00040720878,0.0010170772,0.000625521],"domain_scores_gemma":[0.99872553,0.00008485414,0.00010287893,0.00040162727,0.0005389932,0.00014608378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013734405,0.00020137624,0.00036357794,0.0004820044,0.0002753303,0.00004900179,0.00010896689,0.0001663975,0.00002972424],"category_scores_gemma":[0.00080652605,0.00017665135,0.00012139653,0.0008115858,0.00024811534,0.0003072045,0.00016350187,0.0005878303,0.0002316471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003077971,0.00085829437,0.14504315,0.00022891468,0.00013667486,0.00016655707,0.00029103653,9.2759717e-7,0.8315362,0.00019326904,0.0007952954,0.020441893],"study_design_scores_gemma":[0.0025467607,0.0008396433,0.05946633,0.00030844234,0.00002824283,0.0000129482205,0.0000917898,0.00011571434,0.9328442,0.00017406692,0.0034068883,0.00016493743],"about_ca_topic_score_codex":0.0026561702,"about_ca_topic_score_gemma":0.00006227004,"teacher_disagreement_score":0.10130805,"about_ca_system_score_codex":0.0002980732,"about_ca_system_score_gemma":0.0002673591,"threshold_uncertainty_score":0.72036326},"labels":[],"label_agreement":null},{"id":"W1467889550","doi":"10.1128/9781555815493.ch4","title":"Nucleoside Analogue Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase","year":2014,"lang":"en","type":"book-chapter","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Reverse transcriptase; Retrovirus; Virology; Biology; Integrase; Nucleoside analogue; Lamivudine; Integrase inhibitor; Nucleoside Reverse Transcriptase Inhibitor; Context (archaeology); Virus; Viral replication; RNA; Nucleoside; Human immunodeficiency virus (HIV); Genetics; Hepatitis B virus; Gene; Viral load; Antiretroviral therapy","score_opus":0.07815633392520493,"score_gpt":0.36183706447076064,"score_spread":0.2836807305455557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1467889550","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06708606,0.0018029602,0.000013105252,0.0010624435,0.00018668399,0.0013340625,0.00016494439,0.00007693454,0.9282728],"genre_scores_gemma":[0.46714237,0.0006598747,0.00007650138,0.00003363082,0.00010729831,0.00001222504,0.00028977424,0.0000688895,0.5316094],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964154,0.00010897425,0.0007037261,0.00062258437,0.0015148319,0.0006345069],"domain_scores_gemma":[0.99840665,0.00013072591,0.00015757029,0.0007444395,0.00043178245,0.00012885848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012622005,0.0004145235,0.0009001633,0.0009948263,0.00025710635,0.000027804093,0.00027993324,0.00040513853,0.0004548467],"category_scores_gemma":[0.0000897695,0.0003504976,0.00041814026,0.00019208937,0.00067631446,0.00006900971,0.00013596592,0.0010898263,0.0010134734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014115709,0.001580569,0.0038563244,0.0023006632,0.0020591612,0.0034823597,0.002965743,1.6953388e-7,0.41737685,0.20944856,0.29818353,0.05733452],"study_design_scores_gemma":[0.0059041437,0.003112143,0.0019193605,0.0053297523,0.0007735731,0.000051400326,0.00027026696,0.000016739856,0.15157159,0.0067396425,0.8229507,0.0013606977],"about_ca_topic_score_codex":0.00034177682,"about_ca_topic_score_gemma":0.000080917365,"teacher_disagreement_score":0.52476716,"about_ca_system_score_codex":0.0002035213,"about_ca_system_score_gemma":0.00037194218,"threshold_uncertainty_score":0.9998947},"labels":[],"label_agreement":null},{"id":"W1566796706","doi":"10.1016/j.antiviral.2015.08.016","title":"A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Saskatchewan; Canadian Food Inspection Agency","funders":"","keywords":"Virology; Virulence; Biology; Immunity; Virus; Immunology; Gene; Immune system; Genetics","score_opus":0.07800638220671052,"score_gpt":0.34971737636711586,"score_spread":0.27171099416040534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566796706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910725,0.0069368635,0.000014820265,0.00020283602,0.000086582826,0.001496282,0.00036490583,0.000040384846,0.0017500963],"genre_scores_gemma":[0.9978335,0.0010644885,0.000044284137,0.000028426055,0.00003347047,0.00028754456,0.00014597997,0.000034678742,0.00052761764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99421775,0.0028720156,0.0004724922,0.000727101,0.0004024845,0.0013081304],"domain_scores_gemma":[0.99805397,0.00032497948,0.00010398582,0.0007565595,0.00053293345,0.00022754674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038695787,0.00030238632,0.0005114214,0.00074969017,0.00031075085,0.000054724773,0.00068763376,0.00032227865,0.000037204685],"category_scores_gemma":[0.0016210745,0.00026199655,0.000097473676,0.00060636963,0.0016253561,0.00038313575,0.00087112543,0.0013821223,0.00034235904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006461668,0.002785589,0.0020143664,0.00015784653,0.00013774273,0.00048340656,0.0036121854,0.0000072166854,0.8714389,0.00046629607,0.00036500674,0.11206974],"study_design_scores_gemma":[0.0054534185,0.0038064488,0.06551676,0.00018492424,0.00002075496,0.000022281636,0.0023572594,0.00020443357,0.91380787,0.0033549934,0.0046620285,0.00060879946],"about_ca_topic_score_codex":0.008136416,"about_ca_topic_score_gemma":0.0031920425,"teacher_disagreement_score":0.11146095,"about_ca_system_score_codex":0.0002404425,"about_ca_system_score_gemma":0.00084117794,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W1671096404","doi":"10.1016/j.antiviral.2015.09.003","title":"Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Synthesis and bioactivity of alkaloids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Herpes simplex virus; MAPK/ERK pathway; Oxidative stress; Harmine; NF-κB; Virology; Virus; Biology; Chemistry; Immunology; Cell biology; Inflammation; Signal transduction; Pharmacology; Biochemistry","score_opus":0.10819647722950669,"score_gpt":0.35453320565488994,"score_spread":0.24633672842538323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1671096404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641705,0.00046556036,0.00025982194,0.0002129089,0.000055592256,0.00025011587,0.000070090784,0.000019275596,0.0022496025],"genre_scores_gemma":[0.99852115,0.00030870506,0.00019499056,0.000046647092,0.00027928682,0.000020592986,0.00014262246,0.000026963788,0.00045905093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796665,0.00033346214,0.00019258102,0.0005349113,0.00047130312,0.0005011136],"domain_scores_gemma":[0.99919146,0.00008084575,0.000072439885,0.00029822145,0.00025513957,0.00010186337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009263162,0.00020217602,0.00020938717,0.00007133133,0.0002476999,0.00012059518,0.00016261238,0.00025276744,0.000010396446],"category_scores_gemma":[0.00040075515,0.00017919569,0.00006301863,0.00020394403,0.00025418884,0.000034690147,0.0003351748,0.00023611814,0.000015003804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010379433,0.00016849139,0.001420119,0.000015586089,0.00005154761,0.0000049268074,0.00020475962,4.7741077e-7,0.944482,0.000029533161,0.0029221766,0.05059654],"study_design_scores_gemma":[0.0005034184,0.0006411822,0.0009758776,0.000027462984,0.000008418582,0.0000023589732,0.0004741725,0.000071701514,0.98237497,0.00025175881,0.014445271,0.0002234084],"about_ca_topic_score_codex":0.0022173522,"about_ca_topic_score_gemma":0.000325911,"teacher_disagreement_score":0.050373133,"about_ca_system_score_codex":0.00003143201,"about_ca_system_score_gemma":0.00010363586,"threshold_uncertainty_score":0.7307388},"labels":[],"label_agreement":null},{"id":"W1834034354","doi":"10.1016/j.antiviral.2015.09.007","title":"Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Herpes simplex virus; Medicine; Chemokine; Valaciclovir; Artesunate; Encephalitis; Viral encephalitis; Viral load; Immunology; Pharmacology; Virus; Virology; Herpesviridae; Inflammation; Viral disease","score_opus":0.17225452963641924,"score_gpt":0.43378255078694333,"score_spread":0.2615280211505241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834034354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926379,0.0001229682,0.000023524559,0.0014636037,0.000069647394,0.0015896517,0.000039638075,0.000042105225,0.0040109754],"genre_scores_gemma":[0.9967736,0.00013537427,0.0002575946,0.00024764598,0.000057333637,0.00013012733,0.00001966759,0.00004162406,0.0023370348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685234,0.0005491723,0.00050028716,0.00043576144,0.0009356485,0.00072677375],"domain_scores_gemma":[0.99823,0.0005340061,0.00008664538,0.0005433016,0.00044291303,0.00016314794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016992618,0.0002599603,0.00064528437,0.00041966533,0.00015537975,0.00006182624,0.000275793,0.00009756292,0.000032919084],"category_scores_gemma":[0.0003359003,0.00014044563,0.00009276505,0.0015731337,0.0004463248,0.00020438191,0.00012757254,0.00041683143,0.0001322852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031279158,0.0060604275,0.477959,0.00014885263,0.00078336935,0.00099328,0.0058452357,0.000009838998,0.070579946,0.0005591927,0.003509602,0.40227208],"study_design_scores_gemma":[0.030917399,0.013318639,0.5883179,0.0004213973,0.000081108956,0.000051578783,0.0037910484,0.0006249301,0.31985566,0.00065050647,0.04131535,0.0006544864],"about_ca_topic_score_codex":0.01050594,"about_ca_topic_score_gemma":0.0038069035,"teacher_disagreement_score":0.4016176,"about_ca_system_score_codex":0.00014400296,"about_ca_system_score_gemma":0.00036246888,"threshold_uncertainty_score":0.9960832},"labels":[],"label_agreement":null},{"id":"W1837132695","doi":"10.1016/j.antiviral.2015.09.006","title":"Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Santen","keywords":"Antiviral therapy; Medicine; Peripheral; Immunology; Chronic hepatitis; Virology; Internal medicine; Virus","score_opus":0.05325281740686058,"score_gpt":0.3352460753609724,"score_spread":0.2819932579541118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1837132695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969201,0.0009886974,0.00000902438,0.000026314556,0.00039430248,0.00019903734,0.0000050499802,0.000012872409,0.0014445952],"genre_scores_gemma":[0.9968017,0.0006196151,0.0000050292256,0.0000074413056,0.00001895001,0.000010828354,0.000061508574,0.000011107185,0.00246382],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830943,0.0005209021,0.00031534574,0.00029903458,0.00013020361,0.00042507914],"domain_scores_gemma":[0.9993595,0.000101619094,0.000075685,0.00020718673,0.00023938638,0.000016653375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067539705,0.00012993896,0.00033333868,0.00077323255,0.00010657228,0.000026478057,0.00014057239,0.00013827588,0.00015173892],"category_scores_gemma":[0.000086830354,0.00011337231,0.00008823076,0.00088989886,0.0002966324,0.00025725318,0.000107737935,0.0004766265,0.000094619456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083684875,0.00024337441,0.48202765,0.000022731518,0.00033991755,0.0000046116297,0.00081215135,0.000007841732,0.5091903,0.000035736208,0.00047230188,0.0060065496],"study_design_scores_gemma":[0.00255755,0.0009042418,0.68567777,0.000037066766,0.000035766923,9.619401e-7,0.0003380938,0.00032295322,0.30889675,0.000014001902,0.0010733334,0.00014147563],"about_ca_topic_score_codex":0.0010657108,"about_ca_topic_score_gemma":0.00027013425,"teacher_disagreement_score":0.20365015,"about_ca_system_score_codex":0.00020977532,"about_ca_system_score_gemma":0.0001012566,"threshold_uncertainty_score":0.46231887},"labels":[],"label_agreement":null},{"id":"W1963713293","doi":"10.1016/j.antiviral.2012.06.005","title":"Is minocycline useful for therapy of acute viral encephalitis?","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Minocycline; Medicine; Neuroprotection; Disease; Encephalitis; Clinical trial; Immunology; Virus; Pharmacology; Internal medicine; Antibiotics; Biology","score_opus":0.5484741983498679,"score_gpt":0.515536734200781,"score_spread":0.032937464149086826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963713293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008130686,0.9856799,0.00008905788,0.0000443957,0.0007531389,0.0029059327,0.0016338535,0.000056609395,0.00070640544],"genre_scores_gemma":[0.008168134,0.9881291,0.000068351794,0.00013793891,0.00038013147,0.000272738,0.000022392805,0.00013922379,0.0026819818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429375,0.0013298502,0.0007961462,0.001051001,0.0012807627,0.00124852],"domain_scores_gemma":[0.9953808,0.003171199,0.00033711965,0.0007897164,0.00018744387,0.00013372173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012102904,0.0004961327,0.0015447829,0.0005602241,0.00027020823,0.00009732078,0.001267227,0.00031804692,0.00009940915],"category_scores_gemma":[0.0004819469,0.00037971017,0.0008790934,0.00086237956,0.00041940878,0.00024968863,0.00039238477,0.0007400161,0.00030962023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001344481,0.0004635184,0.000005061864,0.003611758,0.000093168586,0.000079414,0.000053493433,4.1378563e-9,0.1708811,0.0039897654,0.0013174606,0.8193708],"study_design_scores_gemma":[0.00022097903,0.00048533158,0.0000017309037,0.0005585132,0.00008984981,0.000023754816,0.0000014730841,0.0000031954378,0.44880503,0.00009503498,0.549502,0.00021309448],"about_ca_topic_score_codex":0.000011648358,"about_ca_topic_score_gemma":6.7906797e-7,"teacher_disagreement_score":0.8191577,"about_ca_system_score_codex":0.00003896842,"about_ca_system_score_gemma":0.00029439913,"threshold_uncertainty_score":0.9998655},"labels":[],"label_agreement":null},{"id":"W1965267706","doi":"10.1016/s0166-3542(03)00133-5","title":"Genomic analysis of a recently identified virus (SEN virus) and genotypes D and H by polymerase chain reaction","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Genotype; Polymerase chain reaction; Biology; Virology; Virus; Hepatitis C virus; DNA sequencing; Genetics; DNA; Gene","score_opus":0.05762883819172862,"score_gpt":0.3236960327803968,"score_spread":0.26606719458866823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965267706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960528,0.0018303538,0.0000022760457,0.00015271251,0.000021314208,0.00014522707,0.000077196906,0.00001567381,0.0017024211],"genre_scores_gemma":[0.9956472,0.00362907,0.000012722501,0.000023954331,0.00002335124,0.000010011754,0.000016246548,0.0000012322822,0.00063624297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863297,0.00031756493,0.00018300003,0.0003217829,0.0002572293,0.00028746508],"domain_scores_gemma":[0.9994186,0.00031527173,0.000058037607,0.0000582632,0.000102908605,0.000046907164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089110836,0.00009990941,0.00022250516,0.00010657231,0.00041438546,0.00005846182,0.00007959342,0.0000710438,0.000053797776],"category_scores_gemma":[0.00022887044,0.00004732913,0.00005867988,0.001163064,0.0002896701,0.000118368356,0.00010171057,0.00015790426,0.00001599606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049282837,0.00006192939,0.0356372,0.000003827839,0.00014879735,0.0000013578523,0.00008024656,4.7864678e-8,0.9488241,0.00037438652,0.00032060788,0.0144982],"study_design_scores_gemma":[0.0001334949,0.0003310389,0.69788563,0.000008129256,0.00012028768,0.0000018725758,0.00067472365,0.00004287686,0.29490158,0.0003343859,0.005399174,0.0001668163],"about_ca_topic_score_codex":0.007884093,"about_ca_topic_score_gemma":0.0067028664,"teacher_disagreement_score":0.66224843,"about_ca_system_score_codex":0.000027258004,"about_ca_system_score_gemma":0.000007721707,"threshold_uncertainty_score":0.9987225},"labels":[],"label_agreement":null},{"id":"W1965398894","doi":"10.1016/j.antiviral.2011.10.019","title":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Dengue virus; Sepsis; Immunology; Context (archaeology); Dengue fever; Biology; Immunosuppression; Pathogenesis; Immune system; Viral pathogenesis; Virus; Virology; Medicine; Viral replication","score_opus":0.13182307340431137,"score_gpt":0.4872482166468658,"score_spread":0.3554251432425544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965398894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080821256,0.994738,0.000098048346,0.000035654914,0.0001508128,0.0022359686,0.000041577732,0.000018456038,0.0018732593],"genre_scores_gemma":[0.00095226936,0.9973954,0.0010777621,0.000016465425,0.00012432988,0.00018949482,0.000041525083,0.000053934953,0.00014884037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947708,0.0028953922,0.00092058064,0.00052091625,0.00045326122,0.0004390509],"domain_scores_gemma":[0.99737406,0.0006406534,0.0003006631,0.0010452097,0.00055732724,0.000082095255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006580052,0.00034603412,0.002225704,0.0005090937,0.00018966294,0.00002839164,0.00027812945,0.00034063763,0.00026834203],"category_scores_gemma":[0.0011161682,0.0002055794,0.0011252925,0.0011084764,0.00069026963,0.00009953567,0.00031321298,0.0011410987,0.000027670658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002451889,0.00027502343,0.000027835147,0.066776805,0.00052874873,0.000002251032,0.00006822617,1.5762779e-9,0.0034755338,0.0023569306,0.00014521331,0.9263189],"study_design_scores_gemma":[0.00023830742,0.0013362959,0.00003777672,0.055568445,0.0018155716,0.00010349717,0.00004823627,0.000002655249,0.002248033,0.0013411929,0.9370519,0.00020812395],"about_ca_topic_score_codex":0.0005800474,"about_ca_topic_score_gemma":0.000011928362,"teacher_disagreement_score":0.93690664,"about_ca_system_score_codex":0.000080023325,"about_ca_system_score_gemma":0.00053868355,"threshold_uncertainty_score":0.8383285},"labels":[],"label_agreement":null},{"id":"W1966157617","doi":"10.1016/j.antiviral.2010.07.006","title":"Interferon-β modulates type 1 immunity during influenza virus infection","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Immune system; Immunology; Influenza A virus; Biology; Virology; Interferon; Virus; Population; Immunity; Medicine","score_opus":0.18545032678141038,"score_gpt":0.4830819267779633,"score_spread":0.2976315999965529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966157617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985524,0.00021529672,0.0000029690577,0.00019861199,0.00024477113,0.0005334308,0.000006137526,0.00012982686,0.01314498],"genre_scores_gemma":[0.99694055,0.0005849375,0.00009484277,0.000089192596,0.00033270277,0.000041419902,0.00000780071,0.00004252489,0.0018660355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99706686,0.0002667067,0.00030325772,0.0003810514,0.0010381878,0.00094396214],"domain_scores_gemma":[0.9976241,0.00028582598,0.000040281364,0.00070662866,0.0012052582,0.00013788066],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018153018,0.00019858433,0.00031627182,0.00066629547,0.00067237567,0.00010651211,0.00023623699,0.00019874508,0.0002097698],"category_scores_gemma":[0.0036105784,0.00016677762,0.000103718055,0.0010521915,0.000676242,0.00036020167,0.00069018675,0.002937835,0.0016722572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001158197,0.00018699256,0.14815202,0.00012958632,0.0000955954,0.00004842267,0.0003586528,8.886996e-7,0.84552157,0.00016881192,0.0005322686,0.003646963],"study_design_scores_gemma":[0.0010183674,0.0007163017,0.51710826,0.000090023736,0.000011451267,0.000018937853,0.000081956765,0.00013641124,0.4734096,0.00025203935,0.006995904,0.00016071838],"about_ca_topic_score_codex":0.003649909,"about_ca_topic_score_gemma":0.00085821375,"teacher_disagreement_score":0.372112,"about_ca_system_score_codex":0.000113027236,"about_ca_system_score_gemma":0.00022609941,"threshold_uncertainty_score":0.9993624},"labels":[],"label_agreement":null},{"id":"W1967728176","doi":"10.1016/j.antiviral.2004.06.008","title":"Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada; University of Alberta","funders":"","keywords":"Immunogenicity; Recombinant DNA; Virology; Biology; Inclusion bodies; Protein subunit; Glycoprotein; Escherichia coli; Virus; Antigen; Immune system; Immunization; Immunity; Humoral immunity; Microbiology; Molecular biology; Gene; Immunology; Biochemistry","score_opus":0.2232394123698678,"score_gpt":0.48438324054563925,"score_spread":0.2611438281757714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967728176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992009,0.0010473743,0.00045003227,0.00129644,0.00003752232,0.0043817684,0.000015457616,0.000016053518,0.0007463543],"genre_scores_gemma":[0.9975963,0.0004789996,0.00026339627,0.000008059383,0.000038441114,0.0010850085,0.000016718122,0.000017332794,0.0004957228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758536,0.00058723334,0.00024915283,0.0002591413,0.00088199903,0.00043711625],"domain_scores_gemma":[0.9967422,0.00028635317,0.00005361664,0.00030169825,0.0025677616,0.000048366524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067759706,0.00010409864,0.00026412352,0.00033272876,0.00027035584,0.000028021874,0.00009976871,0.00012920998,0.000013021827],"category_scores_gemma":[0.0060680136,0.00008592567,0.00005957323,0.0004904962,0.00059232034,0.00017115685,0.00015838003,0.0005698184,0.000015586309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013021725,0.0017631971,0.015654039,0.0005150839,0.00030150043,0.000020589725,0.0009964992,0.0000020488067,0.74036175,0.0036601997,0.00008831734,0.23533459],"study_design_scores_gemma":[0.012799976,0.026148887,0.18003882,0.0014839881,0.00017190792,0.00005513412,0.0011827584,0.00054512743,0.7289666,0.047841962,0.0004929423,0.00027192064],"about_ca_topic_score_codex":0.001457396,"about_ca_topic_score_gemma":0.00014617512,"teacher_disagreement_score":0.23506266,"about_ca_system_score_codex":0.00021494401,"about_ca_system_score_gemma":0.00070984435,"threshold_uncertainty_score":0.72644174},"labels":[],"label_agreement":null},{"id":"W1967732746","doi":"10.1016/j.antiviral.2011.07.007","title":"High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tetherin; Flow cytometry; Cell biology; Cell; Viral replication; Stromal cell; Function (biology); Replication (statistics); Biology; Cell culture; Chemistry; Virology; Molecular biology; Virus; Biochemistry; Cancer research; Genetics","score_opus":0.06273332628503661,"score_gpt":0.3541660564287749,"score_spread":0.29143273014373827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967732746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293596,0.00039323827,0.000063716696,0.00011478474,0.00017730631,0.00054578274,0.00018020923,0.000023265042,0.0055657504],"genre_scores_gemma":[0.9952751,0.00009766164,0.00040735747,0.000006171544,0.000016912416,0.000016790793,0.00023665592,0.000018870809,0.00392452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973069,0.00093760743,0.00041246353,0.0003632465,0.00029279856,0.00068702095],"domain_scores_gemma":[0.99834573,0.0005388336,0.00009752712,0.0004434274,0.0005252289,0.00004925112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018132213,0.00015093257,0.00034318585,0.0003455667,0.00013464739,0.000010163452,0.0003488827,0.00022881861,0.00062768406],"category_scores_gemma":[0.0003509185,0.00012502409,0.00009937323,0.0007250931,0.00052009907,0.00015101748,0.00029156182,0.00039443834,0.004414131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004398939,0.0005569362,0.01696904,0.000056094228,0.00011165354,0.000011015485,0.000916568,9.048203e-7,0.9721722,0.00034264196,0.0068439282,0.0015790955],"study_design_scores_gemma":[0.00096656574,0.00081313704,0.124172226,0.000044509386,0.000009640431,0.0000010360659,0.00021861035,0.00000128057,0.8728058,0.00020374876,0.00067256554,0.000090909765],"about_ca_topic_score_codex":0.004024684,"about_ca_topic_score_gemma":0.00014944303,"teacher_disagreement_score":0.107203186,"about_ca_system_score_codex":0.000061740386,"about_ca_system_score_gemma":0.00018084093,"threshold_uncertainty_score":0.9963611},"labels":[],"label_agreement":null},{"id":"W1968490745","doi":"10.1016/j.antiviral.2005.01.002","title":"Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Centers for Disease Control and Prevention","keywords":"Cytopathic effect; Interferon; Virology; Virus; In vitro; IC50; Medicine; Immunology; Pharmacology; Biology","score_opus":0.1717717720682427,"score_gpt":0.4396021920681019,"score_spread":0.26783041999985924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968490745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432004,0.0003676268,0.00013121299,0.0007891218,0.000036736175,0.0006589398,0.000024056544,0.000036187757,0.013636056],"genre_scores_gemma":[0.9935909,0.00002377837,0.00026340663,0.0055632098,0.00020458638,0.00004981212,0.000007953726,0.000052351872,0.00024399033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99598354,0.0003597608,0.0004987079,0.0006150944,0.0015717188,0.0009711892],"domain_scores_gemma":[0.99844754,0.00025153515,0.00005304084,0.0007374197,0.00044806662,0.00006238826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955699,0.0002203172,0.00047280092,0.0010107758,0.000080823695,0.000050323702,0.00045762124,0.00022593995,0.000033095333],"category_scores_gemma":[0.00015728171,0.00019753931,0.00014136513,0.00094790576,0.00041969694,0.00046040342,0.00022276292,0.0010645924,0.0003292284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020787304,0.0012452556,0.009349,0.00019016823,0.000016574117,0.0001000506,0.00093605806,0.000003893175,0.9619692,0.000097514014,0.0016078054,0.02240577],"study_design_scores_gemma":[0.0025745183,0.0018566315,0.0015044495,0.00017512267,0.000007221426,0.0000025033535,0.00024338326,0.026309924,0.96149397,0.00027615044,0.0053855153,0.00017061329],"about_ca_topic_score_codex":0.0028837349,"about_ca_topic_score_gemma":0.00079868163,"teacher_disagreement_score":0.026306031,"about_ca_system_score_codex":0.00030029967,"about_ca_system_score_gemma":0.0008049211,"threshold_uncertainty_score":0.80554193},"labels":[],"label_agreement":null},{"id":"W1969487400","doi":"10.1016/j.antiviral.2006.07.004","title":"Resveratrol inhibition of varicella-zoster virus replication in vitro","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Varicella zoster virus; Virus; Virology; Viral replication; Biology; In vitro; Western blot; Replication (statistics); Pharmacology; Gene; Biochemistry","score_opus":0.05591106995852922,"score_gpt":0.39263303028605123,"score_spread":0.336721960327522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969487400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95217896,0.0000771582,0.000048600272,0.0003114839,0.000019772335,0.00037322447,0.000010573433,0.000016516487,0.046963733],"genre_scores_gemma":[0.99744505,0.000043285876,0.00018738036,0.000030437835,0.000070610855,0.000044356057,0.0000619129,0.000012227344,0.0021047462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998745,0.00013628301,0.00024151544,0.00025849175,0.00036628466,0.0002524127],"domain_scores_gemma":[0.9992832,0.00009121605,0.00003547604,0.00038082295,0.00018651354,0.00002276462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007427316,0.00006885698,0.00015341086,0.00037994655,0.000063360945,0.000014636384,0.00003189947,0.00008222749,0.00003153387],"category_scores_gemma":[0.00009373364,0.000059465256,0.00004988653,0.00065739744,0.00008683298,0.00009291759,0.000033725835,0.0002389429,0.00016302467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004322997,0.0008173885,0.015841391,0.000033584813,0.0000143677635,0.00006236835,0.00003556689,5.840195e-7,0.9492715,0.00050161686,0.0009286754,0.032060686],"study_design_scores_gemma":[0.0012147776,0.00021563134,0.07078335,0.000052915726,0.000009864735,0.000005815165,0.00001692953,0.00012301165,0.9226963,0.0008428658,0.003989064,0.000049508606],"about_ca_topic_score_codex":0.004257718,"about_ca_topic_score_gemma":0.00017017746,"teacher_disagreement_score":0.05494196,"about_ca_system_score_codex":0.00012539153,"about_ca_system_score_gemma":0.000078040226,"threshold_uncertainty_score":0.6436424},"labels":[],"label_agreement":null},{"id":"W1971489080","doi":"10.1016/s0166-3542(02)00212-7","title":"Inhibition of adenovirus infection and adenain by green tea catechins","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Virus; Epigallocatechin gallate; IC50; Green tea extract; Catechin; Titer; Proteases; Virology; Cell culture; Green tea; Chemistry; Biology; Molecular biology; Polyphenol; In vitro; Biochemistry; Antioxidant; Food science; Enzyme","score_opus":0.05105207776088401,"score_gpt":0.37036638308542197,"score_spread":0.319314305324538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971489080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911642,0.00046878785,0.00005247568,0.0003322432,0.000026574708,0.0003023698,0.0000075513412,0.000023614919,0.007622193],"genre_scores_gemma":[0.9981846,0.00022932289,0.000041325093,0.000034974826,0.00004017762,0.000011314345,0.000011391471,0.000014451236,0.0014323964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881065,0.00021240022,0.00013235417,0.00018572931,0.000378656,0.00028022207],"domain_scores_gemma":[0.99956995,0.00009852117,0.000027615437,0.00014878123,0.00009462858,0.000060527513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088788057,0.00007761329,0.00016085916,0.00018986037,0.00008927468,0.000014024482,0.000022520751,0.000097686396,0.000018848177],"category_scores_gemma":[0.0003530279,0.00006503153,0.00003235378,0.00036396147,0.00017780834,0.00010256931,0.000034015513,0.00033964048,0.000040400166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105910716,0.00018631475,0.074437484,0.00021265264,0.000022062148,0.000024189414,0.00027557247,3.1622097e-8,0.8958412,0.0014078368,0.00556989,0.021916896],"study_design_scores_gemma":[0.0013921914,0.0013376431,0.09006526,0.00017698712,0.000019668109,0.000034976132,0.00010933255,0.000035498175,0.9011192,0.0009165621,0.004679749,0.00011297815],"about_ca_topic_score_codex":0.0027542734,"about_ca_topic_score_gemma":0.00008841876,"teacher_disagreement_score":0.021803917,"about_ca_system_score_codex":0.000037728605,"about_ca_system_score_gemma":0.000063727915,"threshold_uncertainty_score":0.4163656},"labels":[],"label_agreement":null},{"id":"W1971864726","doi":"10.1016/s0166-3542(01)00219-4","title":"Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Oseltamivir; Virology; IC50; Neuraminidase inhibitor; Virus; Microbiology; Influenza season; Human influenza; Biology; In vitro; Medicine; Coronavirus disease 2019 (COVID-19); Influenza vaccine; Biochemistry; Internal medicine; Infectious disease (medical specialty)","score_opus":0.26255678178263037,"score_gpt":0.4476073942188827,"score_spread":0.18505061243625232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971864726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991466,0.0010125383,6.808098e-7,0.0025978244,0.000045962865,0.0010459234,0.000054638927,0.00002398092,0.005303814],"genre_scores_gemma":[0.9975109,0.0011582818,0.00004576818,0.0006905738,0.00008640873,0.00004627376,0.0000025697395,0.000026344496,0.00043287603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672765,0.00031460458,0.0004096195,0.0005048909,0.0009440739,0.001099136],"domain_scores_gemma":[0.9976001,0.00042773984,0.000034578596,0.0005327815,0.0008127627,0.0005920644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152589,0.00020700567,0.00044619894,0.0008590115,0.00028845965,0.000053394106,0.00018139329,0.00012041546,0.0003109483],"category_scores_gemma":[0.0036948062,0.00016258162,0.00007125966,0.00095093064,0.0006246621,0.00015224532,0.00036324273,0.00073285185,0.00022265596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088391296,0.00062708766,0.58283395,0.0004301292,0.00016862822,0.00017509182,0.0036115185,7.031034e-7,0.29252812,0.00021195957,0.014808405,0.1037205],"study_design_scores_gemma":[0.0024113632,0.0041830787,0.7159747,0.0003409035,0.000036821006,0.000012064526,0.0010890756,0.00058579916,0.20672344,0.00021364012,0.06798804,0.00044106774],"about_ca_topic_score_codex":0.049908742,"about_ca_topic_score_gemma":0.10192491,"teacher_disagreement_score":0.13314079,"about_ca_system_score_codex":0.0003159273,"about_ca_system_score_gemma":0.00017671526,"threshold_uncertainty_score":0.956418},"labels":[],"label_agreement":null},{"id":"W1973211512","doi":"10.1016/s0166-3542(03)00153-0","title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Agriculture","keywords":"Human metapneumovirus; Ribavirin; Virology; Pneumovirinae; Virus; Palivizumab; Antibody; Paramyxoviridae; Metapneumovirus; Biology; Immune system; Monoclonal antibody; Immunology; Respiratory tract infections; Medicine; Respiratory system; Viral disease; Hepatitis C virus","score_opus":0.11421737952203412,"score_gpt":0.45716061104667566,"score_spread":0.34294323152464157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973211512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293494,0.0024059531,0.0000045274737,0.000120286786,0.00002795784,0.00073757034,0.00003212377,0.000009956931,0.00372671],"genre_scores_gemma":[0.9995559,0.00008639902,0.000021509839,0.000033591066,0.000019229788,0.0000290558,0.0000036166791,0.000023663857,0.00022702228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603015,0.0014814578,0.0006801538,0.00037001536,0.00096940633,0.00046879487],"domain_scores_gemma":[0.99875706,0.00027809583,0.00012744738,0.00047398734,0.00028315443,0.00008027663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032917736,0.00016280585,0.0005583245,0.00052515254,0.00022478699,0.000032911135,0.0001336875,0.00017222961,0.000025647128],"category_scores_gemma":[0.0009823259,0.00012583713,0.000081470294,0.0011047543,0.0012133241,0.00018504997,0.0002443599,0.0009909788,0.00000790793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026541832,0.00036525168,0.13622828,0.00014483422,0.00002572159,0.000009802112,0.00011736643,2.958624e-7,0.85927683,0.00067204586,0.00018880462,0.002705333],"study_design_scores_gemma":[0.0013221898,0.0007801986,0.15931916,0.000103180835,0.0000133344365,0.0000038613202,0.00020716377,0.000034589233,0.8374753,0.00020239774,0.00045589864,0.00008269555],"about_ca_topic_score_codex":0.0008630535,"about_ca_topic_score_gemma":0.00013951004,"teacher_disagreement_score":0.023090882,"about_ca_system_score_codex":0.00010609553,"about_ca_system_score_gemma":0.00020099887,"threshold_uncertainty_score":0.51314896},"labels":[],"label_agreement":null},{"id":"W1973288655","doi":"10.1016/s0166-3542(00)00085-1","title":"A novel high throughput screening assay for HCV NS3 helicase activity","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Helicase; Biotinylation; NS3; Oligonucleotide; Chemistry; DNA; Molecular biology; High-throughput screening; Recombinant DNA; Biochemistry; Escherichia coli; Biology; Enzyme; Protease; RNA; Gene","score_opus":0.22963710279890556,"score_gpt":0.4795701508401942,"score_spread":0.24993304804128866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973288655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93414855,0.000098653494,0.008318927,0.005894582,0.000053902302,0.002112336,0.00018408455,0.00013220753,0.049056787],"genre_scores_gemma":[0.96896434,0.00029835443,0.0069855433,0.00023096228,0.0005262958,0.00025982305,0.000053423486,0.00008373336,0.022597548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952879,0.0004256976,0.00029502914,0.0007684316,0.0016764959,0.0015464793],"domain_scores_gemma":[0.99681324,0.0014363031,0.00003326309,0.00079480826,0.00063980196,0.00028258676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004203178,0.00023366792,0.00048259995,0.0004179701,0.00053064415,0.00014352662,0.00035570614,0.00023886627,0.0008497303],"category_scores_gemma":[0.0022256882,0.0002076344,0.00020753393,0.0011210596,0.0004515664,0.00040222838,0.00020731334,0.001260262,0.0011207907],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036257685,0.00071923074,0.0029407912,0.00017725279,0.0001190296,0.00029910036,0.0001415877,0.000001343823,0.13820891,0.00071430503,0.011877973,0.8411747],"study_design_scores_gemma":[0.016700985,0.009527981,0.05840086,0.0009632361,0.00010259964,0.00013185579,0.00022158788,0.028738182,0.38594747,0.0013836934,0.4966274,0.0012541679],"about_ca_topic_score_codex":0.0042352173,"about_ca_topic_score_gemma":0.00032264533,"teacher_disagreement_score":0.8399205,"about_ca_system_score_codex":0.00019192639,"about_ca_system_score_gemma":0.00048638144,"threshold_uncertainty_score":0.999657},"labels":[],"label_agreement":null},{"id":"W1974685109","doi":"10.1016/j.antiviral.2012.06.003","title":"Countermeasures against viral diseases of farmed fish","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Prince Edward Island","funders":"","keywords":"Aquaculture; Biology; Fish farming; Outbreak; Fish <Actinopterygii>; Population; Biotechnology; Fishery; Virology; Environmental health; Medicine","score_opus":0.1246550332103546,"score_gpt":0.4021714001815911,"score_spread":0.2775163669712365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974685109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026500114,0.98957926,0.000001660977,0.000020423655,0.00051670976,0.0011383387,0.001241662,0.000061230414,0.0071757403],"genre_scores_gemma":[0.015664946,0.96730185,0.0000026354792,0.000039400467,0.00016570762,0.000106837615,0.0033798486,0.00006968183,0.013269085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959437,0.0013896237,0.0006798637,0.00059721374,0.0002222004,0.0011673622],"domain_scores_gemma":[0.9982949,0.00037063463,0.00029609108,0.0007224911,0.00026858362,0.000047331017],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009370724,0.00051844766,0.0016577084,0.0005793056,0.0002759997,0.00005208297,0.0010540477,0.00062647986,0.00026185918],"category_scores_gemma":[0.0002163516,0.00038468651,0.0008369379,0.00052354345,0.001033364,0.00017407896,0.00071456976,0.0010850498,0.0023344127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072802344,0.0004777223,0.00009143666,0.010754601,0.0010905897,0.000022768883,0.000076424694,5.244695e-9,0.0012672716,0.0005889363,0.09369447,0.891863],"study_design_scores_gemma":[0.00037614748,0.00007807967,0.00009716335,0.0032806222,0.00084608275,0.0000040004015,0.000073931944,3.614773e-8,0.00029071828,0.000016564747,0.99455845,0.00037821458],"about_ca_topic_score_codex":0.00004193691,"about_ca_topic_score_gemma":0.000015374033,"teacher_disagreement_score":0.90086395,"about_ca_system_score_codex":0.0001059889,"about_ca_system_score_gemma":0.00032641372,"threshold_uncertainty_score":0.9998605},"labels":[],"label_agreement":null},{"id":"W1975018200","doi":"10.1016/j.antiviral.2009.07.009","title":"Novel HCV replication mouse model using human hepatocellular carcinoma xenografts","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Virology; Cell culture; In vivo; Viral replication; Biology; Hepatocellular carcinoma; Virus; Population; Interferon; Hepatitis C virus; Cell; Cancer research; Medicine; Genetics","score_opus":0.2845902453334538,"score_gpt":0.46226274454808347,"score_spread":0.1776724992146297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975018200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772646,0.000100895595,0.002464303,0.0009789888,0.00001751138,0.0010789558,0.000022940034,0.00010485183,0.017966961],"genre_scores_gemma":[0.9897496,0.000066890854,0.0029835065,0.00018782767,0.00025289305,0.00003084087,0.000075015385,0.000059060163,0.006594326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953313,0.00021416156,0.00043242506,0.00084936124,0.0020054658,0.0011673054],"domain_scores_gemma":[0.9971584,0.00007908365,0.000057255405,0.0015708382,0.0008663912,0.00026801837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002484429,0.00021903694,0.0003761868,0.00077079,0.0005491066,0.00012179673,0.00040659585,0.00022231381,0.000030411575],"category_scores_gemma":[0.0006952021,0.00021220668,0.00014508016,0.0010683065,0.0002991005,0.0003139907,0.00019653894,0.0011141074,0.00020885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001176072,0.00042065553,0.052057277,0.00004939663,0.000017472732,0.000084360654,0.00017844672,0.000010779893,0.93436706,0.0012498974,0.0011266798,0.010320379],"study_design_scores_gemma":[0.0018423182,0.0010058399,0.022124797,0.00011779224,0.000024609024,0.000017230728,0.000066325294,0.3675091,0.6046958,0.0009328751,0.0013176431,0.000345649],"about_ca_topic_score_codex":0.0013603092,"about_ca_topic_score_gemma":0.000032688255,"teacher_disagreement_score":0.3674983,"about_ca_system_score_codex":0.0004049124,"about_ca_system_score_gemma":0.00053103827,"threshold_uncertainty_score":0.8653537},"labels":[],"label_agreement":null},{"id":"W1978815542","doi":"10.1016/j.antiviral.2007.06.010","title":"Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ritonavir; Drug resistance; Protease; Protease inhibitor (pharmacology); Virology; Biology; Drug; Human immunodeficiency virus (HIV); Virus; Genetics; Viral load; Pharmacology; Antiretroviral therapy; Enzyme","score_opus":0.10836164955973147,"score_gpt":0.47973365930862316,"score_spread":0.3713720097488917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978815542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010950713,0.9779668,0.00000430089,0.00027153597,0.000044270688,0.0038239742,0.000024002671,0.000036252393,0.0068781613],"genre_scores_gemma":[0.0034117333,0.9824776,0.0007672261,0.000010632756,0.00013527808,0.0001800157,0.00018420683,0.00006696704,0.012766345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569166,0.0009009865,0.0008358773,0.00088920194,0.0009697229,0.00071254733],"domain_scores_gemma":[0.99820465,0.0006356153,0.00012560452,0.00042777543,0.0004198603,0.0001865205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002233201,0.00038467164,0.0014787515,0.00096674054,0.000099154495,0.000050766954,0.0001429876,0.00041372393,0.000017524777],"category_scores_gemma":[0.0019333618,0.00028604455,0.00029698864,0.0012353604,0.00042474855,0.00008801033,0.00022081852,0.0015850597,0.000257485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053347094,0.0033131866,0.0411296,0.01139503,0.0005536499,0.0032530646,0.0005679943,6.2299144e-10,0.000002227997,0.0007791353,0.006027055,0.9324456],"study_design_scores_gemma":[0.0030881136,0.00038954816,0.0051699067,0.023618352,0.00025316636,0.000005457566,0.0001474784,6.245551e-7,0.000024554065,0.00005797214,0.9668276,0.0004172318],"about_ca_topic_score_codex":0.000014247528,"about_ca_topic_score_gemma":0.000048954036,"teacher_disagreement_score":0.9608005,"about_ca_system_score_codex":0.00048524264,"about_ca_system_score_gemma":0.0009177675,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W1979574354","doi":"10.1016/j.antiviral.2014.12.005","title":"Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?","year":2014,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"RHOA; Fasudil; Rho-associated protein kinase; Medicine; Vascular permeability; Proinflammatory cytokine; Endothelial dysfunction; In vivo; Immunology; Inflammation; Pharmacology; Cancer research; Cell biology; Biology; Kinase; Signal transduction; Pathology; Internal medicine","score_opus":0.08941675248692306,"score_gpt":0.38204714690685576,"score_spread":0.2926303944199327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979574354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024763172,0.9668701,0.000028312594,0.0001813784,0.0017123247,0.0033921706,0.00037423943,0.00006927393,0.0026090008],"genre_scores_gemma":[0.20957795,0.78313595,9.0568074e-7,0.000058320315,0.000128719,0.0002729222,0.00019862564,0.000045106204,0.0065815262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922091,0.005627696,0.0006635985,0.0004975279,0.0003468972,0.0006551944],"domain_scores_gemma":[0.99713176,0.0012890963,0.0005615756,0.0006129321,0.00038231193,0.000022341328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033401903,0.0003955786,0.0010800352,0.0002034132,0.000871865,0.000047630438,0.0006104361,0.00071982155,0.00030160154],"category_scores_gemma":[0.0007892747,0.00018253489,0.00055979326,0.00074536586,0.0011153494,0.000113700764,0.00037828033,0.0021408373,0.00030427254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065940985,0.001242759,0.00045617178,0.0015802426,0.0034309651,0.000012463818,0.00024186904,0.000003142019,0.18293795,0.0013266861,0.03427574,0.7738326],"study_design_scores_gemma":[0.0010147813,0.00056988804,0.0005530446,0.0019596422,0.0005295031,0.000019860814,0.00002208963,0.0000049140313,0.031981558,0.000038369086,0.9630621,0.00024422334],"about_ca_topic_score_codex":0.0004384464,"about_ca_topic_score_gemma":0.00011818819,"teacher_disagreement_score":0.9287864,"about_ca_system_score_codex":0.00027721564,"about_ca_system_score_gemma":0.0005762882,"threshold_uncertainty_score":0.9300992},"labels":[],"label_agreement":null},{"id":"W1979634477","doi":"10.1016/j.antiviral.2007.03.001","title":"Insertions in the β3–β4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Reverse transcriptase; Viral replication; Protease; Biology; Virology; Drug resistance; Virus; Mechanism of action; Enzyme; Drug; Gene; Genetics; Pharmacology; In vitro; Polymerase chain reaction; Biochemistry","score_opus":0.23435612412653742,"score_gpt":0.45694309828154583,"score_spread":0.22258697415500842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979634477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84470516,0.15351164,0.0000034413754,0.000069421665,0.000015089284,0.001283273,0.000060330694,0.000005785613,0.00034582845],"genre_scores_gemma":[0.579012,0.4206609,0.00002445433,0.0000047571307,0.000005071811,0.000021858523,0.00004281626,0.000009063727,0.00021907873],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760854,0.000556511,0.00068822916,0.00041105074,0.0004961163,0.00023957518],"domain_scores_gemma":[0.99828225,0.0003613793,0.0002124273,0.00071725086,0.0003941975,0.0000324845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003542434,0.00020649601,0.0007988031,0.000507035,0.00011941883,0.000008631863,0.00018111445,0.00015073227,0.000007125837],"category_scores_gemma":[0.00041619985,0.00012695503,0.00010982112,0.0010052976,0.00053067255,0.000093391434,0.000052691288,0.0005814125,0.0000033695012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010922697,0.0058578607,0.009812148,0.038983516,0.00055406307,0.000040340925,0.016062168,1.3854815e-7,0.17929678,0.017356671,0.00038389186,0.7305602],"study_design_scores_gemma":[0.013620568,0.015876858,0.15498334,0.10317221,0.0032762322,0.00022467555,0.01737405,0.00007835067,0.55448896,0.013919211,0.119895644,0.00308992],"about_ca_topic_score_codex":0.0011336472,"about_ca_topic_score_gemma":0.00026120275,"teacher_disagreement_score":0.7274702,"about_ca_system_score_codex":0.00010278547,"about_ca_system_score_gemma":0.00029361525,"threshold_uncertainty_score":0.5177076},"labels":[],"label_agreement":null},{"id":"W1980089445","doi":"10.1016/j.antiviral.2007.03.013","title":"Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Vesicular stomatitis virus; Biology; Immune system; Proinflammatory cytokine; Microbiology; Virus; Lactobacillus rhamnosus; Innate immune system; Probiotic; Interferon; Chemokine; Cytokine; Lipopolysaccharide; Vesicular stomatitis Indiana virus; Immunology; Virology; Inflammation; Bacteria","score_opus":0.03826843277098236,"score_gpt":0.325582049487448,"score_spread":0.28731361671646566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980089445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967531,0.000028812543,0.000027762002,0.0005880443,0.00005636936,0.00050842395,0.0001025383,0.00004068083,0.0018942758],"genre_scores_gemma":[0.9988272,0.00002432085,0.00041716802,0.00008952269,0.0000833499,0.000009495225,0.000042688083,0.0000036084255,0.00050264236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977766,0.00040478996,0.0002938876,0.0003698849,0.00050561165,0.0006492196],"domain_scores_gemma":[0.9988618,0.0005413392,0.000073067196,0.000139437,0.00027914398,0.00010524425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020815826,0.00016603069,0.0002383771,0.0001262909,0.00027898824,0.000101252306,0.00035814857,0.000085033294,0.000047536858],"category_scores_gemma":[0.00023510105,0.00007103162,0.00007694171,0.0011664007,0.00024315043,0.00019670298,0.00019465432,0.00032799423,0.000114748356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015834711,0.0002535675,0.0025237808,0.000013735926,0.000028056145,0.00008204535,0.000098473174,2.5002637e-7,0.9679592,0.000071235234,0.00027074202,0.02711539],"study_design_scores_gemma":[0.00020175292,0.0016046467,0.31905398,0.00012528025,0.0000056258327,0.0000049145547,0.0002900354,0.000023157736,0.6765762,0.00002415863,0.0019349979,0.00015526665],"about_ca_topic_score_codex":0.0005390177,"about_ca_topic_score_gemma":0.0012711276,"teacher_disagreement_score":0.3165302,"about_ca_system_score_codex":0.00006541147,"about_ca_system_score_gemma":0.00003988652,"threshold_uncertainty_score":0.28965855},"labels":[],"label_agreement":null},{"id":"W1981742167","doi":"10.1016/j.antiviral.2007.06.014","title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Virology; Viral replication; Hepatitis B virus; Biology; Reverse transcriptase; Nucleoside analogue; In vitro; Nucleoside; Hepatitis B virus PRE beta; RNA; Transcription (linguistics); Virus; Hepatitis B virus DNA polymerase; Gene; Genetics","score_opus":0.2316583127402806,"score_gpt":0.4500056234932374,"score_spread":0.21834731075295682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981742167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95202196,0.0007243496,0.00020708628,0.006865582,0.000059002847,0.00086516695,0.00001836515,0.000024915431,0.039213594],"genre_scores_gemma":[0.96628964,0.0006290958,0.00012492707,0.00018032381,0.0001600274,0.000046973204,0.000010831956,0.000028431405,0.032529756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996879,0.00029535327,0.00042202542,0.0004120476,0.0012333645,0.0007582177],"domain_scores_gemma":[0.99630845,0.0017335009,0.0001286944,0.0010600371,0.0007081161,0.000061219565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006130494,0.00014906364,0.0002577839,0.000118431344,0.0012998269,0.00003074514,0.00034422617,0.000071868686,0.00003391859],"category_scores_gemma":[0.0035434202,0.00008043423,0.00009936994,0.0006112487,0.0012599815,0.00009158082,0.00083421374,0.00054764986,0.00020118394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009841955,0.00011259567,0.25529695,0.00005889638,0.00019755233,0.000064924185,0.002531048,2.8604728e-7,0.609274,0.0016364796,0.031057723,0.0987853],"study_design_scores_gemma":[0.00049164187,0.00025279354,0.40622994,0.00010022528,0.000019212772,0.000009128052,0.00054247485,0.00008379766,0.5775909,0.00041248283,0.014173371,0.00009405717],"about_ca_topic_score_codex":0.0025043201,"about_ca_topic_score_gemma":0.007347526,"teacher_disagreement_score":0.150933,"about_ca_system_score_codex":0.0004014636,"about_ca_system_score_gemma":0.0001359922,"threshold_uncertainty_score":0.9997349},"labels":[],"label_agreement":null},{"id":"W1982168548","doi":"10.1016/j.antiviral.2014.04.001","title":"E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; World Health Organization","keywords":"Rilpivirine; Tenofovir; Emtricitabine; Reverse transcriptase; Virology; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Biology; Genotype; Coinfection; Viral load; Medicine; Antiretroviral therapy; Genetics; Polymerase chain reaction; Gene","score_opus":0.07436114394507591,"score_gpt":0.36826208167537855,"score_spread":0.2939009377303026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982168548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512006,0.0003279252,0.000022379629,0.011947604,0.000023432804,0.0011248612,0.00052546465,0.00002373291,0.00088454195],"genre_scores_gemma":[0.9950631,0.00014823435,0.00009410278,0.00026106837,0.00001445336,0.00030583568,0.0010238903,0.000026763553,0.003062521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969057,0.0009981706,0.00038257378,0.00052519573,0.00010700344,0.0010813541],"domain_scores_gemma":[0.9980758,0.0012016529,0.000039879054,0.00053296617,0.00010575233,0.0000439738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020595994,0.00017893006,0.00034993864,0.00089512777,0.00017070897,0.000038913717,0.0003642134,0.00023851464,0.00004539565],"category_scores_gemma":[0.000798041,0.00016349832,0.00008767055,0.0009640799,0.00036237852,0.00019356857,0.00012143375,0.00088280434,0.0004759772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015469964,0.00087909546,0.80948085,0.00007417167,0.00004268919,0.000040759278,0.0013832442,0.0000016858422,0.12857713,0.0012257351,0.04611491,0.010632759],"study_design_scores_gemma":[0.0063464534,0.0005952449,0.84000057,0.00017815699,0.000007331206,0.000007558835,0.00051106454,0.00007309093,0.02188241,0.0006381008,0.12952906,0.00023098466],"about_ca_topic_score_codex":0.0031260613,"about_ca_topic_score_gemma":0.006252283,"teacher_disagreement_score":0.10669472,"about_ca_system_score_codex":0.00016112739,"about_ca_system_score_gemma":0.000105551146,"threshold_uncertainty_score":0.6667268},"labels":[],"label_agreement":null},{"id":"W1985314955","doi":"10.1016/j.antiviral.2009.10.022","title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oak Ridge Institute for Science and Education; Public Health Agency of Canada","keywords":"Neuraminidase; Zanamivir; Oseltamivir; Virology; Biology; Pyrosequencing; Virus; Neuraminidase inhibitor; Influenza A virus; Microbiology; Gene; Genetics; Medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.14969893046777089,"score_gpt":0.44321918422021617,"score_spread":0.2935202537524453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985314955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950928,0.0022593613,0.0000436521,0.00010215393,0.000027426433,0.0006894994,0.000010900194,0.000027944827,0.0017462585],"genre_scores_gemma":[0.99777406,0.00076332927,0.0010653351,0.00012851699,0.000080590915,0.0000107537535,0.0000013057404,0.000025355765,0.00015073785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965323,0.000457245,0.0005466541,0.00050070754,0.0010884112,0.00087468274],"domain_scores_gemma":[0.99861455,0.00037655572,0.00009087919,0.00039617435,0.00042970126,0.0000921599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017179247,0.00021002218,0.00047458688,0.0009570857,0.00025874903,0.00005257192,0.00015439582,0.00014733248,0.00000347423],"category_scores_gemma":[0.002051851,0.00019577316,0.000076032666,0.0013811811,0.00067302136,0.00029369938,0.00016468034,0.0009105477,0.000009986089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017699982,0.000112792695,0.027084487,0.0002143334,0.00002667537,0.0004613854,0.00032345287,0.000004325027,0.9485245,0.000028478722,0.000021345006,0.02142823],"study_design_scores_gemma":[0.0016053392,0.0007801929,0.4912265,0.00043037973,0.00001543865,0.000012040589,0.00025900567,0.0020238028,0.5031705,0.00010931767,0.00020584598,0.0001616258],"about_ca_topic_score_codex":0.0008008873,"about_ca_topic_score_gemma":0.00050005544,"teacher_disagreement_score":0.46414202,"about_ca_system_score_codex":0.00024151795,"about_ca_system_score_gemma":0.00020093421,"threshold_uncertainty_score":0.7983397},"labels":[],"label_agreement":null},{"id":"W1985429202","doi":"10.1016/j.antiviral.2014.06.018","title":"Hepatitis C: The next 25 years","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hepatitis C; Viral hepatitis; Hepatitis C virus; Blood supply; Hepatitis; Intensive care medicine; Drug; Liver cancer; Virology; Cancer; Immunology; Virus; Pharmacology; Internal medicine; Surgery","score_opus":0.16165426852073508,"score_gpt":0.4389191428899932,"score_spread":0.27726487436925806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985429202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200914,0.00013909843,0.00007202606,0.0052963383,0.00008103963,0.0005106823,0.0000048310167,0.000052702282,0.17375183],"genre_scores_gemma":[0.9858886,0.001073775,0.00015556932,0.00046461,0.0004381588,0.000056932306,0.000011139819,0.000038635477,0.011872591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600816,0.00078529824,0.00020689255,0.000344997,0.0017845904,0.00087005674],"domain_scores_gemma":[0.9978173,0.00085932063,0.000021311991,0.000784584,0.000376483,0.00014105158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035695403,0.00011121761,0.00022332041,0.00027941045,0.00028863372,0.00015863583,0.00042109325,0.000107071755,0.00031780385],"category_scores_gemma":[0.0028204757,0.00007704638,0.00010129246,0.0008872179,0.00061251497,0.0001689936,0.000315371,0.0011009051,0.0054477868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106352134,0.00014007586,0.24137382,0.00006465781,0.0000561151,0.0002152964,0.00040553018,1.2969629e-7,0.020235462,0.009262477,0.075944774,0.65219533],"study_design_scores_gemma":[0.00088780327,0.000837882,0.46691787,0.000106214036,0.000010673476,0.000014164639,0.00010682107,0.0022805324,0.0072373184,0.0013224707,0.52012336,0.00015485894],"about_ca_topic_score_codex":0.0034679978,"about_ca_topic_score_gemma":0.00053894153,"teacher_disagreement_score":0.6520404,"about_ca_system_score_codex":0.00009794704,"about_ca_system_score_gemma":0.00024952088,"threshold_uncertainty_score":0.9953266},"labels":[],"label_agreement":null},{"id":"W1986261107","doi":"10.1016/j.antiviral.2014.08.012","title":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Lactoferrin; Innate immune system; Mechanism (biology); Intracellular; Replication (statistics); Mechanism of action; Immune system; Cell biology; Virology; Biology; Chemistry; Immunology; Genetics","score_opus":0.028903829377682773,"score_gpt":0.3240006065069876,"score_spread":0.2950967771293048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986261107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624664,0.00020972181,0.00084941357,0.000775881,0.000023053892,0.00039859198,0.000012143999,0.0000035306011,0.0014810133],"genre_scores_gemma":[0.9981654,0.00020352003,0.0000202543,0.000012442836,0.00003140338,0.00005255191,0.00008066989,0.000011794254,0.0014219215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987335,0.000284123,0.00021226415,0.00022742235,0.0003210081,0.00022165693],"domain_scores_gemma":[0.9989928,0.000048469316,0.00014776234,0.0005497127,0.0002473072,0.0000139219965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022505922,0.00006804694,0.00008594217,0.000030873,0.00016443741,0.000023906307,0.00021523779,0.00010187328,0.0000013208144],"category_scores_gemma":[0.0008291346,0.000045105444,0.00006023245,0.00018912669,0.00017365334,0.000006260826,0.00015759708,0.00016601974,0.0000031387851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006670075,0.00008708084,0.0001152582,0.00001371064,0.000026631833,3.3177347e-8,0.00002032942,9.797129e-7,0.985589,0.0024370588,0.0005874306,0.011055733],"study_design_scores_gemma":[0.00030380767,0.00023767824,0.00048600364,0.00002270028,0.0000036971107,1.0965112e-7,0.00014814877,0.00033647858,0.99235225,0.0013828176,0.004677762,0.000048534905],"about_ca_topic_score_codex":0.00026163305,"about_ca_topic_score_gemma":0.00002847922,"teacher_disagreement_score":0.011007198,"about_ca_system_score_codex":0.00000928182,"about_ca_system_score_gemma":0.000034914316,"threshold_uncertainty_score":0.18393466},"labels":[],"label_agreement":null},{"id":"W1986568660","doi":"10.1016/s0166-3542(01)00156-5","title":"Preclinical evaluation of docusate as protective agent from herpes simplex viruses","year":2001,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre; University of British Columbia; Adidas (Canada)","funders":"","keywords":"Vero cell; Microbicide; Herpes simplex virus; Infectivity; Virology; In vitro; Medicine; Transmission (telecommunications); Cytotoxicity; Pharmacology; Virus; Biology; Biochemistry; Human immunodeficiency virus (HIV)","score_opus":0.3997688392587814,"score_gpt":0.5588411416944103,"score_spread":0.15907230243562892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986568660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97237235,0.00022523767,0.000029246165,0.00026764884,0.000058821224,0.001288228,0.000018120629,0.000029691946,0.025710644],"genre_scores_gemma":[0.99865377,0.00019580468,0.0001090753,0.000049763723,0.00014085585,0.00017376378,0.000018519155,0.00001847901,0.00063999207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970037,0.0007180465,0.00030076253,0.00033837633,0.00131053,0.00032863618],"domain_scores_gemma":[0.9982637,0.00042593008,0.000060761642,0.00036066593,0.0008113477,0.000077559336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022314533,0.000113292655,0.0002523106,0.00019071775,0.0001434305,0.000024549803,0.00008212489,0.00011966181,0.00071905524],"category_scores_gemma":[0.0016151653,0.00008714307,0.000111568195,0.00047279458,0.0002116805,0.00012867921,0.00008122542,0.00028840924,0.00079904223],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008877765,0.0013990871,0.031595826,0.00001633458,0.00035609023,0.000068738416,0.0002761492,0.0000024776477,0.007148762,0.00014129576,0.00038332405,0.95772415],"study_design_scores_gemma":[0.009507708,0.0035288434,0.51096535,0.00045411222,0.00048210096,0.000019059311,0.0005480251,0.002186337,0.3406531,0.02391086,0.107429214,0.00031531777],"about_ca_topic_score_codex":0.0065685646,"about_ca_topic_score_gemma":0.00036126908,"teacher_disagreement_score":0.95740885,"about_ca_system_score_codex":0.00017588901,"about_ca_system_score_gemma":0.0004139138,"threshold_uncertainty_score":0.99997896},"labels":[],"label_agreement":null},{"id":"W1987049523","doi":"10.1016/s0166-3542(02)00054-2","title":"Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Vero cell; Herpes simplex virus; Virus; Multiplicity of infection; Virology; Dendrimer; Chemistry; Biology; Biochemistry","score_opus":0.24256393751138813,"score_gpt":0.44642734447980914,"score_spread":0.203863406968421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987049523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651957,0.0018885387,0.000012315994,0.000072913106,0.00001558846,0.0003553316,0.000042397896,0.000010363429,0.0010830028],"genre_scores_gemma":[0.9912267,0.007940243,0.00018068212,0.0000057051548,0.00002510217,0.000009618803,0.0000078304765,0.000012141231,0.0005920328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830043,0.00018637127,0.00043512505,0.00027122803,0.00058905734,0.00021779859],"domain_scores_gemma":[0.9985212,0.0003777206,0.00021325644,0.00042075414,0.00041791104,0.000049127368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007594922,0.00010542532,0.00034335227,0.00031459017,0.0000579762,0.000007158355,0.00005864619,0.00010815337,0.00010727006],"category_scores_gemma":[0.00061332225,0.00009003324,0.00007367838,0.0005229841,0.00038255507,0.0002343239,0.000078319186,0.00017105388,0.000011334086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030927602,0.00072155864,0.057468474,0.00044931922,0.00013042128,0.0000066700427,0.00034839255,0.0000012754073,0.7853601,0.000090347276,0.00016386887,0.15495028],"study_design_scores_gemma":[0.0006947797,0.0009513291,0.06585532,0.0005211249,0.000056117788,0.0000040859354,0.000120359975,0.00020786878,0.9310086,0.000058970578,0.00046755504,0.000053901804],"about_ca_topic_score_codex":0.0021697162,"about_ca_topic_score_gemma":0.00017542683,"teacher_disagreement_score":0.15489638,"about_ca_system_score_codex":0.0000385258,"about_ca_system_score_gemma":0.00006454371,"threshold_uncertainty_score":0.36714488},"labels":[],"label_agreement":null},{"id":"W1987223696","doi":"10.1016/s0166-3542(02)00100-6","title":"Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"CTL*; Virology; Reverse transcriptase; Cytotoxic T cell; Epitope; Human immunodeficiency virus (HIV); Drug resistance; Biology; Antiretroviral drug; Lentivirus; Immunology; Viral load; Viral disease; Antiretroviral therapy; Antibody; Polymerase chain reaction; Genetics; In vitro; Gene","score_opus":0.03245605493870297,"score_gpt":0.2868322076955744,"score_spread":0.2543761527568714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987223696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847454,0.013757463,0.000012358655,0.00023216718,0.00007816254,0.00033892546,0.0003095839,0.000013814607,0.0005121556],"genre_scores_gemma":[0.9930099,0.0017759594,0.00027917814,0.000009617049,0.000013352143,0.000011216281,0.00006182839,0.000019617615,0.004819277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758554,0.0007817819,0.00044712573,0.00042316006,0.0002572765,0.00050514593],"domain_scores_gemma":[0.99897575,0.00040078297,0.00013109698,0.00028198076,0.00016369582,0.000046675967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009333127,0.00018469474,0.00050980435,0.00033255544,0.00020814607,0.000014689457,0.00019168854,0.00020045128,0.00013288822],"category_scores_gemma":[0.0002629071,0.00016026631,0.00011809791,0.00045089645,0.0009286746,0.00020783009,0.000093600036,0.00045834162,0.000050577633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094968826,0.0002127878,0.051957536,0.000100519734,0.00028965884,0.000033923316,0.0018711989,1.1880876e-7,0.9403689,0.0003318461,0.0015713152,0.0023125026],"study_design_scores_gemma":[0.0034302506,0.0007562123,0.028425306,0.00026178648,0.00006021167,0.0000062153176,0.000519349,0.000025748066,0.96539426,0.00018903203,0.00077001506,0.0001615903],"about_ca_topic_score_codex":0.0041513667,"about_ca_topic_score_gemma":0.0005018141,"teacher_disagreement_score":0.02502538,"about_ca_system_score_codex":0.00007790962,"about_ca_system_score_gemma":0.000120859324,"threshold_uncertainty_score":0.65354705},"labels":[],"label_agreement":null},{"id":"W1988425276","doi":"10.1016/j.antiviral.2004.05.004","title":"Mycophenolic acid inhibits avian reovirus replication","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"IMP dehydrogenase; Mycophenolic acid; Virology; Viral replication; Quail; Inosine; Guanosine; Mycophenolate; Vero cell; Biology; Immunosuppression; Chemistry; Virus; Enzyme; Medicine; Biochemistry; Immunology; Transplantation","score_opus":0.13077872199249463,"score_gpt":0.4509954694682013,"score_spread":0.32021674747570666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988425276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97027135,0.00036573378,0.00022500448,0.012004555,0.000050057926,0.0005904066,0.0000108933555,0.00008650547,0.016395487],"genre_scores_gemma":[0.9951206,0.0007031085,0.0009626173,0.0006783889,0.0003292448,0.00008511758,0.00006871178,0.000032495256,0.002019734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966755,0.00034557682,0.00034755617,0.0006491881,0.0008128299,0.0011693459],"domain_scores_gemma":[0.9983596,0.000045156907,0.00004187951,0.000913617,0.00037864695,0.0002610647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023556731,0.00014642713,0.00033619578,0.00040881726,0.000247415,0.000043436827,0.00025062467,0.00015003713,0.00006209766],"category_scores_gemma":[0.003129766,0.00012637586,0.00011651316,0.00072705426,0.00046405473,0.00019943723,0.00022960811,0.0009878875,0.0021109174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008975404,0.0003309857,0.02795843,0.000094848634,0.00004385063,0.00033138573,0.00015007143,7.1707586e-7,0.91248643,0.0031623351,0.0065065767,0.04803684],"study_design_scores_gemma":[0.006521169,0.0065856744,0.33619246,0.0006361471,0.000020086167,0.00051269657,0.00032518612,0.00007381789,0.6138925,0.014548028,0.020320263,0.00037196974],"about_ca_topic_score_codex":0.00068544236,"about_ca_topic_score_gemma":0.000104915205,"teacher_disagreement_score":0.308234,"about_ca_system_score_codex":0.00026807594,"about_ca_system_score_gemma":0.00030699195,"threshold_uncertainty_score":0.99866605},"labels":[],"label_agreement":null},{"id":"W1990365048","doi":"10.1016/j.antiviral.2006.01.006","title":"Treatment of respiratory virus infections","year":2006,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Coronaviridae; Respiratory tract infections; Pneumonia; Virology; Paramyxoviridae; Biology; Virus; Respiratory system; Immunology; Respiratory disease; Viral disease; Medicine; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Disease; Internal medicine; Lung; Infectious disease (medical specialty)","score_opus":0.37923235705705133,"score_gpt":0.5594505361829851,"score_spread":0.1802181791259338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990365048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00097537535,0.94300455,0.0000073221536,0.000015861744,0.00013552098,0.0028420046,0.000115848925,0.000090054076,0.05281346],"genre_scores_gemma":[0.0007518078,0.9869101,0.000028714123,0.000006724034,0.00066545565,0.000735309,0.00011233999,0.00014489377,0.010644626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937201,0.0016322617,0.0011986574,0.0008385742,0.0015746396,0.001035762],"domain_scores_gemma":[0.9961796,0.0010303953,0.00023819505,0.0014837694,0.0008900425,0.00017799331],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013021217,0.0005509779,0.0025583578,0.0033212604,0.0003890073,0.000071954535,0.00030688103,0.00071756,0.00013086772],"category_scores_gemma":[0.00062924734,0.00040578734,0.0011948335,0.0036209694,0.0013556251,0.00015769676,0.00020014327,0.0013659997,0.0016449479],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004170375,0.0021398948,0.0003444053,0.008331351,0.00038810147,0.0002907817,0.000016726448,8.1472706e-8,0.00037252676,0.00044458068,0.005351419,0.9822784],"study_design_scores_gemma":[0.0006310588,0.005844504,0.00010155505,0.0028877608,0.0003549412,0.000059005335,0.000009346536,0.0000018990987,0.001024325,0.000034453325,0.98879254,0.0002585972],"about_ca_topic_score_codex":0.0012678358,"about_ca_topic_score_gemma":0.00014978499,"teacher_disagreement_score":0.9834411,"about_ca_system_score_codex":0.0013169197,"about_ca_system_score_gemma":0.0030732232,"threshold_uncertainty_score":0.9998394},"labels":[],"label_agreement":null},{"id":"W1991039118","doi":"10.1016/j.antiviral.2011.03.005","title":"Human subtilase Site-1 Protease (S1P): An Emerging Host Cell Target for Hepatitis C Virus (HCV) Infection and HCV-associated Steatogenesis","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Virology; Hepatitis C virus; Host (biology); Virus; Biology; Protease; Enzyme; Genetics","score_opus":0.1554881728256816,"score_gpt":0.4146878387245104,"score_spread":0.2591996658988288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991039118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836046,0.00013536884,0.00010409016,0.00011228079,0.000059504477,0.002822629,0.00022010603,0.00013724732,0.008048336],"genre_scores_gemma":[0.9949392,0.00055871624,0.00054687174,0.00005859941,0.00017781297,0.0005347268,0.00021959368,0.000118741584,0.0028457285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952805,0.0008670452,0.0004712833,0.00081318355,0.0012495458,0.0013184113],"domain_scores_gemma":[0.9976122,0.00019396355,0.000104764156,0.0005889085,0.0010395631,0.00046063747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003128648,0.00030293665,0.0004970168,0.0008742564,0.00090200285,0.00013428282,0.000204937,0.00029081258,0.0003099637],"category_scores_gemma":[0.0012736768,0.00029796216,0.00014701809,0.0009235407,0.00038267116,0.0005698663,0.00025545337,0.0007932034,0.00018703795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043814586,0.000979541,0.75804025,0.00032216686,0.00006882519,0.00021485549,0.0010864502,1.0623393e-7,0.22569214,0.000080988735,0.0015199683,0.011556579],"study_design_scores_gemma":[0.0036952174,0.0064138416,0.5269808,0.00021011992,0.000073803174,0.0000045611782,0.0001537052,0.0017629627,0.45486856,0.00033884,0.004961897,0.00053564954],"about_ca_topic_score_codex":0.04644784,"about_ca_topic_score_gemma":0.009843235,"teacher_disagreement_score":0.2310594,"about_ca_system_score_codex":0.00027646738,"about_ca_system_score_gemma":0.00036298958,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W1994650473","doi":"10.1016/j.antiviral.2014.12.006","title":"Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Oseltamivir; Neuraminidase; Virology; Biology; Microbiology; Virus; Permissive; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.09438723836665959,"score_gpt":0.41512561662025416,"score_spread":0.3207383782535946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994650473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917429,0.0007696518,0.000004750265,0.0029768918,0.000032303135,0.0014813528,0.000054131735,0.00001310763,0.0029248914],"genre_scores_gemma":[0.99849826,0.00011775001,0.000028016277,0.00057063426,0.0001963023,0.00026908529,0.000007769292,0.000034513345,0.00027767694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9933819,0.001882578,0.00052252907,0.0005438512,0.0023052967,0.00136384],"domain_scores_gemma":[0.99590343,0.002631457,0.00012295727,0.0007886569,0.0004602676,0.00009321798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008856873,0.000290986,0.0005761503,0.0005973447,0.00037813804,0.00010118132,0.00083845033,0.00015234755,0.000020624148],"category_scores_gemma":[0.006313415,0.00015996872,0.00012972023,0.0012963044,0.0013460816,0.00019462449,0.00056005694,0.001791282,0.000030796033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036036568,0.0009388204,0.08772834,0.0007098702,0.00010917536,0.00059982075,0.021552691,0.000011453512,0.8088546,0.0045036967,0.00057356386,0.07081432],"study_design_scores_gemma":[0.004991236,0.002422859,0.9028826,0.0006262656,0.000033703785,0.000019393425,0.0150657585,0.005482726,0.0640117,0.00061636686,0.0035132426,0.00033415158],"about_ca_topic_score_codex":0.0025363981,"about_ca_topic_score_gemma":0.0035518587,"teacher_disagreement_score":0.81515425,"about_ca_system_score_codex":0.00017609107,"about_ca_system_score_gemma":0.00047640622,"threshold_uncertainty_score":0.7782328},"labels":[],"label_agreement":null},{"id":"W1995785316","doi":"10.1016/j.antiviral.2004.05.006","title":"The synergistic effects of betulin with acyclovir against herpes simplex viruses","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Betulin; Herpes simplex virus; Vero cell; EC50; Cytotoxicity; Chemistry; Virology; Pharmacology; Microbiology; In vitro; Virus; Biology; Biochemistry","score_opus":0.0216731183844416,"score_gpt":0.3243221376922729,"score_spread":0.30264901930783134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995785316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631864,0.001594224,0.000067113586,0.0004887574,0.000050733095,0.00024805302,0.000008578671,0.0000073364517,0.0012165493],"genre_scores_gemma":[0.99811536,0.00093630713,0.00010945894,0.000068594774,0.00017875446,0.00001866665,0.000009108703,0.000021117354,0.0005426457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985751,0.00018268288,0.00013914994,0.00029756498,0.0003826299,0.00042289996],"domain_scores_gemma":[0.9990367,0.0002941881,0.00004879363,0.00042472818,0.00015893638,0.000036627276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050450105,0.00012752174,0.00014248303,0.00004668204,0.00029736076,0.000046938232,0.00032516703,0.000090955466,9.2974466e-7],"category_scores_gemma":[0.0007153783,0.000074251664,0.000069023525,0.00020973186,0.0006184204,0.000007497012,0.00016403737,0.00017068115,0.0000105631525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003043354,0.00007996199,0.0001724489,0.0000553951,0.00008113995,0.000013945265,0.000028948241,0.0000072967227,0.932125,0.00052637456,0.00048259634,0.066122614],"study_design_scores_gemma":[0.00035863355,0.0004934152,0.001077368,0.000044988446,0.000007200047,8.8932427e-7,0.000118287266,0.000002798758,0.97695607,0.00035239037,0.020477979,0.00010998685],"about_ca_topic_score_codex":0.00021178382,"about_ca_topic_score_gemma":0.00017379857,"teacher_disagreement_score":0.06601262,"about_ca_system_score_codex":0.0000182117,"about_ca_system_score_gemma":0.00014357064,"threshold_uncertainty_score":0.30278948},"labels":[],"label_agreement":null},{"id":"W1996784803","doi":"10.1016/s0166-3542(01)00154-1","title":"Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase","year":2001,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Medical Research Council","keywords":"Papain; Cystatin; Chemistry; Biochemistry; Proteolysis; Proteases; Protease; Molecular biology; Cystatin C; Enzyme; Biology","score_opus":0.06773983730893288,"score_gpt":0.4123001302398757,"score_spread":0.3445602929309428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996784803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593473,0.0002937314,0.000036561447,0.00018711052,0.000011003395,0.00023138676,0.00002429237,0.000008247923,0.013272954],"genre_scores_gemma":[0.99667233,0.00036272142,0.00012828632,0.000046532587,0.0001075743,0.000028273635,0.000049354017,0.000029613095,0.00257534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831045,0.00031547542,0.00016462588,0.00034494468,0.00042606136,0.0004384297],"domain_scores_gemma":[0.9991823,0.000066793385,0.000037056485,0.0003709892,0.00026627898,0.00007658543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066883536,0.00011952531,0.00014021415,0.00018720917,0.00020209631,0.000038860107,0.0002269525,0.00006141421,0.00005840513],"category_scores_gemma":[0.00008995579,0.00010133225,0.00003982321,0.00029673058,0.00049544347,0.000013086899,0.00021101396,0.00030836285,0.000023037712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002449782,0.00014661925,0.008222468,0.000020766633,0.00005623874,0.00005037732,0.0000912133,8.6419226e-7,0.98095745,0.00010061952,0.0010195757,0.0068840208],"study_design_scores_gemma":[0.0010143287,0.007845534,0.0048197173,0.000038211543,0.0000061471624,0.000044046796,0.00037986875,0.000021872605,0.98104817,0.000093712835,0.004531102,0.00015731047],"about_ca_topic_score_codex":0.00022380803,"about_ca_topic_score_gemma":0.0011346282,"teacher_disagreement_score":0.010737592,"about_ca_system_score_codex":0.0000163755,"about_ca_system_score_gemma":0.00013403708,"threshold_uncertainty_score":0.4132209},"labels":[],"label_agreement":null},{"id":"W1998690587","doi":"10.1016/j.antiviral.2012.09.022","title":"Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"TLR9; TLR3; Agonist; Antagonist; Receptor; Chemokine; Herpes simplex virus; Endocrinology; Internal medicine; Chemistry; Virus; Pharmacology; Medicine; Virology; Toll-like receptor; Innate immune system; Biochemistry; Gene expression","score_opus":0.15171504878649436,"score_gpt":0.43918813687914354,"score_spread":0.28747308809264915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998690587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972973,0.000073612275,0.00018008951,0.00007263059,0.000014602091,0.00029835972,0.000048255824,0.0000103504635,0.0020047869],"genre_scores_gemma":[0.9977494,0.0000992481,0.00043676066,0.00000940132,0.000022371527,0.000023227258,0.00000782465,0.0000142401195,0.0016375566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984473,0.0003274318,0.0002714399,0.000134602,0.00045863507,0.0003606102],"domain_scores_gemma":[0.9991926,0.00025879822,0.000044343815,0.0002609703,0.0001841559,0.000059150098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016139933,0.00007814116,0.00022625325,0.0004242283,0.00004231412,0.0000045621337,0.0000547536,0.00008606616,0.00003489758],"category_scores_gemma":[0.00044972973,0.00006711604,0.0000622399,0.00046426617,0.00015633395,0.0001977129,0.00005284797,0.00015211702,0.000030269974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036187156,0.002427294,0.098777846,0.000111936024,0.00007561756,0.000011303544,0.001708656,0.00009104326,0.7502422,0.0013181618,0.00009195905,0.14152533],"study_design_scores_gemma":[0.0019429864,0.00061955943,0.1913077,0.00011286653,0.0000151947825,0.000002635981,0.00022011208,0.013158261,0.79119843,0.0005372071,0.00078444317,0.00010057674],"about_ca_topic_score_codex":0.001932649,"about_ca_topic_score_gemma":0.000080492486,"teacher_disagreement_score":0.14142475,"about_ca_system_score_codex":0.00009506156,"about_ca_system_score_gemma":0.00014687439,"threshold_uncertainty_score":0.29216},"labels":[],"label_agreement":null},{"id":"W2000002965","doi":"10.1016/j.antiviral.2008.09.003","title":"Perspectives on antiviral drug development","year":2008,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Antiviral drug; Drug; Drug resistance; Human immunodeficiency virus (HIV); Drug development; Virology; Transmission (telecommunications); Drug discovery; Medicine; Hepatitis B; Hepatitis C virus; Hepatitis C; Immunology; Biology; Virus; Bioinformatics; Pharmacology; Computer science","score_opus":0.1582562275679278,"score_gpt":0.4559104479425719,"score_spread":0.2976542203746441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000002965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068916177,0.93000096,0.0000018531744,0.00040465806,0.00011767642,0.0020837737,0.000017761186,0.00012061965,0.06656354],"genre_scores_gemma":[0.0012936163,0.8385057,0.0006492654,0.00001595484,0.00031487393,0.0002901271,0.00025080054,0.00012920049,0.15855049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384254,0.0006459609,0.00077398814,0.0012912572,0.002149725,0.0012965085],"domain_scores_gemma":[0.9978619,0.0006412752,0.00015267068,0.0007812039,0.00037032246,0.00019257766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010315025,0.0008066288,0.0022765347,0.0016183094,0.000613985,0.00008506882,0.00044211413,0.00036032157,0.00008374966],"category_scores_gemma":[0.0003261353,0.0005668631,0.0006834201,0.001430838,0.00045877736,0.00011616278,0.00034908715,0.0019217543,0.00905573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007744348,0.00096750184,0.00013101863,0.0030115147,0.0007653412,0.0018223047,0.0031253227,1.8664654e-9,0.0000012890265,0.0003807271,0.048286933,0.9414306],"study_design_scores_gemma":[0.00069949194,0.00017189095,0.00006313043,0.012609378,0.00012980672,0.00009330369,0.000700423,8.35524e-7,0.00015414853,0.000010890718,0.9848576,0.0005090544],"about_ca_topic_score_codex":0.000012254859,"about_ca_topic_score_gemma":0.000007854852,"teacher_disagreement_score":0.94092155,"about_ca_system_score_codex":0.0012016558,"about_ca_system_score_gemma":0.0034801601,"threshold_uncertainty_score":0.99967825},"labels":[],"label_agreement":null},{"id":"W2000176602","doi":"10.1016/j.antiviral.2005.07.003","title":"Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Protease; Biology; Virology; HIV-1 protease; Protease inhibitor (pharmacology); Saquinavir; Mutation; Genetics; Virus; Enzyme; Gene; Biochemistry; Viral load; Antiretroviral therapy","score_opus":0.03610441450119085,"score_gpt":0.3331935398410232,"score_spread":0.29708912533983234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000176602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957431,0.00005955375,0.00006410736,0.0025319343,0.000038233928,0.0011033216,0.00006272984,0.000017159406,0.00037985586],"genre_scores_gemma":[0.9967998,0.000048241844,0.00005033079,0.000021616195,0.00008772112,0.00010643752,0.00013520903,0.000010652244,0.0027399668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983214,0.0005645663,0.00019689187,0.00031128744,0.00014292086,0.00046292678],"domain_scores_gemma":[0.9993612,0.00013051732,0.000033160064,0.00023122705,0.0002088677,0.000034989796],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013573219,0.00010177701,0.00015328235,0.0001813015,0.00037604306,0.000030292205,0.00014815433,0.00009832441,0.00008498529],"category_scores_gemma":[0.00025407487,0.00006994911,0.000040978768,0.0004218851,0.00021335648,0.00016758994,0.00014113833,0.0004024888,0.0010898869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033665,0.00016963745,0.010111488,0.000019747016,0.000037299964,0.0000014875492,0.0005381548,2.471875e-7,0.9474652,0.000025788297,0.0009523353,0.040341962],"study_design_scores_gemma":[0.0006304235,0.000576979,0.10548484,0.000040460807,0.000006276952,0.000005265774,0.00011752965,0.000038206406,0.88710344,0.00000830626,0.005916886,0.000071358205],"about_ca_topic_score_codex":0.00018297869,"about_ca_topic_score_gemma":0.0001694066,"teacher_disagreement_score":0.095373355,"about_ca_system_score_codex":0.000077679215,"about_ca_system_score_gemma":0.0001330684,"threshold_uncertainty_score":0.99968785},"labels":[],"label_agreement":null},{"id":"W2002008129","doi":"10.1016/j.antiviral.2015.04.003","title":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"U.S. Food and Drug Administration; Council of Agriculture","keywords":"Viral entry; Virology; Infectivity; Hepatitis C virus; Viral replication; Gallic acid; Biology; Viral hepatitis; Potency; Virus; In vitro; Biochemistry","score_opus":0.09149164725371801,"score_gpt":0.3952309950796019,"score_spread":0.3037393478258839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002008129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369926,0.0009886906,0.00006929946,0.00094297534,0.0001406861,0.00073742145,0.00005534894,0.00011350155,0.013252817],"genre_scores_gemma":[0.9906843,0.0047265957,0.00012558697,0.00010933592,0.00034334563,0.000077882134,0.00006415688,0.000071867165,0.0037969775],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99495393,0.00072339136,0.0003655462,0.0006474295,0.0020964486,0.0012132423],"domain_scores_gemma":[0.997839,0.000253769,0.000051185594,0.000526323,0.0008096495,0.0005200716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020996379,0.00025612666,0.00042064136,0.0005683852,0.00029738585,0.00029647572,0.00019860953,0.00027995883,0.00006624801],"category_scores_gemma":[0.0017145164,0.00024204652,0.00008651926,0.00078641466,0.00056636403,0.0005519982,0.00045812823,0.0013843089,0.0006075009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005669602,0.00028924303,0.6857817,0.00010353953,0.0000728899,0.00040873428,0.000547583,2.0902273e-7,0.25219905,0.00008040882,0.033383124,0.026566543],"study_design_scores_gemma":[0.004975152,0.004755126,0.30383548,0.0003889399,0.000055816075,0.00008719371,0.00010826155,0.0023516403,0.62307775,0.00045521974,0.05925847,0.0006509563],"about_ca_topic_score_codex":0.03426951,"about_ca_topic_score_gemma":0.0015206264,"teacher_disagreement_score":0.3819462,"about_ca_system_score_codex":0.00029656108,"about_ca_system_score_gemma":0.0003912654,"threshold_uncertainty_score":0.98703706},"labels":[],"label_agreement":null},{"id":"W2002206731","doi":"10.1016/j.antiviral.2009.02.174","title":"Novel Broad-Spectrum Biopharmaceuticals: From HIV-1 to Pandemic Influenza A Virus","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Virology; Pandemic; Broad spectrum; Human immunodeficiency virus (HIV); Virus; Influenza pandemic; Pandemic influenza; Coronavirus disease 2019 (COVID-19); Biology; Influenza A virus; Medicine; Chemistry; Infectious disease (medical specialty); Internal medicine; Disease","score_opus":0.2141721517263861,"score_gpt":0.490463956815787,"score_spread":0.27629180508940093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002206731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646919,0.0012749706,0.00019239433,0.01595518,0.00007698755,0.00076963083,0.0001855867,0.0001152101,0.01673819],"genre_scores_gemma":[0.9838001,0.00069914927,0.0009235646,0.005268704,0.0007719727,0.000027624554,0.000054491647,0.000034010543,0.00842037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995344,0.00019619254,0.00042348178,0.00073113793,0.0018479072,0.001457269],"domain_scores_gemma":[0.9979822,0.0005604514,0.000031074203,0.0005485386,0.00029133057,0.00058642693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012565866,0.00027336806,0.0004908992,0.00058521493,0.00030175078,0.00011892541,0.00048581022,0.00019146684,0.00047159483],"category_scores_gemma":[0.00061311794,0.00021661326,0.00018805216,0.0012478955,0.00031063834,0.0001619402,0.0003325783,0.0014711049,0.0055766585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029766248,0.00060938176,0.025260158,0.00003067671,0.00008445715,0.00028436145,0.00026636917,7.1887905e-7,0.90850955,0.0015080076,0.009256163,0.05121351],"study_design_scores_gemma":[0.00335142,0.002274373,0.39585933,0.00033924083,0.00004142459,0.000078484656,0.0001629892,0.00083849457,0.27393302,0.0028803132,0.31968895,0.000551976],"about_ca_topic_score_codex":0.0020252436,"about_ca_topic_score_gemma":0.00011013038,"teacher_disagreement_score":0.63457656,"about_ca_system_score_codex":0.00016355592,"about_ca_system_score_gemma":0.00031458752,"threshold_uncertainty_score":0.9951976},"labels":[],"label_agreement":null},{"id":"W2003245115","doi":"10.1016/j.antiviral.2011.06.005","title":"In vitro inhibition of CSFV replication by multiple siRNA expression","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"RNA interference; Small interfering RNA; Biology; NS5B; Plasmid; Virology; Gene; Viral replication; Virus; Transfection; RNA; Genetics; Hepatitis C virus","score_opus":0.17359921168412148,"score_gpt":0.3523805968135741,"score_spread":0.1787813851294526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003245115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992752,0.00006329183,0.0000056258687,0.00047347494,0.000012413865,0.00017931416,0.000016696185,0.000012606229,0.006484545],"genre_scores_gemma":[0.9992834,0.00008306731,0.000050435377,0.00006960516,0.00003513162,0.000023987224,0.000080646736,6.145041e-7,0.00037314065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884266,0.0002757622,0.00018061009,0.0002646018,0.00018371941,0.00025263862],"domain_scores_gemma":[0.99958295,0.00020956575,0.00004753772,0.000074090276,0.000058167185,0.000027710113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010198426,0.000055242923,0.00010758319,0.000030449815,0.00006967555,0.000006396762,0.00013934152,0.00006400886,0.00010678023],"category_scores_gemma":[0.000350291,0.000023170565,0.0000387608,0.00032312566,0.00009983845,0.00017579913,0.00012658992,0.0001185164,0.000058719146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023428453,0.00012828266,0.021904022,0.0000056826357,0.0000012904692,0.0000021667888,0.00003871427,1.0756243e-8,0.9591498,0.00023119067,0.0076512983,0.010653301],"study_design_scores_gemma":[0.00010340346,0.00015697967,0.25137514,0.000014819607,9.750964e-7,7.7882405e-8,0.0001634254,0.00009890186,0.7443681,0.0021533938,0.001508989,0.000055834334],"about_ca_topic_score_codex":0.0014265409,"about_ca_topic_score_gemma":0.000088340625,"teacher_disagreement_score":0.22947113,"about_ca_system_score_codex":0.000013161689,"about_ca_system_score_gemma":0.0000027454994,"threshold_uncertainty_score":0.21565126},"labels":[],"label_agreement":null},{"id":"W2003619922","doi":"10.1016/j.antiviral.2011.03.180","title":"Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Neuraminidase; Virus; Influenza A virus; Virology; Viral replication; Biology; Enzyme; In vitro; Context (archaeology); Oseltamivir; Orthomyxoviridae; Chemistry; Stereochemistry; Biochemistry; Medicine","score_opus":0.25990652627166566,"score_gpt":0.4751847363712849,"score_spread":0.21527821009961923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003619922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707089,0.00008417905,0.0000040428295,0.0003097769,0.000021186905,0.0012192302,0.0000248792,0.00004662042,0.027581165],"genre_scores_gemma":[0.99900043,0.00011245933,0.000183549,0.00017565604,0.000025316516,0.0001695238,0.00000713856,0.00003128182,0.00029464765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654746,0.00050140114,0.0004211233,0.0006148361,0.0012207543,0.00069441646],"domain_scores_gemma":[0.99796337,0.00035376276,0.000076173244,0.00094965176,0.0005440348,0.00011302079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029234942,0.00017178238,0.00041044882,0.0012584195,0.000121812496,0.000013674718,0.00017436188,0.00016572655,0.00002309988],"category_scores_gemma":[0.003628435,0.0001522039,0.000089137175,0.0017278265,0.00035667708,0.00021170347,0.00028005024,0.0009357812,0.0003137124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059277504,0.00066253595,0.009092093,0.00009412775,0.000042669228,0.00006595502,0.0018895259,6.239367e-7,0.9491502,0.0005416775,0.00023371018,0.032299127],"study_design_scores_gemma":[0.00092985574,0.0008833843,0.25770652,0.00018657302,0.0000053328404,0.0000016628932,0.00012886622,0.000053574833,0.73924786,0.0004861255,0.00027602896,0.00009422259],"about_ca_topic_score_codex":0.0032162166,"about_ca_topic_score_gemma":0.00013827327,"teacher_disagreement_score":0.24861442,"about_ca_system_score_codex":0.00032012246,"about_ca_system_score_gemma":0.00019719881,"threshold_uncertainty_score":0.6206695},"labels":[],"label_agreement":null},{"id":"W2003698226","doi":"10.1016/j.antiviral.2013.08.001","title":"Overexpression of microRNA gga-miR-21 in chicken fibroblasts suppresses replication of infectious bursal disease virus through inhibiting VP1 translation","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"State Key Laboratory of Veterinary Biotechnology; National Natural Science Foundation of China","keywords":"Infectious bursal disease; Biology; Virology; Molecular biology; Virus; microRNA; Viral replication; Luciferase; Cell culture; Gene; Gene expression; Reporter gene; Fibroblast; Transfection; Genetics; Virulence","score_opus":0.06339650058971748,"score_gpt":0.389819341118367,"score_spread":0.32642284052864956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003698226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962356,0.0005156322,0.000046708607,0.0006435703,0.00001916684,0.0008025705,0.000050781346,0.00002474411,0.0016612103],"genre_scores_gemma":[0.999247,0.0001949794,0.00013030463,0.00004450506,0.00006389762,0.00006187895,0.00012346345,0.000020831974,0.00011310516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801046,0.0003244652,0.00044118796,0.000404724,0.00046446495,0.00035470005],"domain_scores_gemma":[0.9987477,0.00033691432,0.00012735552,0.00044858461,0.00026146628,0.00007799988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045486985,0.00013296162,0.00029879404,0.00026028603,0.00008278301,0.0000141239525,0.00011900916,0.00014234165,0.00011067579],"category_scores_gemma":[0.0009799988,0.000116315634,0.0001023646,0.00047487448,0.0003470981,0.0005006261,0.00008517765,0.00037418483,0.000039479753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009392058,0.0005293126,0.111920424,0.0004300455,0.00001920816,0.0000072656694,0.0004225612,0.0000053391327,0.8803151,0.0001587054,0.00061639934,0.004636396],"study_design_scores_gemma":[0.001136709,0.00040880963,0.44121093,0.0007039891,0.000018296756,0.0000018686487,0.00008699675,0.00032997908,0.55412996,0.0018384483,0.000053048607,0.000080963095],"about_ca_topic_score_codex":0.0015894042,"about_ca_topic_score_gemma":0.000054706536,"teacher_disagreement_score":0.32929048,"about_ca_system_score_codex":0.00003290449,"about_ca_system_score_gemma":0.00015238456,"threshold_uncertainty_score":0.4743214},"labels":[],"label_agreement":null},{"id":"W2004584518","doi":"10.1016/j.antiviral.2004.02.007","title":"Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Primase; Helicase; Biology; Herpes simplex virus; Virology; Virus; In vitro; DNA; Molecular biology; Gene; Biochemistry; Polymerase chain reaction; RNA; Reverse transcriptase","score_opus":0.04945904907619818,"score_gpt":0.36482395878672674,"score_spread":0.31536490971052855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004584518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981457,0.00002789243,0.00013700814,0.0007498213,0.000051190727,0.0005087705,0.00003888595,0.000012984314,0.00032772607],"genre_scores_gemma":[0.9994049,0.000031198233,0.00023889118,0.00008192076,0.000042939948,0.00001204819,0.000022264117,0.000015342024,0.00015048051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884665,0.00009511298,0.00024593135,0.00018674466,0.0004238666,0.00020168845],"domain_scores_gemma":[0.99923396,0.00007089925,0.000065741944,0.0002744731,0.00030179348,0.000053146116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000371585,0.000090799884,0.00018009289,0.00020829933,0.00013064392,0.000014182657,0.00005737812,0.00007202786,0.000012489217],"category_scores_gemma":[0.00023237886,0.000063596264,0.000052594827,0.000691617,0.00017673144,0.00007584519,0.0000599031,0.00012630876,0.00001604064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061481324,0.0003736062,0.007142784,0.00007296079,0.00002806109,0.00000695948,0.00018906564,0.0000025646714,0.9523956,0.0003086882,0.000017735729,0.038847167],"study_design_scores_gemma":[0.0010261895,0.0007291145,0.16042721,0.00018112164,0.000022762877,0.0000012320288,0.000028620463,0.00005990731,0.83498144,0.00011477799,0.0023727799,0.000054828437],"about_ca_topic_score_codex":0.0009967259,"about_ca_topic_score_gemma":0.00010218535,"teacher_disagreement_score":0.15328443,"about_ca_system_score_codex":0.00008891228,"about_ca_system_score_gemma":0.00022798427,"threshold_uncertainty_score":0.25933802},"labels":[],"label_agreement":null},{"id":"W2006110359","doi":"10.1016/j.antiviral.2007.08.009","title":"Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cidofovir; Thymidine kinase; Foscarnet; Virology; Herpes simplex virus; Ribonucleotide reductase; Recombinant DNA; DNA polymerase; Biology; Molecular biology; Nucleoside; Thymidine; Gene; Virus; DNA; Herpesviridae; Protein subunit; Biochemistry; Viral disease","score_opus":0.08441485098573778,"score_gpt":0.40943498478703716,"score_spread":0.32502013380129935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006110359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409586,0.00080614176,0.000013544266,0.0018680077,0.00003165885,0.0006157442,0.00002849842,0.000012977544,0.0025275447],"genre_scores_gemma":[0.9976172,0.0018125225,0.00002367149,0.00010605119,0.00008909423,0.00003139208,0.0000061178985,0.000015022177,0.00029893653],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825466,0.00037392197,0.00022835213,0.00024542585,0.0004806129,0.00041700318],"domain_scores_gemma":[0.99809015,0.0013259642,0.00005991789,0.00037163924,0.00009979974,0.000052524232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022457016,0.00014514678,0.00019941868,0.00018013104,0.0005801011,0.00006658104,0.00015091986,0.000067647496,0.000012672664],"category_scores_gemma":[0.0004206262,0.000060112794,0.000046955884,0.00086671714,0.0006790759,0.00013714205,0.00009404363,0.00037074636,0.0000052034216],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097527547,0.0006330968,0.00575641,0.00006007213,0.00013579127,0.00023009823,0.002094901,9.030646e-7,0.4103428,0.00050510344,0.000058224192,0.5792073],"study_design_scores_gemma":[0.0014544225,0.00082759425,0.39978474,0.00014457882,0.00007825997,0.000017266564,0.003958121,0.00020837151,0.57959485,0.00024898647,0.013522672,0.000160146],"about_ca_topic_score_codex":0.0028222604,"about_ca_topic_score_gemma":0.005588298,"teacher_disagreement_score":0.57904714,"about_ca_system_score_codex":0.000043134667,"about_ca_system_score_gemma":0.00016464255,"threshold_uncertainty_score":0.44617274},"labels":[],"label_agreement":null},{"id":"W2009729050","doi":"10.1016/j.antiviral.2014.12.017","title":"SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Agence Nationale de Recherches sur le Sida et les Hépatites Virales; Canada Research Chairs","keywords":"Hepatitis C virus; Virology; Hepatocellular carcinoma; Biology; Viral load; Cirrhosis; Viral replication; Virus; Hepatitis C; Regulator; Immunology; Medicine; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.21696002062450206,"score_gpt":0.47724900180064167,"score_spread":0.26028898117613963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009729050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92839426,0.00017427746,0.000023460381,0.0032478303,0.00014417898,0.00080924743,0.000019965004,0.000045897763,0.06714091],"genre_scores_gemma":[0.9949554,0.00022496005,0.00006654274,0.00007656378,0.0003533957,0.000058869773,0.000021278405,0.000036641242,0.0042063002],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99531376,0.0008999991,0.00035076425,0.00032498376,0.002340299,0.0007702019],"domain_scores_gemma":[0.99727774,0.00047234443,0.000053096453,0.00069377635,0.0012693092,0.00023372911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005543916,0.00014255257,0.00030907095,0.0004974255,0.0001895952,0.00007183421,0.00026123784,0.00015885956,0.00009104646],"category_scores_gemma":[0.0046703476,0.00009516617,0.00012846902,0.0014062766,0.0007755401,0.00022020236,0.00035471827,0.0011458028,0.0010680757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001201337,0.0007145741,0.631199,0.00023509601,0.00013790325,0.00027920594,0.0020025868,0.0000013353939,0.017899595,0.0010168379,0.21263503,0.13267753],"study_design_scores_gemma":[0.007398963,0.0100472905,0.29620466,0.00077525043,0.00007658673,0.00008794613,0.0022350291,0.0027838722,0.30108503,0.0029173684,0.375763,0.0006250068],"about_ca_topic_score_codex":0.0040871343,"about_ca_topic_score_gemma":0.00047532798,"teacher_disagreement_score":0.33499432,"about_ca_system_score_codex":0.00024801062,"about_ca_system_score_gemma":0.0011457201,"threshold_uncertainty_score":0.9997097},"labels":[],"label_agreement":null},{"id":"W2010436800","doi":"10.1016/j.antiviral.2007.10.009","title":"Treatment of yellow fever","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Ribavirin; Cytokine storm; Medicine; Immunology; Immune system; Cytokine; Virology; Virus; Hepatitis C virus; Disease; Infectious disease (medical specialty); Internal medicine","score_opus":0.3535669420986561,"score_gpt":0.5642778286320669,"score_spread":0.2107108865334108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010436800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014291675,0.9783102,0.0000039930324,0.000042000407,0.00007232944,0.0014347242,0.00005450244,0.000016839156,0.019922486],"genre_scores_gemma":[0.001992716,0.9718187,0.000023043662,0.000010581002,0.00044973474,0.000091623035,0.0001243606,0.000052312676,0.025436962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973558,0.00022642099,0.00047372965,0.00043911044,0.0008836887,0.0006212028],"domain_scores_gemma":[0.9983889,0.00041293338,0.000098997385,0.000704034,0.00025604555,0.00013907664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050905626,0.00028000365,0.001711018,0.00048256535,0.000059403545,0.000019338873,0.00018322961,0.0002676987,0.00015582182],"category_scores_gemma":[0.0001358232,0.00017919447,0.0009601005,0.00062088674,0.0002066736,0.000031091076,0.00006625537,0.00033948905,0.00054006896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089621826,0.000541137,0.00006746615,0.007108815,0.00032222265,0.0004513309,0.000017066961,1.193047e-9,0.000007852019,0.00022811991,0.0017509311,0.9894154],"study_design_scores_gemma":[0.0007667368,0.0010636603,0.00007659082,0.004039361,0.00069108076,0.000017742163,0.000021518916,0.0000041050625,0.000032706463,0.0000145672975,0.9931441,0.000127832],"about_ca_topic_score_codex":0.00017028512,"about_ca_topic_score_gemma":0.000008039174,"teacher_disagreement_score":0.99139315,"about_ca_system_score_codex":0.00021810894,"about_ca_system_score_gemma":0.0009046759,"threshold_uncertainty_score":0.7307339},"labels":[],"label_agreement":null},{"id":"W2010598858","doi":"10.1016/j.antiviral.2010.03.010","title":"Dengue virus replicons: Production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Agence Nationale de la Recherche","keywords":"Replicon; Dengue virus; Virology; Dengue fever; Biology; Flavivirus; Subgenomic mRNA; Green fluorescent protein; Ribavirin; Virus; Molecular biology; Hepatitis C virus; Gene; RNA; Genetics; Plasmid","score_opus":0.048485389364271866,"score_gpt":0.3572641395959428,"score_spread":0.3087787502316709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010598858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997112,0.0003244009,0.000030861298,0.00066210085,0.00008559927,0.001573669,0.00014893923,0.00000764395,0.000054781296],"genre_scores_gemma":[0.9994912,0.000062866835,0.00006788431,0.000016293397,0.00012275648,0.000054449152,0.00010321753,0.000015107577,0.00006623301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739707,0.0006252757,0.0003052043,0.00042063344,0.0010329785,0.0002188258],"domain_scores_gemma":[0.9983151,0.00020549883,0.00014659973,0.00059429684,0.000629114,0.00010940886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021851864,0.0001413732,0.00032271724,0.00015975696,0.00007745437,0.000034043383,0.0001300308,0.00007856985,0.000028590774],"category_scores_gemma":[0.00063759106,0.00009596472,0.00005585488,0.00022179454,0.0002652086,0.00011190939,0.00012456537,0.0003375442,7.08632e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012783773,0.001052835,0.019136371,0.000105209525,0.000035258323,8.561191e-7,0.00017651216,0.0000013009077,0.9504697,0.000006667345,0.00055294065,0.027183976],"study_design_scores_gemma":[0.0013743355,0.00054980355,0.22653139,0.0001013846,0.00012107229,2.6853914e-7,0.00020162166,0.0021790618,0.7688095,0.000020885713,0.000049258993,0.00006144499],"about_ca_topic_score_codex":0.0033429698,"about_ca_topic_score_gemma":0.0005911459,"teacher_disagreement_score":0.20739502,"about_ca_system_score_codex":0.000034670484,"about_ca_system_score_gemma":0.00016742748,"threshold_uncertainty_score":0.5053593},"labels":[],"label_agreement":null},{"id":"W2010807197","doi":"10.1016/j.antiviral.2006.11.011","title":"Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide☆","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; AIDS Vancouver; Dalhousie University; University of Toronto; University Health Network; Hôpital Notre-Dame; Maple Leaf Medical Clinic","funders":"","keywords":"Enfuvirtide; Clade; Biology; Mutation; Virology; Gp41; Virus; Genetics; Genotype; Gene; Phylogenetics","score_opus":0.028212271865364583,"score_gpt":0.32589654145777236,"score_spread":0.2976842695924078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010807197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983474,0.000054623444,0.00032279082,0.000352074,0.000016255965,0.0005692798,0.00005856439,0.000011591649,0.00026743466],"genre_scores_gemma":[0.9983301,0.0000064102114,0.00047490638,0.000018302775,0.0000067936485,0.00006496745,0.0005854546,0.000008914792,0.00050410756],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800366,0.00071314635,0.00025016873,0.00034493825,0.00023671212,0.0004513912],"domain_scores_gemma":[0.9992191,0.00030853236,0.000049953203,0.00016600286,0.00023453994,0.0000218785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013627625,0.00012222577,0.00017794037,0.00042589422,0.00014003462,0.000022593293,0.0001244336,0.00011260008,0.000036052556],"category_scores_gemma":[0.0003052314,0.00009113433,0.00001562931,0.00040055538,0.00015839878,0.00012194953,0.000086470754,0.00029638692,0.0004919753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001599982,0.0010609551,0.47192842,0.0000374949,0.00007352133,0.000056682922,0.0006290165,0.000017656426,0.49826136,0.0005759457,0.00087637966,0.02488257],"study_design_scores_gemma":[0.0017891766,0.0009029016,0.83517826,0.000047718633,0.0000032997802,0.0000011768636,0.000041517495,0.000006944802,0.16150461,0.000083358136,0.00035858256,0.00008243753],"about_ca_topic_score_codex":0.00043959435,"about_ca_topic_score_gemma":0.00048747874,"teacher_disagreement_score":0.36324987,"about_ca_system_score_codex":0.00012206023,"about_ca_system_score_gemma":0.00011780278,"threshold_uncertainty_score":0.6323511},"labels":[],"label_agreement":null},{"id":"W2011966733","doi":"10.1016/j.antiviral.2008.10.005","title":"Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"Canadian Institutes of Health Research; Health Canada; Ontario HIV Treatment Network; Hamilton Health Sciences; Canadian Foundation for AIDS Research; amfAR, The Foundation for AIDS Research","keywords":"TLR3; Innate immune system; Herpes simplex virus; Interferon; Biology; TLR4; Viral replication; Immunology; Virus; Microbicides for sexually transmitted diseases; Virology; Immune system; Toll-like receptor; Microbiology; Medicine","score_opus":0.0553254321926722,"score_gpt":0.35779364521489493,"score_spread":0.3024682130222227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011966733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795985,0.000097932025,0.0000097493075,0.000044930457,0.00012524672,0.00040029586,0.000052436826,0.000029406869,0.0012801703],"genre_scores_gemma":[0.9970451,0.0018526631,0.000023116196,0.000017547094,0.00008179039,0.000028448412,0.00008294372,0.00003007483,0.00083831523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977795,0.000285639,0.000461543,0.00030508556,0.0006183212,0.00054991763],"domain_scores_gemma":[0.9990469,0.00014738402,0.000105101186,0.00028191265,0.00033633944,0.000082345025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066423905,0.00017364783,0.0004726961,0.0007924876,0.00015180698,0.000011956247,0.00007989397,0.00019457837,0.000051009476],"category_scores_gemma":[0.00031739537,0.00015001385,0.00009467022,0.0010921229,0.0004217662,0.00024209938,0.00010441346,0.0004113834,0.000035782024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020844617,0.0021464769,0.3117757,0.00013246857,0.00016959923,0.00007720568,0.000774276,0.0000010559824,0.61016464,0.000022580867,0.0004093875,0.07224214],"study_design_scores_gemma":[0.0017788712,0.0010856932,0.53191346,0.00007080121,0.000012519217,0.000012794422,0.00004664661,0.00002698501,0.46316728,0.00003769845,0.0017480135,0.0000992266],"about_ca_topic_score_codex":0.0026745328,"about_ca_topic_score_gemma":0.0000665037,"teacher_disagreement_score":0.22013776,"about_ca_system_score_codex":0.0003808807,"about_ca_system_score_gemma":0.00037436295,"threshold_uncertainty_score":0.61173874},"labels":[],"label_agreement":null},{"id":"W2012849897","doi":"10.1016/j.antiviral.2005.12.006","title":"Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institut National de la Recherche Scientifique; Armand Frappier Museum","funders":"","keywords":"Protease; Protease inhibitor (pharmacology); Virology; Virus; Drug resistance; In vitro; Biology; Enzyme inhibitor; Microbiology; Enzyme; Viral load; Antiretroviral therapy; Biochemistry","score_opus":0.04953128474737692,"score_gpt":0.3854512389809993,"score_spread":0.3359199542336224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012849897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799623,0.00039650218,0.000016617463,0.00031145124,0.000038414764,0.001111234,0.000049155093,0.00004117814,0.018073171],"genre_scores_gemma":[0.94566745,0.000032512275,0.00058204564,0.0000057460575,0.000080462225,0.00006342034,0.00004013713,0.000029038103,0.053499196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760056,0.00010593153,0.00032370424,0.00048392068,0.00088059524,0.0006052796],"domain_scores_gemma":[0.9989536,0.000099085715,0.00009398318,0.0003646564,0.00043215725,0.000056527533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008521036,0.00021230658,0.00038445144,0.0002977408,0.00036257776,0.00007152296,0.00012934367,0.000117107455,0.00003213354],"category_scores_gemma":[0.00017574479,0.00017409428,0.00007797918,0.0007554545,0.0006545627,0.00025162066,0.00017828487,0.00040289058,0.00007916112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082417676,0.0014659719,0.08713567,0.00024140753,0.000040477345,0.000079031684,0.00016583734,4.018573e-8,0.9062014,0.0010540299,0.0012892482,0.0015026613],"study_design_scores_gemma":[0.0022180227,0.000370329,0.29276747,0.00022141005,0.000020341542,0.0000045080346,0.000040495393,0.00003605295,0.70259947,0.00017473337,0.0013679643,0.0001792303],"about_ca_topic_score_codex":0.0006746979,"about_ca_topic_score_gemma":0.00014849067,"teacher_disagreement_score":0.20563178,"about_ca_system_score_codex":0.00011338275,"about_ca_system_score_gemma":0.000349892,"threshold_uncertainty_score":0.7099359},"labels":[],"label_agreement":null},{"id":"W2013130286","doi":"10.1016/j.antiviral.2006.06.011","title":"Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Herpes simplex virus; Resveratrol; Vero cell; Viral replication; Virology; Biology; Virus; NF-κB; IκBα; Molecular biology; Cell biology; Signal transduction; Biochemistry","score_opus":0.05431705798884728,"score_gpt":0.3811911008338261,"score_spread":0.32687404284497884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013130286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701062,0.00009945057,0.0000049636815,0.00022013411,0.00006957326,0.0005116834,0.000049861734,0.00009251172,0.02884563],"genre_scores_gemma":[0.9969923,0.00016610474,0.00009372186,0.000053515298,0.00016741273,0.00002703225,0.000034303102,0.000046917987,0.0024186913],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997681,0.00028246897,0.00029728707,0.00039550493,0.0006046574,0.0007390375],"domain_scores_gemma":[0.9990254,0.0002765785,0.00003215094,0.00038770333,0.00019751338,0.00008067513],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003414394,0.00018672591,0.0003111055,0.0005107531,0.00022590856,0.00010126963,0.00011483859,0.00017480117,0.0005448031],"category_scores_gemma":[0.00013832295,0.00015660797,0.000101999685,0.0008997994,0.00019095842,0.00020904563,0.0001063143,0.00049603207,0.0011704011],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012061798,0.006606117,0.18871588,0.00023088824,0.00027932817,0.002310332,0.0005036048,0.000013259759,0.5248527,0.0019761352,0.040530387,0.23277518],"study_design_scores_gemma":[0.0033204993,0.00063933386,0.27209064,0.000116671654,0.00002297757,0.000010663881,0.00008238441,0.00021893729,0.35974365,0.000521826,0.36296967,0.00026275305],"about_ca_topic_score_codex":0.013234494,"about_ca_topic_score_gemma":0.0017341379,"teacher_disagreement_score":0.32243928,"about_ca_system_score_codex":0.00018670294,"about_ca_system_score_gemma":0.00015295974,"threshold_uncertainty_score":0.9996073},"labels":[],"label_agreement":null},{"id":"W2014016939","doi":"10.1016/j.antiviral.2011.06.003","title":"Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Biology; Virology; Reverse genetics; Viral replication; Virus; Transcription (linguistics); Viral life cycle; Marburg virus; Reverse transcriptase; Genome; Genetics; RNA; Computational biology; Ebola virus; Gene","score_opus":0.3154312292024623,"score_gpt":0.45617233691124487,"score_spread":0.14074110770878256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014016939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025663465,0.9689815,0.00007299529,0.00006558365,0.000082995924,0.0041934326,0.00045261788,0.00004018228,0.00044722154],"genre_scores_gemma":[0.016810277,0.98081404,0.0003819226,0.00010137941,0.0001530655,0.0004913942,0.00004632602,0.00008249714,0.001119076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689865,0.0005762346,0.0005890562,0.00088522607,0.00044448406,0.00060637295],"domain_scores_gemma":[0.998141,0.00063604006,0.00014398684,0.0005152887,0.00035016527,0.00021350464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016297133,0.0003735958,0.0011093764,0.00050129,0.0003929315,0.00020207379,0.00011946759,0.0003332142,0.000021788384],"category_scores_gemma":[0.00021604329,0.00028534446,0.0001674568,0.00040919686,0.00067321083,0.00016938399,0.00011158558,0.00059599255,0.000024256085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005353532,0.00035906033,0.000706876,0.021788355,0.0005556955,0.000026677526,0.0008913432,7.104821e-8,0.006515982,0.0009120048,0.00255367,0.9651549],"study_design_scores_gemma":[0.0015136113,0.001315244,0.00042413446,0.0027199602,0.0006315965,0.00013333358,0.000528626,0.00025863244,0.0011540079,0.0002752673,0.9906234,0.00042216908],"about_ca_topic_score_codex":0.0011371752,"about_ca_topic_score_gemma":0.0002053857,"teacher_disagreement_score":0.9880698,"about_ca_system_score_codex":0.00009635161,"about_ca_system_score_gemma":0.0002476303,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2015128810","doi":"10.1016/j.antiviral.2007.08.012","title":"Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Kaohsiung Medical University","keywords":"Traditional medicine; Herpes simplex virus; Virus; Houttuynia cordata; In vitro; Medicine; Virology; Pharmacology; Biology; Chemistry; Biochemistry; Chromatography","score_opus":0.056148839739850576,"score_gpt":0.41364932108400554,"score_spread":0.35750048134415496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015128810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814424,0.00045708887,0.00003606187,0.0001969585,0.00011578494,0.0005489733,0.000011044678,0.00006199758,0.017129691],"genre_scores_gemma":[0.9949695,0.0003974863,0.00015516752,0.00008639815,0.00016215116,0.000022425711,0.000030061234,0.00003176593,0.0041450458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982605,0.00013531209,0.00026762093,0.0003497354,0.0004004102,0.00058640755],"domain_scores_gemma":[0.9990421,0.00020258201,0.000031276217,0.0002757102,0.00031600188,0.00013234859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011416922,0.00016852898,0.00025949982,0.0006014334,0.0002479892,0.00005996928,0.00005900438,0.00015804809,0.00007835912],"category_scores_gemma":[0.00073359726,0.00013562756,0.000044926634,0.00182257,0.00019448546,0.00022082136,0.00010615969,0.00046963705,0.00025397935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016337472,0.002655763,0.47660878,0.00012315347,0.0002087374,0.00038990253,0.0008567196,7.9461233e-7,0.20433654,0.00031922903,0.0037578226,0.3091088],"study_design_scores_gemma":[0.0045547322,0.0013958825,0.7236231,0.00018300327,0.000052232448,0.00011450828,0.00027215117,0.0002330792,0.10745526,0.0009636978,0.16077687,0.0003754887],"about_ca_topic_score_codex":0.00484184,"about_ca_topic_score_gemma":0.003128679,"teacher_disagreement_score":0.3087333,"about_ca_system_score_codex":0.00017714196,"about_ca_system_score_gemma":0.00018543105,"threshold_uncertainty_score":0.73194456},"labels":[],"label_agreement":null},{"id":"W2016436352","doi":"10.1016/j.antiviral.2007.09.005","title":"Genistein treatment of cells inhibits arenavirus infection","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Arenavirus; Biology; Virology; Genistein; Viral envelope; Tyrosine kinase; Signal transduction; Virus; Lymphocytic choriomeningitis; Cell biology; In vitro; Biochemistry; Cytotoxic T cell","score_opus":0.15465793012101997,"score_gpt":0.4753572917764967,"score_spread":0.32069936165547674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016436352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597119,0.00017503132,0.0002053167,0.00013953664,0.00009301704,0.000556723,0.000007767728,0.000036789206,0.03907393],"genre_scores_gemma":[0.9900571,0.0007433159,0.00013845795,0.000012951328,0.00023405372,0.000017175185,0.000011312062,0.000022556624,0.008763084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783117,0.00013241355,0.0003145232,0.00028463744,0.0007917234,0.0006455315],"domain_scores_gemma":[0.9987683,0.00025375411,0.00004008083,0.00030059263,0.00050810963,0.00012913444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013994608,0.00012878029,0.0002777051,0.0007196509,0.00018962368,0.00002753118,0.000052463576,0.00013550461,0.00009247168],"category_scores_gemma":[0.00011743797,0.00009915556,0.00016467694,0.0011104379,0.00028645052,0.000105025836,0.000061850275,0.00031514798,0.0004111256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044440877,0.0008700524,0.027760098,0.00006358791,0.00005252062,0.000101520396,0.0001524293,4.0571544e-7,0.8289339,0.00022650171,0.00048564016,0.14090891],"study_design_scores_gemma":[0.0011053609,0.0036138906,0.051115938,0.00005416312,0.000014835612,0.000021764537,0.00007392113,0.000057476882,0.93266356,0.00007866006,0.011121327,0.00007910572],"about_ca_topic_score_codex":0.0036333785,"about_ca_topic_score_gemma":0.0004731104,"teacher_disagreement_score":0.14082982,"about_ca_system_score_codex":0.00027982,"about_ca_system_score_gemma":0.00018971144,"threshold_uncertainty_score":0.54926056},"labels":[],"label_agreement":null},{"id":"W2016760300","doi":"10.1016/j.antiviral.2011.03.029","title":"Rigid Amphipathic Fusion Inhibitors (RAFIs) Inhibit Infectivity of Enveloped Viruses by Targeting Envelope Lipids to Prevent Fusion With Cellular Membranes","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Infectivity; Lipid bilayer fusion; Membrane; Viral envelope; Fusion; Amphiphile; Envelope (radar); Chemistry; Virology; Cell fusion; Cell biology; Biology; Virus; Biochemistry; Cell; Copolymer; Computer science","score_opus":0.0741322587692607,"score_gpt":0.35651485776092035,"score_spread":0.28238259899165963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016760300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911605,0.000550902,0.00023053255,0.0001905205,0.00009855526,0.0016946832,0.000015735885,0.00009733194,0.0059612384],"genre_scores_gemma":[0.99754477,0.00011030432,0.00041754884,0.0011980352,0.00023632427,0.00013501843,0.000011809932,0.00008891489,0.0002572884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937148,0.0008866513,0.0006638401,0.000935056,0.0025765926,0.0012230541],"domain_scores_gemma":[0.99750525,0.0004894361,0.000145357,0.0007394928,0.0009598419,0.00016061738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005001772,0.00040231965,0.0007111381,0.0009726526,0.0003909952,0.00006144673,0.0004460762,0.00031161396,0.000055583172],"category_scores_gemma":[0.0016550312,0.00030558743,0.00016752147,0.002175297,0.0005591672,0.00037239408,0.0008393239,0.0012253294,0.0002904506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018794435,0.0012137912,0.094725214,0.0005802985,0.00006333406,0.00013170279,0.002237445,9.477106e-8,0.88988894,0.000048309674,0.0012770221,0.007954413],"study_design_scores_gemma":[0.0012306002,0.002465454,0.0049231607,0.0007638382,0.00002711035,0.000007692962,0.00038953277,0.000052249998,0.9718641,0.000076603756,0.01786073,0.0003389437],"about_ca_topic_score_codex":0.0034751815,"about_ca_topic_score_gemma":0.00021687985,"teacher_disagreement_score":0.08980206,"about_ca_system_score_codex":0.00021480177,"about_ca_system_score_gemma":0.0008749858,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W2020887516","doi":"10.1016/j.antiviral.2014.02.005","title":"The beginning of the end: What is the future of interferon therapy for chronic hepatitis C?","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"","keywords":"Simeprevir; Ribavirin; Sofosbuvir; Medicine; Interferon; Hepatitis C; Pegylated interferon; Virology; Daclatasvir; Hepatitis C virus; Internal medicine; Pharmacology; Virus","score_opus":0.05609946185193702,"score_gpt":0.4059276083611312,"score_spread":0.34982814650919414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020887516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94256616,0.01014304,0.00009273861,0.041656476,0.00033851148,0.0020470577,0.000021880856,0.000012702874,0.00312144],"genre_scores_gemma":[0.96934175,0.02790794,0.000025681382,0.0002584494,0.0005684881,0.00012739863,0.000004270976,0.00003433975,0.0017316736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965052,0.0008099174,0.00033566492,0.0002641293,0.0014300253,0.00065505283],"domain_scores_gemma":[0.99598235,0.002098348,0.00010075425,0.001064404,0.00070713484,0.000046989335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004447374,0.0001343957,0.00028341686,0.00011275339,0.00052855816,0.00010523728,0.00089509395,0.00011055549,0.000058774414],"category_scores_gemma":[0.00061294134,0.00005841521,0.00023363665,0.00058635726,0.0012979252,0.00017740612,0.00031764328,0.00080179493,0.000021781729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004948127,0.00007078794,0.024892379,0.00014930723,0.000117582706,0.0000011551679,0.0012665039,2.8441232e-7,0.045259565,0.003498194,0.011642565,0.91260684],"study_design_scores_gemma":[0.0022944591,0.0047491654,0.05159696,0.0008943851,0.000022381326,0.0000040807518,0.0016438296,0.0034091487,0.4338302,0.0023326096,0.49906057,0.00016220377],"about_ca_topic_score_codex":0.00095547334,"about_ca_topic_score_gemma":0.0010304214,"teacher_disagreement_score":0.91244465,"about_ca_system_score_codex":0.00011746986,"about_ca_system_score_gemma":0.00046605789,"threshold_uncertainty_score":0.47822598},"labels":[],"label_agreement":null},{"id":"W2021712772","doi":"10.1016/j.antiviral.2012.05.006","title":"SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Hepatitis C virus; Viral replication; Virology; Hepatocellular carcinoma; In vivo; Viral load; Steatosis; Replicon; Pharmacology; Virus; In vitro; Medicine; Biology; Chemistry; Cancer research; Internal medicine; Biochemistry","score_opus":0.3412660151930021,"score_gpt":0.532633570903136,"score_spread":0.19136755571013392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021712772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011989164,0.94043183,0.00010831206,0.0020188023,0.00027969666,0.016166484,0.00079959625,0.00030134633,0.027904753],"genre_scores_gemma":[0.008354546,0.9745626,0.0012820255,0.00022486379,0.0011076757,0.0021886742,0.0005895545,0.00029265045,0.011397403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98938096,0.0018252257,0.0012939614,0.001749394,0.0034341204,0.0023163436],"domain_scores_gemma":[0.9936421,0.0009135382,0.000194493,0.0025671397,0.0015541668,0.0011285988],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006719014,0.00066107017,0.0021431202,0.0023732127,0.00049754366,0.00037766603,0.00060717337,0.00057925866,0.00034506142],"category_scores_gemma":[0.0047905613,0.00059055316,0.00047168182,0.0045885677,0.00024776015,0.0003402734,0.0010985996,0.0025167218,0.023689847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009146571,0.0003183889,0.00036798883,0.008641102,0.00013430412,0.00031118537,0.0003538073,5.96669e-8,0.0008521087,0.00016299359,0.015438822,0.97332776],"study_design_scores_gemma":[0.00035348677,0.00095478684,0.00029289702,0.014728985,0.0001702714,0.00006031687,0.000013904781,0.000008988783,0.0015726886,0.000022958946,0.98129904,0.00052164576],"about_ca_topic_score_codex":0.00362267,"about_ca_topic_score_gemma":0.0007952212,"teacher_disagreement_score":0.97280616,"about_ca_system_score_codex":0.0015158594,"about_ca_system_score_gemma":0.0022071863,"threshold_uncertainty_score":0.9997845},"labels":[],"label_agreement":null},{"id":"W2025220076","doi":"10.1016/s0166-3542(00)00071-1","title":"An in vitro system for the enzymological analysis of avian hepatitis B virus replication and inhibition in core particles","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Duck hepatitis B virus; Polymerase; Viral replication; Biology; Virology; Reverse transcriptase; Context (archaeology); Nucleic acid; Hepatitis B virus; Virus; Enzyme; Molecular biology; RNA; Hepadnaviridae; Biochemistry; Gene","score_opus":0.12555117207709154,"score_gpt":0.4187944444722624,"score_spread":0.29324327239517084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025220076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829865,0.0002438619,0.00003114788,0.0004735646,0.000005024469,0.00065497815,0.00006546156,0.000012921213,0.00021439101],"genre_scores_gemma":[0.9986853,0.0008616338,0.00012079012,0.00003585002,0.000022223338,0.00019285869,0.0000433882,0.0000069847842,0.000030982592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986042,0.0002365734,0.00030026477,0.0002909293,0.00030346622,0.00026461162],"domain_scores_gemma":[0.9989361,0.0005300105,0.00003336265,0.00033845374,0.00013090375,0.0000311749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018799829,0.00006744092,0.00029738728,0.00032807235,0.000094780895,0.000015514499,0.000051902687,0.000065113796,0.000011858163],"category_scores_gemma":[0.00044234932,0.000047220743,0.000047648213,0.0011386662,0.00023991322,0.00008418899,0.000027095886,0.00016834408,0.0000054173415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005998442,0.0001634044,0.669353,0.00006112916,0.00006736793,0.000033116794,0.00064015423,0.000004759637,0.28640193,0.00037903473,0.000027140995,0.04226913],"study_design_scores_gemma":[0.00045377854,0.00031101072,0.8653316,0.00006281607,0.00006323895,0.0000019821107,0.00019383305,0.01964738,0.113741904,0.000103069164,0.00004558982,0.000043812877],"about_ca_topic_score_codex":0.016649295,"about_ca_topic_score_gemma":0.027718637,"teacher_disagreement_score":0.1959786,"about_ca_system_score_codex":0.0000916734,"about_ca_system_score_gemma":0.000031773357,"threshold_uncertainty_score":0.99002296},"labels":[],"label_agreement":null},{"id":"W2025612185","doi":"10.1016/j.antiviral.2013.04.001","title":"Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Integrase; DNA; High-throughput screening; HIV Long Terminal Repeat; Ligand binding assay; Biology; Binding site; Small molecule; Virology; Biochemistry; Long terminal repeat; Chemistry; Molecular biology; Gene; Genome","score_opus":0.07631490118335602,"score_gpt":0.36356287961036593,"score_spread":0.2872479784270099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025612185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871071,0.000030234629,0.008322019,0.001790273,0.000086885935,0.0020241805,0.00006728696,0.00003466399,0.0005373467],"genre_scores_gemma":[0.95219654,0.000012089674,0.03996525,0.000010079072,0.000046094272,0.00041425863,0.0004547387,0.000035900805,0.0068650446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969107,0.00011072906,0.0009193542,0.000445886,0.0010475033,0.0005658254],"domain_scores_gemma":[0.9976801,0.00051335426,0.00022303581,0.0003806787,0.0010701923,0.00013260753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024066279,0.00023313912,0.00045438792,0.000980808,0.00017557593,0.000044088007,0.00023656314,0.00013386151,0.000057721612],"category_scores_gemma":[0.0011449135,0.00018028298,0.00016496367,0.0008828664,0.00029282673,0.00020480614,0.00010099175,0.00030594305,0.0002787518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000315766,0.001516574,0.01978412,0.00045616017,0.00021960518,0.000007575858,0.0014818881,3.6867553e-7,0.93048126,0.00038507336,0.009507031,0.035844598],"study_design_scores_gemma":[0.0028114521,0.00014043451,0.0049546165,0.00081034546,0.000051119456,0.0000014380987,0.0016985436,0.002560717,0.98561144,0.00004010369,0.0011472458,0.00017257214],"about_ca_topic_score_codex":0.000051758063,"about_ca_topic_score_gemma":0.00002255771,"teacher_disagreement_score":0.055130173,"about_ca_system_score_codex":0.00029706937,"about_ca_system_score_gemma":0.001006262,"threshold_uncertainty_score":0.7351727},"labels":[],"label_agreement":null},{"id":"W2026540826","doi":"10.1016/j.antiviral.2008.03.004","title":"Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lactoferrin; Heparan sulfate; Biology; Cell; Herpes simplex virus; Chondroitin sulfate; Virology; Cell culture; Biochemistry; Virus; Glycosaminoglycan; Genetics","score_opus":0.0687695916473367,"score_gpt":0.37244540710001567,"score_spread":0.30367581545267897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026540826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94443434,0.00020676076,0.000037374306,0.00021603242,0.000022742954,0.0003820566,0.000026121324,0.000021142192,0.054653432],"genre_scores_gemma":[0.9894616,0.00047360058,0.00014796521,0.000060635073,0.00003405211,0.000018825116,0.000023148403,0.000019545889,0.00976064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868244,0.00011116165,0.00018031817,0.00025274657,0.00043579692,0.00033754954],"domain_scores_gemma":[0.9993479,0.00012572516,0.000026688664,0.0002208991,0.000159412,0.00011933973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031855234,0.00010745312,0.00021744311,0.00027231255,0.00016016209,0.000010073767,0.000038062895,0.00009044145,0.000056728197],"category_scores_gemma":[0.00007257544,0.00008930674,0.000046279158,0.0004699264,0.00016692233,0.00008636951,0.00007541649,0.00028904338,0.00025810886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035574337,0.0020470484,0.1725762,0.00018011522,0.00004426967,0.0002660911,0.00079700124,2.3257434e-7,0.77456707,0.000072189396,0.034817196,0.014276815],"study_design_scores_gemma":[0.0019157242,0.0012580431,0.036970653,0.00008328559,0.000018332987,0.00002108011,0.00012851918,0.000023661905,0.9476244,0.000048632995,0.011801513,0.0001061786],"about_ca_topic_score_codex":0.0012882854,"about_ca_topic_score_gemma":0.000031850595,"teacher_disagreement_score":0.17305729,"about_ca_system_score_codex":0.000057891386,"about_ca_system_score_gemma":0.00009574111,"threshold_uncertainty_score":0.36418232},"labels":[],"label_agreement":null},{"id":"W2029796174","doi":"10.1016/j.antiviral.2003.07.001","title":"Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Hairless; Lesion; Herpes simplex virus; Erythema; In vivo; Pharmacology; Medicine; Virus; In vitro; Dermatology; Chemistry; Immunology; Biology; Surgery; Biochemistry","score_opus":0.03585109773665064,"score_gpt":0.40037928020784286,"score_spread":0.36452818247119223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029796174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90748906,0.000033453438,0.000023420338,0.00008548111,0.000057255056,0.0007110521,0.000006271069,0.000028633665,0.091565385],"genre_scores_gemma":[0.9987134,0.000080322185,0.000046906123,0.000040632578,0.000037587357,0.00009686523,0.000006372371,0.000021831791,0.0009560932],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980171,0.00051671,0.00025465796,0.00030942683,0.00045546843,0.00044668847],"domain_scores_gemma":[0.99854285,0.00092822197,0.000031424126,0.00032558382,0.00009989239,0.000072049195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008193305,0.00015081868,0.00034662965,0.00041488608,0.00015794596,0.00002222232,0.000068553105,0.00014068242,0.000083966974],"category_scores_gemma":[0.00055166904,0.00011779021,0.00009609546,0.0007320699,0.00016187616,0.00004129332,0.000030526007,0.00045512445,0.00023634583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030180505,0.004743854,0.058839742,0.00037004115,0.00032122782,0.0008867261,0.000304129,0.000029737676,0.05991212,0.013546866,0.00074160227,0.8572859],"study_design_scores_gemma":[0.0073138704,0.00884303,0.008217604,0.00025826873,0.00007537834,0.00010438999,0.000075164055,0.00011213124,0.89000976,0.00068670535,0.08401762,0.0002860895],"about_ca_topic_score_codex":0.00093107444,"about_ca_topic_score_gemma":0.00033252468,"teacher_disagreement_score":0.8569998,"about_ca_system_score_codex":0.00015445224,"about_ca_system_score_gemma":0.00013948766,"threshold_uncertainty_score":0.48033452},"labels":[],"label_agreement":null},{"id":"W2030885831","doi":"10.1016/j.antiviral.2011.11.009","title":"Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Cathepsin B; Endosome; Cell biology; Intracellular; Virology; Virus; Biology; HEK 293 cells; Viral envelope; Endocytosis; Extracellular; Pinocytosis; Cell culture; Cell","score_opus":0.06858855620436495,"score_gpt":0.33198507517379383,"score_spread":0.2633965189694289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030885831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953444,0.0013156915,0.000003795488,0.00005595531,0.000022005068,0.00035688028,0.00003479676,0.0000102920585,0.0028561694],"genre_scores_gemma":[0.99805534,0.0004998196,0.000059138223,0.0000074449,0.0000037124219,0.00003972985,0.000016432426,0.000010768418,0.001307628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979579,0.00069092185,0.00024594457,0.0003122771,0.00010733764,0.0006856417],"domain_scores_gemma":[0.9993748,0.00028078785,0.00003070475,0.00021040744,0.00007254226,0.000030740943],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010174843,0.00010924047,0.00020952684,0.0004293092,0.0000902167,0.00001081882,0.000119234865,0.000118171374,0.0001703431],"category_scores_gemma":[0.00024575877,0.00008371697,0.00003190991,0.00058038975,0.00057400315,0.00013021186,0.00015081087,0.00042286457,0.00091023237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009977167,0.0008887308,0.14875413,0.000061125305,0.0000084497615,0.00039748306,0.0017627695,2.3418362e-7,0.8424153,0.0003540029,0.00030554712,0.004054552],"study_design_scores_gemma":[0.0017828987,0.00090907863,0.13650048,0.00007318562,0.0000030473027,0.000013064907,0.0005597574,0.0000051446295,0.859798,0.0002379462,0.000037650003,0.00007974629],"about_ca_topic_score_codex":0.0018931313,"about_ca_topic_score_gemma":0.0011488798,"teacher_disagreement_score":0.017382741,"about_ca_system_score_codex":0.000055357978,"about_ca_system_score_gemma":0.00013736034,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W2030941371","doi":"10.1016/j.antiviral.2011.07.011","title":"Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Influenza A virus subtype H5N1; Viral replication; Biology; Virology; Virus; In vitro; Cyclooxygenase; Enzyme; Genetics","score_opus":0.1347770368377143,"score_gpt":0.448703199644244,"score_spread":0.3139261628065297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030941371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94005275,0.000105655425,0.0000043917016,0.000050824056,0.000071031835,0.0012485767,0.000011862419,0.000041147883,0.058413785],"genre_scores_gemma":[0.99898046,0.00017912417,0.00006759994,0.00004452053,0.00013286206,0.00012724756,0.000005729903,0.00003601897,0.0004264247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99581146,0.0010762651,0.0003653033,0.00047713536,0.0013293754,0.0009404656],"domain_scores_gemma":[0.9980765,0.00087168295,0.000063924235,0.0003737524,0.00053903507,0.00007512796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033696617,0.00023122848,0.0006150068,0.0013228424,0.0001544589,0.000016640555,0.00014484538,0.0001724589,0.000019989822],"category_scores_gemma":[0.0031814761,0.00017764962,0.0001575645,0.0017192967,0.0006297178,0.000215127,0.00023740965,0.0013839087,0.0002537125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01997127,0.0007754001,0.39989153,0.00041701453,0.00014886392,0.00022660999,0.0013449374,1.5817392e-7,0.5534291,0.00019802012,0.0012224915,0.022374611],"study_design_scores_gemma":[0.0024278022,0.006142339,0.2216676,0.00024122141,0.000012299396,0.0000029484604,0.000043300835,0.00007907039,0.7690412,0.00007719433,0.00015538413,0.000109632456],"about_ca_topic_score_codex":0.002784234,"about_ca_topic_score_gemma":0.00012810848,"teacher_disagreement_score":0.21561208,"about_ca_system_score_codex":0.00030680082,"about_ca_system_score_gemma":0.00022571944,"threshold_uncertainty_score":0.72443414},"labels":[],"label_agreement":null},{"id":"W2031242404","doi":"10.1016/j.antiviral.2007.03.010","title":"Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin–carbohydrate complex from Prunella vulgaris","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Innovation and Technology Fund; Chinese University of Hong Kong; University of Hong Kong; Dalhousie University","keywords":"Prunella vulgaris; In vivo; Rhamnose; Vero cell; Biochemistry; Galactose; Polysaccharide; Microbiology; Chemistry; Biology; In vitro; Pharmacology; Medicine","score_opus":0.06156448742838446,"score_gpt":0.3458857927590903,"score_spread":0.2843213053307059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031242404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998113,0.0006464266,0.000013130953,0.00011219223,0.000029372444,0.00019064515,0.00004530133,0.000004468082,0.0008454641],"genre_scores_gemma":[0.99877346,0.00058762537,0.0002194807,0.000011402261,0.00010572516,0.0000050766703,0.000014813433,0.000016897438,0.0002655192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985678,0.00014115329,0.00027374196,0.0003522431,0.00031158334,0.00035347842],"domain_scores_gemma":[0.9993961,0.00010281867,0.00007554289,0.00026144442,0.00012787052,0.00003625557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006010895,0.00013211126,0.00027852503,0.00014443648,0.000051222414,0.000016992737,0.00017341782,0.00017745135,0.000006222336],"category_scores_gemma":[0.00016513774,0.00011151667,0.00005681812,0.00019055771,0.00053050346,0.00001642209,0.00020178172,0.00018384201,6.5314487e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051585515,0.00013591831,0.0039206375,0.000064455715,0.000047968755,0.0000028061008,0.00017381295,6.898303e-7,0.9888136,0.000020229741,0.000401479,0.0059025437],"study_design_scores_gemma":[0.00026903691,0.00010735602,0.0037654545,0.00004527192,0.0000056665963,0.0000010672375,0.00068510004,0.00008640614,0.9942486,0.00009317416,0.00057099113,0.000121822086],"about_ca_topic_score_codex":0.0021186676,"about_ca_topic_score_gemma":0.00037428265,"teacher_disagreement_score":0.0057807215,"about_ca_system_score_codex":0.000017617307,"about_ca_system_score_gemma":0.00008054751,"threshold_uncertainty_score":0.4547518},"labels":[],"label_agreement":null},{"id":"W2031618987","doi":"10.1016/j.antiviral.2012.12.023","title":"Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HBeAg; Hepatitis B virus; Medicine; Gastroenterology; Antigen; Basal (medicine); Hepatitis B; Mutant; Lamivudine; Chronic hepatitis; Virology; Internal medicine; Immunology; Virus; Biology; HBsAg","score_opus":0.15386927165674616,"score_gpt":0.4300484610500494,"score_spread":0.2761791893933032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031618987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715316,0.00041392015,0.000009629802,0.0010103607,0.00003841106,0.0007109296,0.000060420778,0.000018271592,0.00058486906],"genre_scores_gemma":[0.99801725,0.0004884668,0.00046295126,0.0001264374,0.000074756535,0.00002983521,0.0000016921672,0.000024750243,0.0007738332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800926,0.0002586,0.00024651692,0.00029383542,0.0005621788,0.00062959973],"domain_scores_gemma":[0.99871,0.0004206972,0.000037027858,0.0002807557,0.00035270493,0.00019885346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018487284,0.00014534024,0.00034903173,0.00028078156,0.00013251284,0.00002311377,0.0000966713,0.00008448752,0.000026752421],"category_scores_gemma":[0.0021845996,0.00012200343,0.000026995483,0.0003280282,0.00047352636,0.0002671357,0.00042521374,0.0002945796,0.00006272888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008846299,0.00006520408,0.7798362,0.00010895051,0.00003504671,0.000037309423,0.0033409318,2.1497877e-8,0.20996667,0.00002576262,0.00056348246,0.0051358067],"study_design_scores_gemma":[0.0004362898,0.0012844307,0.93282676,0.00037257155,0.000009727985,0.000023327348,0.0000945662,0.000020739639,0.064258054,0.000051756837,0.00051460706,0.000107190615],"about_ca_topic_score_codex":0.0016126465,"about_ca_topic_score_gemma":0.0005911901,"teacher_disagreement_score":0.15299056,"about_ca_system_score_codex":0.000056632183,"about_ca_system_score_gemma":0.000117272255,"threshold_uncertainty_score":0.49751556},"labels":[],"label_agreement":null},{"id":"W2034970205","doi":"10.1016/j.antiviral.2008.04.003","title":"Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Retinoid; Measles virus; Retinoid X receptor beta; Biology; Cell culture; Retinoic acid; Retinoid X receptor gamma; Retinol; Retinoid X receptor alpha; Signal transduction; Cancer research; Cell biology; Virology; Vitamin; Measles; Endocrinology; Genetics","score_opus":0.04906167600686478,"score_gpt":0.2991390698049771,"score_spread":0.25007739379811234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034970205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080116,0.0011440526,0.000097722324,0.0001120491,0.0000907463,0.00026371249,0.00001641413,0.000033471024,0.007440685],"genre_scores_gemma":[0.9957863,0.0017667254,0.0008356277,0.000108106535,0.00042036665,0.000032859483,0.00011651798,0.0000721337,0.0008613363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967193,0.0005053039,0.00040401763,0.00075570226,0.0007443349,0.00087134395],"domain_scores_gemma":[0.99892426,0.0000692106,0.00007649886,0.00052171084,0.00030480503,0.0001034959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001463835,0.00025350862,0.00027374885,0.0002124692,0.0003881051,0.000054006698,0.00054317724,0.00038015042,0.000041072064],"category_scores_gemma":[0.0006231733,0.00024838117,0.0001373739,0.0005508099,0.0005846664,0.000019149986,0.0004034195,0.00073469715,0.0002701022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051078596,0.00011875632,0.0009572098,0.00005133418,0.000015497002,0.00009689512,0.00025958873,0.000002079509,0.99257684,0.000061804356,0.0021672368,0.0031819686],"study_design_scores_gemma":[0.00052131584,0.00033598032,0.00022372747,0.000044081436,0.000002929272,0.000028777911,0.00021121709,0.00007136665,0.9863141,0.00017130391,0.011773939,0.00030122124],"about_ca_topic_score_codex":0.000112884474,"about_ca_topic_score_gemma":0.000010833216,"teacher_disagreement_score":0.009606702,"about_ca_system_score_codex":0.00007474653,"about_ca_system_score_gemma":0.00029049095,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W2037465112","doi":"10.1016/j.antiviral.2013.01.003","title":"Current and future approaches to the therapy of human rabies","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Rabies; Rabies virus; Medicine; Regimen; Coma (optics); Rabies vaccine; Intensive care medicine; Disease; Immunology; Virology; Surgery; Internal medicine","score_opus":0.4699903491001967,"score_gpt":0.4608586767891744,"score_spread":0.009131672311022299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037465112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085468986,0.99515086,0.0000027994013,0.0010987149,0.0003520796,0.0015952392,0.000031013347,0.000014735838,0.00089988305],"genre_scores_gemma":[0.0025617348,0.9948041,0.0000049187593,0.000025651905,0.00033314485,0.00048332318,0.00007775052,0.00002387415,0.0016854901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948372,0.003531516,0.0004905431,0.0004667704,0.00007809757,0.0005958694],"domain_scores_gemma":[0.997844,0.0012830434,0.0001596437,0.0006023813,0.00009201154,0.000018961753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027385799,0.00030178178,0.0013775976,0.00025320376,0.00045914535,0.000023400158,0.00076606986,0.0005654954,0.00008559035],"category_scores_gemma":[0.00017407491,0.00015143627,0.0002746965,0.0003007576,0.0010409369,0.00005101075,0.00033502778,0.00174348,0.00061147293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020121503,0.000049371283,0.000034741868,0.0007134112,0.00026092108,4.8643125e-7,0.000170629,3.867076e-9,0.00012239719,0.008010032,0.016467093,0.9741508],"study_design_scores_gemma":[0.00019717123,0.0002628034,0.00014965229,0.00063252065,0.000037433612,0.000007411119,0.00013682489,9.945309e-8,0.000074628006,0.00036305055,0.99799144,0.00014693246],"about_ca_topic_score_codex":0.00007000195,"about_ca_topic_score_gemma":0.000014887822,"teacher_disagreement_score":0.9815244,"about_ca_system_score_codex":0.000018420722,"about_ca_system_score_gemma":0.00012255786,"threshold_uncertainty_score":0.7859451},"labels":[],"label_agreement":null},{"id":"W2045993180","doi":"10.1016/j.antiviral.2014.02.017","title":"Oseltamivir–zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Zanamivir; Oseltamivir; Virology; Combination therapy; Medicine; Neuraminidase inhibitor; Virus; Influenza A virus; Titer; Pharmacology; Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.14426044425505627,"score_gpt":0.4450199786447343,"score_spread":0.30075953438967806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045993180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083364,0.0005004392,0.00007288612,0.0028508622,0.00003759253,0.0022202434,0.000025502555,0.00011693248,0.0033419211],"genre_scores_gemma":[0.9904189,0.0015252702,0.0003443951,0.006445173,0.00011323502,0.00029095734,0.000008581858,0.00011071724,0.0007427366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941298,0.0009014016,0.00057142146,0.0009910892,0.0019648625,0.0014414204],"domain_scores_gemma":[0.99671763,0.0012199157,0.00007989216,0.00071811513,0.0009864083,0.000278049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030011975,0.00047771155,0.0008454637,0.0016601394,0.00045785753,0.00023427435,0.00038909566,0.00024264427,0.00005338345],"category_scores_gemma":[0.0014469889,0.00037520152,0.00009230074,0.0023302333,0.00085427676,0.0005742269,0.00031383903,0.0012379446,0.00027902058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084402,0.0009891291,0.49152285,0.00022512076,0.0003147477,0.00008281903,0.0055109835,0.000005191453,0.3985624,0.0015782601,0.0015047708,0.09126351],"study_design_scores_gemma":[0.012492723,0.006029274,0.808412,0.00044398554,0.000017673558,0.0000098362825,0.00045664812,0.0010401004,0.13321833,0.00026495362,0.037008345,0.0006061363],"about_ca_topic_score_codex":0.003202469,"about_ca_topic_score_gemma":0.0011445599,"teacher_disagreement_score":0.31688914,"about_ca_system_score_codex":0.00027540184,"about_ca_system_score_gemma":0.0003383707,"threshold_uncertainty_score":0.99987},"labels":[],"label_agreement":null},{"id":"W2047767458","doi":"10.1016/j.antiviral.2010.06.001","title":"Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Drug resistance; Virology; Biology; Mutation; Virus; Protease; Protease inhibitor (pharmacology); Recombinant DNA; Resistance mutation; Human immunodeficiency virus (HIV); Lentivirus; Genetics; Viral disease; Enzyme; Viral load; Gene; Reverse transcriptase; Polymerase chain reaction; Antiretroviral therapy","score_opus":0.025592750565193487,"score_gpt":0.35780198163759624,"score_spread":0.33220923107240274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047767458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689973,0.00008914124,0.00003817463,0.004118184,0.000044323337,0.0011192842,0.000072608476,0.000024841569,0.007593697],"genre_scores_gemma":[0.8479516,0.000036174577,0.0021011466,0.000020454567,0.00008783236,0.00012512061,0.00018398059,0.00002197224,0.14947172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735385,0.00010411487,0.0004276824,0.0005189373,0.0010025554,0.00059286266],"domain_scores_gemma":[0.9987206,0.00016080204,0.00008544118,0.0005305662,0.00036444503,0.00013813056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011065904,0.00021552497,0.00059960625,0.0011678666,0.000111893525,0.0000372359,0.00022893024,0.00015434485,0.00009645897],"category_scores_gemma":[0.00045615705,0.00016375381,0.00014165798,0.0027459501,0.00029538822,0.00014594742,0.00012608686,0.0008171135,0.00017633157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001277901,0.0024713657,0.37676072,0.00035066914,0.00079965673,0.00053743226,0.0063510383,6.74006e-7,0.57386756,0.00037728783,0.034794874,0.002410801],"study_design_scores_gemma":[0.006887408,0.00018323571,0.30520064,0.0007024949,0.00050621544,0.000004967856,0.0010315172,0.0006945027,0.65556246,0.0000639427,0.028659895,0.0005027088],"about_ca_topic_score_codex":0.00015152029,"about_ca_topic_score_gemma":0.0018257098,"teacher_disagreement_score":0.14187801,"about_ca_system_score_codex":0.00010419346,"about_ca_system_score_gemma":0.00034550828,"threshold_uncertainty_score":0.66776866},"labels":[],"label_agreement":null},{"id":"W2050801792","doi":"10.1016/j.antiviral.2005.08.004","title":"Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Vero cell; Herpes simplex virus; Dendrimer; Microbicide; HSL and HSV; Chemistry; Cytotoxicity; IC50; Virology; Cytotoxic T cell; In vitro; Virus; Biology; Biochemistry","score_opus":0.13400769923431005,"score_gpt":0.42914197169751717,"score_spread":0.2951342724632071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050801792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819099,0.0054779244,0.0000090909425,0.0004054046,0.000060365,0.0005878067,0.00013729278,0.000027508333,0.011384732],"genre_scores_gemma":[0.9963086,0.00040435363,0.00008124096,0.000059836482,0.000051259398,0.00006721464,0.00019172583,0.000021229065,0.0028145323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633074,0.0016255364,0.000315835,0.00037998075,0.00048226674,0.0008656605],"domain_scores_gemma":[0.99827176,0.0003415844,0.0000646378,0.0004124097,0.0008775373,0.000032089585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037818742,0.00016695904,0.00027387586,0.00037795838,0.0002852171,0.000029738456,0.0003274833,0.00016572517,0.00062388397],"category_scores_gemma":[0.00055987743,0.00013600473,0.000107969645,0.00038939508,0.0005972924,0.0001931718,0.0001863636,0.00037528126,0.007262442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016622856,0.00032654766,0.001481611,0.000010326223,0.0002521883,0.0000075788917,0.00021294068,0.0000034877035,0.6338268,0.00007330651,0.011574163,0.35206482],"study_design_scores_gemma":[0.0023046837,0.00025887068,0.0051779137,0.000043588367,0.000047321464,0.000005417984,0.0001928638,0.00005170993,0.8845749,0.00009142241,0.10712097,0.00013032668],"about_ca_topic_score_codex":0.0014742918,"about_ca_topic_score_gemma":0.001887574,"teacher_disagreement_score":0.3519345,"about_ca_system_score_codex":0.00020367083,"about_ca_system_score_gemma":0.00058070803,"threshold_uncertainty_score":0.99351054},"labels":[],"label_agreement":null},{"id":"W2051824837","doi":"10.1016/j.antiviral.2007.12.006","title":"Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970–2007)","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Provincial Laboratory of Public Health","funders":"","keywords":"Adamantane; Virology; Virus; Amino acid; Amino acid substitution; Influenza A virus; Drug resistance; Biology; Mutation; Microbiology; Chemistry; Genetics; Gene","score_opus":0.24203572411408283,"score_gpt":0.4491608887736014,"score_spread":0.20712516465951855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051824837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953525,0.0020047878,0.0000013463613,0.00049648416,0.000060045422,0.0006471622,0.000039373503,0.000032931195,0.043192882],"genre_scores_gemma":[0.99365944,0.00020922748,0.00019279584,0.0011103484,0.00028585945,0.000080291786,0.00001875672,0.00005546363,0.004387804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941789,0.00043972518,0.0006377137,0.0007178198,0.0025236572,0.0015021962],"domain_scores_gemma":[0.9970601,0.001340123,0.00007796987,0.0007351077,0.0005911111,0.00019557208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010773252,0.0002858837,0.00062605966,0.00048718622,0.00083115423,0.000043294756,0.00039251414,0.00014317052,0.00016156245],"category_scores_gemma":[0.0035246483,0.00026428883,0.00009072763,0.0012220816,0.00069316605,0.00025765732,0.0003823124,0.0014654136,0.00019167893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000977581,0.00023466672,0.89992994,0.00016932422,0.00017368713,0.0064437618,0.0021461495,0.000003913862,0.05647702,0.00047259012,0.032341644,0.0006297124],"study_design_scores_gemma":[0.003236509,0.00021576806,0.92736864,0.00068740355,0.000014765807,0.000015139209,0.0007059009,0.000103862585,0.014930291,0.00036926806,0.05192145,0.0004309829],"about_ca_topic_score_codex":0.93637866,"about_ca_topic_score_gemma":0.95885414,"teacher_disagreement_score":0.041546732,"about_ca_system_score_codex":0.0009534746,"about_ca_system_score_gemma":0.0020412933,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2054452932","doi":"10.1016/j.antiviral.2015.01.001","title":"Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Virology; Immunization; Nasal administration; Transmission (telecommunications); Virus; Ebola virus; Medicine; Biology; Antibody; Immunology","score_opus":0.08187384616496686,"score_gpt":0.39539693342040827,"score_spread":0.3135230872554414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054452932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968774,0.00066825404,0.0031310753,0.0011278623,0.00003542948,0.0015236941,0.00006292681,0.0001838812,0.00357911],"genre_scores_gemma":[0.99688727,0.00032868382,0.0009330536,0.00006790978,0.00025629677,0.00009636027,0.00036017067,0.00008490425,0.0009853353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99576074,0.00077995285,0.00038146292,0.00061918393,0.0016003072,0.00085838145],"domain_scores_gemma":[0.9973424,0.00017756176,0.000060356873,0.0005765421,0.0013538041,0.00048934855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015392132,0.00028167033,0.00044677517,0.0005556842,0.00036926143,0.00019936425,0.0002742591,0.0002687751,0.0002984572],"category_scores_gemma":[0.00044843904,0.00020551009,0.000066786386,0.0018481478,0.00020050223,0.0005491119,0.00012003271,0.001284221,0.00020765081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050864727,0.0007780227,0.0064761858,0.00005242019,0.000097271644,0.00014605053,0.00044658047,0.0000029927085,0.94226676,0.00005264667,0.005979516,0.038615048],"study_design_scores_gemma":[0.008849648,0.014912087,0.03403461,0.00034231323,0.000060718638,0.000055576147,0.00045465498,0.005436271,0.9187772,0.00050276564,0.016079158,0.0004949852],"about_ca_topic_score_codex":0.011608402,"about_ca_topic_score_gemma":0.00054472755,"teacher_disagreement_score":0.038120065,"about_ca_system_score_codex":0.00020840748,"about_ca_system_score_gemma":0.0006501038,"threshold_uncertainty_score":0.99497336},"labels":[],"label_agreement":null},{"id":"W2055698455","doi":"10.1016/j.antiviral.2006.02.008","title":"Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Quest Diagnostics; University of Washington","keywords":"Protease inhibitor (pharmacology); Protease; Virology; HIV-1 protease; Human immunodeficiency virus (HIV); Term (time); Medicine; Biology; Enzyme; Viral load; Antiretroviral therapy; Biochemistry","score_opus":0.025661647620190287,"score_gpt":0.32368918038969136,"score_spread":0.29802753276950106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055698455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928543,0.00024682627,0.000027804945,0.00064053177,0.000029339935,0.0041309963,0.00010511425,0.00006684118,0.0018982195],"genre_scores_gemma":[0.97310394,0.00006040677,0.00061656506,0.0000053842764,0.00012553533,0.0007080472,0.00040387112,0.000050420815,0.02492581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674934,0.00037071353,0.0004802108,0.0005627393,0.0011260872,0.0007109175],"domain_scores_gemma":[0.998198,0.00036878246,0.00019503769,0.00038250117,0.0006967283,0.00015900683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006027121,0.00033183637,0.0004767,0.0004405467,0.00033644104,0.00006151772,0.0001273315,0.00014823722,0.000051535342],"category_scores_gemma":[0.0003453037,0.00023572033,0.00012343153,0.0007797765,0.0004625952,0.00026696955,0.00009339566,0.0003707047,0.00014842875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013951435,0.00321451,0.95352376,0.00042668727,0.00026772518,0.0009765174,0.0008219309,0.0000028926586,0.036931258,0.000026128244,0.00065641996,0.0017570081],"study_design_scores_gemma":[0.0074198702,0.002033079,0.56748056,0.0031552776,0.0003089752,0.000052942396,0.00021066146,0.00021661958,0.41870797,0.000058378508,0.000035446035,0.00032019717],"about_ca_topic_score_codex":0.00046173885,"about_ca_topic_score_gemma":0.0000694648,"teacher_disagreement_score":0.3860432,"about_ca_system_score_codex":0.00053888,"about_ca_system_score_gemma":0.00092643965,"threshold_uncertainty_score":0.9612396},"labels":[],"label_agreement":null},{"id":"W2055770088","doi":"10.1016/j.antiviral.2013.05.003","title":"The lung microvascular endothelium as a therapeutic target in severe influenza","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"ARDS; Lung; Hypoxemia; Endothelium; Sepsis; Medicine; Immunology; Endothelial stem cell; Biology; Internal medicine","score_opus":0.25162348157591524,"score_gpt":0.5184449099430837,"score_spread":0.26682142836716843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055770088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029766184,0.9782945,0.0000011050878,0.0003171059,0.00010813834,0.005915266,0.000023522874,0.000054410822,0.0149883265],"genre_scores_gemma":[0.00016291425,0.9847327,0.000062178624,0.00028859748,0.00034852632,0.0017381636,0.000025175399,0.00017409088,0.012467676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901238,0.002692726,0.0010604303,0.0009756277,0.0027052427,0.002442164],"domain_scores_gemma":[0.9937952,0.0032853908,0.00017011164,0.00170007,0.00086298323,0.0001862146],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00637698,0.00071620854,0.0023049132,0.0011365117,0.0007608146,0.00035124118,0.0012554489,0.0005749823,0.00015519556],"category_scores_gemma":[0.003188674,0.0004032452,0.0009389363,0.0020977554,0.0011954271,0.00021841165,0.001186649,0.0047907475,0.0056903516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015383339,0.00017672914,0.00035342795,0.014604217,0.0014687687,0.00042427244,0.0002564409,7.830649e-8,0.00013528943,0.00074935687,0.0141990185,0.9674786],"study_design_scores_gemma":[0.0008869792,0.00025958507,0.00008881035,0.0082050655,0.00016116754,0.000075383316,0.00015505325,0.000013583288,0.00010340978,0.0003954438,0.98927546,0.00038003968],"about_ca_topic_score_codex":0.0009815918,"about_ca_topic_score_gemma":0.000039728293,"teacher_disagreement_score":0.97507644,"about_ca_system_score_codex":0.0008636136,"about_ca_system_score_gemma":0.0026117754,"threshold_uncertainty_score":0.9998419},"labels":[],"label_agreement":null},{"id":"W2061934699","doi":"10.1016/j.antiviral.2008.02.001","title":"Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University; Public Health Agency of Canada; University of Manitoba","funders":"Canadian Institutes of Health Research; Manitoba Medical Service Foundation","keywords":"Influenza A virus subtype H5N1; Virology; Neuraminidase; Biology; Transduction (biophysics); Influenza A virus; Hemagglutinin (influenza); Viral vector; Oseltamivir; Neuraminidase inhibitor; Virus; Recombinant DNA; Medicine; Biochemistry; Gene","score_opus":0.16225901549436017,"score_gpt":0.4067390509268816,"score_spread":0.24448003543252145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061934699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953087,0.00031820187,0.0009825004,0.00017911314,0.00007764461,0.0015950967,0.00018977954,0.00005433559,0.0012946469],"genre_scores_gemma":[0.99755675,0.000164401,0.0010676087,0.00004372655,0.00024903665,0.00013418237,0.000062919346,0.000047491787,0.0006738858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960512,0.00033647384,0.00069986476,0.0004460854,0.0017365023,0.0007299026],"domain_scores_gemma":[0.99695915,0.0004178922,0.00021025167,0.0005091868,0.0018056041,0.00009788593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013515712,0.00021908608,0.00070892327,0.0006059815,0.00031906215,0.00001735483,0.00025664383,0.00017123636,0.000009213139],"category_scores_gemma":[0.0012469948,0.00019026785,0.00014747854,0.00069365255,0.0007094385,0.00024693846,0.00022324397,0.00046807135,0.00003244069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023767096,0.00022084216,0.023941245,0.0015199191,0.00021512223,0.000069138965,0.00087352446,0.0000018649055,0.967609,0.0014023836,0.00024284411,0.0015273943],"study_design_scores_gemma":[0.0028659059,0.001041165,0.17543417,0.00078608375,0.00003429154,0.000013956617,0.0005013388,0.00022890492,0.81864756,0.000019586685,0.00027456478,0.00015245467],"about_ca_topic_score_codex":0.00037473335,"about_ca_topic_score_gemma":0.000010253214,"teacher_disagreement_score":0.15149292,"about_ca_system_score_codex":0.00017404441,"about_ca_system_score_gemma":0.00047337968,"threshold_uncertainty_score":0.77588975},"labels":[],"label_agreement":null},{"id":"W2065172397","doi":"10.1016/s0166-3542(00)00080-2","title":"Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Cidofovir; Titer; Inoculation; Regimen; Erythema; Medicine; Virology; Surgery; Immunology; Virus","score_opus":0.04584998312997246,"score_gpt":0.39394726894424786,"score_spread":0.3480972858142754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065172397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.891957,0.0006215481,0.0000018626903,0.001415503,0.00002137407,0.0006103788,0.0000028054824,0.000019456838,0.105350055],"genre_scores_gemma":[0.9797674,0.0028527156,0.000039337774,0.000107684704,0.00015087804,0.000042009433,0.0000049458654,0.000016005884,0.01701905],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766266,0.0002141187,0.00017744703,0.00038845357,0.0010109753,0.0005463653],"domain_scores_gemma":[0.99854046,0.0007346986,0.000013558357,0.00037974707,0.00015426187,0.0001772511],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031833,0.00013132919,0.00032872637,0.00017180694,0.00011597917,0.00003242706,0.00012548442,0.00011507106,0.00095622416],"category_scores_gemma":[0.00028460025,0.0000946356,0.00007661809,0.00031388682,0.00035412397,0.000060904546,0.00007308676,0.0004549084,0.00021668871],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002899681,0.00063951395,0.009813718,0.0003739092,0.00007379009,0.001209478,0.00036862213,2.4385722e-7,0.013268202,0.00061050494,0.00102181,0.96972054],"study_design_scores_gemma":[0.009355562,0.035760242,0.2383644,0.00046780222,0.000091647344,0.0002864319,0.00023836856,0.0005139729,0.67352283,0.0019422667,0.039020207,0.00043624704],"about_ca_topic_score_codex":0.0007292842,"about_ca_topic_score_gemma":0.00005471715,"teacher_disagreement_score":0.9692843,"about_ca_system_score_codex":0.00014994941,"about_ca_system_score_gemma":0.00016974573,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W2065243148","doi":"10.1016/j.antiviral.2007.08.001","title":"Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Canadian Institutes of Health Research","keywords":"Ficolin; Porcine reproductive and respiratory syndrome virus; Recombinant DNA; Collectin; Lectin pathway; Biology; Lectin; Complement system; Arterivirus; In vitro; Innate immune system; Virus; Glycoprotein; Virology; Molecular biology; Immune system; Mannan-binding lectin; Biochemistry; Classical complement pathway; Immunology","score_opus":0.08025344957853148,"score_gpt":0.3493860978206842,"score_spread":0.2691326482421527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065243148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966414,0.00066023495,4.297353e-7,0.00033076797,0.00003765533,0.00032992035,0.000026007867,0.00002443074,0.0019491705],"genre_scores_gemma":[0.9993799,0.00028426055,0.000026325759,0.000017808716,0.00010636144,0.000013301684,0.0000033146991,0.0000019850813,0.00016675825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806273,0.00025407842,0.0003051682,0.00053854455,0.00036414282,0.00047532335],"domain_scores_gemma":[0.9987494,0.000824412,0.00008103353,0.00008826488,0.00019875528,0.000058181948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036370573,0.00014707274,0.00032121764,0.00016588795,0.00029635,0.000029578325,0.000114734954,0.00011524633,0.000012779998],"category_scores_gemma":[0.0009954099,0.000069524445,0.000036702444,0.0011940891,0.0006938123,0.00022863278,0.00034054526,0.00042240505,0.0000077454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000374074,0.0001538334,0.12085704,0.00001304166,0.00001350853,0.000040985848,0.00011875325,7.685397e-8,0.84630793,0.000109393506,0.00006781129,0.03194352],"study_design_scores_gemma":[0.00015893664,0.0008417052,0.6283331,0.000024246487,0.000002958979,0.000013432811,0.0003628581,0.0000041769094,0.3696347,0.00020186481,0.0003319503,0.00009008174],"about_ca_topic_score_codex":0.0023870133,"about_ca_topic_score_gemma":0.0021929976,"teacher_disagreement_score":0.5074761,"about_ca_system_score_codex":0.000049903087,"about_ca_system_score_gemma":0.00001803337,"threshold_uncertainty_score":0.36084658},"labels":[],"label_agreement":null},{"id":"W2065462956","doi":"10.1016/j.antiviral.2004.08.004","title":"A novel model of HPV infection in meshed human foreskin grafts","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Foreskin; In situ hybridization; Papilloma; Histology; Medicine; HPV infection; Pathology; Virology; Biology; Cell culture; Cervical cancer; Gene expression; Internal medicine; Cancer; Gene","score_opus":0.2000282829938549,"score_gpt":0.47451939844230784,"score_spread":0.27449111544845295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065462956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9246173,0.00005987021,0.0007390549,0.00062011596,0.000014822055,0.00049568136,0.000007074071,0.000018976007,0.073427096],"genre_scores_gemma":[0.99864477,0.00013013402,0.00023524453,0.000038810736,0.0000707029,0.000044444136,0.000014794501,0.000020756133,0.0008003673],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977086,0.000059939655,0.00027416024,0.0002911588,0.0011027068,0.0005634385],"domain_scores_gemma":[0.9990779,0.00007386178,0.000023430426,0.00029883801,0.0004345091,0.00009143579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013255958,0.00009806128,0.0002783213,0.00067107944,0.00009112849,0.000019599378,0.00013131485,0.000118925724,0.00020726424],"category_scores_gemma":[0.0003522622,0.00008438721,0.000097259785,0.0010290081,0.00027363127,0.00012854449,0.0001593869,0.0007600562,0.000037086396],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021871359,0.0030051153,0.10102595,0.0010122451,0.00007665887,0.000090404,0.0011125241,0.00046876541,0.77663803,0.04479463,0.0006272055,0.068961315],"study_design_scores_gemma":[0.0069844676,0.0012528477,0.8098239,0.0000870436,0.000009899802,0.000006211939,0.000055840857,0.0052181715,0.15649857,0.019837327,0.00008250443,0.00014325546],"about_ca_topic_score_codex":0.008837501,"about_ca_topic_score_gemma":0.0047041876,"teacher_disagreement_score":0.70879793,"about_ca_system_score_codex":0.0002707842,"about_ca_system_score_gemma":0.0004383903,"threshold_uncertainty_score":0.99776274},"labels":[],"label_agreement":null},{"id":"W2066743245","doi":"10.1016/j.antiviral.2005.10.007","title":"Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Terry Fox Research Institute","funders":"","keywords":"TLR9; CpG Oligodeoxynucleotide; Innate immune system; Immune system; Agonist; TLR7; Immunology; Biology; CpG site; Chemokine; Receptor; Toll-like receptor","score_opus":0.10050744449403827,"score_gpt":0.4613525181820126,"score_spread":0.36084507368797436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066743245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992444,0.0004689099,0.0000146247185,0.0002902279,0.00001747826,0.00036578602,0.000006499227,0.0000115236835,0.006380946],"genre_scores_gemma":[0.99799126,0.0012555184,0.00032042214,0.0000040283353,0.000048701633,0.000031825813,0.000006154859,0.000011653753,0.0003304554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987966,0.00013801301,0.00031008266,0.0002021108,0.00029081348,0.0002623966],"domain_scores_gemma":[0.99945724,0.00013505948,0.000051512434,0.00016709555,0.00014110847,0.00004800367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028773394,0.000104293955,0.00035567183,0.00046610317,0.00005793406,0.00000951014,0.000029429046,0.00008109585,0.000025888268],"category_scores_gemma":[0.00006876789,0.00008363152,0.00003798277,0.0004315638,0.00024124378,0.000100685334,0.000029453513,0.00016441722,0.000022453529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042891924,0.0026193669,0.6988621,0.0000833305,0.000091614485,0.00001688307,0.0007214965,0.0000026155724,0.03158422,0.0006020637,0.00009429355,0.26489308],"study_design_scores_gemma":[0.002912838,0.004896688,0.6817903,0.00016450338,0.000046845496,0.00001572425,0.00015084383,0.0007927656,0.30384874,0.0001358134,0.0051636794,0.000081254424],"about_ca_topic_score_codex":0.0051987236,"about_ca_topic_score_gemma":0.0014271928,"teacher_disagreement_score":0.27226454,"about_ca_system_score_codex":0.0001708213,"about_ca_system_score_gemma":0.00010289122,"threshold_uncertainty_score":0.785895},"labels":[],"label_agreement":null},{"id":"W2067082178","doi":"10.1016/s0166-3542(03)00112-8","title":"HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Electroretinography; Retinal; Erg; Retinitis; Medicine; Cidofovir; Ophthalmology; Cytomegalovirus retinitis; Retinal degeneration; Retina; Virology; Virus; Biology; Human cytomegalovirus","score_opus":0.07454354648736128,"score_gpt":0.3840748088871355,"score_spread":0.30953126239977424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067082178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861419,0.00094393274,0.00003449946,0.0012204177,0.000013191392,0.0024981645,0.000026171689,0.00002451042,0.009097174],"genre_scores_gemma":[0.99655515,0.0021815656,0.00009631008,0.00016209921,0.000050803716,0.00043695304,0.000019991237,0.000047202713,0.000449927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941276,0.0014327697,0.00042590286,0.00054463133,0.0023384804,0.0011306237],"domain_scores_gemma":[0.9976354,0.0005767371,0.0000703034,0.00085608533,0.000660381,0.00020108686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066527394,0.00024420407,0.00044307756,0.00086432626,0.00024857567,0.000075050644,0.00055301806,0.00017408453,0.00007953223],"category_scores_gemma":[0.001548865,0.00016557756,0.00024202654,0.002655915,0.00062080484,0.0001305198,0.00007102478,0.0016238048,0.000043002325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021283338,0.0008740355,0.056229305,0.000092837785,0.00004775979,0.00016520983,0.00043163673,4.4476987e-8,0.9324685,0.00073185796,0.004682616,0.0021478732],"study_design_scores_gemma":[0.001984502,0.0016702033,0.024019634,0.00017328703,0.00000891885,0.000010688104,0.00034770145,0.000016805887,0.96654075,0.0006738624,0.0043601654,0.00019348584],"about_ca_topic_score_codex":0.0010312292,"about_ca_topic_score_gemma":0.00014566357,"teacher_disagreement_score":0.034072254,"about_ca_system_score_codex":0.000113163835,"about_ca_system_score_gemma":0.001212888,"threshold_uncertainty_score":0.70547146},"labels":[],"label_agreement":null},{"id":"W2067685971","doi":"10.1016/j.antiviral.2014.08.015","title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Dosing; Ribavirin; Internal medicine; Gastroenterology; Placebo; Hepatitis C virus; MiR-122; Chronic hepatitis; Hepatitis C; Virus; Immunology; Pathology","score_opus":0.017970550729739267,"score_gpt":0.32018224973390513,"score_spread":0.3022116990041659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067685971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843466,0.000937367,0.000066614455,0.00003017262,0.000022111155,0.00029176276,0.000013303766,0.0000030757421,0.00020094476],"genre_scores_gemma":[0.99792594,0.0016914661,0.0000327106,0.0000111329755,0.000063887695,0.0000058859414,0.0001698922,0.000015105417,0.000083978695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988281,0.00026207496,0.00018530145,0.00026444744,0.00019890879,0.00026113258],"domain_scores_gemma":[0.9994864,0.00004384514,0.000045366956,0.00025160212,0.0001391957,0.000033604538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465458,0.00008670537,0.000120693534,0.00009933595,0.000047553476,0.0000136952585,0.00013672073,0.00009670157,0.000009626319],"category_scores_gemma":[0.00016957786,0.00008183842,0.000038225015,0.00014861733,0.00017530176,0.000005762059,0.00012176623,0.00010092662,0.000006803625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019890268,0.00006992736,0.3902185,0.000022051056,0.000011020659,5.661165e-7,0.00001582166,0.000001003737,0.5803499,0.000016909895,0.00005402442,0.029041352],"study_design_scores_gemma":[0.0011430874,0.00037080058,0.6664938,0.000026385835,9.954514e-7,1.9504827e-7,7.270416e-7,0.000036933114,0.33156544,0.00001369486,0.00029068245,0.000057324018],"about_ca_topic_score_codex":0.00013375831,"about_ca_topic_score_gemma":0.00020336742,"teacher_disagreement_score":0.27627525,"about_ca_system_score_codex":0.00003994352,"about_ca_system_score_gemma":0.00008301741,"threshold_uncertainty_score":0.3337274},"labels":[],"label_agreement":null},{"id":"W2070125035","doi":"10.1016/j.antiviral.2013.10.007","title":"The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Herpes simplex virus; Etanercept; Tumor necrosis factor alpha; Immune system; Virus; Medicine; Antibody; Encephalitis; Viral encephalitis; Pathogenesis; Immunology; Viral load; Virology; Combination therapy; Pharmacology","score_opus":0.08247525602762802,"score_gpt":0.4055634919178162,"score_spread":0.3230882358901882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070125035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965268,0.00009309504,0.0001182744,0.0003118495,0.000027520087,0.0015523125,0.00007670017,0.000029110688,0.001264357],"genre_scores_gemma":[0.9984303,0.00078845944,0.00023840046,0.000034746572,0.000028748755,0.00010804146,0.00007860094,0.00003901945,0.00025368712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676657,0.00081532786,0.00053685036,0.00040921185,0.0008473706,0.0006246986],"domain_scores_gemma":[0.99781126,0.0005853724,0.00012601959,0.0005777446,0.00077828503,0.00012130364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016233659,0.00023911698,0.00062257395,0.00046004212,0.00023083072,0.00006571251,0.00024908016,0.00008800863,0.000029449113],"category_scores_gemma":[0.00020092756,0.00015523891,0.000086030435,0.0011605372,0.0005384127,0.0004402702,0.00011034707,0.00026666356,0.000032589018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036147372,0.008958681,0.48801324,0.00012345501,0.0004251722,0.000082223036,0.0009042138,0.00010148393,0.29343414,0.0014851558,0.00017312559,0.20268437],"study_design_scores_gemma":[0.006825608,0.002901934,0.7811611,0.00022971338,0.000025222771,0.0000048281336,0.0005760744,0.012248131,0.19464178,0.0007798599,0.0003768683,0.00022885867],"about_ca_topic_score_codex":0.036914017,"about_ca_topic_score_gemma":0.0028228336,"teacher_disagreement_score":0.2931479,"about_ca_system_score_codex":0.000072936906,"about_ca_system_score_gemma":0.0002879203,"threshold_uncertainty_score":0.96949923},"labels":[],"label_agreement":null},{"id":"W2070528933","doi":"10.1016/j.antiviral.2009.05.004","title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Internal ribosome entry site; Protein kinase R; RNA; Biology; Translation (biology); EIF-2 kinase; Virology; Eukaryotic translation; Protein biosynthesis; Picornavirus; Interferon; Molecular biology; Ribosome; RNA silencing; Initiation factor; Messenger RNA; Phosphorylation; Cell biology; RNA interference; Biochemistry; Protein kinase A; Gene","score_opus":0.03611876428698934,"score_gpt":0.3623040886127023,"score_spread":0.32618532432571296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070528933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902368,0.000053201282,0.0015171797,0.0029413647,0.000012792819,0.0001588246,0.00002521576,0.00000497055,0.005049657],"genre_scores_gemma":[0.9984539,0.000018204846,0.00014023646,0.00023007095,0.00006485292,0.0000031100626,0.000116487325,0.000005363073,0.0009677863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990409,0.00011893597,0.00011393096,0.00019245688,0.00035614567,0.00017762117],"domain_scores_gemma":[0.9995547,0.000021031563,0.000021483382,0.00015510201,0.0001868811,0.00006080827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030521656,0.000062347775,0.00007089783,0.00007767215,0.00006758815,0.000015906062,0.00008124186,0.00006404994,0.0000075166117],"category_scores_gemma":[0.00015508795,0.00005970043,0.0000504545,0.00017698099,0.00005743299,0.000007731986,0.000023304437,0.00006490022,0.000011986664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002490679,0.000111725545,0.0009964337,0.0000041411936,0.0000065299355,9.96049e-7,0.000022948425,0.000015932545,0.9480635,0.00035840704,0.009366163,0.04080414],"study_design_scores_gemma":[0.00029116226,0.00026445196,0.123671025,0.000009682673,0.000001648976,3.6945733e-7,0.000020009029,0.00012946846,0.8711191,0.00034763082,0.004071551,0.000073935],"about_ca_topic_score_codex":0.000032159656,"about_ca_topic_score_gemma":0.000005094068,"teacher_disagreement_score":0.12267459,"about_ca_system_score_codex":0.000008144424,"about_ca_system_score_gemma":0.00007997214,"threshold_uncertainty_score":0.24345128},"labels":[],"label_agreement":null},{"id":"W2070756649","doi":"10.1016/j.antiviral.2013.02.016","title":"Capripoxvirus-vectored vaccines against livestock diseases in Africa","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Saskatchewan; Canadian Food Inspection Agency","funders":"University of Alberta; University of Saskatchewan","keywords":"Livestock; Rift Valley fever; Vaccination; Virology; Monkeypox; Veterinary medicine; Biology; Environmental health; Medicine; Virus; Recombinant DNA","score_opus":0.14490181865148902,"score_gpt":0.405438003530366,"score_spread":0.260536184878877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070756649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006764982,0.9843643,8.30403e-7,0.000047361795,0.00036998573,0.0022460336,0.00036081564,0.00009440085,0.01183978],"genre_scores_gemma":[0.0033499906,0.9686033,0.000010685547,0.000013791881,0.00018293594,0.00093034346,0.0006678393,0.00011279516,0.026128326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912245,0.0036319823,0.0009098152,0.0011690856,0.00036398254,0.0027006324],"domain_scores_gemma":[0.9962193,0.002068504,0.00018009095,0.0011042381,0.00029856188,0.00012932946],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014148898,0.00071721093,0.0022589508,0.0019207749,0.0003969692,0.00017411177,0.0017638855,0.0010776576,0.0005743521],"category_scores_gemma":[0.001816603,0.0005325133,0.0006384493,0.0017642727,0.0007184563,0.00031566207,0.0011624421,0.003470692,0.024049154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006416726,0.0003321862,0.000083578205,0.0029593091,0.000269271,0.00017081467,0.000097195974,2.4836156e-8,0.0007548046,0.00019677808,0.05105717,0.9440147],"study_design_scores_gemma":[0.000586523,0.00024033136,0.00021796522,0.0039811186,0.00006271166,0.000012829176,0.00006199923,9.3410347e-7,0.00012738825,0.00015201578,0.9940216,0.0005345797],"about_ca_topic_score_codex":0.0009644284,"about_ca_topic_score_gemma":0.00019901167,"teacher_disagreement_score":0.94348013,"about_ca_system_score_codex":0.00032882148,"about_ca_system_score_gemma":0.0013652464,"threshold_uncertainty_score":0.99971265},"labels":[],"label_agreement":null},{"id":"W2072181122","doi":"10.1016/j.antiviral.2005.06.008","title":"Effect of resveratrol on herpes simplex virus vaginal infection in the mouse","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Herpes simplex virus; Placebo; Virus; Vagina; Viral shedding; Viral replication; Medicine; Biology; Immunology; Virology; Pharmacology; Internal medicine; Surgery; Pathology","score_opus":0.055579206244588134,"score_gpt":0.4385959232346391,"score_spread":0.38301671699005096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072181122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836626,0.00004279657,0.000005744806,0.0005136417,0.000020595422,0.0005793664,0.0000059695312,0.000019029549,0.015150243],"genre_scores_gemma":[0.9987493,0.0001758239,0.000014202312,0.000084919906,0.00014349793,0.00006706254,0.000009101643,0.000013606767,0.0007424714],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979561,0.00076933287,0.00017674013,0.0001970587,0.0005681815,0.0003325848],"domain_scores_gemma":[0.99898267,0.00057112455,0.000025638004,0.0003116549,0.000077616955,0.000031311796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020176475,0.00010971206,0.00019821804,0.00034145472,0.00013518849,0.000025792047,0.00007511394,0.0000791531,0.000051424],"category_scores_gemma":[0.0002802793,0.000064884174,0.000083861334,0.00058409694,0.00012435981,0.00010159109,0.000028020771,0.00042512492,0.0003239259],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016049693,0.0015117177,0.07004747,0.000081333754,0.00008420657,0.000082991304,0.00028794532,0.000012206204,0.008703359,0.0005115726,0.0027614383,0.9143108],"study_design_scores_gemma":[0.005180772,0.009192925,0.13170177,0.00012816189,0.00005088891,0.000020160049,0.00003222933,0.00041022088,0.71856356,0.000086266555,0.13449454,0.00013849577],"about_ca_topic_score_codex":0.0025271485,"about_ca_topic_score_gemma":0.0007203577,"teacher_disagreement_score":0.9141723,"about_ca_system_score_codex":0.00012128066,"about_ca_system_score_gemma":0.00005867135,"threshold_uncertainty_score":0.41635203},"labels":[],"label_agreement":null},{"id":"W2073165330","doi":"10.1016/j.antiviral.2010.07.001","title":"Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Québec; Amylin Pharmaceuticals","keywords":"Human metapneumovirus; Medicine; Monoclonal antibody; Titer; Immunology; Virology; Antibody titer; Antibody; Respiratory system; Respiratory tract infections; Internal medicine","score_opus":0.12414931626722309,"score_gpt":0.43937494630224727,"score_spread":0.3152256300350242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073165330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959099,0.00022764908,0.000008610948,0.00029119413,0.0000104129385,0.0016587295,0.0000113893075,0.000012716266,0.0018693776],"genre_scores_gemma":[0.99893326,0.00005362881,0.00010663946,0.000026013186,0.000033239805,0.00010501435,0.0000038580265,0.000030102801,0.0007082554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725044,0.00041016904,0.00043030476,0.0003393337,0.0011010368,0.00046872042],"domain_scores_gemma":[0.99853855,0.00018549792,0.00009050292,0.00059363496,0.0005210432,0.000070767106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00283972,0.00015041785,0.0003620931,0.00075219426,0.000193857,0.00003472177,0.0002625681,0.00014774973,0.00001236807],"category_scores_gemma":[0.0005159822,0.00009781314,0.00008061757,0.0009290142,0.0009253964,0.00014618413,0.0002654809,0.0014953628,0.000009040199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035225422,0.00047419596,0.021354375,0.00021747204,0.000025718718,0.000008265021,0.00023862963,0.0000132915275,0.9634794,0.0031185085,0.0000023423743,0.010715543],"study_design_scores_gemma":[0.0010470588,0.0012725177,0.051985327,0.00007958132,0.0000117933205,0.0000043766354,0.00010740365,0.008355397,0.93616074,0.00086197763,0.000013941897,0.00009987337],"about_ca_topic_score_codex":0.0006689159,"about_ca_topic_score_gemma":0.00031077978,"teacher_disagreement_score":0.030630952,"about_ca_system_score_codex":0.000034988927,"about_ca_system_score_gemma":0.00033015813,"threshold_uncertainty_score":0.64966905},"labels":[],"label_agreement":null},{"id":"W2073480716","doi":"10.1016/j.antiviral.2014.03.017","title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Hepatitis D virus; Virology; Hepatitis D; Viral entry; Medicine; Entry inhibitor; Hepatitis B virus; In vitro; Viral replication; Virus; Pharmacology; Biology; HBsAg","score_opus":0.22382249421954814,"score_gpt":0.379732559637433,"score_spread":0.15591006541788488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073480716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927346,0.00061098824,0.000061490995,0.0034979384,0.000041972777,0.00093949086,0.0000051957863,0.000040607065,0.002067715],"genre_scores_gemma":[0.9956896,0.00030904496,0.00035106795,0.00080348755,0.00019720175,0.00009626779,0.0000014371992,0.000039214334,0.0025126867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974623,0.0004902528,0.00024075918,0.0002755562,0.0009973514,0.000533818],"domain_scores_gemma":[0.99823976,0.00041898628,0.00004433331,0.0005969869,0.0006230079,0.00007694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014015123,0.00015479152,0.00037940667,0.00018475163,0.0002269842,0.000050455415,0.00019908098,0.000060486076,0.0000058396663],"category_scores_gemma":[0.00091134664,0.00007825061,0.00005877996,0.0005927931,0.0006407462,0.00014178886,0.00024890064,0.00044477198,0.00011173858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015015111,0.000492047,0.30836883,0.00027621273,0.00053043675,0.000016363318,0.0070677623,0.0000042777765,0.61129457,0.0010776644,0.009785968,0.05958436],"study_design_scores_gemma":[0.0010418781,0.002961703,0.3542731,0.0003923895,0.000104846156,0.0000067364235,0.0008267419,0.0007003692,0.51854855,0.00007450381,0.12081443,0.00025475724],"about_ca_topic_score_codex":0.0026838288,"about_ca_topic_score_gemma":0.0010758303,"teacher_disagreement_score":0.11102846,"about_ca_system_score_codex":0.000031616317,"about_ca_system_score_gemma":0.00019175795,"threshold_uncertainty_score":0.40571645},"labels":[],"label_agreement":null},{"id":"W2073526348","doi":"10.1016/j.antiviral.2011.04.001","title":"Interferon-γ influences immunity elicited by vaccines against very virulent Marek’s disease virus","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Marek's disease; Virulence; Virology; Biology; Vaccination; Virus; Immunity; Interferon; Plasmid; Immune system; Microbiology; Immunology; Gene","score_opus":0.11537763320337872,"score_gpt":0.3926820829303194,"score_spread":0.2773044497269407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073526348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97896236,0.000630281,0.000014544035,0.00016041024,0.000118017946,0.0004682379,0.00006785784,0.00008851924,0.019489747],"genre_scores_gemma":[0.99615806,0.0012438297,0.000044189444,0.00022533881,0.00007200359,0.00008951888,0.000080729165,0.00003209602,0.0020542573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978715,0.00031744887,0.00029029528,0.00036568905,0.000550088,0.0006049736],"domain_scores_gemma":[0.9986954,0.00013496635,0.000043841428,0.0005751989,0.0003046712,0.00024592344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005955012,0.00020860691,0.00027122835,0.00035454295,0.00035915343,0.00005530053,0.00021572608,0.00009894351,0.00029443405],"category_scores_gemma":[0.00032264236,0.00016151756,0.00012826291,0.0006036888,0.00022843103,0.00028405426,0.00023055312,0.00057622674,0.0010089077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004295226,0.0054427655,0.67882144,0.00020288801,0.0007043123,0.0007665771,0.00096492475,2.6558587e-7,0.0855519,0.0002455975,0.01934367,0.20366041],"study_design_scores_gemma":[0.003104302,0.0020702062,0.8225701,0.00049730885,0.00013174223,0.00000851541,0.0004452238,0.00013726074,0.1365327,0.00055525504,0.033478577,0.00046884888],"about_ca_topic_score_codex":0.0047630845,"about_ca_topic_score_gemma":0.00013820692,"teacher_disagreement_score":0.20319156,"about_ca_system_score_codex":0.00015106946,"about_ca_system_score_gemma":0.0001867769,"threshold_uncertainty_score":0.9997689},"labels":[],"label_agreement":null},{"id":"W2073739863","doi":"10.1016/j.antiviral.2014.06.020","title":"Analysis of the transcriptome and immune function of monocytes during IFNα-based therapy in chronic HCV revealed induction of TLR7 responsiveness","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Sociale en Geesteswetenschappen, NWO; Virgo Consortium; Bristol-Myers Squibb","keywords":"TLR7; Immunology; Immune system; Cytokine; Monocyte; In vivo; Interferon; Biology; Ex vivo; Transcriptome; Medicine; Toll-like receptor; Innate immune system; Gene expression; Gene","score_opus":0.033448616487475644,"score_gpt":0.31304291380127547,"score_spread":0.2795942973137998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073739863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973214,0.0021295159,0.000044705062,0.000103716244,0.000061313534,0.0002526252,0.0000036081158,0.000004797055,0.000078274665],"genre_scores_gemma":[0.9993324,0.00040987923,0.000002759904,0.0000024481228,0.000006676924,0.0000132745345,0.000015714128,0.0000069168614,0.00020987853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972878,0.0018068418,0.00042415786,0.00016542323,0.00010749519,0.00020827445],"domain_scores_gemma":[0.99886024,0.00041658265,0.00016941482,0.00032354894,0.00022610425,0.000004102653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022196616,0.000085160194,0.00035348107,0.0009197047,0.00009782449,0.0000041784747,0.00016260099,0.00015661833,0.00002390082],"category_scores_gemma":[0.00024987588,0.00006314855,0.00012861569,0.0013556727,0.00041908116,0.00011468434,0.000038231632,0.0002745341,0.0000021931842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038025482,0.000057176607,0.01873067,0.0000764846,0.00024314856,1.4983698e-7,0.00034833048,0.000057165784,0.9644295,0.00016618005,0.0000016513665,0.012087006],"study_design_scores_gemma":[0.0008392671,0.00029305127,0.46714053,0.00005966596,0.000029308008,1.9792003e-7,0.00008822426,0.0000830693,0.5313709,0.000032441294,0.000033532822,0.000029863082],"about_ca_topic_score_codex":0.0005278078,"about_ca_topic_score_gemma":0.00007054143,"teacher_disagreement_score":0.44840986,"about_ca_system_score_codex":0.00005256446,"about_ca_system_score_gemma":0.00013414749,"threshold_uncertainty_score":0.25751233},"labels":[],"label_agreement":null},{"id":"W2074366047","doi":"10.1016/j.antiviral.2006.10.012","title":"Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Virology; Neuraminidase inhibitor; Oseltamivir; Virus; Influenza A virus; Mutation; Recombinant DNA; Hemagglutinin (influenza); Recombinant virus; Biology; Influenzavirus B; Orthomyxoviridae; Gene; Genetics; Medicine","score_opus":0.0685784773872101,"score_gpt":0.38464928073487814,"score_spread":0.316070803347668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074366047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628526,0.0004322728,0.000007146339,0.00030746494,0.000018506373,0.00095561804,0.000034528268,0.000040613308,0.0019185883],"genre_scores_gemma":[0.99830776,0.00031788505,0.00016366882,0.000091563124,0.00005377136,0.00008011498,0.00004128483,0.000043683172,0.0009002834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99649143,0.00042831898,0.0005049968,0.00048629014,0.0012218071,0.0008671534],"domain_scores_gemma":[0.99813974,0.00035805706,0.00009838074,0.00035538673,0.0009754254,0.000073028605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014227764,0.00023137833,0.00056180195,0.0009354831,0.00020638334,0.000059452228,0.00015275467,0.000102128026,0.000010189096],"category_scores_gemma":[0.00060217804,0.00017615099,0.000043400698,0.001996354,0.0007406859,0.00030588664,0.00019665986,0.0006989892,0.000021731383],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042806845,0.00035924165,0.13176212,0.00025687608,0.000047341,0.00010629208,0.0003220531,3.3393803e-7,0.86021554,0.00022576064,0.000103509,0.0023202233],"study_design_scores_gemma":[0.0020839905,0.00052911683,0.56012,0.00025165392,0.0000124499065,0.000004956543,0.00015475681,0.0001342556,0.4353392,0.00006471227,0.0011661745,0.00013874836],"about_ca_topic_score_codex":0.0035148251,"about_ca_topic_score_gemma":0.0008054,"teacher_disagreement_score":0.42835787,"about_ca_system_score_codex":0.00017439087,"about_ca_system_score_gemma":0.00039226844,"threshold_uncertainty_score":0.71832293},"labels":[],"label_agreement":null},{"id":"W2074806701","doi":"10.1016/j.antiviral.2008.01.152","title":"Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions","year":2008,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Outbreak; Case fatality rate; Medicine; Ebola virus; Ebolavirus; Marburg virus; Ebola vaccine; Infectious disease (medical specialty); Ebola Hemorrhagic Fever; Virology; Intensive care medicine; Disease; Clinical trial; Environmental health; Pathology; Population","score_opus":0.3371074663774374,"score_gpt":0.5050210633326645,"score_spread":0.16791359695522712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074806701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00560221,0.98711056,0.00002540531,0.00023279617,0.000043028274,0.0029942843,0.0001882514,0.000038437924,0.0037650345],"genre_scores_gemma":[0.014400068,0.9716656,0.000371944,0.000008583602,0.00032489953,0.00022284461,0.0001418748,0.000069995396,0.012794185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738765,0.00023941435,0.00054746494,0.0006279669,0.00049729896,0.00070020254],"domain_scores_gemma":[0.99665457,0.0021134536,0.00012902443,0.0003495177,0.00050062133,0.00025282544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036071183,0.00039890356,0.0015632872,0.0008614489,0.0003954142,0.00009064383,0.00010266307,0.00031293678,0.000028849794],"category_scores_gemma":[0.0003831735,0.0002841304,0.00031281135,0.00091094367,0.00038604386,0.00013488432,0.00013858933,0.0004870537,0.000020762074],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006878104,0.00026499655,0.00019687564,0.0055405633,0.00030274727,0.00007579564,0.000077182514,1.4374368e-7,0.00012908687,0.00022879416,0.0016314508,0.99148357],"study_design_scores_gemma":[0.010184119,0.016204454,0.0026632855,0.01537437,0.0019061725,0.0037069821,0.0013299857,0.00059506315,0.00043232462,0.0023092893,0.944005,0.0012889407],"about_ca_topic_score_codex":0.0018300934,"about_ca_topic_score_gemma":0.000044828936,"teacher_disagreement_score":0.9901946,"about_ca_system_score_codex":0.00019809802,"about_ca_system_score_gemma":0.001603735,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2075138163","doi":"10.1016/j.antiviral.2011.09.004","title":"FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"TLR4; Innate immune system; TLR2; Lung; Immunology; Influenza A virus; Biology; Virus; Inflammation; Immune system; Virology; Microbiology; Medicine","score_opus":0.2980825734765801,"score_gpt":0.46947228715747213,"score_spread":0.171389713680892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075138163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835311,0.000288345,0.000015092422,0.000804978,0.00008139396,0.002606991,0.000006537764,0.000056769957,0.012608765],"genre_scores_gemma":[0.997839,0.00029518042,0.000085715394,0.00056511204,0.00015270525,0.0005573213,0.0000031190432,0.000040639126,0.00046120622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99426925,0.001797045,0.0005652438,0.00063391565,0.0014396489,0.0012948863],"domain_scores_gemma":[0.9983539,0.00060645025,0.000074613876,0.0004447582,0.00043619756,0.00008407459],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008140225,0.00028392414,0.00045273488,0.002510902,0.00041277884,0.00012593137,0.00036986519,0.00023462216,0.0000069234657],"category_scores_gemma":[0.006161866,0.00021312284,0.00010046296,0.003842956,0.00042082954,0.00065466214,0.00041482467,0.0023790246,0.00029164425],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069883214,0.0006478209,0.43540478,0.00033963975,0.00008037369,0.0007983816,0.023628248,0.0000037248458,0.5065535,0.00024419194,0.00097378774,0.0243373],"study_design_scores_gemma":[0.002173154,0.0015034686,0.7011299,0.0009499414,0.000011802328,0.000020611616,0.0020334697,0.00021987589,0.28988403,0.00019645249,0.0015458124,0.0003314652],"about_ca_topic_score_codex":0.007612703,"about_ca_topic_score_gemma":0.0022334738,"teacher_disagreement_score":0.26572514,"about_ca_system_score_codex":0.00046071573,"about_ca_system_score_gemma":0.00036948358,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2075666829","doi":"10.1016/j.antiviral.2013.04.013","title":"Viral envelope glycoprotein processing by proprotein convertases","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Université de Lausanne; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Viral envelope; Glycoprotein; Biology; Viral pathogenesis; Furin; Viral entry; Virology; Virus; Computational biology; Cell biology; Viral replication; Genetics; Enzyme","score_opus":0.11346925902047274,"score_gpt":0.4158452883780427,"score_spread":0.30237602935756996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075666829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027264768,0.99168795,0.000013154569,0.00008145107,0.00023311384,0.0035086928,0.00016503654,0.00012414558,0.0039138026],"genre_scores_gemma":[0.001991892,0.85586226,0.000030759118,0.000030531788,0.00005952695,0.0012112376,0.00064907304,0.00012256339,0.14004217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99306047,0.0030714897,0.0009365987,0.0010040313,0.00027145966,0.0016559506],"domain_scores_gemma":[0.99805635,0.00045333419,0.00030162072,0.00074779114,0.00039884914,0.000042033906],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015090186,0.00075730385,0.0020635254,0.00066028396,0.00066849304,0.00026796432,0.001314716,0.0012530928,0.0019500375],"category_scores_gemma":[0.00068623567,0.00053412793,0.0004461208,0.0006269775,0.0012839008,0.00034924626,0.0007130181,0.0030407603,0.02737309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011570902,0.00015828648,5.65366e-7,0.0052379183,0.00022631422,0.000023847015,0.00005245324,3.879045e-10,0.0156102665,0.000114515584,0.06564037,0.91281974],"study_design_scores_gemma":[0.00037274894,0.00056281866,5.7545424e-7,0.0044220784,0.00012802202,0.00007255997,0.000068182824,2.822401e-7,0.05928729,0.000027414248,0.93449026,0.00056775246],"about_ca_topic_score_codex":0.0006774704,"about_ca_topic_score_gemma":0.000006032364,"teacher_disagreement_score":0.912252,"about_ca_system_score_codex":0.00022095945,"about_ca_system_score_gemma":0.0012995098,"threshold_uncertainty_score":0.99971104},"labels":[],"label_agreement":null},{"id":"W2077581494","doi":"10.1016/j.antiviral.2012.08.012","title":"WFDC1/ps20: A host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"CXCL1; Biology; Immunology; Immune system; Microbiology; Virology; Chemokine","score_opus":0.07389450539630842,"score_gpt":0.36413159282337065,"score_spread":0.2902370874270622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077581494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947183,0.0011053149,0.00002530948,0.0021624863,0.00058852055,0.0005501795,0.000018624663,0.00006689637,0.0007643677],"genre_scores_gemma":[0.99387676,0.0009302023,0.000008280564,0.00018743494,0.00013239302,0.00010644112,0.000027615963,0.000021561555,0.0047093215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99569356,0.002651518,0.0002667932,0.0002587344,0.0002072557,0.000922146],"domain_scores_gemma":[0.99805284,0.0011486076,0.0000718378,0.0004816993,0.00020799892,0.000037014943],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028720377,0.00018669551,0.00021273262,0.0004357846,0.0007857136,0.000087599954,0.00034363923,0.0002248725,0.00029293646],"category_scores_gemma":[0.0011995261,0.0001284026,0.000102803104,0.00062040973,0.00037061918,0.00061133096,0.00031132766,0.00072082016,0.0054152277],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022297078,0.00008575719,0.074753046,0.000008919401,0.000058338675,0.000004361185,0.0015355865,3.555559e-7,0.9112876,0.00022991777,0.0028160783,0.0069902977],"study_design_scores_gemma":[0.00022008808,0.00029615435,0.47235373,0.000020706295,0.00000469535,0.000011924814,0.00007113722,8.469433e-7,0.43587056,0.000016694743,0.09103885,0.000094616145],"about_ca_topic_score_codex":0.004590111,"about_ca_topic_score_gemma":0.00033915672,"teacher_disagreement_score":0.47541708,"about_ca_system_score_codex":0.000107833956,"about_ca_system_score_gemma":0.0001232742,"threshold_uncertainty_score":0.9953592},"labels":[],"label_agreement":null},{"id":"W2080095545","doi":"10.1016/j.antiviral.2015.03.001","title":"Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; National Natural Science Foundation of China","keywords":"Interferon; Suppressor of cytokine signaling 1; Virology; Cytokine; Suppressor; Virus; Hepatitis B virus; MiR-122; Immunology; Medicine; Biology; Hepatitis C virus; Gene; Genetics","score_opus":0.08123459829342115,"score_gpt":0.3823441300280892,"score_spread":0.30110953173466803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080095545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663943,0.0007953228,0.00007004262,0.00019417115,0.0000725708,0.00046459105,0.00020345958,0.000012796001,0.0015475946],"genre_scores_gemma":[0.9986501,0.00068034534,0.00021981631,0.000007742339,0.00003941101,0.000024638826,0.00009999312,0.000021639313,0.00025635763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699384,0.00038958978,0.0007114921,0.00027492802,0.001236885,0.00039324266],"domain_scores_gemma":[0.99783343,0.00062756473,0.00019836989,0.0002980996,0.00096651266,0.00007604798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015052985,0.00014404759,0.0006370688,0.0004521406,0.000033134776,0.000006233399,0.00018445832,0.0001271878,0.00006793355],"category_scores_gemma":[0.0020075697,0.000121173995,0.00007518383,0.00068131764,0.0005084436,0.00019590712,0.0002085598,0.00029906278,0.00001890188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008935118,0.0004953302,0.14644541,0.0002710551,0.000046052155,0.000008557253,0.0011657424,0.0000013919116,0.8457435,0.00003342547,0.004027759,0.0008682967],"study_design_scores_gemma":[0.0018795382,0.0013955566,0.05229896,0.0008242377,0.000015624611,8.60074e-7,0.00016333647,0.00044693495,0.9424983,0.00016692656,0.00022476426,0.00008490489],"about_ca_topic_score_codex":0.021879705,"about_ca_topic_score_gemma":0.002266591,"teacher_disagreement_score":0.096754886,"about_ca_system_score_codex":0.00008722957,"about_ca_system_score_gemma":0.00017577862,"threshold_uncertainty_score":0.9846337},"labels":[],"label_agreement":null},{"id":"W2081116136","doi":"10.1016/j.antiviral.2013.09.018","title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Ottawa; Health Canada","funders":"","keywords":"Epitope; Neuraminidase; Monoclonal antibody; Virology; Antibody; Biology; Influenza A virus; Virus; Viral replication; Amino acid; Peptide sequence; Immunology; Biochemistry; Gene","score_opus":0.18397769633088198,"score_gpt":0.4747452553409837,"score_spread":0.29076755901010176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081116136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96090096,0.0005301107,0.0000085268675,0.0018528068,0.000053069693,0.0012009408,0.000012740127,0.00014658622,0.035294242],"genre_scores_gemma":[0.9953581,0.00037418745,0.0002691366,0.00086621026,0.00025767408,0.000054437794,0.000025820298,0.00005999035,0.002734419],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9949313,0.0004473167,0.00042058717,0.0006479841,0.0018563329,0.0016965034],"domain_scores_gemma":[0.9968745,0.0007563398,0.00006663405,0.00057904195,0.0014540391,0.0002694187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017422928,0.00028560995,0.0005065306,0.0008402016,0.00047896866,0.00022105723,0.0003478413,0.00018132772,0.00024577833],"category_scores_gemma":[0.002794618,0.00023615465,0.00015660521,0.001190779,0.00097578135,0.00072114874,0.00075880525,0.0014647453,0.00483252],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002748545,0.00032717537,0.17072044,0.00026183776,0.00023825116,0.00071667944,0.0008350925,8.322878e-7,0.80244535,0.0010001874,0.013363403,0.009815899],"study_design_scores_gemma":[0.006119503,0.0023240608,0.6174193,0.00078920694,0.000082387094,0.00006892685,0.004703662,0.0016347372,0.3145988,0.0007428619,0.050605383,0.0009111746],"about_ca_topic_score_codex":0.0019976161,"about_ca_topic_score_gemma":0.000019946705,"teacher_disagreement_score":0.48784655,"about_ca_system_score_codex":0.00018995965,"about_ca_system_score_gemma":0.0003784617,"threshold_uncertainty_score":0.99594235},"labels":[],"label_agreement":null},{"id":"W2086230721","doi":"10.1016/j.antiviral.2006.05.013","title":"Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?","year":2006,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Microbicides for sexually transmitted diseases; Microbicide; Drug; Human immunodeficiency virus (HIV); Potency; Vaginal microbicide; Drug resistance; Pharmacology; HIV drug resistance; Virology; Limiting; Medicine; Population; Biology; Antiretroviral therapy; Viral load; In vitro; Microbiology; Health services","score_opus":0.13677041303927173,"score_gpt":0.42541701983054114,"score_spread":0.2886466067912694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086230721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06265764,0.9310784,0.0000640004,0.00034820594,0.00007751024,0.0017532553,0.00015134885,0.000028083337,0.0038415866],"genre_scores_gemma":[0.26920164,0.7177317,0.0005962055,0.000018079261,0.0000938169,0.00040953327,0.00046119542,0.000111505964,0.01137631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311936,0.0032524774,0.0010984157,0.0010109615,0.00036750137,0.001151304],"domain_scores_gemma":[0.9960489,0.0023065375,0.000314468,0.00086456677,0.0004443274,0.000021146468],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0047175772,0.0004699255,0.0012855319,0.0012372456,0.0005557623,0.00016336342,0.00094700704,0.00042024578,0.000067277906],"category_scores_gemma":[0.0005033303,0.0003329315,0.00023421239,0.0015647304,0.001219346,0.00022027368,0.00029525725,0.0028248597,0.00035959634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005497452,0.0038569435,0.01552462,0.0562648,0.001693846,0.00031091334,0.008005203,0.0000023023583,0.100626186,0.002041872,0.053213328,0.75791025],"study_design_scores_gemma":[0.0006235209,0.000058156784,0.005962653,0.0055832686,0.00005357766,0.000027301003,0.00062512286,5.657941e-7,0.017353632,0.00006383687,0.96919304,0.0004553342],"about_ca_topic_score_codex":0.00016292598,"about_ca_topic_score_gemma":0.0004355955,"teacher_disagreement_score":0.9159797,"about_ca_system_score_codex":0.00022959827,"about_ca_system_score_gemma":0.0025200956,"threshold_uncertainty_score":0.99991226},"labels":[],"label_agreement":null},{"id":"W2086933325","doi":"10.1016/j.antiviral.2007.08.008","title":"Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Oseltamivir; Neuraminidase; Neuraminidase inhibitor; Virology; Influenza A virus; Recombinant DNA; Microbiology; Mutant; Biology; Influenza A virus subtype H5N1; Zanamivir; Virus; Medicine; Gene; Genetics; Coronavirus disease 2019 (COVID-19); Internal medicine; Infectious disease (medical specialty)","score_opus":0.1371009898528008,"score_gpt":0.4384835129207547,"score_spread":0.3013825230679539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086933325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917416,0.000986919,0.0000040953228,0.0004261298,0.00007207314,0.00093380985,0.00006552233,0.000024683306,0.0057451776],"genre_scores_gemma":[0.99862933,0.00036174824,0.000058182948,0.00017889652,0.0001202032,0.00001577895,0.0000022034503,0.00003616092,0.0005975168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99542123,0.00049787544,0.0005915038,0.00047857975,0.002044608,0.0009662276],"domain_scores_gemma":[0.9955755,0.0022385484,0.0001913908,0.00079155306,0.0010485738,0.0001544754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038061407,0.00025757356,0.00061355764,0.00053370366,0.00033876943,0.000035369496,0.00035797656,0.00016680216,0.000009383825],"category_scores_gemma":[0.0060084905,0.00017142162,0.00017856293,0.0013482505,0.0025674384,0.00023694652,0.0008370066,0.0010449755,0.000015489177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002694209,0.0004333826,0.14456117,0.0005859241,0.00011016515,0.0000848648,0.00045809237,3.8212656e-7,0.82232505,0.00026131765,0.00061484805,0.027870622],"study_design_scores_gemma":[0.00095395267,0.00068128086,0.47908786,0.0002276515,0.000020516374,0.0000030136766,0.00033246784,0.000032777752,0.51707995,0.000039842944,0.0014440049,0.00009669582],"about_ca_topic_score_codex":0.0005480548,"about_ca_topic_score_gemma":0.00020782207,"teacher_disagreement_score":0.3345267,"about_ca_system_score_codex":0.000091378104,"about_ca_system_score_gemma":0.00037805474,"threshold_uncertainty_score":0.94598335},"labels":[],"label_agreement":null},{"id":"W2089734387","doi":"10.1016/j.antiviral.2004.12.009","title":"Development of a cotton rat–human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Université Laval","keywords":"Virus; Virology; Biology; Human metapneumovirus; Titer; Inoculation; Metapneumovirus; Respiratory tract; Respiratory system; Immunology; Respiratory tract infections; Anatomy","score_opus":0.38593757445326443,"score_gpt":0.5472659183829395,"score_spread":0.16132834392967504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089734387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373794,0.0008714904,0.0028670672,0.00031524902,0.00003348535,0.0015194595,0.000010300259,0.000040745126,0.00060425856],"genre_scores_gemma":[0.98197496,0.00014598227,0.015336476,0.000042341617,0.00015449591,0.00016780464,0.000015729818,0.00005339627,0.002108784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962145,0.00033112953,0.0007417583,0.0006501006,0.0012641882,0.00079833524],"domain_scores_gemma":[0.9981688,0.00029467835,0.00012708851,0.00036805312,0.0008856273,0.00015570111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005424655,0.00024693678,0.00056881027,0.00092914316,0.0008184607,0.00017158076,0.00017927056,0.00015694583,0.000022100054],"category_scores_gemma":[0.00084389054,0.00021957335,0.00010360246,0.00056660787,0.00034807753,0.0005690385,0.00042916162,0.00055331783,0.000020381682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033173646,0.00017659763,0.003058756,0.00043729917,0.00010999096,0.000009221466,0.0007448945,0.000014872823,0.8961328,0.00041080022,0.00024111259,0.09833187],"study_design_scores_gemma":[0.004836731,0.0012771767,0.026959568,0.00039875164,0.00012411011,0.00004148711,0.00074794894,0.14491534,0.81860495,0.0008388996,0.00082848227,0.00042653145],"about_ca_topic_score_codex":0.00006146652,"about_ca_topic_score_gemma":0.00013175541,"teacher_disagreement_score":0.14490047,"about_ca_system_score_codex":0.00012219556,"about_ca_system_score_gemma":0.00044375326,"threshold_uncertainty_score":0.89539415},"labels":[],"label_agreement":null},{"id":"W2090894089","doi":"10.1016/j.antiviral.2015.03.016","title":"The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"European Research Council; Bill and Melinda Gates Foundation","keywords":"Biology; Genome; G-quadruplex; Herpes simplex virus; Nucleic acid; DNA; Viral replication; Virology; Virus; Guanine; Genetics; Gene; Nucleotide","score_opus":0.1761714675678894,"score_gpt":0.43790408665086966,"score_spread":0.2617326190829803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090894089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913899,0.00035405252,0.0008057199,0.002969845,0.000074877324,0.0022312899,0.0002853,0.000036342743,0.0018526756],"genre_scores_gemma":[0.9978722,0.00035856274,0.00012487402,0.000046377652,0.00009802563,0.00027810066,0.00003491296,0.000039314513,0.0011476345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99764633,0.00033086323,0.0004644731,0.00036677672,0.00055078056,0.00064074766],"domain_scores_gemma":[0.99503875,0.0026288857,0.00019676035,0.0009221762,0.0010987879,0.00011465108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023730504,0.00020285019,0.0004372607,0.00019110402,0.0006825063,0.000054755295,0.0003272989,0.00012994165,0.000004126577],"category_scores_gemma":[0.0016978872,0.00011723202,0.0002573175,0.0008166056,0.00090597826,0.0001623372,0.00019409326,0.00031476753,0.00001964052],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071541304,0.003472798,0.061047766,0.00026835667,0.0021719097,0.000018937764,0.0027194135,0.000026055828,0.34210157,0.003609157,0.0059117055,0.5714982],"study_design_scores_gemma":[0.011972617,0.003805421,0.38376004,0.00014942684,0.0003674789,0.00002301342,0.0022886747,0.0062993937,0.37851167,0.0020649352,0.2102934,0.0004639411],"about_ca_topic_score_codex":0.0037282002,"about_ca_topic_score_gemma":0.0017870012,"teacher_disagreement_score":0.57103425,"about_ca_system_score_codex":0.00016005216,"about_ca_system_score_gemma":0.00053634896,"threshold_uncertainty_score":0.5635948},"labels":[],"label_agreement":null},{"id":"W2091134244","doi":"10.1016/j.antiviral.2010.10.001","title":"Nigericin is a potent inhibitor of the early stage of vaccinia virus replication","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Public Health Agency; Gilead Sciences","keywords":"Vaccinia; Nigericin; Virology; Orthopoxvirus; Biology; Virus; Viral replication; Poxviridae; Gene; Genetics; Recombinant DNA","score_opus":0.04046852519623202,"score_gpt":0.35574083595253747,"score_spread":0.31527231075630546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091134244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945942,0.00020975777,0.0000048100087,0.00062524166,0.00016564465,0.0003985495,0.0001507193,0.000011783116,0.0038393042],"genre_scores_gemma":[0.98559874,0.00010309849,0.000016631535,0.0000360931,0.000030665688,0.000019292731,0.00000853045,0.000012798171,0.0141741205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981471,0.00045582716,0.00031854786,0.0003187317,0.00024622917,0.00051360787],"domain_scores_gemma":[0.99808276,0.00028046477,0.00011480624,0.0010805773,0.00041809713,0.000023291715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017691591,0.000100094374,0.00021358792,0.0001914257,0.00019333567,0.000013842541,0.0006775612,0.00022029933,0.0002616918],"category_scores_gemma":[0.0009297116,0.000066559376,0.00012424414,0.000535789,0.0006626783,0.00009790643,0.00041745094,0.0010988859,0.00036546992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030836696,0.00014322303,0.015669331,0.000026555923,0.000040750838,0.0000013556888,0.0003784423,1.5690793e-8,0.9673019,0.0008569965,0.0044503743,0.010822659],"study_design_scores_gemma":[0.0003954576,0.00027363517,0.12594594,0.000018649074,0.0000028761508,0.00000193521,0.00007634743,0.0000024361755,0.8588093,0.00016042608,0.014258352,0.000054646098],"about_ca_topic_score_codex":0.0033970163,"about_ca_topic_score_gemma":0.0003007951,"teacher_disagreement_score":0.11027661,"about_ca_system_score_codex":0.000017702563,"about_ca_system_score_gemma":0.00022891349,"threshold_uncertainty_score":0.51352954},"labels":[],"label_agreement":null},{"id":"W2092528857","doi":"10.1016/j.antiviral.2013.03.014","title":"Influenza virus resistance to neuraminidase inhibitors","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Neuraminidase inhibitor; Oseltamivir; Medicine; Antiviral drug; Drug resistance; Pandemic; Virus; Virology; Drug; Intensive care medicine; Pharmacology; Biology; Coronavirus disease 2019 (COVID-19); Microbiology; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.41699606212396134,"score_gpt":0.5538126083726812,"score_spread":0.13681654624871986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092528857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004405075,0.96896327,0.0000012597088,0.00030847278,0.00019404698,0.0061083757,0.00013656126,0.00014368715,0.023703832],"genre_scores_gemma":[0.000064991604,0.9662065,0.00029296617,0.0004516276,0.0009400315,0.001750506,0.000043042986,0.00022681618,0.030023549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.989699,0.0013780402,0.0013139662,0.0014788174,0.0036435812,0.0024866115],"domain_scores_gemma":[0.99386406,0.0018222693,0.00019230548,0.0018683273,0.0016209213,0.00063212693],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033170087,0.00086760166,0.0030854591,0.0023985882,0.0006004813,0.0003239273,0.0009949522,0.0006682886,0.00015347327],"category_scores_gemma":[0.00813411,0.0006408494,0.00077956566,0.0038288166,0.0008661763,0.00030129758,0.0017869361,0.004052336,0.022660727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016369393,0.00017567076,0.000028622626,0.020724013,0.00032601546,0.0005073764,0.0001434239,1.5496115e-8,0.00020017942,0.00017735975,0.16469806,0.81285554],"study_design_scores_gemma":[0.00042500618,0.0004968536,0.000047924656,0.01953906,0.00016466134,0.000011332335,0.00005823494,6.108917e-7,0.00043461839,0.000038202714,0.9782597,0.00052379136],"about_ca_topic_score_codex":0.000310253,"about_ca_topic_score_gemma":0.00008883908,"teacher_disagreement_score":0.8135616,"about_ca_system_score_codex":0.0008454418,"about_ca_system_score_gemma":0.0017911601,"threshold_uncertainty_score":0.9996043},"labels":[],"label_agreement":null},{"id":"W2093922965","doi":"10.1016/j.antiviral.2009.08.009","title":"Human H1 promoter expressed short hairpin RNAs (shRNAs) suppress avian influenza virus replication in chicken CH-SAH and canine MDCK cells","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Krell Institute; Ontario Ministry of Agriculture, Food and Rural Affairs; Poultry Industry Council; Agriculture and Agri-Food Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Poultry Research Council","keywords":"Virology; Biology; Viral replication; Replication (statistics); Small hairpin RNA; Influenza A virus; Avian influenza virus; Virus; Cell biology; Gene; Influenza A virus subtype H5N1; RNA; Genetics","score_opus":0.06178441009399893,"score_gpt":0.3820911159581269,"score_spread":0.32030670586412796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093922965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927213,0.0010851766,0.0000063263033,0.0007206155,0.00009072588,0.00066220603,0.000030427733,0.000054296423,0.004628924],"genre_scores_gemma":[0.9917539,0.00018032963,0.000013235349,0.00022777493,0.000037254948,0.00004747692,0.000066315064,0.000024649691,0.0076490985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996985,0.0009126615,0.0004496172,0.00068290235,0.0001436486,0.0008261583],"domain_scores_gemma":[0.9988018,0.00012906382,0.00005568019,0.00082140765,0.00015744488,0.000034569177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014409127,0.00023750309,0.00036063365,0.00047592333,0.00033935532,0.00009203182,0.00049456686,0.00034596087,0.00015277172],"category_scores_gemma":[0.00022610376,0.0002136336,0.00006649643,0.0002996965,0.00042997402,0.0002794068,0.0002389886,0.0010327565,0.0002950762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006433399,0.00026519643,0.0015779234,0.000018779701,0.00003102835,0.000023953262,0.00091888296,2.7384343e-7,0.98200506,0.0004358558,0.00310267,0.010977026],"study_design_scores_gemma":[0.00094529806,0.0007196626,0.10755686,0.00010137802,0.000005844389,0.000013944706,0.00015371351,0.000011104477,0.87579834,0.0001733671,0.014309581,0.00021088959],"about_ca_topic_score_codex":0.0013593766,"about_ca_topic_score_gemma":0.00034578392,"teacher_disagreement_score":0.10620671,"about_ca_system_score_codex":0.000076463955,"about_ca_system_score_gemma":0.00008215339,"threshold_uncertainty_score":0.87117255},"labels":[],"label_agreement":null},{"id":"W2094644660","doi":"10.1016/j.antiviral.2014.12.009","title":"Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Virology; Epitope; Virus; Neutralizing antibody; Paramyxoviridae; Mononegavirales; Antibody; Hemagglutinin (influenza); Influenza A virus; Biology; Immunology; Viral disease","score_opus":0.125006831271783,"score_gpt":0.4234490907906369,"score_spread":0.29844225951885395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094644660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907449,0.00032775637,0.0013000777,0.0002535784,0.00021336698,0.004097168,0.000012248566,0.0001817861,0.0028691215],"genre_scores_gemma":[0.9975827,0.00007975594,0.00017330976,0.00016891735,0.0004315176,0.00075837027,0.000009491672,0.00012367492,0.000672281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918219,0.002511492,0.0010866176,0.0010819349,0.0021508231,0.0013472615],"domain_scores_gemma":[0.9961679,0.00025576324,0.0003107792,0.0013063923,0.0014658383,0.00049333484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00493274,0.00045128545,0.0008594602,0.0014784586,0.0008196021,0.00020732527,0.00046436788,0.00034536855,0.000110815236],"category_scores_gemma":[0.004084364,0.00039555645,0.00028148227,0.0016851142,0.0005801058,0.0008276613,0.0004725583,0.0019676287,0.00025527985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004746228,0.00058330636,0.008687853,0.000686143,0.00005796365,0.000054684915,0.00017248541,0.0000116159135,0.9413148,0.00030375159,0.0002534117,0.043127738],"study_design_scores_gemma":[0.0036867408,0.003150466,0.030653654,0.0016104822,0.00004230672,0.0000052474006,0.000113633636,0.0012212179,0.95141345,0.00040654783,0.0072968956,0.0003993737],"about_ca_topic_score_codex":0.0014194286,"about_ca_topic_score_gemma":0.00015883247,"teacher_disagreement_score":0.042728364,"about_ca_system_score_codex":0.00042556744,"about_ca_system_score_gemma":0.0010287821,"threshold_uncertainty_score":0.9998496},"labels":[],"label_agreement":null},{"id":"W2095227056","doi":"10.1016/j.antiviral.2011.09.006","title":"Camelpox: Target for eradication?","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Insect and Pesticide Research","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"National Institutes of Health","keywords":"Virology; Medicine","score_opus":0.3008840712665263,"score_gpt":0.3864906124540429,"score_spread":0.08560654118751665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095227056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935154,0.00011371238,0.000029914381,0.0007422574,0.000054159183,0.0004637143,0.00003811435,0.000038428818,0.06336565],"genre_scores_gemma":[0.99626994,0.00004500209,0.0005742391,0.000042371994,0.0002982053,0.000096659045,0.000044963002,0.0000011923933,0.0026274545],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984453,0.00017159998,0.00012172572,0.00024542306,0.00042065082,0.0005953126],"domain_scores_gemma":[0.99893486,0.00059148273,0.000018262366,0.00006841081,0.00031909285,0.00006791186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014806502,0.00007242868,0.00009826569,0.00003452128,0.00042342348,0.000052705916,0.00038032245,0.00007805206,0.0010970974],"category_scores_gemma":[0.00031544553,0.00002716725,0.00006908574,0.0004869897,0.00016445137,0.000116364194,0.00008354547,0.00022552312,0.00038588446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000395296,0.0003883739,0.03852684,0.000033179498,0.00003128224,0.000018796829,0.000568512,4.9038498e-8,0.6298744,0.040648084,0.024071572,0.26544362],"study_design_scores_gemma":[0.0004361168,0.0033686815,0.43989325,0.000035101064,0.0000067332608,0.0000058501732,0.0006568182,0.00046958195,0.31327033,0.1119735,0.12942845,0.0004555914],"about_ca_topic_score_codex":0.00092979736,"about_ca_topic_score_gemma":0.0002364962,"teacher_disagreement_score":0.4013664,"about_ca_system_score_codex":0.000019572137,"about_ca_system_score_gemma":0.000030486899,"threshold_uncertainty_score":0.99981606},"labels":[],"label_agreement":null},{"id":"W2095491985","doi":"10.1016/j.antiviral.2012.08.010","title":"The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Polymerase; Biology; DNA polymerase; Nucleic acid; Reverse transcriptase; DNA; Virology; RNA; Primer (cosmetics); Virus; Viral replication; Genetics; Chemistry; Gene","score_opus":0.2695881361853387,"score_gpt":0.486886444217496,"score_spread":0.21729830803215727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095491985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020091219,0.9714241,0.000032519594,0.00012225892,0.0001810368,0.0023146586,0.00011061281,0.000029121145,0.005694474],"genre_scores_gemma":[0.2997592,0.69798964,0.000078821606,0.000003117443,0.00015183474,0.000078929836,0.0000137152065,0.00008383406,0.0018408988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939289,0.0013479525,0.0009057858,0.00069714064,0.0018687382,0.0012514888],"domain_scores_gemma":[0.9953245,0.0023062967,0.0005013127,0.0010830379,0.00058267696,0.00020218878],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006992609,0.0005025099,0.002416029,0.00088892697,0.00047153945,0.00010122246,0.0005570113,0.0006557808,0.000057747384],"category_scores_gemma":[0.0007905109,0.00031909125,0.00068797625,0.0015608149,0.0014906449,0.0003343307,0.0008592646,0.0024830427,0.000111183974],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037528484,0.0003080702,0.000093290895,0.014504573,0.00038596927,0.000015313242,0.0000962977,2.1293607e-9,0.007998136,0.003487386,0.00019084441,0.97254485],"study_design_scores_gemma":[0.00083533477,0.0013733701,0.0007223019,0.0071169566,0.0007465648,0.000050397794,0.00020396562,0.000052861804,0.051593557,0.00085139374,0.9359443,0.00050899567],"about_ca_topic_score_codex":0.0013667655,"about_ca_topic_score_gemma":0.00013154186,"teacher_disagreement_score":0.9720358,"about_ca_system_score_codex":0.0002276554,"about_ca_system_score_gemma":0.0010027278,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W2107333674","doi":"10.1016/s0166-3542(00)00114-5","title":"A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Heritage Medical Research Clinic","funders":"","keywords":"cccDNA; Circular DNA; Virology; Virus; Biology; DNA; Hepatitis B virus; Genome; DNA virus; Polymerase chain reaction; Viral replication; Duck hepatitis B virus; Hepadnaviridae; Gene; Genetics","score_opus":0.11831721330333456,"score_gpt":0.35728792592048025,"score_spread":0.2389707126171457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107333674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986494,0.00035357696,0.0000117882055,0.0019404048,0.00006178965,0.0008502778,0.00023586332,0.00001784866,0.01003444],"genre_scores_gemma":[0.9967937,0.0011343703,0.000035719575,0.0000923384,0.00009062718,0.00010838925,0.0000068502777,0.000001680636,0.0017363371],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982697,0.00039920944,0.0001933297,0.00023925451,0.00050352013,0.00039501901],"domain_scores_gemma":[0.9965874,0.0028570483,0.000056186243,0.00010151181,0.0003773783,0.00002049799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013128904,0.00011006819,0.00017359665,0.000015101965,0.0012124175,0.000049684324,0.00043841594,0.000058302525,0.00026669228],"category_scores_gemma":[0.00055370637,0.000032273532,0.00020261107,0.00068002136,0.00078476657,0.000107814245,0.0001420377,0.00025439213,0.00010679112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007886434,0.0006485398,0.1009087,0.000056696397,0.00040447648,0.0000062686163,0.0024136957,0.0000030775689,0.58197725,0.08051595,0.0092241,0.22305258],"study_design_scores_gemma":[0.00030176158,0.0016691711,0.8898176,0.00006895608,0.000031648728,0.0000026394723,0.0023908243,0.00046339055,0.04692842,0.0058284886,0.052296523,0.00020055908],"about_ca_topic_score_codex":0.0064463546,"about_ca_topic_score_gemma":0.010923031,"teacher_disagreement_score":0.7889089,"about_ca_system_score_codex":0.000043468415,"about_ca_system_score_gemma":0.000024177967,"threshold_uncertainty_score":0.97450024},"labels":[],"label_agreement":null},{"id":"W2108231926","doi":"10.1016/j.antiviral.2011.05.016","title":"Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Thunder Bay Regional Research Institute","funders":"Cancer Prevention Research Trust","keywords":"Lopinavir; HeLa; Foreskin; Toxicity; Cancer research; Chemistry; Human papillomavirus; Cell culture; Virology; Medicine; Pharmacology; Cell; Biology; Virus; Internal medicine; Biochemistry; Viral load","score_opus":0.30516797746407687,"score_gpt":0.4535937317886897,"score_spread":0.14842575432461286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108231926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84082454,0.00018538609,0.000050485265,0.00044244216,0.000112485584,0.0014201915,0.000037762427,0.000088258275,0.15683848],"genre_scores_gemma":[0.97711664,0.000121340236,0.00017277763,0.000056052955,0.0004188309,0.00018977666,0.0000846811,0.00006848097,0.021771442],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962633,0.00028660512,0.00042726487,0.00073340355,0.0010417273,0.0012476486],"domain_scores_gemma":[0.99825513,0.00021019057,0.000052224892,0.0005923228,0.00061394,0.0002761598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011698935,0.00028397303,0.00051880995,0.00043392312,0.000974051,0.00010661876,0.00029297615,0.0002328655,0.002847757],"category_scores_gemma":[0.00017989703,0.0002165664,0.00036870767,0.0005530822,0.00048267996,0.00015279133,0.0002537049,0.00075906655,0.00051962875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018225595,0.006576418,0.14770061,0.00082206243,0.0015668995,0.0026736292,0.008762296,7.835005e-7,0.47187728,0.018380508,0.008825454,0.3145885],"study_design_scores_gemma":[0.013471121,0.017622773,0.61453146,0.00026677622,0.0002392108,0.00012809286,0.0020269884,0.000432297,0.3279955,0.012013635,0.010388561,0.00088359875],"about_ca_topic_score_codex":0.0054757427,"about_ca_topic_score_gemma":0.0006555068,"teacher_disagreement_score":0.46683085,"about_ca_system_score_codex":0.0004371044,"about_ca_system_score_gemma":0.00030932672,"threshold_uncertainty_score":0.9980638},"labels":[],"label_agreement":null},{"id":"W2114506463","doi":"10.1016/j.antiviral.2009.04.009","title":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herbal Medicine Research Studies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Virus; Common cold; Chemokine; Proinflammatory cytokine; Virology; Echinacea (animal); Interleukin 8; Respiratory system; Secretion; Herb; Biology; Immunology; Medicine; Cytokine; Microbiology; Inflammation; Traditional medicine","score_opus":0.07492421491050086,"score_gpt":0.40564794554532757,"score_spread":0.33072373063482674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114506463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891306,0.0049641565,0.000063948384,0.0022295485,0.00007073186,0.0014290923,0.00011080226,0.00008551541,0.0019155692],"genre_scores_gemma":[0.9972902,0.0010968045,0.00023970318,0.00022185869,0.00026181224,0.000036036883,0.000016652875,0.00004046478,0.00079649925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99459964,0.00072205684,0.0006394361,0.00067395385,0.0023571795,0.0010077349],"domain_scores_gemma":[0.99784845,0.00054349494,0.00014382113,0.00047444945,0.0007480456,0.00024176015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037538765,0.00032938566,0.0007917342,0.00047299862,0.00032308992,0.000051127136,0.00021698422,0.00023682168,0.000015400658],"category_scores_gemma":[0.00415375,0.000261785,0.00012961718,0.0007486777,0.0010819333,0.00045404,0.00019614752,0.0012548406,0.000018856395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024076954,0.00038479338,0.053104937,0.00026745064,0.00011615666,0.00014799695,0.00030072453,4.3817558e-8,0.8036271,0.000027643606,0.08022736,0.05938815],"study_design_scores_gemma":[0.010176763,0.009097739,0.10250997,0.0011863066,0.00008620249,0.000033350996,0.0016621425,0.00014183005,0.7935913,0.00019869424,0.080788165,0.0005275336],"about_ca_topic_score_codex":0.00029135312,"about_ca_topic_score_gemma":0.00002686966,"teacher_disagreement_score":0.058860615,"about_ca_system_score_codex":0.00025086105,"about_ca_system_score_gemma":0.00046221347,"threshold_uncertainty_score":0.99998343},"labels":[],"label_agreement":null},{"id":"W2119169700","doi":"10.1016/j.antiviral.2010.08.015","title":"Cholera toxin inhibits HIV-1 replication in human colorectal epithelial HT-29 cells through adenylate cyclase activation","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Vibrio bacteria research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Université Laval","keywords":"Cholera toxin; Vibrio cholerae; Biology; Cholera; Microbiology; Virology; Enterotoxin; Receptor; Viral replication; Toxin; Clostridium difficile toxin A; Virus; Clostridium difficile; Bacteria","score_opus":0.03564670251154885,"score_gpt":0.3734541258528648,"score_spread":0.33780742334131597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119169700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946321,0.000021642805,0.00003201718,0.001328142,0.00008851599,0.00061223976,0.000044520213,0.000018655883,0.003222147],"genre_scores_gemma":[0.9970479,0.00012815192,0.00019947483,0.00006643548,0.0004572957,0.00013657077,0.00024896106,0.000034667013,0.0016805299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974701,0.00027383302,0.00028511617,0.00075793674,0.00052635354,0.0006867078],"domain_scores_gemma":[0.9988326,0.00006763023,0.00006609277,0.00067234057,0.0002996957,0.0000616582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012798973,0.00018091174,0.00018595022,0.00017584619,0.00030667125,0.000108910936,0.00034702584,0.00026554422,0.000026866019],"category_scores_gemma":[0.0008155014,0.00017446249,0.00007024428,0.00040985274,0.00038799352,0.000042966418,0.00051579124,0.00084937504,0.00011949749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000242059,0.00015820707,0.0016516706,0.000019342466,0.000019036092,0.000007159312,0.00035871827,0.0000010946379,0.9939338,0.00013980902,0.0016729421,0.0017961756],"study_design_scores_gemma":[0.00079276494,0.00034966142,0.030429257,0.000024004728,0.0000017272384,0.000001914231,0.000072831084,0.00003571888,0.9549616,0.0001457938,0.013008811,0.00017594345],"about_ca_topic_score_codex":0.00026485827,"about_ca_topic_score_gemma":0.00030908416,"teacher_disagreement_score":0.038972214,"about_ca_system_score_codex":0.000053500346,"about_ca_system_score_gemma":0.00015073574,"threshold_uncertainty_score":0.7114374},"labels":[],"label_agreement":null},{"id":"W2121716762","doi":"10.1016/j.antiviral.2013.08.019","title":"Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medicinska Forskningsrådet; Vetenskapsrådet; Canadian Institutes of Health Research; IngaBritt och Arne Lundbergs Forskningsstiftelse; Canada Research Chairs; Västra Götalandsregionen","keywords":"Vero cell; Herpes simplex virus; Infectivity; Virology; Genital herpes; Virus; Biology; In vivo; Viral replication; In vitro; HSL and HSV; Viral shedding","score_opus":0.04922621266507007,"score_gpt":0.33401577345602834,"score_spread":0.2847895607909583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121716762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429184,0.00052475487,0.000011748797,0.00032179404,0.00012367748,0.0003700688,0.000032355772,0.00003196824,0.004291819],"genre_scores_gemma":[0.99590373,0.00046878826,0.000057024507,0.000038583523,0.000032195443,0.000018528646,0.00004326298,0.000024964118,0.0034129445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761415,0.00074180035,0.00036594583,0.00041535113,0.00010560968,0.00075713964],"domain_scores_gemma":[0.99840254,0.0008329755,0.00009610432,0.00033660582,0.0003097934,0.000022011112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095052045,0.00019889005,0.00045330406,0.0004118994,0.00015724958,0.000040431118,0.00033956103,0.00024337567,0.0005345192],"category_scores_gemma":[0.0005939714,0.00017214629,0.0001005399,0.0006435605,0.0008309516,0.000390578,0.00028518925,0.00057559594,0.0014107492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020683146,0.00035002903,0.0034087028,0.000044711553,0.00005452985,0.0000066577513,0.00019914388,0.0000012547192,0.94867116,0.00037738783,0.0059625437,0.040717043],"study_design_scores_gemma":[0.00052402844,0.00044004037,0.0493029,0.00012966803,0.000008252889,0.000009330938,0.00043568798,0.000017556007,0.9439182,0.0007591046,0.0042466945,0.0002085364],"about_ca_topic_score_codex":0.020059854,"about_ca_topic_score_gemma":0.001313437,"teacher_disagreement_score":0.045894194,"about_ca_system_score_codex":0.00005846344,"about_ca_system_score_gemma":0.00013823873,"threshold_uncertainty_score":0.99936676},"labels":[],"label_agreement":null},{"id":"W2149363016","doi":"10.1016/j.antiviral.2009.07.005","title":"Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"Michael Smith Health Research BC; Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; National Institute of General Medical Sciences; Heart and Stroke Foundation of Canada","keywords":"Small interfering RNA; HeLa; Folate receptor; RNA; Biology; Ligand (biochemistry); Coxsackievirus; Gene silencing; Viral replication; Chemistry; In vitro; Molecular biology; Cell biology; Virology; Receptor; Virus; Biochemistry; Cancer cell; Gene; Enterovirus; Cancer; Genetics","score_opus":0.06344989725394086,"score_gpt":0.3639606113438208,"score_spread":0.30051071408987995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149363016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965053,0.0012117141,0.00015959481,0.0001066356,0.00007909046,0.0001723956,0.000016612059,0.000012576562,0.0017360342],"genre_scores_gemma":[0.9981212,0.00085833966,0.00019344309,0.00014041814,0.00017484456,0.000002036871,0.00004942746,0.000019170286,0.00044113916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981013,0.0001894758,0.00030909732,0.00042382462,0.00040241214,0.00057392014],"domain_scores_gemma":[0.9989019,0.000029250094,0.00008050409,0.0004220844,0.0005022904,0.000063975254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006539763,0.00017352366,0.00024798524,0.00020281183,0.00015370517,0.00005147834,0.0003715108,0.00017826134,0.000010721673],"category_scores_gemma":[0.0001529918,0.0001638024,0.00013530503,0.00037793754,0.00019646654,0.000019816096,0.00015707074,0.00026699677,0.000043427066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016244919,0.0000919362,0.0031192193,0.000013049547,0.000046330664,0.00002640373,0.000045904973,0.000013791263,0.9894703,0.00004186791,0.0010617627,0.005906963],"study_design_scores_gemma":[0.00038357062,0.000652168,0.005793734,0.00006950589,0.000010002316,0.00000768379,0.00011207806,0.000421105,0.99137926,0.00013349752,0.00085224956,0.00018515825],"about_ca_topic_score_codex":0.00019595932,"about_ca_topic_score_gemma":0.000015755071,"teacher_disagreement_score":0.005721804,"about_ca_system_score_codex":0.000019658079,"about_ca_system_score_gemma":0.00018795866,"threshold_uncertainty_score":0.6679668},"labels":[],"label_agreement":null},{"id":"W2176296348","doi":"10.1016/j.antiviral.2015.11.001","title":"Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung","keywords":"Woodchuck hepatitis virus; Entecavir; CpG Oligodeoxynucleotide; Peripheral blood mononuclear cell; Immune system; Immunology; TLR9; Hepatitis B virus; CpG site; In vivo; Virology; Biology; Viral replication; Viral load; Virus; Medicine; Hepadnaviridae; In vitro; Lamivudine; Gene expression","score_opus":0.15894257964627648,"score_gpt":0.4176381085681958,"score_spread":0.25869552892191927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176296348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782306,0.00043246424,0.00016927789,0.00035247163,0.000023814471,0.0008103198,0.000009966215,0.000026813888,0.00035179875],"genre_scores_gemma":[0.99795973,0.0016495229,0.00013596109,0.000018086179,0.000033810622,0.000100824764,0.000011780887,0.000020779295,0.00006948362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752367,0.00056660693,0.00049118744,0.00041711432,0.000671353,0.00033010077],"domain_scores_gemma":[0.99870145,0.0002365501,0.0001645791,0.0003017117,0.0005302684,0.0000654366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033459316,0.00015834409,0.00040448134,0.0007306739,0.000106846375,0.000026751173,0.000058007652,0.00014842751,0.0000010505516],"category_scores_gemma":[0.0013175019,0.00015111367,0.00004200225,0.0005417921,0.0005071637,0.0005720791,0.00019110246,0.0004074185,0.000002741895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024999965,0.0002928493,0.08958088,0.000103301274,0.000026298405,0.000003380942,0.0029232453,0.0000056150798,0.88425595,0.000831145,0.000019229698,0.0194581],"study_design_scores_gemma":[0.002749667,0.0029839848,0.35717982,0.00034247423,0.000009158054,0.0000024296246,0.00010532873,0.0048303455,0.62871075,0.0029753773,0.0000056372737,0.00010502062],"about_ca_topic_score_codex":0.0041279164,"about_ca_topic_score_gemma":0.0005683725,"teacher_disagreement_score":0.26759893,"about_ca_system_score_codex":0.00029577577,"about_ca_system_score_gemma":0.00026141133,"threshold_uncertainty_score":0.6240203},"labels":[],"label_agreement":null},{"id":"W2223974350","doi":"10.1016/j.antiviral.2015.11.012","title":"Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; U.S. Public Health Service; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Ebola virus; Virology; Serology; Ebolavirus; Antibody; Filoviridae; VP40; Nucleoprotein; Biology; Viral matrix protein; Glycoprotein; Virus; Marburg virus; Immunology; Viral disease; Molecular biology; Paramyxoviridae","score_opus":0.16506675775502133,"score_gpt":0.519286898507329,"score_spread":0.3542201407523077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223974350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486464,0.00021952654,0.0008137724,0.0008946836,0.0000144525175,0.002484129,0.000034442957,0.000016301063,0.0006580616],"genre_scores_gemma":[0.99277425,0.00005935701,0.0055194567,0.000017776634,0.000032008265,0.00024868644,0.000012964854,0.00002319349,0.001312307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979111,0.00046866588,0.00030551277,0.00036989286,0.00047051275,0.0004743106],"domain_scores_gemma":[0.99840546,0.0005300385,0.000048454367,0.00018428065,0.0007022532,0.00012954343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035729397,0.00012934557,0.0003551407,0.0010297429,0.00013833608,0.000053465177,0.00008699416,0.0001314198,0.000005153006],"category_scores_gemma":[0.0025792804,0.00011104507,0.00003486186,0.0005401977,0.00037622254,0.00019667094,0.00018978018,0.00033632666,0.000013175522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045088176,0.00019937742,0.022205357,0.00032459365,0.000014504767,0.00003824721,0.0008395946,1.3301499e-7,0.9618991,0.0029926496,0.00007475223,0.006902869],"study_design_scores_gemma":[0.005652653,0.021711605,0.17505553,0.00055799185,0.0000250207,0.000041070823,0.001924397,0.003895372,0.7835266,0.006562279,0.0007285097,0.00031897172],"about_ca_topic_score_codex":0.0014445656,"about_ca_topic_score_gemma":0.00081658055,"teacher_disagreement_score":0.1783725,"about_ca_system_score_codex":0.00008025825,"about_ca_system_score_gemma":0.00022474532,"threshold_uncertainty_score":0.45282865},"labels":[],"label_agreement":null},{"id":"W2224426314","doi":"10.1016/j.antiviral.2015.10.007","title":"Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Virus; Antibody; Immunology; CD8; Virology; Immune system; Agonistic behaviour; Medicine; Respiratory system; Biology; Internal medicine","score_opus":0.1589316779338063,"score_gpt":0.4936297213999463,"score_spread":0.33469804346614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224426314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862692,0.0002620696,0.0002057196,0.0011674311,0.0003936038,0.0019340968,0.00004626722,0.00027564986,0.009445973],"genre_scores_gemma":[0.9916042,0.00011634256,0.0000748019,0.00020089636,0.001766708,0.00026795885,0.00004384473,0.00011827002,0.005806967],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99255246,0.0011334879,0.00064653245,0.0011179138,0.0029017068,0.0016479208],"domain_scores_gemma":[0.99513865,0.00022018787,0.000080879174,0.0013483757,0.001716074,0.0014958174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033015923,0.0004010673,0.0005889263,0.0019496095,0.000776221,0.00048726855,0.00043858678,0.0002549882,0.00011747202],"category_scores_gemma":[0.0051116394,0.00037637164,0.00022583656,0.0029352827,0.0005887062,0.0008958077,0.0007458061,0.001704593,0.005025041],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004181839,0.00044588666,0.03625046,0.00022932868,0.00019354688,0.0022451987,0.0002780423,0.000031741885,0.9408404,0.00027711136,0.008672879,0.006353529],"study_design_scores_gemma":[0.006536144,0.0059679924,0.46647215,0.0007324205,0.00022549187,0.000116090334,0.00036947188,0.0005873212,0.4564831,0.00052969943,0.06083347,0.0011466522],"about_ca_topic_score_codex":0.0020377322,"about_ca_topic_score_gemma":0.00009528716,"teacher_disagreement_score":0.48435733,"about_ca_system_score_codex":0.0011469332,"about_ca_system_score_gemma":0.0020579412,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W2238087249","doi":"10.1016/j.antiviral.2016.01.001","title":"Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"National Natural Science Foundation of China; Manitoba Health Research Council; Canadian Institutes of Health Research; Canadian Foundation for AIDS Research","keywords":"Ebola virus; Virology; Prunella vulgaris; Vero cell; Ebolavirus; Virus; Filoviridae; Biology; Medicine; Viral disease; Paramyxoviridae","score_opus":0.028903295284684893,"score_gpt":0.3544381305793759,"score_spread":0.325534835294691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238087249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753726,0.00003600853,0.000026561289,0.00013150461,0.000083386156,0.0010318484,0.00005874861,0.000016645079,0.0010780286],"genre_scores_gemma":[0.99854326,0.0005607829,0.000005263931,0.000008861396,0.00010888609,0.00003623071,0.000013547523,0.000024289146,0.0006988833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971287,0.00094167504,0.000390945,0.0002868371,0.00092098984,0.00033080394],"domain_scores_gemma":[0.9983297,0.0006135746,0.0001646987,0.00040586884,0.00040603394,0.00008014685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019765792,0.00014663872,0.00036730003,0.00046433552,0.00012369802,0.000014668232,0.000107384985,0.00019116433,0.00005392557],"category_scores_gemma":[0.001146915,0.0000794618,0.00010891566,0.00070270675,0.0005944915,0.0002242391,0.00013426106,0.0004451337,0.000021645235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016026968,0.00035016172,0.03342439,0.0002636752,0.00003926643,0.000005159343,0.0000723848,9.330511e-8,0.9024946,0.0000324476,0.000030190535,0.061684955],"study_design_scores_gemma":[0.0012158715,0.0034541383,0.2413433,0.00043150262,0.000015550859,0.0000051931293,0.0000071974578,0.00007185455,0.7532076,0.000018655319,0.00017381151,0.000055278735],"about_ca_topic_score_codex":0.0015591104,"about_ca_topic_score_gemma":0.000105153835,"teacher_disagreement_score":0.20791891,"about_ca_system_score_codex":0.000071746974,"about_ca_system_score_gemma":0.00015700808,"threshold_uncertainty_score":0.32403582},"labels":[],"label_agreement":null},{"id":"W2260339506","doi":"10.1016/j.antiviral.2016.02.006","title":"Statins can exert dual, concentration dependent effects on HCV entry in vitro","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Pravastatin; Downregulation and upregulation; Atorvastatin; In vitro; In vivo; Pharmacology; Medicine; Statin; Ribavirin; HMG-CoA reductase; Viral entry; Reductase; Hepatitis C virus; Immunology; Cholesterol; Chemistry; Virus; Biology; Internal medicine; Enzyme; Biochemistry; Viral replication","score_opus":0.06674329022386635,"score_gpt":0.4132207350815794,"score_spread":0.34647744485771304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260339506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730462,0.00008951849,0.000030470488,0.0043907566,0.00011071815,0.0011695472,0.000041177853,0.00003894976,0.021082658],"genre_scores_gemma":[0.99323463,0.0009460755,0.000058033824,0.00021554252,0.0002436569,0.00012687097,0.000028325747,0.000037127502,0.0051097516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99525464,0.00085026864,0.00028904632,0.00050119543,0.0020027412,0.0011021079],"domain_scores_gemma":[0.9975404,0.001434597,0.000031105465,0.00044797114,0.0003355817,0.00021030965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017126536,0.00016093558,0.00029811767,0.00040355095,0.00011996478,0.000056914847,0.00016227526,0.00013701592,0.00009880686],"category_scores_gemma":[0.003264655,0.00011093971,0.00005688842,0.00054762437,0.00022165441,0.00015857379,0.00013212212,0.0007012464,0.0009385825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009589073,0.00020587319,0.037169505,0.00007917588,0.00001785754,0.000915654,0.00018143265,3.807551e-8,0.65603584,0.00021351624,0.0035645082,0.3006577],"study_design_scores_gemma":[0.003390036,0.0010694821,0.037444126,0.00055545004,0.0000041693384,0.000002864908,0.00006077903,0.00009019513,0.95431274,0.00016284193,0.0027705743,0.00013676185],"about_ca_topic_score_codex":0.0011979481,"about_ca_topic_score_gemma":0.00057970185,"teacher_disagreement_score":0.30052093,"about_ca_system_score_codex":0.0006575808,"about_ca_system_score_gemma":0.0006364031,"threshold_uncertainty_score":0.9998393},"labels":[],"label_agreement":null},{"id":"W2304592771","doi":"10.1016/j.antiviral.2016.03.012","title":"Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Taipei Medical University; Ministry of Science and Technology, Taiwan","keywords":"Hepatitis C virus; Virology; Hepatocellular carcinoma; Ribavirin; Hepatitis C; Medicine; Entry inhibitor; Viral entry; Virus; Viral replication; Cancer research","score_opus":0.07069911098754443,"score_gpt":0.41576671697176837,"score_spread":0.3450676059842239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304592771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343824,0.00016208115,0.00027019504,0.0010158501,0.000050226034,0.0005320509,0.00016721005,0.000024891651,0.0043392587],"genre_scores_gemma":[0.99566066,0.0025295718,0.000106536936,0.000030171672,0.00008635717,0.000042875738,0.000017206803,0.000030434632,0.0014962032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956281,0.00066053355,0.0005273817,0.0005271542,0.002009167,0.00064766774],"domain_scores_gemma":[0.9966223,0.0012998632,0.00016919526,0.00066425046,0.0010496103,0.00019473207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001777824,0.0001934443,0.0007986084,0.0021918206,0.00013751126,0.00004233075,0.00020359861,0.00018198135,0.0003061049],"category_scores_gemma":[0.0026707822,0.00014279266,0.00026666495,0.0021094508,0.00085844845,0.0002673697,0.00024181265,0.00041528285,0.00009654264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008042333,0.0003840764,0.35081366,0.00019405523,0.0006726389,0.0001492806,0.00008529113,5.781677e-7,0.61942697,0.00010561851,0.00092081266,0.02644282],"study_design_scores_gemma":[0.0011378032,0.00067593047,0.36074853,0.00028917476,0.00018105355,0.0000035020769,0.000034029035,0.0004968377,0.635768,0.00012498908,0.00043064432,0.000109514935],"about_ca_topic_score_codex":0.02351273,"about_ca_topic_score_gemma":0.0017031133,"teacher_disagreement_score":0.026333304,"about_ca_system_score_codex":0.0001900673,"about_ca_system_score_gemma":0.00058482157,"threshold_uncertainty_score":0.9829898},"labels":[],"label_agreement":null},{"id":"W2350561728","doi":"10.1016/j.antiviral.2016.05.006","title":"The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Zanamivir; Oseltamivir; Neuraminidase; Virology; Titer; Biology; Virus; Microbiology; Resistance mutation; Medicine; RNA; Reverse transcriptase; Coronavirus disease 2019 (COVID-19)","score_opus":0.14260972703069322,"score_gpt":0.43415358660680564,"score_spread":0.2915438595761124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2350561728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951627,0.00077643775,0.00001372342,0.0020889598,0.00003921292,0.0013457992,0.000033105527,0.000025971509,0.00051406573],"genre_scores_gemma":[0.9982627,0.0007075059,0.000057291196,0.00015025109,0.000043785163,0.00022474589,0.0000042210436,0.00004166873,0.0005078126],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99477035,0.0010036818,0.00074201386,0.0007057158,0.0013203137,0.0014579286],"domain_scores_gemma":[0.9970556,0.0019433163,0.0000801787,0.00046759745,0.00032581083,0.00012753197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042860303,0.00027983714,0.000488968,0.0011022609,0.0002781672,0.00015483378,0.00032615216,0.00016001855,0.0000039538295],"category_scores_gemma":[0.0027318527,0.00017661156,0.00007295154,0.0011375484,0.0009383212,0.00086502783,0.0005227718,0.0010413278,0.00005384978],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03248166,0.00035433625,0.030701691,0.00023438358,0.00006212381,0.00212605,0.0029595122,0.000026746515,0.9023242,0.00048132773,0.00014499355,0.028102985],"study_design_scores_gemma":[0.01560481,0.0009131587,0.8415733,0.001083618,0.000014200191,0.000021807295,0.0020685403,0.03360177,0.101017736,0.0032964658,0.00029282004,0.00051178725],"about_ca_topic_score_codex":0.0026272591,"about_ca_topic_score_gemma":0.002789572,"teacher_disagreement_score":0.8108716,"about_ca_system_score_codex":0.0004766267,"about_ca_system_score_gemma":0.0003132149,"threshold_uncertainty_score":0.7202011},"labels":[],"label_agreement":null},{"id":"W2413117341","doi":"10.1016/j.antiviral.2016.10.008","title":"Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Immunology; Virus; Pneumonia; Innate immune system; Nasal administration; Chemokine; Immune system; Context (archaeology); Respiratory tract; Lower respiratory tract infection; Medicine; Viral pneumonia; Respiratory system; Disease; Biology; Respiratory tract infections; Internal medicine; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19)","score_opus":0.08884647766459165,"score_gpt":0.3814603324629072,"score_spread":0.2926138547983156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413117341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994485,0.00029696996,0.0005286815,0.0013499701,0.00007165009,0.0016408417,0.00005330986,0.00006862441,0.0015049209],"genre_scores_gemma":[0.99707425,0.0005180397,0.00014133846,0.000014955573,0.0001374532,0.00030909054,0.000009594498,0.00006418486,0.0017310802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964808,0.00037359534,0.0005042442,0.00054139335,0.0012669468,0.0008329924],"domain_scores_gemma":[0.9978822,0.00026233276,0.00011259396,0.0006592195,0.0009431661,0.00014051508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014261499,0.0002700859,0.00051077944,0.0008782632,0.00024430244,0.000047796268,0.00022973662,0.00018216296,0.000043458047],"category_scores_gemma":[0.00041874297,0.00015361902,0.00014288051,0.0012598292,0.0009241542,0.00037027925,0.00013077469,0.0005537723,0.00015851723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021182492,0.0007999282,0.0042896285,0.0000774856,0.00023352611,0.000087162865,0.00013153942,6.29405e-7,0.91077,0.00010329016,0.000021279322,0.08136727],"study_design_scores_gemma":[0.0042285416,0.008385626,0.030532304,0.00035517334,0.00002390793,0.000042245698,0.000077373144,0.00016345501,0.95446527,0.000036038564,0.0015085572,0.0001814953],"about_ca_topic_score_codex":0.002169469,"about_ca_topic_score_gemma":0.00020400986,"teacher_disagreement_score":0.08118577,"about_ca_system_score_codex":0.00057150953,"about_ca_system_score_gemma":0.0007231805,"threshold_uncertainty_score":0.6264402},"labels":[],"label_agreement":null},{"id":"W2462974575","doi":"10.1016/j.antiviral.2016.07.004","title":"Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Nucleic acid; Virology; Broad spectrum; Antiviral treatment; Antiviral therapy; Hepatitis; Medicine; Biology; Chemistry; Chronic hepatitis; Virus; Combinatorial chemistry; Biochemistry","score_opus":0.08977392654334417,"score_gpt":0.4036727077382293,"score_spread":0.3138987811948851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462974575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012666339,0.97564757,0.0030097477,0.00056717696,0.00038632657,0.006011092,0.00068555726,0.00008912138,0.00093705166],"genre_scores_gemma":[0.120205976,0.8774379,0.0004894723,0.000012071333,0.00034671053,0.00049180095,0.00006669835,0.00012952248,0.00081985927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959187,0.0006769639,0.00067579263,0.0009440981,0.00084070646,0.0009437369],"domain_scores_gemma":[0.99721336,0.0013955265,0.0003794621,0.00062856777,0.00028110645,0.000101980404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009501298,0.0006840672,0.0022153524,0.0007652829,0.0006677513,0.00013766874,0.00017170333,0.00044409445,0.000040683357],"category_scores_gemma":[0.00041760362,0.00042482608,0.0005022712,0.00071067445,0.0009583977,0.00038405994,0.0002846675,0.00043311488,0.000028581368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014727686,0.00032429033,0.005902995,0.0041225473,0.0008015093,0.000033231106,0.00017722983,5.3982813e-8,0.0003430153,0.0004208354,0.00016359892,0.98756343],"study_design_scores_gemma":[0.0158029,0.055521883,0.03849543,0.0686731,0.008729735,0.00041975584,0.00013856639,0.005845248,0.037843782,0.0024808715,0.7612957,0.0047530797],"about_ca_topic_score_codex":0.010372932,"about_ca_topic_score_gemma":0.0029339446,"teacher_disagreement_score":0.9828103,"about_ca_system_score_codex":0.0004184098,"about_ca_system_score_gemma":0.00039657787,"threshold_uncertainty_score":0.99982035},"labels":[],"label_agreement":null},{"id":"W2487753465","doi":"10.1016/j.antiviral.2016.07.015","title":"MERS-CoV spike protein: Targets for vaccines and therapeutics","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chinese Academy of Sciences; National Natural Science Foundation of China","keywords":"Middle East respiratory syndrome coronavirus; Spike Protein; Virology; Middle East respiratory syndrome; Outbreak; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Biology; Medicine; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.2381780743804344,"score_gpt":0.5081083494068118,"score_spread":0.26993027502637745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487753465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007642561,0.98753005,0.00007091657,0.0005357552,0.000106480875,0.006522755,0.00009236895,0.00006974185,0.0043076873],"genre_scores_gemma":[0.00054653286,0.99223185,0.00018183843,0.0017240485,0.0010220517,0.0014828275,0.000020995347,0.0001999075,0.0025899296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492866,0.00051124673,0.0006325822,0.0010457156,0.0013851444,0.0014966673],"domain_scores_gemma":[0.9967367,0.0013208098,0.00013792823,0.00091223634,0.00083336706,0.00005892825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029665085,0.00056473346,0.001861503,0.0009554072,0.00032313302,0.00016483676,0.0006007,0.00064242916,0.000006976496],"category_scores_gemma":[0.0009281516,0.00034450451,0.00056307815,0.00079556904,0.0004499877,0.00016426292,0.00046573655,0.0013174467,0.00045419484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028476273,0.00013765888,0.00008379235,0.021696184,0.00038224785,0.000107532636,0.000036871443,2.2902256e-11,0.010700532,0.00048547232,0.0015642553,0.9645207],"study_design_scores_gemma":[0.0011387919,0.0009771315,0.000007753661,0.010125154,0.00018648717,0.000035101613,0.000021315329,0.0000055738064,0.01829311,0.0006091787,0.9682347,0.0003656942],"about_ca_topic_score_codex":0.00006691019,"about_ca_topic_score_gemma":0.000017415792,"teacher_disagreement_score":0.96667045,"about_ca_system_score_codex":0.00021685741,"about_ca_system_score_gemma":0.0017539246,"threshold_uncertainty_score":0.9999007},"labels":[],"label_agreement":null},{"id":"W2528330764","doi":"10.1016/j.antiviral.2016.09.013","title":"A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Oak Ridge Institute for Science and Education; National Institutes of Health","keywords":"Enzootic; Tick; Crimean–Congo hemorrhagic fever; Livestock; Transmission (telecommunications); Outbreak; Viremia; Tick-borne disease; Virology; Biology; Disease; Hyalomma; Veterinary medicine; Virus; Ecology; Medicine; Ixodidae; Pathology","score_opus":0.1717682286979072,"score_gpt":0.47781609131887426,"score_spread":0.30604786262096706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528330764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12552488,0.8727602,0.0000012566649,0.000066058965,0.000015688458,0.0011692736,0.000012689357,0.0000024114315,0.0004475551],"genre_scores_gemma":[0.3366824,0.66319823,0.000010763445,0.000007321234,0.000014945662,0.000037579204,8.84432e-7,0.000007793111,0.00004007345],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99776345,0.00078273506,0.00063476583,0.00024222204,0.00037822043,0.00019858411],"domain_scores_gemma":[0.99874693,0.00045899276,0.00027824947,0.0002867685,0.00020694085,0.000022113893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015364928,0.00017883314,0.0013014834,0.00019078929,0.00005583391,0.0000033741892,0.00013044619,0.00013495551,0.000016791912],"category_scores_gemma":[0.00052098435,0.00007388903,0.00024219867,0.000528249,0.0010242334,0.000056274483,0.00015148366,0.00040386035,0.0000011124492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012473608,0.00057515403,0.0024613445,0.08902833,0.00022131328,0.0000059539425,0.00053856603,6.6609287e-9,0.035612352,0.0006093759,0.00027304984,0.8705498],"study_design_scores_gemma":[0.0019645235,0.008841019,0.02110339,0.68587184,0.0008433013,0.00022784513,0.0011494874,0.00000965388,0.06666017,0.00044460015,0.21244836,0.0004357999],"about_ca_topic_score_codex":0.00030718246,"about_ca_topic_score_gemma":0.000009589424,"teacher_disagreement_score":0.870114,"about_ca_system_score_codex":0.00004974048,"about_ca_system_score_gemma":0.00013696187,"threshold_uncertainty_score":0.37738305},"labels":[],"label_agreement":null},{"id":"W2553822584","doi":"10.1016/j.antiviral.2016.11.007","title":"The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Zanamivir; Neuraminidase; Oseltamivir; Titer; Virology; Recombinant DNA; Influenza A virus; Virus; Biology; Mutant; Viral replication; Enzyme; Neuraminidase inhibitor; Chemistry; Molecular biology; Gene; Biochemistry; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.10680784441848729,"score_gpt":0.386721984593594,"score_spread":0.27991414017510674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553822584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263537,0.0003983317,0.00002488173,0.0038289062,0.00007547159,0.0026974163,0.00008084906,0.00007019055,0.000188591],"genre_scores_gemma":[0.99876314,0.00015570842,0.000041906504,0.00023873059,0.00013921657,0.00022724553,0.000007856894,0.0000517204,0.00037448865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99359274,0.0014737309,0.00061772857,0.0008786315,0.0020538874,0.0013833076],"domain_scores_gemma":[0.99486095,0.0011809678,0.0001498556,0.0012710575,0.002214624,0.0003225692],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0041315337,0.00040884266,0.00058063655,0.0003546529,0.0013307959,0.00018251933,0.0005280035,0.00015229193,0.00000837438],"category_scores_gemma":[0.005076197,0.00017463257,0.0001057117,0.001143875,0.004952941,0.0007281238,0.0007052339,0.0009286788,0.000051161605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017720431,0.00039286513,0.03429388,0.00025297372,0.00038194246,0.00017428657,0.0065005864,0.000008487334,0.9007946,0.00031193055,0.0005103202,0.038657676],"study_design_scores_gemma":[0.0036209687,0.005091816,0.31421307,0.0008535186,0.000072530696,0.000043774926,0.004338242,0.00041490013,0.6701249,0.000093420786,0.0007219137,0.00041096687],"about_ca_topic_score_codex":0.0023924084,"about_ca_topic_score_gemma":0.00066178426,"teacher_disagreement_score":0.27991918,"about_ca_system_score_codex":0.0003628057,"about_ca_system_score_gemma":0.0010164721,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W2555716205","doi":"10.1016/j.antiviral.2016.11.002","title":"Amending Koch's postulates for viral disease: When “growth in pure culture” leads to a loss of virulence","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"National Institutes of Health","keywords":"Biology; Virulence; Context (archaeology); Hantavirus; Virology; Disease; Bunyaviridae; Virus; Adaptation (eye); Genetics; Medicine; Neuroscience; Gene","score_opus":0.13791039506663785,"score_gpt":0.48508237251174513,"score_spread":0.3471719774451073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555716205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007185222,0.9865113,0.00014349035,0.00045078577,0.00017780179,0.003952371,0.00041591216,0.00004499765,0.0011181007],"genre_scores_gemma":[0.09109182,0.9037024,0.00014531122,0.000029521007,0.00037886912,0.00047534733,0.00009892861,0.000082150866,0.0039956667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966566,0.0003204718,0.00068189413,0.0007100048,0.0007304599,0.00090057706],"domain_scores_gemma":[0.9982305,0.00044387803,0.00014010016,0.00048467415,0.00047102428,0.00022977756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013053624,0.00039673128,0.0015390945,0.0012094014,0.000144204,0.00005674802,0.00039055853,0.0003107589,0.000045270957],"category_scores_gemma":[0.0014817783,0.00025505348,0.0005908062,0.0010595314,0.00027263572,0.00019988022,0.00027872046,0.00077863975,0.00018518901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088036305,0.00081169914,0.0075305304,0.051292773,0.00036953134,0.0003018475,0.00036791348,8.911244e-8,0.0022356235,0.00988846,0.0133036515,0.9130175],"study_design_scores_gemma":[0.0013399129,0.002702467,0.00074957917,0.08836249,0.00038633044,0.000027552485,0.000044664965,0.000010159721,0.0010916013,0.0022557622,0.90226746,0.000761997],"about_ca_topic_score_codex":0.00013699337,"about_ca_topic_score_gemma":0.000025588044,"teacher_disagreement_score":0.9122555,"about_ca_system_score_codex":0.000348734,"about_ca_system_score_gemma":0.0005673489,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W2556090342","doi":"10.1016/j.antiviral.2016.11.017","title":"Synergistic drug combination effectively blocks Ebola virus infection","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; National Center for GM Crops; National Institutes of Health","keywords":"Ebola virus; Drug; Posaconazole; Ebolavirus; Virology; Pharmacology; Toremifene; Mefloquine; Medicine; Antiviral drug; Biology; Virus; Immunology; Microbiology; Malaria; Internal medicine; Chloroquine; Amphotericin B","score_opus":0.05798860668639612,"score_gpt":0.40582580550168074,"score_spread":0.34783719881528463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556090342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96490616,0.00006171572,0.0012477592,0.0014911732,0.00018856733,0.0007493546,0.000011235623,0.00013223807,0.031211788],"genre_scores_gemma":[0.9767158,0.0004707766,0.000025718842,0.00003866805,0.00027445436,0.00011683025,0.000008387503,0.000036772046,0.022312587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99683654,0.00057828106,0.0002558636,0.00047148432,0.001108666,0.00074913446],"domain_scores_gemma":[0.99760073,0.0009818028,0.00004206705,0.0003556279,0.0008660145,0.0001537324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022766583,0.00017388172,0.00027798247,0.0008200814,0.00046279345,0.0000864198,0.000112402755,0.00014395559,0.00022076767],"category_scores_gemma":[0.0016957042,0.000112860136,0.00014578809,0.0010708525,0.00043204633,0.00031145473,0.000177438,0.0006379073,0.001564255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003476187,0.00052692683,0.032631304,0.00007211466,0.00006531692,0.00007725332,0.00005664486,1.8352499e-7,0.8583345,0.0019041888,0.007985985,0.09799796],"study_design_scores_gemma":[0.0029835054,0.0016329864,0.20638612,0.00038077464,0.0000323815,0.000031128337,0.000033238965,0.00032413122,0.77874017,0.002626511,0.006590085,0.00023899008],"about_ca_topic_score_codex":0.0027540207,"about_ca_topic_score_gemma":0.0002694952,"teacher_disagreement_score":0.17375481,"about_ca_system_score_codex":0.0003889245,"about_ca_system_score_gemma":0.00021844514,"threshold_uncertainty_score":0.99921316},"labels":[],"label_agreement":null},{"id":"W2557367716","doi":"10.1016/j.antiviral.2016.11.019","title":"Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institutes of Health; Public Health Agency of Canada; Emergent BioSolutions","keywords":"In vivo; In vitro; Host (biology); Virology; Microbiology; Biology; Chemistry; Biochemistry; Biotechnology; Genetics","score_opus":0.04746248677001807,"score_gpt":0.4019827718104963,"score_spread":0.3545202850404782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557367716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567884,0.000049928276,0.00013916248,0.0015561269,0.00005638651,0.001038477,0.00007695385,0.000009373352,0.0013947475],"genre_scores_gemma":[0.9984117,0.0005160258,0.000097590266,0.000025508569,0.000047729525,0.000108183216,0.0000017834052,0.000016266222,0.0007752154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816513,0.0003278234,0.0002232481,0.0003253114,0.00045779752,0.00050070585],"domain_scores_gemma":[0.9988374,0.00059859385,0.00004127612,0.0002435919,0.00020792746,0.00007120273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013870782,0.00011746799,0.0002729577,0.0005581863,0.00017995446,0.00003371707,0.000085373824,0.00011960965,0.000016749318],"category_scores_gemma":[0.0006284974,0.00007048177,0.000077351266,0.0006522774,0.00045730028,0.00019483613,0.00024240669,0.00046941452,0.0000017407132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035794862,0.00028859783,0.16042191,0.00006701865,0.000019391864,0.000009579457,0.000028744395,5.4197216e-7,0.8198837,0.00006992155,0.00010651979,0.018746143],"study_design_scores_gemma":[0.0021239917,0.00041246496,0.6780331,0.00011609743,0.000006816391,0.000007422595,0.00006422053,0.0012155145,0.3176881,0.00010794815,0.00015340642,0.00007090015],"about_ca_topic_score_codex":0.0012403581,"about_ca_topic_score_gemma":0.00070250145,"teacher_disagreement_score":0.5176112,"about_ca_system_score_codex":0.00015032524,"about_ca_system_score_gemma":0.00028073526,"threshold_uncertainty_score":0.28741634},"labels":[],"label_agreement":null},{"id":"W2586346865","doi":"10.1016/j.antiviral.2017.01.025","title":"Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05–2013/14, Toronto, Canada","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Public Health Ontario; William Osler Health System; Sunnybrook Health Science Centre; St. Michael's Hospital; Izaak Walton Killam Health Centre; Sinai Health System; North York General Hospital; Toronto Public Health; University of Toronto; Toronto East General Hospital; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pandemic; Guideline; Retrospective cohort study; Antiviral treatment; Odds ratio; Medical prescription; Observational study; Internal medicine; Disease; Young adult; Pediatrics; Coronavirus disease 2019 (COVID-19); Virus; Immunology; Infectious disease (medical specialty); Pathology; Pharmacology","score_opus":0.06871343138177273,"score_gpt":0.4055487070867197,"score_spread":0.336835275704947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586346865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948923,0.0008847619,1.8738078e-7,0.00050276174,0.000076699995,0.0010595255,0.00021268969,0.000027201193,0.0023438847],"genre_scores_gemma":[0.9969194,0.00041815403,0.00004810011,0.00030688857,0.00005994884,0.00011570929,0.00004023083,0.000057531972,0.0020340255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946952,0.0004375332,0.0005237281,0.0007802233,0.0019842186,0.0015791245],"domain_scores_gemma":[0.9969388,0.00035107502,0.00014600503,0.0010406942,0.0013036698,0.0002197077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015289693,0.00038086707,0.00077193376,0.0005645364,0.00051245897,0.0002719738,0.00049585133,0.0002100842,0.000041782434],"category_scores_gemma":[0.0032419926,0.00029980252,0.00005296941,0.00054591807,0.00097264186,0.0014236536,0.000571237,0.0011811565,0.000012871181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032982824,0.0002638737,0.9826406,0.000086672015,0.000095631214,0.000316984,0.00053975434,4.939536e-7,0.0017739658,0.000026717767,0.0040578484,0.006899162],"study_design_scores_gemma":[0.0097302785,0.0010470501,0.9839479,0.0003376414,0.000015059855,0.000001334538,0.00019520677,0.000040525952,0.00067014823,0.00000781698,0.0036876223,0.00031945592],"about_ca_topic_score_codex":0.8561526,"about_ca_topic_score_gemma":0.94373,"teacher_disagreement_score":0.08757739,"about_ca_system_score_codex":0.0010950738,"about_ca_system_score_gemma":0.001662814,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W2602370702","doi":"10.1016/j.antiviral.2017.03.016","title":"Comparison of three cell-based drug screening platforms for HSV-1 infection","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institutes of Health; Pittsburgh Center for Kidney Research, University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Fogarty International Center; Scioto Foundation","keywords":"Vero cell; Herpes simplex virus; Virology; Antiviral drug; Neurotropic virus; Encephalitis; Drug; Neurotoxicity; Lytic cycle; Induced pluripotent stem cell; Progenitor cell; HSL and HSV; Biology; Virus; Neural stem cell; Cell culture; Pharmacology; Immunology; Medicine; Stem cell; Toxicity; Internal medicine","score_opus":0.28122368428302413,"score_gpt":0.5167682611950645,"score_spread":0.23554457691204034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602370702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98074114,0.000042053223,0.005751257,0.00017893664,0.0000885109,0.0006720269,0.000013168756,0.0000249896,0.012487921],"genre_scores_gemma":[0.9975502,0.000012329066,0.0011801166,0.0000087476765,0.00009198976,0.000061862804,0.000025020949,0.000019251574,0.0010505129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988446,0.000020770729,0.00020317992,0.00020221065,0.00039511514,0.00033410432],"domain_scores_gemma":[0.99885005,0.00020777015,0.00010331056,0.00047978482,0.00030333732,0.000055754037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007942767,0.00009540153,0.00026336656,0.00021474792,0.00077987724,0.00005852761,0.00010526907,0.00008050817,0.000022186512],"category_scores_gemma":[0.0003029118,0.000074405856,0.00013027503,0.000114293696,0.00020525027,0.00016939717,0.000062841355,0.00027767842,0.000050158997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034517836,0.0005915633,0.902324,0.00014908075,0.000057624708,0.0000055772407,0.000059150956,0.0000062623944,0.003052316,0.00020791143,0.0011085434,0.09209278],"study_design_scores_gemma":[0.004309015,0.0012758692,0.53738856,0.0002562835,0.00006510242,0.0000011905419,0.000060127128,0.010813973,0.43682024,0.0006421597,0.008239693,0.00012777024],"about_ca_topic_score_codex":0.0021929091,"about_ca_topic_score_gemma":0.00065831176,"teacher_disagreement_score":0.4337679,"about_ca_system_score_codex":0.00005134619,"about_ca_system_score_gemma":0.00012649375,"threshold_uncertainty_score":0.5998264},"labels":[],"label_agreement":null},{"id":"W2604663227","doi":"10.1016/j.antiviral.2017.04.004","title":"Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff protein","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China; National Science Foundation","keywords":"Ectopic expression; Herpes simplex virus; Gene knockdown; Viral replication; Biology; Endonuclease; Mutant; Virology; Virus; Molecular biology; Gene; Genetics","score_opus":0.08766925390711647,"score_gpt":0.39740966022177643,"score_spread":0.30974040631465993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604663227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904573,0.00086287764,0.00001284889,0.00092140987,0.00032939066,0.0006999276,0.00004248482,0.000037124857,0.0066366526],"genre_scores_gemma":[0.98340625,0.00021011467,0.000006073448,0.000025103653,0.00005540243,0.000031732783,0.000012772568,0.0000300208,0.016222518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969559,0.0013352718,0.0002853757,0.00040398,0.0001979661,0.0008215572],"domain_scores_gemma":[0.99786013,0.00044995005,0.00021386784,0.0010224476,0.0004362952,0.000017286862],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017662972,0.000238826,0.00039326123,0.00018669052,0.0014139166,0.00013396092,0.0012353514,0.00030613187,0.00029237065],"category_scores_gemma":[0.001337293,0.00016205704,0.00015763729,0.00019829422,0.0017394354,0.000451108,0.00063038233,0.0008395189,0.0019676874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002245917,0.0002381232,0.00036793863,0.00003753691,0.00012552511,0.000012169514,0.00023033009,2.3341766e-8,0.93431586,0.0006270564,0.0011038801,0.060695615],"study_design_scores_gemma":[0.00063648145,0.0008563247,0.031167649,0.00008648144,0.000010906346,0.000007708888,0.00011322853,0.00001981278,0.9398301,0.00009929617,0.027002294,0.00016970868],"about_ca_topic_score_codex":0.001458422,"about_ca_topic_score_gemma":0.0002109314,"teacher_disagreement_score":0.06052591,"about_ca_system_score_codex":0.00004337402,"about_ca_system_score_gemma":0.0001934277,"threshold_uncertainty_score":0.9998861},"labels":[],"label_agreement":null},{"id":"W2751541811","doi":"10.1016/j.antiviral.2017.09.005","title":"Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Natural Sciences and Engineering Research Council of Canada; Defense Advanced Research Projects Agency","keywords":"Polyclonal antibodies; Zika virus; Microcephaly; Antibody; Virology; Biology; Atrophy; Immunology; Virus; Medicine; Pathology","score_opus":0.05516204557119253,"score_gpt":0.40785991560548907,"score_spread":0.35269787003429653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751541811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644125,0.0007344235,0.0000033615042,0.0011012569,0.00005046223,0.0007186464,0.000012620821,0.000014747012,0.0009232225],"genre_scores_gemma":[0.999134,0.00017583882,0.00002056002,0.000023040777,0.00020200256,0.000060777078,0.000013808783,0.000019677396,0.00035026166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981317,0.00019488181,0.0002349445,0.00045328087,0.00047859436,0.00050660374],"domain_scores_gemma":[0.9993194,0.00006189042,0.00004803072,0.00037762764,0.00010608254,0.00008698746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074588007,0.00014461981,0.00030842,0.000261426,0.00032073914,0.000110972,0.00014003513,0.00009253686,0.000019481116],"category_scores_gemma":[0.00047733908,0.0001288144,0.00007649495,0.00014808954,0.0003242094,0.00021924361,0.000104250656,0.0005096705,0.000019046238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030854042,0.0005084048,0.5127427,0.00015154475,0.00002380536,0.00034092693,0.00014940501,7.7122655e-7,0.47865626,0.0001869375,0.000053880613,0.0068768486],"study_design_scores_gemma":[0.002198252,0.0005822261,0.94782907,0.00025282602,0.000025009806,0.000017343333,0.000035951925,0.00020819178,0.04846802,0.00018972033,0.00006905448,0.00012431663],"about_ca_topic_score_codex":0.010465806,"about_ca_topic_score_gemma":0.0019080763,"teacher_disagreement_score":0.43508643,"about_ca_system_score_codex":0.000067430214,"about_ca_system_score_gemma":0.0001562732,"threshold_uncertainty_score":0.9961236},"labels":[],"label_agreement":null},{"id":"W2756406013","doi":"10.1016/j.antiviral.2017.09.006","title":"Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Universiteit Gent; Belgian Federal Science Policy Office; Bundesministerium für Bildung und Forschung; Helmholtz-Alberta Initiative; Deutsches Zentrum für Infektionsforschung","keywords":"Bioavailability; Hepatitis C virus; Flavivirus; Virology; Pharmacology; Viral quasispecies; Virus; Medicine; Hepatitis C; Hepatocellular carcinoma; Entry inhibitor; Viral entry; Viral replication; Internal medicine","score_opus":0.08325274644832413,"score_gpt":0.4054551226464054,"score_spread":0.32220237619808123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756406013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8923929,0.0007224126,0.000008049599,0.0024309498,0.00021939918,0.0017430387,0.00010613917,0.00007853158,0.1022986],"genre_scores_gemma":[0.97277284,0.0037775235,0.00013066742,0.00012619887,0.00038757053,0.00015711605,0.00006254102,0.0000803917,0.022505185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919704,0.0006023943,0.00071498804,0.0011204337,0.0033051758,0.0022865655],"domain_scores_gemma":[0.99596626,0.0004772018,0.0001579543,0.0022427735,0.00068159524,0.00047422238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027016047,0.00039263064,0.0007911136,0.0011737773,0.0011234301,0.0007432634,0.0013766255,0.00031670506,0.0006073216],"category_scores_gemma":[0.001722768,0.0003703815,0.00020147694,0.0008403815,0.0014958894,0.0005152066,0.0014052086,0.0019459716,0.0027137564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085827464,0.0015013884,0.8043438,0.00018294659,0.00012101086,0.003811954,0.00038753968,9.817388e-7,0.14213513,0.00040854022,0.021275343,0.024973053],"study_design_scores_gemma":[0.0058697984,0.0014693498,0.81193644,0.00067828415,0.000032606706,0.00005162502,0.00015347515,0.0048608524,0.097855106,0.0002426554,0.07624493,0.0006048733],"about_ca_topic_score_codex":0.09663768,"about_ca_topic_score_gemma":0.016576087,"teacher_disagreement_score":0.080379926,"about_ca_system_score_codex":0.00065690395,"about_ca_system_score_gemma":0.00097275106,"threshold_uncertainty_score":0.99987483},"labels":[],"label_agreement":null},{"id":"W2758559651","doi":"10.1016/j.antiviral.2017.09.014","title":"Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Ministry of Science and Technology, Taiwan","keywords":"Adjuvant; Virology; Hemagglutinin (influenza); Protein subunit; CpG Oligodeoxynucleotide; Antibody; Virus; Biology; Recombinant DNA; Vaccination; Immunology; Microbiology; Gene; Gene expression","score_opus":0.3827855380291485,"score_gpt":0.5173536423773502,"score_spread":0.13456810434820166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758559651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161376,0.00035167843,0.00024512145,0.0037993304,0.000104627485,0.004863542,0.000027453032,0.000057704598,0.008936816],"genre_scores_gemma":[0.9820175,0.00017569239,0.0032811083,0.000083967214,0.00011770718,0.0013251188,0.000032959455,0.000066853245,0.012899067],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99533176,0.00012475869,0.0006589382,0.0006983683,0.0013665856,0.0018195595],"domain_scores_gemma":[0.99691015,0.00042462203,0.00015062459,0.0010608858,0.0012686136,0.00018509846],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0050197304,0.00030758444,0.0007289217,0.0007770191,0.0013829469,0.00017914214,0.0007107951,0.00019188564,0.000049671995],"category_scores_gemma":[0.007648497,0.00024337925,0.00013203888,0.00045365884,0.00028409724,0.0003697718,0.000992305,0.0010811061,0.0002352645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018626953,0.005302542,0.28255326,0.0028576653,0.00081079005,0.0010354322,0.00640613,0.0000018827334,0.41531518,0.005159844,0.018020742,0.24390957],"study_design_scores_gemma":[0.019871373,0.0025413847,0.6416217,0.0017382017,0.000025191728,0.00002321607,0.00061487366,0.0020416295,0.24414961,0.0008491009,0.08592502,0.00059869693],"about_ca_topic_score_codex":0.000844394,"about_ca_topic_score_gemma":0.0011098133,"teacher_disagreement_score":0.35906842,"about_ca_system_score_codex":0.0005841906,"about_ca_system_score_gemma":0.0015515009,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W2765633725","doi":"10.1016/j.antiviral.2017.10.018","title":"Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Animal and Plant Quarantine Agency","keywords":"Virology; Immunogenicity; Hemagglutinin (influenza); Virus; Epitope; Biology; Recombinant DNA; Influenza A virus; Recombinant virus; Antigenic drift; Immune system; Antibody; Microbiology; Immunology; Gene; Genetics","score_opus":0.1900535117901409,"score_gpt":0.46990630097941666,"score_spread":0.27985278918927575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765633725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031615,0.0055402447,0.000009573047,0.00038580882,0.000055369244,0.001428651,0.000014858112,0.000028945988,0.0022204164],"genre_scores_gemma":[0.9962347,0.0024612644,0.0005689955,0.00004456398,0.000049462324,0.000107000706,0.000007042439,0.000040851904,0.00048612122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958656,0.0004533959,0.00074530655,0.0008181474,0.0010949055,0.0010226765],"domain_scores_gemma":[0.9962456,0.00074033235,0.00028986234,0.0020289684,0.00054955797,0.00014564012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004240058,0.00026502466,0.00077426125,0.0005446909,0.000871231,0.00010876607,0.000559336,0.0001368471,0.000019768144],"category_scores_gemma":[0.006981414,0.0002301902,0.00014703239,0.0005008206,0.0017001574,0.00028047882,0.0009631867,0.0010400384,0.00008039925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017153211,0.00057631294,0.19678861,0.00023667915,0.00018230319,0.00016938301,0.0013755918,0.0000014031535,0.7644145,0.0003328243,0.00007158325,0.03413552],"study_design_scores_gemma":[0.0062212013,0.00073942496,0.80682945,0.0004872873,0.00003150366,0.000018401293,0.00041068735,0.0009766313,0.18204993,0.000111726506,0.0018803524,0.0002434268],"about_ca_topic_score_codex":0.0076625054,"about_ca_topic_score_gemma":0.00015996183,"teacher_disagreement_score":0.61004084,"about_ca_system_score_codex":0.00017902524,"about_ca_system_score_gemma":0.00031835213,"threshold_uncertainty_score":0.99894553},"labels":[],"label_agreement":null},{"id":"W2767690638","doi":"10.1016/j.antiviral.2017.10.022","title":"Activity of nucleic acid polymers in rodent models of HBV infection","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Natural Science Foundation of China; Deutsche Forschungsgemeinschaft","keywords":"HBsAg; Virology; Hepatitis B virus; HBeAg; Woodchuck hepatitis virus; Biology; Hepadnaviridae; Duck hepatitis B virus; Immunology; Virus; Medicine","score_opus":0.17204380165233993,"score_gpt":0.44494416236965606,"score_spread":0.27290036071731616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767690638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687973,0.000110224755,0.000028402268,0.00043114094,0.000048949405,0.00027432837,0.000007283132,0.000007631791,0.030294726],"genre_scores_gemma":[0.9984566,0.00082955474,0.00003323463,0.000005794672,0.000033486052,0.000012535976,9.1921373e-7,0.000012628071,0.0006152706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852145,0.0001406465,0.00019106058,0.00019233082,0.0006395018,0.0003150134],"domain_scores_gemma":[0.9990639,0.0000843788,0.00009689535,0.0004892059,0.00023128564,0.0000343368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010054688,0.00007867139,0.00032686561,0.0003060923,0.00014217643,0.000012892298,0.00013607273,0.00007480264,0.00002596442],"category_scores_gemma":[0.0008402462,0.000070398535,0.000070160684,0.00018284845,0.00047491546,0.00030188425,0.00026614542,0.00033641627,0.000019036925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027215213,0.00026751446,0.5858998,0.00015064639,0.000038202455,0.000018989891,0.0004133778,0.0000010129794,0.37134057,0.0003909724,0.00008793674,0.04111885],"study_design_scores_gemma":[0.00049579,0.00028647773,0.66119164,0.00016224908,0.0000063935436,7.136106e-7,0.000021276846,0.0006575004,0.33681515,0.00029523243,0.000027509632,0.00004009275],"about_ca_topic_score_codex":0.051010177,"about_ca_topic_score_gemma":0.008001902,"teacher_disagreement_score":0.07529184,"about_ca_system_score_codex":0.000086936314,"about_ca_system_score_gemma":0.00013759434,"threshold_uncertainty_score":0.9553092},"labels":[],"label_agreement":null},{"id":"W2767733689","doi":"10.1016/j.antiviral.2017.11.009","title":"HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"Commonwealth of Pennsylvania","keywords":"HBsAg; RNA; Hepatitis B virus; Messenger RNA; Virology; Biology; Molecular biology; Hepatitis B virus PRE beta; Virus; Chemistry; Gene; Biochemistry; Hepatitis B virus DNA polymerase","score_opus":0.19693320588716903,"score_gpt":0.4180343848270063,"score_spread":0.22110117893983725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767733689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585885,0.00018194932,0.00001047039,0.018143596,0.0001241243,0.000667424,0.000042791984,0.000032388263,0.02220877],"genre_scores_gemma":[0.994963,0.00029195906,0.000035305588,0.00043100573,0.0002092458,0.00008524251,0.00005540477,0.00003006301,0.0038987577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966752,0.00029511703,0.0002722443,0.00039004142,0.0017390668,0.00062834186],"domain_scores_gemma":[0.9982894,0.00027410043,0.0000891851,0.0009110917,0.00034636146,0.00008982605],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0018052192,0.00017944441,0.00025958513,0.00016285064,0.0017247872,0.00018097043,0.00042192327,0.00010389622,0.000091769565],"category_scores_gemma":[0.00073246006,0.00012570049,0.000095500516,0.00013962577,0.00051075965,0.00022434945,0.00020726607,0.00075277383,0.00039722392],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048222157,0.0004797819,0.0815726,0.000049433747,0.00021701529,0.00008326989,0.0003477039,5.2621747e-8,0.83727896,0.011234179,0.053910322,0.01434446],"study_design_scores_gemma":[0.0015665693,0.0011541056,0.7812466,0.00025634628,0.000032907996,0.000009778703,0.0001234091,0.00012918489,0.20014551,0.0007292567,0.014389724,0.00021662647],"about_ca_topic_score_codex":0.0026066483,"about_ca_topic_score_gemma":0.0010204964,"teacher_disagreement_score":0.699674,"about_ca_system_score_codex":0.00023059007,"about_ca_system_score_gemma":0.00019271583,"threshold_uncertainty_score":0.99957484},"labels":[],"label_agreement":null},{"id":"W2770489650","doi":"10.1016/j.antiviral.2017.11.013","title":"Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; North Carolina Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Favipiravir; Human metapneumovirus; Medicine; Nitazoxanide; Virology; Clinical trial; Respiratory tract infections; Immunology; Intensive care medicine; Respiratory system; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.3514624045679613,"score_gpt":0.4963894126311662,"score_spread":0.1449270080632049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770489650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546714,0.0012921387,0.00005591094,0.0014914621,0.000117633674,0.0018369512,0.000115723684,0.000071878065,0.009551166],"genre_scores_gemma":[0.9919811,0.0023117308,0.00006849309,0.000036773454,0.00018871082,0.00037084694,0.00004595871,0.000039172686,0.004957226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609053,0.0011674477,0.0005537963,0.00066066865,0.000968783,0.0005587849],"domain_scores_gemma":[0.99731517,0.00078968715,0.00025405094,0.00097347616,0.00054941623,0.00011818974],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0015116492,0.00030384283,0.0004887456,0.0006975624,0.0025210124,0.00039665305,0.00025521423,0.00017649769,0.000112142516],"category_scores_gemma":[0.00089578214,0.00021716207,0.000273632,0.00037372616,0.0029375674,0.0007733931,0.0002901434,0.0005589478,0.00005592731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021108582,0.0063578472,0.54144114,0.00046546623,0.0011616977,0.00010329522,0.001343627,7.589998e-7,0.2689948,0.040004894,0.0044065774,0.13360901],"study_design_scores_gemma":[0.0031510803,0.010832563,0.94012517,0.0004559811,0.00010117073,0.000027349408,0.00035048847,0.00020100648,0.03871222,0.0016671418,0.0041376418,0.00023819959],"about_ca_topic_score_codex":0.00050993386,"about_ca_topic_score_gemma":0.00085463485,"teacher_disagreement_score":0.398684,"about_ca_system_score_codex":0.00019254323,"about_ca_system_score_gemma":0.00023712957,"threshold_uncertainty_score":0.9997759},"labels":[],"label_agreement":null},{"id":"W2770934051","doi":"10.1016/j.antiviral.2017.11.018","title":"Antivirals acting on viral envelopes via biophysical mechanisms of action","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Russian Science Foundation","keywords":"Action (physics); Virology; Biology; Chemistry; Physics","score_opus":0.11041747323040241,"score_gpt":0.39991653348823236,"score_spread":0.28949906025782995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770934051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674464,0.00003038891,0.0012581442,0.0004831734,0.0025885724,0.00025726456,0.000004588342,0.000050209717,0.027881287],"genre_scores_gemma":[0.981041,0.00005710575,0.000033631735,0.00003704351,0.00007607328,0.000012603751,0.000027231497,0.000019417399,0.018695885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983338,0.0004276988,0.00026551977,0.0003444736,0.00015945346,0.000469051],"domain_scores_gemma":[0.99871373,0.00026224757,0.00021476108,0.00058098853,0.0002156892,0.0000125610195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092578545,0.000154513,0.0002673815,0.0002644243,0.0010983605,0.00007991752,0.00041923128,0.00022605898,0.00025220012],"category_scores_gemma":[0.00052601675,0.00013285592,0.00013697647,0.000097325385,0.00043175754,0.0005224687,0.00021603961,0.0008219951,0.0023268792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056465203,0.00019393227,0.00020147103,0.000015784974,0.000064758984,0.0000035242203,0.00008270905,1.5268053e-7,0.9463351,0.004772925,0.0033106355,0.0444544],"study_design_scores_gemma":[0.0005918187,0.00073784223,0.006804041,0.00006569762,0.000008150771,0.000004725341,0.00024328569,0.000031870575,0.9834602,0.0010557027,0.00686861,0.00012806764],"about_ca_topic_score_codex":0.00052728335,"about_ca_topic_score_gemma":0.000013637381,"teacher_disagreement_score":0.04432633,"about_ca_system_score_codex":0.000053419317,"about_ca_system_score_gemma":0.000049238646,"threshold_uncertainty_score":0.9984499},"labels":[],"label_agreement":null},{"id":"W2774265441","doi":"10.1016/j.antiviral.2017.12.006","title":"Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Chronic hepatitis; Hepatology; Medicine; Viral hepatitis; Selection (genetic algorithm); Hepatitis B; Family medicine; Immunology; Internal medicine; Computer science; Virus","score_opus":0.2496520602574766,"score_gpt":0.5155969837215653,"score_spread":0.26594492346408866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774265441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97494733,0.0040135193,0.0008428346,0.010757024,0.00023308938,0.0042422824,0.00022454537,0.000015363667,0.004724013],"genre_scores_gemma":[0.9760575,0.0049950834,0.00042237624,0.000009340971,0.00051702384,0.0006984929,0.00001116834,0.00003629286,0.0172527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686056,0.0001658506,0.00047052,0.00036652444,0.0013553491,0.0007811895],"domain_scores_gemma":[0.9914338,0.004658354,0.00018954417,0.001357473,0.002320345,0.000040468407],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0066865333,0.00012578735,0.0005094432,0.00025208475,0.0011677858,0.00010746869,0.0005678107,0.00011846872,0.000006816174],"category_scores_gemma":[0.01579179,0.000084823194,0.00023743077,0.000254952,0.002387491,0.00029748533,0.0005649924,0.00054282346,0.000005123074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028048842,0.00047554087,0.7163249,0.0056217886,0.0010422969,0.0002941218,0.0026174104,6.9277576e-7,0.05284304,0.024785424,0.121219926,0.07196994],"study_design_scores_gemma":[0.0040906547,0.005432569,0.722393,0.0035973035,0.00016847067,0.000047142734,0.0016057766,0.0011039542,0.18338926,0.008006942,0.06982587,0.00033905896],"about_ca_topic_score_codex":0.009921573,"about_ca_topic_score_gemma":0.01327265,"teacher_disagreement_score":0.13054621,"about_ca_system_score_codex":0.00015807137,"about_ca_system_score_gemma":0.001308471,"threshold_uncertainty_score":0.99667144},"labels":[],"label_agreement":null},{"id":"W2783963160","doi":"10.1016/j.antiviral.2018.01.002","title":"The role of adjuvant immunomodulatory agents for treatment of severe influenza","year":2018,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immunology; Internal medicine; Pharmacology","score_opus":0.3956414398444933,"score_gpt":0.5558238068627308,"score_spread":0.16018236701823751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783963160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015910909,0.98935044,4.158082e-7,0.000015100164,0.00007688446,0.0043868297,0.0003023402,0.000013369864,0.0042635375],"genre_scores_gemma":[0.0012290382,0.99421287,0.00006404986,0.000006771573,0.00026814605,0.0007259548,0.00004180059,0.00008148536,0.003369897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535096,0.00061397464,0.0010360278,0.00050169835,0.001479446,0.0010178937],"domain_scores_gemma":[0.9943344,0.0022936577,0.0003525904,0.0012465252,0.0016837714,0.000089039946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023536482,0.00040859712,0.0022977449,0.000505701,0.00042432093,0.000028523082,0.0005835433,0.00029534101,0.000016040094],"category_scores_gemma":[0.0016939214,0.0002216828,0.0010162935,0.00065338134,0.0015227525,0.000069361646,0.0004187643,0.0003620608,0.00013873083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060003,0.0003369894,0.0002166474,0.010023493,0.0016805741,0.000008971222,0.00025046332,2.215988e-8,0.00010597797,0.00031912324,0.0018593791,0.98459834],"study_design_scores_gemma":[0.001074389,0.0033384836,0.00022498851,0.006285261,0.00035433797,0.0000058077603,0.00018404271,0.000006854409,0.0009918093,0.00018916703,0.98718584,0.00015902564],"about_ca_topic_score_codex":0.00024409863,"about_ca_topic_score_gemma":0.00001924875,"teacher_disagreement_score":0.98532647,"about_ca_system_score_codex":0.0004896265,"about_ca_system_score_gemma":0.001748738,"threshold_uncertainty_score":0.9039962},"labels":[],"label_agreement":null},{"id":"W2789201597","doi":"10.1016/j.antiviral.2018.01.011","title":"Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Public Health Agency of Canada","keywords":"Favipiravir; Marburg virus; Virology; Virus; Ebola virus; Medicine; In vivo; Case fatality rate; Outbreak; Antiviral drug; Immunology; Infectious disease (medical specialty); Disease; Biology; Internal medicine; Coronavirus disease 2019 (COVID-19); Epidemiology","score_opus":0.12762008774026137,"score_gpt":0.44807911248727067,"score_spread":0.32045902474700927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789201597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796746,0.000056996974,0.00009044755,0.00043864246,0.000014806207,0.00076660264,0.000048071164,0.000034760767,0.018875068],"genre_scores_gemma":[0.98198795,0.00033207785,0.00044878398,0.000026691307,0.00010137553,0.000078711666,0.00002075941,0.000038981994,0.01696466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972698,0.0002068216,0.00034433533,0.00045673954,0.00093145174,0.000790862],"domain_scores_gemma":[0.9983786,0.00012225099,0.000047149348,0.00048938557,0.00080985134,0.00015278163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007153721,0.00020032858,0.0004406649,0.0007504906,0.00015156457,0.00005338668,0.00016181968,0.0001455762,0.00014156866],"category_scores_gemma":[0.0001073844,0.00013844766,0.00008585432,0.0013977842,0.00083885266,0.00018943679,0.000085580265,0.00038702533,0.00016133882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006951596,0.0036710424,0.116672635,0.00012582573,0.00015508395,0.0004507163,0.0006240815,0.0000131969655,0.8479401,0.00051133614,0.0006023503,0.022282073],"study_design_scores_gemma":[0.004883915,0.021919956,0.01762505,0.0001722106,0.000026837939,0.000032048625,0.0003837836,0.015378051,0.93830514,0.00019828882,0.0008322923,0.0002424073],"about_ca_topic_score_codex":0.005055033,"about_ca_topic_score_gemma":0.0038642404,"teacher_disagreement_score":0.09904758,"about_ca_system_score_codex":0.00024688625,"about_ca_system_score_gemma":0.00096524064,"threshold_uncertainty_score":0.76417315},"labels":[],"label_agreement":null},{"id":"W2791665254","doi":"10.1016/j.antiviral.2018.02.010","title":"Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Darunavir; Therapeutic drug monitoring; Medicine; Pharmacodynamics; Pharmacokinetics; Internal medicine; Viral load; Salvage therapy; Human immunodeficiency virus (HIV); Enfuvirtide; Drug; Antiretroviral therapy; Oncology; Pharmacology; Virology; Immunology; Chemotherapy","score_opus":0.06808064592542144,"score_gpt":0.3891810107672819,"score_spread":0.32110036484186044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791665254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935404,0.00013360825,0.0000063852967,0.00096559885,0.00013252183,0.0010148395,0.000007517885,0.00010006997,0.004099045],"genre_scores_gemma":[0.9860247,0.00008452437,0.0005855417,0.000024177785,0.00015183337,0.00021685597,0.000053063446,0.000049040696,0.012810292],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970847,0.00037912428,0.00034910426,0.00058244204,0.0007167443,0.00088790443],"domain_scores_gemma":[0.99869204,0.00028565899,0.000057325862,0.00047767293,0.00035730674,0.00012998994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005763835,0.0002970229,0.0003931362,0.00058175967,0.0004271507,0.00008598258,0.00012319564,0.00010108571,0.000053594413],"category_scores_gemma":[0.00022217799,0.00023031868,0.00008726179,0.0011436696,0.00037938848,0.00031677735,0.000082976985,0.0003114828,0.00030875643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082822563,0.0011353041,0.950466,0.00003600632,0.00010034806,0.0033382026,0.008163933,1.2876514e-7,0.008321616,0.00002605301,0.0003322879,0.02725191],"study_design_scores_gemma":[0.016854698,0.003993743,0.42561787,0.0012218489,0.00010541937,0.00020652701,0.006745971,0.00039363932,0.53901464,0.000098440956,0.004946755,0.0008004269],"about_ca_topic_score_codex":0.00035365537,"about_ca_topic_score_gemma":0.00035047188,"teacher_disagreement_score":0.53069305,"about_ca_system_score_codex":0.00069233455,"about_ca_system_score_gemma":0.00037644274,"threshold_uncertainty_score":0.9392123},"labels":[],"label_agreement":null},{"id":"W2793449736","doi":"10.1016/j.antiviral.2018.02.017","title":"Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Jewish General Hospital; McGill University; University of British Columbia; Université de Sherbrooke; Simon Fraser University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Viral replication; Long terminal repeat; Peripheral blood mononuclear cell; NF-κB; Reporter gene; HIV Long Terminal Repeat; Gene; Virology; Cell culture; Gene expression; Molecular biology; Cell biology; Signal transduction; In vitro; Genetics; Virus","score_opus":0.035733694594546506,"score_gpt":0.3503164268284042,"score_spread":0.3145827322338577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793449736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98477715,0.0012343851,0.000013335808,0.0027550303,0.000100064986,0.00067161734,0.00010486822,0.00002800768,0.010315509],"genre_scores_gemma":[0.9753771,0.0001523876,0.000018260225,0.000024492705,0.00007584292,0.00008031694,0.0006103326,0.00001199291,0.023649266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978896,0.0007054669,0.00021786355,0.0004297586,0.00021764591,0.00053967675],"domain_scores_gemma":[0.99846476,0.00025829428,0.000057378184,0.0007366809,0.00046616298,0.000016711372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017853045,0.000108166576,0.00014898404,0.00013816381,0.00041530453,0.000024864432,0.00027861018,0.00008007139,0.00023711348],"category_scores_gemma":[0.00067468523,0.000068196736,0.000055064742,0.00036045702,0.0010382384,0.00011432206,0.00033929833,0.0005958682,0.0032278611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030465022,0.00022406701,0.005849442,0.000014313523,0.000082712526,0.0000043225336,0.00023265732,1.3384995e-8,0.8921531,0.0004536086,0.05345347,0.047227673],"study_design_scores_gemma":[0.0007247913,0.00054800947,0.01333544,0.000019146839,0.000007093993,0.000015910804,0.00016021903,0.0000033051751,0.9725265,0.00030531138,0.012285745,0.000068544956],"about_ca_topic_score_codex":0.0008001299,"about_ca_topic_score_gemma":0.00020111127,"teacher_disagreement_score":0.080373414,"about_ca_system_score_codex":0.000072392846,"about_ca_system_score_gemma":0.000105149455,"threshold_uncertainty_score":0.9975482},"labels":[],"label_agreement":null},{"id":"W2800533296","doi":"10.1016/j.antiviral.2018.04.009","title":"Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Recombinant DNA; Titer; In vitro; Mutant; Enzyme; Oseltamivir; Virus; Biology; Virulence; Chemistry; Virology; IC50; Wild type; Molecular biology; Biochemistry; Gene; Coronavirus disease 2019 (COVID-19)","score_opus":0.26098232952606143,"score_gpt":0.4754012148655624,"score_spread":0.214418885339501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800533296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971978,0.00039692209,0.000002918363,0.00014155317,0.00003687673,0.00064861233,0.000016090451,0.000012966335,0.0015462387],"genre_scores_gemma":[0.99926895,0.00027922637,0.000025834866,0.000018631636,0.000038588063,0.000030446738,0.0000026820371,0.00001836151,0.00031726933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776435,0.00032859124,0.00038682812,0.00037665226,0.00064583117,0.00049772934],"domain_scores_gemma":[0.9985228,0.000321335,0.00006064695,0.00044138147,0.00053675467,0.00011708962],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0013651266,0.00015385177,0.00039227225,0.0010033812,0.00016414402,0.000037620655,0.00013902843,0.00010255531,0.000015554931],"category_scores_gemma":[0.0019302067,0.000109223285,0.00006510123,0.0010720231,0.002739802,0.00027843507,0.0001850678,0.0005525078,0.000037081823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018616356,0.00054505805,0.10622069,0.0002119724,0.00004098282,0.000042590767,0.0002793068,4.6853776e-7,0.8798782,0.00026641917,0.00013672835,0.010515919],"study_design_scores_gemma":[0.00093985227,0.0048738373,0.3633864,0.00034937426,0.0000101030855,0.000019361449,0.000102814294,0.0004040276,0.6296736,0.000091707916,0.0000591144,0.00008983873],"about_ca_topic_score_codex":0.0032539917,"about_ca_topic_score_gemma":0.00013711152,"teacher_disagreement_score":0.2571657,"about_ca_system_score_codex":0.00012475591,"about_ca_system_score_gemma":0.00045180443,"threshold_uncertainty_score":0.9999742},"labels":[],"label_agreement":null},{"id":"W2884966105","doi":"10.1016/j.antiviral.2018.07.016","title":"Natural product-derived compounds in HIV suppression, remission, and eradication strategies","year":2018,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"Alliance for Accelerating Excellence in Science in Africa; Government of the United Kingdom; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; African Academy of Sciences; Canadian Institutes of Health Research; New Partnership for Africa's Development; American Astronautical Society","keywords":"Human immunodeficiency virus (HIV); Antiretroviral therapy; Natural product; Cart; Medicine; Virology; Immunology; Intensive care medicine; Viral load; Biology","score_opus":0.08715928368583975,"score_gpt":0.42213936358265247,"score_spread":0.3349800798968127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884966105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026655884,0.99292064,0.0000010627142,0.00022667299,0.00019550124,0.0012435032,0.0000868963,0.00003793449,0.002622223],"genre_scores_gemma":[0.06405926,0.92725825,0.00004084821,0.0000033083743,0.000096191274,0.00018581872,0.0017810212,0.000036118363,0.006539206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514824,0.0022439214,0.00051015394,0.0008927395,0.00021652714,0.0009883997],"domain_scores_gemma":[0.9983301,0.00062935066,0.00011705204,0.00061478186,0.00026002227,0.000048659345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015523866,0.0003712054,0.0009852072,0.00072960876,0.0004402753,0.00014122883,0.000520455,0.0004240348,0.00009532134],"category_scores_gemma":[0.0005081778,0.00025004326,0.00012762804,0.0006581772,0.0012225831,0.0002487933,0.00045843748,0.001827225,0.0021949492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022747181,0.00044305058,0.00028695344,0.005397152,0.00039143706,0.0001279502,0.00048576455,5.4792877e-9,0.015323882,0.00042392517,0.13671972,0.8401727],"study_design_scores_gemma":[0.0006592117,0.00021958965,0.00055105594,0.0046662055,0.00003692779,0.000069652066,0.00014336559,6.272965e-7,0.0015204905,0.00017797928,0.9916918,0.00026304557],"about_ca_topic_score_codex":0.0001646456,"about_ca_topic_score_gemma":0.00006266818,"teacher_disagreement_score":0.8549721,"about_ca_system_score_codex":0.00017957497,"about_ca_system_score_gemma":0.0010325016,"threshold_uncertainty_score":0.9999952},"labels":[],"label_agreement":null},{"id":"W2886392601","doi":"10.1016/j.antiviral.2018.07.021","title":"A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Krembil Foundation","keywords":"Virology; Ectodomain; Cotton rat; Virus; Mononegavirales; Biology; Vaccination; Paramyxoviridae; Antibody; Immunology; Viral disease","score_opus":0.11584064219681708,"score_gpt":0.43261317176213293,"score_spread":0.3167725295653159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886392601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871982,0.00030599957,0.000037731115,0.00008012009,0.000043097687,0.0031444328,0.000012142477,0.00014482313,0.00903348],"genre_scores_gemma":[0.99861896,0.000039331037,0.00006964476,0.00022972688,0.0002496797,0.00029360928,0.000018747543,0.000080589016,0.00039968654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951259,0.0012068312,0.00047004985,0.0007250287,0.0014734509,0.00099875],"domain_scores_gemma":[0.9969349,0.00018016022,0.00013546582,0.0007832299,0.0017353111,0.00023093211],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0027766621,0.0003437517,0.0005352713,0.001136738,0.0014542036,0.00020721965,0.00029211293,0.0002968165,0.00008299321],"category_scores_gemma":[0.001004116,0.00027097028,0.00006798971,0.0022930112,0.0019370398,0.0006212466,0.00035876065,0.0018927971,0.00031904728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027993054,0.0005934533,0.006388315,0.00011032226,0.00016309861,0.00013874768,0.0005054506,3.3999567e-7,0.96949774,0.00037810722,0.00019742161,0.019227676],"study_design_scores_gemma":[0.0049600797,0.021027116,0.22333261,0.00040997748,0.00003728629,0.000028544497,0.00030259107,0.00029581046,0.7457263,0.0005344412,0.0028880783,0.0004572015],"about_ca_topic_score_codex":0.0033435517,"about_ca_topic_score_gemma":0.00069161755,"teacher_disagreement_score":0.2237715,"about_ca_system_score_codex":0.00040987512,"about_ca_system_score_gemma":0.0007972163,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W2890762658","doi":"10.1016/j.antiviral.2018.09.008","title":"Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of British Columbia; University of Ottawa; AIDS Vancouver; University of Toronto; University Health Network; Toronto General Hospital; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dosing; Medicine; Pharmacokinetics; Pregnancy; Pharmacology; Toxicity; Regimen; Drug; Amniotic fluid; Adverse effect; Therapeutic index; Developmental toxicity; Fetus; Internal medicine; Biology","score_opus":0.1500829631765242,"score_gpt":0.4705371755160908,"score_spread":0.3204542123395666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890762658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863599,0.00057094445,0.00955855,0.00009647957,0.0000645381,0.001701898,0.00007090168,0.000024747247,0.0015520455],"genre_scores_gemma":[0.99285966,0.0006303626,0.0009105194,0.0000062629247,0.00015256893,0.000039291193,0.000011981837,0.000040205032,0.0053491564],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9947886,0.0010254228,0.00125895,0.0005313735,0.0017034372,0.0006922415],"domain_scores_gemma":[0.99629205,0.00045472718,0.00042233625,0.0008984981,0.0018071171,0.0001252821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026582538,0.00020807606,0.0006670084,0.00053970393,0.00020690444,0.000027443399,0.0005747192,0.000104544786,0.000053997835],"category_scores_gemma":[0.0029686957,0.00014935133,0.00032373896,0.0012246338,0.0016648761,0.00028848893,0.000475379,0.0009804418,0.000017971764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003908325,0.012529254,0.09607293,0.001698102,0.0004226572,0.000020699203,0.0025618288,0.00025795033,0.7019564,0.00050185935,0.007542149,0.17252788],"study_design_scores_gemma":[0.006087802,0.059675716,0.0019169705,0.0020197225,0.00017340617,0.000003665847,0.0011081684,0.66598433,0.26273105,0.000043548545,0.000037028014,0.0002185967],"about_ca_topic_score_codex":0.00022990922,"about_ca_topic_score_gemma":0.000025952057,"teacher_disagreement_score":0.66572636,"about_ca_system_score_codex":0.00006299339,"about_ca_system_score_gemma":0.00046391014,"threshold_uncertainty_score":0.61343056},"labels":[],"label_agreement":null},{"id":"W2891172236","doi":"10.1016/j.antiviral.2018.09.007","title":"Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Zanamivir; Neuraminidase; Titer; Virology; Microbiology; Inoculation; Biology; Virus; Medicine; Coronavirus disease 2019 (COVID-19); Immunology","score_opus":0.3656101780992341,"score_gpt":0.5224849922897125,"score_spread":0.15687481419047838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891172236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964549,0.0010975804,0.0000046134833,0.0009402391,0.0000166071,0.0008903238,0.000010171157,0.000012454034,0.000573091],"genre_scores_gemma":[0.99880123,0.0006682674,0.00015913497,0.00014399325,0.00006433657,0.0000692595,0.0000015163611,0.00002066464,0.000071582595],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973257,0.000392984,0.00048501827,0.00037809854,0.0007495332,0.00066864875],"domain_scores_gemma":[0.9979984,0.0009884974,0.00006312309,0.00027521813,0.00059717614,0.00007754645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002183102,0.00015804134,0.0004332907,0.0005395084,0.00020437928,0.000074608484,0.00016372932,0.00009254402,0.000007734271],"category_scores_gemma":[0.0019673242,0.00010422479,0.000023607463,0.00097499456,0.0011932247,0.0003451013,0.00041200453,0.00081381586,0.000011117223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02769039,0.0003925183,0.34383902,0.0003249675,0.00007443458,0.00013265749,0.013025937,0.0000060662624,0.5767708,0.00026610497,0.00015644162,0.03732067],"study_design_scores_gemma":[0.0028709066,0.002454298,0.69929075,0.00027903164,0.000012544669,0.000006838732,0.0020729722,0.022186525,0.26998833,0.00021503454,0.00046535704,0.0001573841],"about_ca_topic_score_codex":0.0012005013,"about_ca_topic_score_gemma":0.00040402656,"teacher_disagreement_score":0.35545176,"about_ca_system_score_codex":0.0000786882,"about_ca_system_score_gemma":0.00019266941,"threshold_uncertainty_score":0.43964863},"labels":[],"label_agreement":null},{"id":"W2897426627","doi":"10.1016/j.antiviral.2018.10.011","title":"Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Canadian Institutes of Health Research; National Science and Technology Major Project; National Natural Science Foundation of China","keywords":"Arenavirus; Lassa virus; Virology; Lassa fever; Ribavirin; Viral hemorrhagic fever; Biology; Virus; Ebola virus; Immunology; Hepatitis C virus","score_opus":0.15191302837352458,"score_gpt":0.4262649843675219,"score_spread":0.2743519559939973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897426627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98450875,0.0005425709,0.00012270415,0.00032922573,0.00023903222,0.000575369,0.000097363976,0.00007997696,0.013504991],"genre_scores_gemma":[0.9912314,0.00028400394,0.00036986062,0.00013321155,0.0012752789,0.000020695625,0.00009466032,0.00006623611,0.006524672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99542373,0.0005268506,0.00042568916,0.0007333076,0.0017889653,0.0011014286],"domain_scores_gemma":[0.9973009,0.00039394957,0.000094513525,0.00096382917,0.00093636214,0.00031045242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014320342,0.0002886264,0.0005331465,0.00060950883,0.00039271117,0.00013131484,0.00039712124,0.00029938156,0.002525768],"category_scores_gemma":[0.0004884941,0.00023668022,0.00020935143,0.0008514485,0.0011777387,0.00044674915,0.00034876398,0.0011953991,0.0007021897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009158911,0.0009990266,0.11683492,0.000078658166,0.00017075168,0.0006124402,0.0006821384,1.7391406e-7,0.8401674,0.000086716194,0.0101352595,0.029316638],"study_design_scores_gemma":[0.0015026354,0.0019614089,0.058252715,0.00017627473,0.00006631025,0.00003363339,0.00083385606,0.000717579,0.93041116,0.0005034331,0.0052579604,0.00028304904],"about_ca_topic_score_codex":0.0058138864,"about_ca_topic_score_gemma":0.000328612,"teacher_disagreement_score":0.09024376,"about_ca_system_score_codex":0.00013589821,"about_ca_system_score_gemma":0.000321734,"threshold_uncertainty_score":0.9983861},"labels":[],"label_agreement":null},{"id":"W2899793329","doi":"10.1016/j.antiviral.2018.11.002","title":"HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Natural Science Foundation of China","keywords":"Antigen; Virology; Immunology; Immunity; Cytokine; DNA vaccination; Biology; Medicine; Immune system; Immunization","score_opus":0.08113860884448572,"score_gpt":0.33944982225560627,"score_spread":0.25831121341112057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899793329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517554,0.00071039516,0.000016733513,0.0019234219,0.00011760575,0.0010033858,0.00035228473,0.00012498673,0.00057564036],"genre_scores_gemma":[0.9917078,0.0063704997,0.00019391274,0.00009950064,0.00031121253,0.000012406641,0.00012620461,0.000083875224,0.0010946078],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962912,0.00037302464,0.00040088934,0.0008910451,0.0010849867,0.0009588155],"domain_scores_gemma":[0.99724567,0.00040235766,0.00013769232,0.00067490025,0.0013516414,0.0001877565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016209361,0.00036326604,0.0006709633,0.00028035382,0.0008211709,0.00011742913,0.00019073483,0.0002445048,0.000057525358],"category_scores_gemma":[0.0009266369,0.00029932405,0.0000455705,0.0011513628,0.00063224905,0.00035937247,0.0004020788,0.0009216805,0.000113643546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004269236,0.00028793907,0.40773728,0.000026149228,0.00016508572,0.000055174274,0.0014130933,2.786187e-8,0.5872568,0.0000033548893,0.0021825028,0.00044569754],"study_design_scores_gemma":[0.0017907034,0.0008188284,0.55028963,0.0001501593,0.000017190545,0.0000079180045,0.00029180312,0.00006775187,0.44549388,0.000014211103,0.0008498804,0.00020803926],"about_ca_topic_score_codex":0.0063027227,"about_ca_topic_score_gemma":0.0036970538,"teacher_disagreement_score":0.14255235,"about_ca_system_score_codex":0.00015216353,"about_ca_system_score_gemma":0.00020405653,"threshold_uncertainty_score":0.9999459},"labels":[],"label_agreement":null},{"id":"W2901227506","doi":"10.1016/j.antiviral.2018.11.011","title":"Tomatidine, a novel antiviral compound towards dengue virus","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Wageningen University and Research; Centers for Disease Control and Prevention; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Universiteit Leiden; Leids Universitair Medisch Centrum; European Commission; Ministère de l'Économie, de la Science et de l'Innovation - Québec; University of South Carolina; Universitair Medisch Centrum Groningen; Universidad de Antioquia; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS); Rijksuniversiteit Groningen; Purdue University","keywords":"Dengue virus; Dengue fever; Virology; Virus; Antiviral drug; Biology; Serotype","score_opus":0.09638298681734651,"score_gpt":0.42689965675007807,"score_spread":0.33051666993273154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901227506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93814474,0.00037276148,0.00039744345,0.0015908667,0.00021765745,0.00070324953,0.00006703081,0.00011155885,0.05839469],"genre_scores_gemma":[0.9925169,0.0000808494,0.00036921861,0.00052490353,0.001439017,0.000049950508,0.000039204402,0.000049870017,0.004930122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966084,0.00016439905,0.00033799335,0.0005821298,0.001293451,0.0010136273],"domain_scores_gemma":[0.99810475,0.00016083542,0.000053220265,0.00069835543,0.0007765742,0.00020624904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010980553,0.0002360141,0.00044661266,0.00032218537,0.00036670963,0.0001506653,0.0003526196,0.00014334678,0.00026042943],"category_scores_gemma":[0.000596846,0.0001939744,0.00021413488,0.000782591,0.00065054593,0.00022567985,0.00027664524,0.00053529395,0.0013660574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002042354,0.0018087937,0.022979375,0.00024040724,0.00031668122,0.0006078997,0.00048685094,6.102342e-8,0.8046361,0.008106006,0.049019553,0.109755896],"study_design_scores_gemma":[0.012986229,0.005416593,0.5468536,0.00072429003,0.000269892,0.00014889568,0.0010475062,0.011681974,0.31263012,0.00132336,0.10582397,0.0010935772],"about_ca_topic_score_codex":0.0011655325,"about_ca_topic_score_gemma":0.0002041897,"teacher_disagreement_score":0.5238742,"about_ca_system_score_codex":0.00009777016,"about_ca_system_score_gemma":0.0004916572,"threshold_uncertainty_score":0.9994115},"labels":[],"label_agreement":null},{"id":"W2905300319","doi":"10.1016/j.antiviral.2018.12.010","title":"Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Krembil Foundation","keywords":"Cotton rat; Virology; Vaccination; Virus; Antibody; Mononegavirales; Medicine; Immunology; Paramyxoviridae; Neutralization; Biology; Viral disease","score_opus":0.10821387608094216,"score_gpt":0.4117631069643261,"score_spread":0.3035492308833839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905300319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993788,0.000074403426,0.0011482687,0.0002860214,0.000024966064,0.002991655,0.000018214268,0.00011918602,0.0015492882],"genre_scores_gemma":[0.9977918,0.0000037863151,0.00069624366,0.00009324312,0.00022185803,0.0004176431,0.000035106634,0.00008116852,0.00065910374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99622613,0.0003482594,0.0004193429,0.0006974097,0.0014294789,0.00087938854],"domain_scores_gemma":[0.9980121,0.000083744926,0.00012072439,0.0005855155,0.0010545094,0.00014339802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010522746,0.00028746016,0.00039789997,0.001197758,0.00042287222,0.00017935902,0.00022637814,0.00019114124,0.00022488933],"category_scores_gemma":[0.00027076254,0.00020473421,0.00004774222,0.0028696316,0.00038592506,0.00049992476,0.0000923037,0.0010444571,0.00020252631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012172245,0.0006127389,0.07788392,0.00009660723,0.0000807912,0.00013763047,0.00014070878,0.0000049304313,0.88548905,0.00006323255,0.000033498258,0.023284627],"study_design_scores_gemma":[0.004934746,0.013796021,0.3348275,0.00046073116,0.000017619963,0.000019031759,0.000059685695,0.0037073614,0.641362,0.000050222632,0.0005458614,0.00021919566],"about_ca_topic_score_codex":0.025312103,"about_ca_topic_score_gemma":0.007582197,"teacher_disagreement_score":0.25694358,"about_ca_system_score_codex":0.00040161324,"about_ca_system_score_gemma":0.0007937669,"threshold_uncertainty_score":0.9811784},"labels":[],"label_agreement":null},{"id":"W2907851514","doi":"10.1016/j.antiviral.2019.01.001","title":"VER-155008 induced Hsp70 proteins expression in fish cell cultures while impeding replication of two RNA viruses","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Huntsman Marine Science Centre; University of Guelph; University of the Fraser Valley; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Elanco Animal Health","keywords":"Virology; Biology; Infectious pancreatic necrosis virus; Virus; Viral replication; Hsp70; RNA; Cell culture; Cytopathic effect; Embryo; Gene; Heat shock protein; Cell biology; Genetics","score_opus":0.05979420935482495,"score_gpt":0.368471086363464,"score_spread":0.30867687700863905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907851514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804367,0.0003140486,0.000005242769,0.00009729223,0.00014492703,0.000979814,0.00003173137,0.00003263289,0.010350661],"genre_scores_gemma":[0.9952641,0.00008514647,0.000026643691,0.0000466782,0.00003201687,0.00005575533,0.00017118202,0.00001785345,0.0043006176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982639,0.00028854614,0.00029604736,0.00054346636,0.00012339556,0.00048466623],"domain_scores_gemma":[0.9989815,0.00014651283,0.000113821574,0.00058497523,0.00015719826,0.00001602361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080152263,0.00015617492,0.0002490872,0.00027959063,0.00012992584,0.000030268975,0.00041879396,0.00020144372,0.00020483806],"category_scores_gemma":[0.00019327218,0.00012620332,0.000081444305,0.00043225265,0.00012340533,0.00025273577,0.00037343058,0.00051701453,0.00066320854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002037324,0.00017566053,0.007452569,0.000086790234,0.000019529136,0.0000030482236,0.0006538548,7.110786e-7,0.978831,0.0003815111,0.011522452,0.00066912797],"study_design_scores_gemma":[0.001363374,0.0001740969,0.007135692,0.00014796916,0.0000073420283,6.102749e-7,0.0010870108,0.000003626367,0.98413175,0.00008389029,0.005719328,0.00014530397],"about_ca_topic_score_codex":0.00028157965,"about_ca_topic_score_gemma":0.000066971494,"teacher_disagreement_score":0.007220457,"about_ca_system_score_codex":0.00005079503,"about_ca_system_score_gemma":0.000057929225,"threshold_uncertainty_score":0.85244256},"labels":[],"label_agreement":null},{"id":"W2912166467","doi":"10.1016/j.antiviral.2019.02.005","title":"Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Hepatitis B virus; RNase H; Virology; DNA; Biology; Molecular biology; Cytotoxicity; Viral replication; DNA replication; Ribonuclease; RNA; RNase P; Chemistry; Virus; In vitro; Gene; Genetics","score_opus":0.0396463608960163,"score_gpt":0.3570163981326019,"score_spread":0.3173700372365856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912166467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894186,0.00073792035,0.000019943798,0.0024974078,0.00006622183,0.0008247052,0.000036856392,0.000051092706,0.006347203],"genre_scores_gemma":[0.996263,0.0013117001,0.00013347573,0.00010662174,0.00014413192,0.000032775413,0.00008494228,0.00003331815,0.001890013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976003,0.0001543957,0.0004046287,0.00053334696,0.00088691845,0.0004204229],"domain_scores_gemma":[0.99852896,0.00018711104,0.00009556184,0.00060196954,0.00048146502,0.000104924824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013971389,0.00014907471,0.0003888825,0.00033859423,0.00012168238,0.00001942043,0.00006954332,0.00013841633,0.000038568825],"category_scores_gemma":[0.00089255575,0.00013593663,0.00006676351,0.00063297583,0.00038186368,0.00023836683,0.00021021173,0.00041899586,0.00029023545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021682474,0.00021901763,0.107836306,0.00023899968,0.000037917256,0.000012967347,0.0002402725,1.0136035e-7,0.866835,0.00044325818,0.017794918,0.006124419],"study_design_scores_gemma":[0.0022419512,0.0017326245,0.052147806,0.00053426763,0.00003537469,0.000019725217,0.00018576534,0.0008117371,0.9349026,0.00045038864,0.0067110234,0.00022670571],"about_ca_topic_score_codex":0.00088590843,"about_ca_topic_score_gemma":0.00003912642,"teacher_disagreement_score":0.06806763,"about_ca_system_score_codex":0.00008335516,"about_ca_system_score_gemma":0.00008534363,"threshold_uncertainty_score":0.55433345},"labels":[],"label_agreement":null},{"id":"W2912481674","doi":"10.1016/j.antiviral.2019.01.011","title":"Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Merck Sharp and Dohme; Canada Research Chairs","keywords":"Human cytomegalovirus; Virology; Biology; Drug resistance; Ganciclovir; Virus; Microbiology","score_opus":0.42709707190366647,"score_gpt":0.5536105815723571,"score_spread":0.12651350966869063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912481674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009158513,0.975901,0.0000018488765,0.000041862873,0.00008481224,0.0023441878,0.00009723916,0.000022174707,0.012348345],"genre_scores_gemma":[0.0056866207,0.97238666,0.0005866237,0.000016161594,0.00016554214,0.00008225578,0.000114641996,0.00012766852,0.020833848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99113774,0.0014759427,0.002798863,0.0011514783,0.0023849716,0.001051014],"domain_scores_gemma":[0.9950921,0.0017645396,0.0006567194,0.0014612254,0.0007578693,0.00026757992],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0093201315,0.00057101744,0.0048848595,0.0013823631,0.00023430299,0.000062909494,0.0008085608,0.0006581629,0.00012772858],"category_scores_gemma":[0.0006454444,0.00044797198,0.00091986783,0.0014412653,0.0013483907,0.00014726215,0.0012923673,0.0026728692,0.0003388192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024864852,0.00043744314,0.00082725036,0.10352174,0.00052749907,0.00008868978,0.00013860248,7.667823e-10,0.00025017865,0.0007438473,0.0034100255,0.8898061],"study_design_scores_gemma":[0.0010158757,0.00032470087,0.0013492177,0.03221062,0.00028614257,0.000009929649,0.000028801756,9.0500237e-7,0.0003250813,0.000057307847,0.9640288,0.0003626463],"about_ca_topic_score_codex":0.00015292967,"about_ca_topic_score_gemma":0.00022796066,"teacher_disagreement_score":0.96061873,"about_ca_system_score_codex":0.00025476253,"about_ca_system_score_gemma":0.0033592805,"threshold_uncertainty_score":0.9997972},"labels":[],"label_agreement":null},{"id":"W2915009094","doi":"10.1016/j.antiviral.2019.02.009","title":"Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"HBsAg; In vitro; Secretion; Nucleic acid; Immune system; Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Chemistry; Virology; Biology; Medicine; Immunology; Cancer research; Biochemistry; Virus; Internal medicine","score_opus":0.04038057639909725,"score_gpt":0.3535649606924945,"score_spread":0.31318438429339723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915009094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689207,0.00045196692,0.000005009976,0.0006129087,0.000067772846,0.00052994024,0.000025109735,0.000018659766,0.029367926],"genre_scores_gemma":[0.9956593,0.00063781074,0.00004220351,0.00008554652,0.000039984985,0.000014869367,0.000034632074,0.000023012317,0.0034626464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979641,0.0002165849,0.00027175108,0.00027872642,0.0007997543,0.0004691215],"domain_scores_gemma":[0.999347,0.00012970014,0.00004542623,0.0002507964,0.00017681922,0.000050285747],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009501841,0.000106071704,0.0003017571,0.000364819,0.000048587946,0.0000120456425,0.00007266904,0.00010954594,0.0003901378],"category_scores_gemma":[0.00019328222,0.00009835848,0.00006053528,0.0006579195,0.00021057569,0.00015752498,0.00011622358,0.00043291287,0.00083576964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016884855,0.00013407682,0.092827596,0.00013954357,0.000016412152,0.000022385806,0.0004655835,6.864766e-8,0.89758736,0.00008839915,0.004066245,0.004483506],"study_design_scores_gemma":[0.0013130663,0.00086558535,0.061268542,0.00040885244,0.000007449328,0.0000016821659,0.00044427745,0.00017572536,0.9337344,0.00010704384,0.0015544005,0.00011897977],"about_ca_topic_score_codex":0.003207504,"about_ca_topic_score_gemma":0.0004377418,"teacher_disagreement_score":0.036147058,"about_ca_system_score_codex":0.00013112336,"about_ca_system_score_gemma":0.00010776891,"threshold_uncertainty_score":0.9999422},"labels":[],"label_agreement":null},{"id":"W2918933655","doi":"10.1016/j.antiviral.2019.03.001","title":"Characterization of Reston virus infection in ferrets","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency; University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Public Health Agency; Public Health Agency of Canada","keywords":"Virology; Biology; Virus; Viremia; Ebolavirus; Viral replication; Pathogenicity; Immunology; Microbiology; Ebola virus","score_opus":0.08145172780756879,"score_gpt":0.42790763926845854,"score_spread":0.3464559114608897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918933655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812411,0.00001575584,0.000023292576,0.00023472476,0.00008753097,0.00060423097,0.0000045931342,0.000018989402,0.017769793],"genre_scores_gemma":[0.99537575,0.00047676679,0.000011941119,0.0000184744,0.00006174215,0.000020340382,0.00003135298,0.000016186419,0.0039874446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983531,0.00021772491,0.0002360443,0.00023391926,0.0006173551,0.00034181448],"domain_scores_gemma":[0.99927396,0.000092148795,0.00003408067,0.00024575277,0.000312038,0.000042038893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012149082,0.0000766466,0.00021573632,0.00084832736,0.00004959775,0.0000215228,0.000058032903,0.00011606574,0.00015258827],"category_scores_gemma":[0.00021287531,0.000066951994,0.000060597376,0.0012791399,0.00010036967,0.00022426106,0.00008682619,0.0005534757,0.00054560805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019685944,0.00016420911,0.31187016,0.00008217917,0.0000066111334,0.000013318567,0.00004547209,3.8178922e-7,0.6818855,0.0002440997,0.00003186339,0.0054594055],"study_design_scores_gemma":[0.0005561761,0.0005622488,0.65372604,0.00011885957,0.0000020110342,0.00000753232,0.000013202175,0.00047079456,0.34386915,0.0000762904,0.0005517954,0.0000458916],"about_ca_topic_score_codex":0.003298716,"about_ca_topic_score_gemma":0.00036172953,"teacher_disagreement_score":0.3418559,"about_ca_system_score_codex":0.00011623011,"about_ca_system_score_gemma":0.0001530728,"threshold_uncertainty_score":0.701287},"labels":[],"label_agreement":null},{"id":"W2924181747","doi":"10.1016/j.antiviral.2019.03.009","title":"GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Medical Research Council","keywords":"Chikungunya; Virology; Epidemiology; Outbreak; Disease; Biology; Medicine; Pathology","score_opus":0.3143008299577493,"score_gpt":0.5086522754351819,"score_spread":0.1943514454774326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924181747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030680455,0.9825747,0.0000025141383,0.00034180802,0.00039231777,0.0027411326,0.00022554492,0.00006865381,0.010585272],"genre_scores_gemma":[0.0037910058,0.98303205,0.000016439903,0.00020819118,0.0013871513,0.00026648384,0.00068375317,0.00009338116,0.010521553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464005,0.0007582595,0.00093547517,0.0014072817,0.0011175402,0.001141401],"domain_scores_gemma":[0.99556065,0.0020848457,0.00026267106,0.0014559594,0.00029092198,0.0003449572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002048379,0.0005980188,0.002465154,0.00040322414,0.00021163811,0.00014988249,0.000402088,0.0007212509,0.00016438113],"category_scores_gemma":[0.004881925,0.00039466724,0.00069952366,0.00058586465,0.00041665597,0.00006815299,0.0005024258,0.0019002196,0.001204745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023293415,0.00045101345,0.0029563042,0.008566355,0.00037206348,0.0045613907,0.000011246547,1.35965275e-8,0.00000770509,0.0012955195,0.032963917,0.9485815],"study_design_scores_gemma":[0.0006087364,0.0012297846,0.0017783382,0.011511761,0.00058337,0.00021259188,0.000016126687,0.000006880203,0.0000063951843,0.00006284001,0.9835883,0.00039490964],"about_ca_topic_score_codex":0.00011740912,"about_ca_topic_score_gemma":0.000015360336,"teacher_disagreement_score":0.95062435,"about_ca_system_score_codex":0.00015025033,"about_ca_system_score_gemma":0.00087621,"threshold_uncertainty_score":0.9998505},"labels":[],"label_agreement":null},{"id":"W2930758931","doi":"10.1016/j.antiviral.2019.03.014","title":"Identification of a clinical compound losmapimod that blocks Lassa virus entry","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China; Public Health Agency; Public Health Agency of Canada","keywords":"Lassa virus; Lassa fever; Virology; Arenavirus; Biology; Virus; Immunology; Antigen","score_opus":0.1868226214171019,"score_gpt":0.5032365179607636,"score_spread":0.3164138965436617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930758931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96344,0.00013856363,0.00006294471,0.00064589246,0.00022989948,0.0007457024,0.000019530622,0.00003150538,0.034685954],"genre_scores_gemma":[0.97372615,0.0005418864,0.000043229007,0.000044068933,0.00021116003,0.000018686756,0.000019046993,0.000023327193,0.025372429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649745,0.00048777027,0.000641267,0.00044823662,0.0013822241,0.00054305827],"domain_scores_gemma":[0.9977105,0.00075113465,0.00011398932,0.00062970497,0.0006680375,0.00012661204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045388937,0.0001223647,0.00046381349,0.00043266342,0.00012753141,0.00006593692,0.00022485395,0.00020900484,0.00038344396],"category_scores_gemma":[0.0006635918,0.00010011225,0.00024140226,0.0007316675,0.0004374427,0.00018728283,0.00023745456,0.0010801725,0.0018618973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008006433,0.00111417,0.46521336,0.0002089309,0.00013856932,0.000055799075,0.000084048006,6.622244e-7,0.49951896,0.0007739219,0.008548392,0.02354255],"study_design_scores_gemma":[0.0034618839,0.0019056625,0.44558376,0.0002465252,0.00004034405,0.000041529325,0.00045002156,0.0035799565,0.53065807,0.00070950424,0.013103623,0.00021908553],"about_ca_topic_score_codex":0.0005106512,"about_ca_topic_score_gemma":0.000047253736,"teacher_disagreement_score":0.031139124,"about_ca_system_score_codex":0.000065231856,"about_ca_system_score_gemma":0.00033382172,"threshold_uncertainty_score":0.99891526},"labels":[],"label_agreement":null},{"id":"W2949120013","doi":"10.1016/j.antiviral.2019.104542","title":"Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Genome British Columbia","keywords":"Neuraminidase; Sialic acid; Virus; Biology; Wild type; Mutant; Virology; Influenza A virus; Hemagglutinin (influenza); Titer; Orthomyxoviridae; Neuraminidase inhibitor; Molecular biology; Biochemistry; Gene","score_opus":0.16928875617667422,"score_gpt":0.46163906468421,"score_spread":0.2923503085075358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949120013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940415,0.0004928633,0.000025233388,0.00047276402,0.00010096104,0.0032853917,0.00015601936,0.00006619557,0.0013590415],"genre_scores_gemma":[0.99787277,0.00007684846,0.0004713043,0.00043602192,0.0002218378,0.00029924998,0.00002634606,0.00009403023,0.0005016086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938825,0.00042437942,0.0008287677,0.0009129976,0.0020826873,0.0018686686],"domain_scores_gemma":[0.99635035,0.0011475378,0.00014134572,0.0008991768,0.0012122259,0.00024934878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032658258,0.000380982,0.000964422,0.0013196688,0.00022316189,0.00010131326,0.0004945755,0.00025555905,0.00004234135],"category_scores_gemma":[0.003840225,0.0003283569,0.00020365985,0.0015908573,0.000543587,0.00055232213,0.0005196894,0.0013333795,0.00019499862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031106276,0.00087529,0.023952141,0.0007691731,0.00012215709,0.0001426509,0.001090894,0.000004324593,0.9625554,0.0003689523,0.00029222097,0.0067161396],"study_design_scores_gemma":[0.008292586,0.004382569,0.035566628,0.00057162513,0.000032107375,0.000015184924,0.0010661586,0.0029279704,0.94267565,0.00022386672,0.0038597977,0.00038584406],"about_ca_topic_score_codex":0.0014604435,"about_ca_topic_score_gemma":0.0003794812,"teacher_disagreement_score":0.019879768,"about_ca_system_score_codex":0.000346888,"about_ca_system_score_gemma":0.00086028705,"threshold_uncertainty_score":0.99991685},"labels":[],"label_agreement":null},{"id":"W2955217622","doi":"10.1016/j.antiviral.2019.104543","title":"Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Vancouver Infectious Diseases Centre; Canada Research Chairs; McGill University; Maple Leaf Medical Clinic","funders":"Janssen Pharmaceuticals; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Arthur Foundation; Johnson and Johnson; Gilead Sciences; Merck; Yale University","keywords":"Darunavir; Emtricitabine; Tenofovir alafenamide; Medicine; Internal medicine; Adverse effect; Cobicistat; Gastroenterology; Viral load; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.03428119433678359,"score_gpt":0.3278131052699593,"score_spread":0.29353191093317577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955217622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746078,0.00032147884,0.0001028256,0.009004117,0.00012303477,0.014133737,0.00018161756,0.000048706515,0.0014766589],"genre_scores_gemma":[0.9912064,0.00015592988,0.0008027208,0.00015892151,0.0001239466,0.0007403575,0.000108065986,0.0000782579,0.006625365],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99092317,0.0024418202,0.0017861694,0.0014630387,0.002111089,0.0012747007],"domain_scores_gemma":[0.9926049,0.004470679,0.0006093415,0.0014635789,0.0005187762,0.0003327348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0046829423,0.00072723534,0.0020512203,0.0006683177,0.00041693545,0.000120945864,0.00069180893,0.00021072266,0.0000374516],"category_scores_gemma":[0.0039996747,0.00037768984,0.00028381214,0.002272336,0.000531924,0.0003575413,0.00071353203,0.0007495413,0.000051208055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8734399,0.0034662336,0.0034142577,0.00009829073,0.0005308661,0.00015020114,0.025442882,0.00021945912,0.08052601,0.000027641125,0.00044527173,0.012239003],"study_design_scores_gemma":[0.913333,0.013431582,0.007004165,0.0036452983,0.00044805591,0.000011141267,0.0041122623,0.004363256,0.05199674,0.00005205001,0.00085058034,0.00075187086],"about_ca_topic_score_codex":0.0024975666,"about_ca_topic_score_gemma":0.00029665508,"teacher_disagreement_score":0.039893106,"about_ca_system_score_codex":0.00079496694,"about_ca_system_score_gemma":0.001211618,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W2962367258","doi":"10.1016/j.antiviral.2019.104561","title":"The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Shionogi; Canadian Institutes of Health Research; BioCryst","keywords":"Neuraminidase; Virology; Residue (chemistry); Influenzavirus B; Virus; Chemistry; Substitution (logic); Orthomyxoviridae; Influenza A virus; Microbiology; Biology; Biochemistry","score_opus":0.11997820566410337,"score_gpt":0.4380638959558294,"score_spread":0.318085690291726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962367258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989732,0.0010555043,0.0000029095893,0.0036893848,0.0003079408,0.0034368099,0.000028966218,0.00006743985,0.0016790201],"genre_scores_gemma":[0.9970417,0.00020056833,0.000013035102,0.0005092258,0.00026446255,0.00013025916,0.000013825188,0.00005676708,0.0017701746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9927105,0.0012493965,0.0008445104,0.0009374256,0.0021972423,0.0020609638],"domain_scores_gemma":[0.9939752,0.0025239477,0.00011592103,0.0018694132,0.0012250949,0.0002904087],"candidate_categories":["metaresearch","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009960584,0.00037473682,0.0005564898,0.00066175574,0.001368211,0.00046258216,0.00067962514,0.0002023254,0.000030739753],"category_scores_gemma":[0.013076276,0.00022735356,0.00018307539,0.0029669278,0.001263687,0.00062995026,0.0010734693,0.0021989406,0.0014706089],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003086439,0.00029222277,0.12348715,0.0002773495,0.00014602547,0.00024806053,0.0031968905,0.000032889948,0.85756207,0.00046841896,0.008083195,0.0031192778],"study_design_scores_gemma":[0.0025137153,0.00096299424,0.55955076,0.000639141,0.00003639801,0.000027384043,0.0022870703,0.00061484653,0.42721793,0.00037038015,0.005331855,0.00044749738],"about_ca_topic_score_codex":0.009118218,"about_ca_topic_score_gemma":0.0041800737,"teacher_disagreement_score":0.43606362,"about_ca_system_score_codex":0.0009257125,"about_ca_system_score_gemma":0.0012788984,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W2963915114","doi":"10.1016/j.antiviral.2019.104566","title":"Responses of human mast cells and epithelial cells following exposure to influenza A virus","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta; Lung Association, Alberta and NWT; American Academy of Allergy Asthma and Immunology","keywords":"Innate immune system; Mast cell; Biology; Prostaglandin D2; Chemokine; Virus; Influenza A virus; Immune system; Cell culture; Virology; Histamine; Immunology; Interleukin 8; Receptor; Cytokine","score_opus":0.0467525850937612,"score_gpt":0.3536596534192745,"score_spread":0.30690706832551334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963915114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945706,0.00026267493,0.0000071365544,0.000056536897,0.0011873756,0.00033469926,0.000015136062,0.000021051032,0.003544771],"genre_scores_gemma":[0.9515149,0.0000306863,0.00001383284,0.00010829068,0.00002207505,0.000009438833,0.000008505398,0.000015824578,0.04827643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983981,0.0005511832,0.00026696865,0.0002889518,0.00010633822,0.00038843742],"domain_scores_gemma":[0.99918807,0.00032746675,0.00005072484,0.00028753962,0.00012807197,0.00001816098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000992095,0.00011791247,0.00023547001,0.00036427946,0.00019586559,0.000030301644,0.0001708172,0.00016594723,0.00040270397],"category_scores_gemma":[0.00010549432,0.00010614435,0.00009217598,0.00023044978,0.00012283219,0.00016122145,0.00019267073,0.00045562963,0.0030995873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009328389,0.00007453239,0.0023044571,0.000021259204,0.000055500648,0.0000039309925,0.0006488766,4.7164156e-7,0.99070746,0.0001408583,0.0039601782,0.0011496518],"study_design_scores_gemma":[0.0007986205,0.0013901967,0.0055881543,0.00004957064,0.0000068556246,0.000002308981,0.00067285,8.081479e-7,0.9450588,0.00002244629,0.046304766,0.000104577266],"about_ca_topic_score_codex":0.00046580893,"about_ca_topic_score_gemma":0.0000224391,"teacher_disagreement_score":0.0456486,"about_ca_system_score_codex":0.000028145876,"about_ca_system_score_gemma":0.00004698202,"threshold_uncertainty_score":0.9976766},"labels":[],"label_agreement":null},{"id":"W2970630414","doi":"10.1016/j.antiviral.2019.104594","title":"Innate immune protection from pneumonia virus of mice induced by a novel immunomodulator is prolonged by dual treatment and mediated by macrophages","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Innate immune system; Nasal administration; Immunology; Immune system; Respiratory tract; Virus; Pneumonia; Lung; Lower respiratory tract infection; Medicine; Respiratory system; Biology; Respiratory tract infections; Internal medicine","score_opus":0.06255313066928946,"score_gpt":0.37170194956335884,"score_spread":0.30914881889406937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970630414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929926,0.0023069093,0.000011030604,0.00088702317,0.00007062071,0.0027994185,0.00061668904,0.00005268802,0.00026302485],"genre_scores_gemma":[0.9954647,0.0005470685,0.000021271253,0.000051650703,0.000040805575,0.00028147083,0.00019997825,0.00006648565,0.0033265578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99646956,0.00047832253,0.00054547464,0.00073186477,0.0010446651,0.0007301119],"domain_scores_gemma":[0.9983657,0.0002397305,0.00014289109,0.00060679426,0.0004969293,0.00014794704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010371258,0.00030751427,0.0006099087,0.0004207573,0.00021254586,0.00009669669,0.0001841572,0.0003249502,0.00013531937],"category_scores_gemma":[0.00036476043,0.00025296956,0.000100543104,0.0009916344,0.00035173114,0.00032976494,0.00021108834,0.00094320404,0.0002995747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013412755,0.0009834872,0.005432548,0.000083201056,0.00031018263,0.0000092878445,0.00030125232,3.923819e-8,0.98253983,0.0000025941204,0.0013583406,0.0076379473],"study_design_scores_gemma":[0.0042404155,0.0053429157,0.020499961,0.000083124636,0.000027396023,0.000006815966,0.00011365985,0.00038844772,0.9657979,0.000011864463,0.0032892243,0.00019826868],"about_ca_topic_score_codex":0.015492047,"about_ca_topic_score_gemma":0.00004451119,"teacher_disagreement_score":0.016741937,"about_ca_system_score_codex":0.00033095657,"about_ca_system_score_gemma":0.00027959573,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W2974084556","doi":"10.1016/j.antiviral.2019.104611","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Chikungunya; Epidemiology; Virology; Outbreak; Medicine; Disease; Natural history; Environmental health; Pathology","score_opus":0.23129628375727188,"score_gpt":0.4956612875635213,"score_spread":0.2643650038062494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974084556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019665835,0.96824056,0.000045594097,0.00049791904,0.0005006943,0.004140377,0.0013167324,0.000100553916,0.0054917084],"genre_scores_gemma":[0.052837066,0.9363889,0.000022296808,0.00013237471,0.0011204669,0.00031057096,0.0029769673,0.000117640484,0.0060937274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99010193,0.0021126966,0.0022788106,0.0020284017,0.0018021417,0.0016759881],"domain_scores_gemma":[0.99326485,0.0025377914,0.00092045136,0.0021445407,0.0006222596,0.0005101189],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0063830786,0.000960046,0.0047518644,0.0004607626,0.0003056703,0.00011267482,0.00065199094,0.001156154,0.00021373454],"category_scores_gemma":[0.007831906,0.0006761543,0.001459806,0.0010171966,0.0008055432,0.00018284925,0.000690885,0.0026346694,0.000516265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013146634,0.0011464474,0.006657712,0.022845143,0.0010499589,0.0024032264,0.000024732148,4.733915e-7,0.00015257424,0.0044509224,0.029861165,0.930093],"study_design_scores_gemma":[0.0012949201,0.0018190048,0.010355113,0.017752422,0.0013946629,0.00025915774,0.000032878037,0.000074975804,0.00008378999,0.0001921574,0.9660223,0.0007186123],"about_ca_topic_score_codex":0.0006617809,"about_ca_topic_score_gemma":0.000055073433,"teacher_disagreement_score":0.93616116,"about_ca_system_score_codex":0.0003883995,"about_ca_system_score_gemma":0.0011389948,"threshold_uncertainty_score":0.9996663},"labels":[],"label_agreement":null},{"id":"W2982098704","doi":"10.1016/j.antiviral.2019.104640","title":"The Biosafety Level 4 Zoonotic Laboratory Network (BSL4ZNet): Report of a workshop on live animal handling","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Canadian Food Inspection Agency","funders":"National Institutes of Health; Commonwealth Scientific and Industrial Research Organisation; U.S. Department of Agriculture","keywords":"Biosafety; Animal welfare; Excellence; Animal health; Library science; Political science; Medicine; Environmental health; Medical education; Veterinary medicine; Law; Biology; Pathology; Computer science","score_opus":0.3675134541537822,"score_gpt":0.43602542996875276,"score_spread":0.06851197581497054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982098704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025438922,0.9903787,8.788063e-7,0.0007173047,0.00023512113,0.0011425823,0.000099371486,0.000033336233,0.0048488057],"genre_scores_gemma":[0.019183245,0.9760159,0.000012942028,0.000048619324,0.00091174763,0.000058930145,0.00017356439,0.0000056812178,0.0035893566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951079,0.0016815504,0.0008085415,0.00073267217,0.00065496686,0.0010143778],"domain_scores_gemma":[0.9925066,0.0064316452,0.00044093118,0.00028611574,0.00025188603,0.00008277607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00548529,0.00034639085,0.0012013431,0.00004744909,0.00061641866,0.00010404015,0.00097628904,0.0003726363,0.0000697427],"category_scores_gemma":[0.0015682048,0.00010918857,0.0005413763,0.0012512609,0.00044133628,0.00007858305,0.0006705051,0.0009798094,0.0007011463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018075742,0.00008644114,0.00025633848,0.0011144816,0.00019907109,0.00013020234,0.000009797591,8.7109515e-7,0.000030100737,0.0043498785,0.028046079,0.96559596],"study_design_scores_gemma":[0.000047295147,0.00046977296,0.0047988547,0.003467433,0.0001168379,0.0000027149883,0.00011369479,0.000023741044,0.0000011988622,0.00017525257,0.99052244,0.00026075626],"about_ca_topic_score_codex":0.00014176551,"about_ca_topic_score_gemma":0.00020975525,"teacher_disagreement_score":0.96533525,"about_ca_system_score_codex":0.00006695583,"about_ca_system_score_gemma":0.00013491506,"threshold_uncertainty_score":0.9012051},"labels":[],"label_agreement":null},{"id":"W2993785019","doi":"10.1016/j.antiviral.2019.104670","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Medical Research Council","keywords":"Alphavirus; Virology; Chikungunya; Biology; Virus","score_opus":0.24054939034977815,"score_gpt":0.5018523121365485,"score_spread":0.2613029217867703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993785019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027455026,0.94808084,0.0000017776637,0.0004145136,0.00036986155,0.0028507668,0.0000999072,0.00008356807,0.045353256],"genre_scores_gemma":[0.011139347,0.9584676,0.000012393104,0.00019149338,0.0013060394,0.00023712046,0.0003969361,0.00010357437,0.028145486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99372953,0.00083760865,0.0009303241,0.0016150636,0.0016134426,0.0012740358],"domain_scores_gemma":[0.99660015,0.0008471681,0.00027999954,0.0015979571,0.00028244467,0.00039226553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002344835,0.00063666416,0.0026279776,0.00052060746,0.0002107143,0.0001867137,0.00043721558,0.0006799448,0.0003176229],"category_scores_gemma":[0.0018904546,0.00043529348,0.0008093856,0.0006961485,0.00035874403,0.00009646929,0.0005105478,0.002119269,0.0015717266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003864187,0.0005560224,0.0007274547,0.012568607,0.0005075629,0.010628274,0.000017341872,1.499108e-8,0.000018319712,0.003630511,0.019082189,0.9518773],"study_design_scores_gemma":[0.00079468195,0.00132683,0.0010270121,0.01084899,0.0007226236,0.00055724184,0.000016200407,0.000008204393,0.000014147628,0.00014893962,0.9841117,0.00042337895],"about_ca_topic_score_codex":0.00017004383,"about_ca_topic_score_gemma":0.000026611031,"teacher_disagreement_score":0.96502954,"about_ca_system_score_codex":0.00022199209,"about_ca_system_score_gemma":0.0010995134,"threshold_uncertainty_score":0.99980986},"labels":[],"label_agreement":null},{"id":"W2999137482","doi":"10.1016/j.antiviral.2019.104703","title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Diabetes Canada","keywords":"Lassa fever; Immunology; Immune system; Interferon; Acquired immune system; Disease; Virology; Biology; Immunity; Dengue fever; Virus; Medicine; Internal medicine","score_opus":0.4794942360077474,"score_gpt":0.5268524292306945,"score_spread":0.047358193222947154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999137482","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58903205,0.40266833,0.000004367293,0.0015202307,0.00040234305,0.0057649165,0.000056138513,0.000048723177,0.0005028801],"genre_scores_gemma":[0.27485687,0.72096086,0.000044108354,0.0000783922,0.00014413282,0.00007103709,0.000014710503,0.00007984382,0.003750049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879003,0.008532529,0.0005749812,0.0007604249,0.0013870901,0.0008446841],"domain_scores_gemma":[0.9844387,0.013247356,0.00010859782,0.0006456068,0.0013488249,0.00021092748],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008397984,0.00037059197,0.0010788081,0.0018426313,0.0007533429,0.00021536787,0.00033283635,0.00037601643,0.00003503352],"category_scores_gemma":[0.020674262,0.00023329521,0.00010226209,0.004644198,0.0003473732,0.00018383276,0.001127683,0.0033759214,0.00015219265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10339287,0.0003403822,0.000077434175,0.0027154407,0.00018197623,0.0005878584,0.00039018152,0.0000010558199,0.003474724,0.00013184572,0.005034728,0.8836715],"study_design_scores_gemma":[0.0022523107,0.062468216,0.006815896,0.022959417,0.00016364716,0.00013495213,0.0004861854,0.00038315373,0.002679572,0.0000691659,0.9009733,0.0006141903],"about_ca_topic_score_codex":0.0006672328,"about_ca_topic_score_gemma":0.00023826955,"teacher_disagreement_score":0.8959386,"about_ca_system_score_codex":0.00054741104,"about_ca_system_score_gemma":0.001564815,"threshold_uncertainty_score":0.9989233},"labels":[],"label_agreement":null},{"id":"W3005409321","doi":"10.1016/j.antiviral.2020.104742","title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1837,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Horizon 2020; Canadian Institutes of Health Research","keywords":"Furin; Virology; Coronavirus; Biology; Genome; Cleavage (geology); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Glycoprotein; Coronavirus disease 2019 (COVID-19); Betacoronavirus; Pandemic; Genetics; Clade; Computational biology; Gene; Phylogenetic tree; Infectious disease (medical specialty); Medicine","score_opus":0.11049972145780963,"score_gpt":0.41003661453462376,"score_spread":0.29953689307681414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005409321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771473,0.0011503058,0.0000114412305,0.015549801,0.00010876669,0.0020041761,0.000037887636,0.000017896378,0.0039724326],"genre_scores_gemma":[0.9899626,0.00010448567,0.000014989637,0.008583468,0.00018323267,0.000036726993,0.000001366293,0.000038215854,0.0010749286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950374,0.0008146564,0.0005654965,0.0004467307,0.0022647884,0.0008709413],"domain_scores_gemma":[0.9974969,0.00091658375,0.00014130273,0.001084886,0.00029396467,0.00006635958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014848936,0.00020998828,0.0004604841,0.00013451006,0.00025290647,0.000056645436,0.0012210789,0.00016446627,0.000012515907],"category_scores_gemma":[0.00165743,0.00010784586,0.00028906873,0.0016028767,0.0009841816,0.0000928526,0.0010845525,0.0016786237,0.00017905072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028322465,0.00023025127,0.10667693,0.00019262059,0.00007334563,0.000086184846,0.0017917531,2.944099e-7,0.86295193,0.0011968481,0.01008497,0.0138826035],"study_design_scores_gemma":[0.0025683944,0.0008269674,0.17724107,0.00029932396,0.000015233477,0.000006835736,0.00062977616,0.00021365262,0.7367215,0.00041419076,0.08093864,0.00012442586],"about_ca_topic_score_codex":0.011114544,"about_ca_topic_score_gemma":0.0043367585,"teacher_disagreement_score":0.12623046,"about_ca_system_score_codex":0.00018366189,"about_ca_system_score_gemma":0.0017164472,"threshold_uncertainty_score":0.9954705},"labels":[],"label_agreement":null},{"id":"W3007824046","doi":"10.1016/j.antiviral.2020.104753","title":"Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Oseltamivir; Virus; Pandemic; Virology; Placebo; Medicine; Influenza A virus; Antibody; Immunology; Biology; Internal medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.18570863436949855,"score_gpt":0.44838690740384346,"score_spread":0.2626782730343449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007824046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915003,0.0042967685,0.000007739947,0.0005580305,0.000016986412,0.0014570128,0.000044096887,0.00009121998,0.0020278073],"genre_scores_gemma":[0.9969998,0.0015427297,0.00018345768,0.0009905777,0.00009797847,0.000046325353,0.0000103904595,0.000060711085,0.00006803673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99498945,0.0005574048,0.00075070537,0.00076875556,0.0016705602,0.0012631025],"domain_scores_gemma":[0.9971835,0.0010514196,0.00012905693,0.0005152693,0.0008434062,0.00027733645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016779257,0.00037473647,0.00097467453,0.00070782035,0.00020521689,0.00007111118,0.00037462343,0.00023950946,0.00003766598],"category_scores_gemma":[0.0043554823,0.0002960766,0.00010123369,0.0025355835,0.001236404,0.00035008727,0.0006450524,0.0018312071,0.0001732879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069345245,0.00034949492,0.614545,0.00044630893,0.00022588915,0.00038692783,0.0017909227,0.000009181891,0.3695211,0.00007204337,0.000612882,0.0051057423],"study_design_scores_gemma":[0.010460832,0.002269095,0.9306362,0.00061393174,0.00004280822,0.000029347217,0.00039023292,0.00025487223,0.05076032,0.000033830693,0.0041780462,0.00033048034],"about_ca_topic_score_codex":0.0017334962,"about_ca_topic_score_gemma":0.00015040278,"teacher_disagreement_score":0.31876078,"about_ca_system_score_codex":0.00014628239,"about_ca_system_score_gemma":0.0006357302,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null},{"id":"W3011607905","doi":"10.1016/j.antiviral.2020.104774","title":"Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Helmholtz-Alberta Initiative; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft; Helmholtz Association; Deutsches Zentrum für Infektionsforschung; National Science Foundation","keywords":"Virus; In vivo; Viral entry; Virology; Biology; Ex vivo; Pneumovirinae; Microbiology; Viral replication; Paramyxoviridae; Viral disease","score_opus":0.12217450116967979,"score_gpt":0.42640825407755867,"score_spread":0.3042337529078789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011607905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89742935,0.00045969777,0.000028949322,0.0009945136,0.00008552892,0.00090960914,0.000022365344,0.00008645641,0.09998355],"genre_scores_gemma":[0.9955525,0.00017527919,0.000078274716,0.00082610326,0.00067929813,0.000050092818,0.000008795586,0.0000752934,0.0025543852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99467355,0.0008203747,0.0006803675,0.0007077422,0.0021691178,0.000948866],"domain_scores_gemma":[0.997604,0.00041489382,0.00010475565,0.00068629754,0.0007502054,0.00043981534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018123324,0.000261105,0.0005660747,0.000684275,0.00025517822,0.000074424315,0.00041719852,0.00027007016,0.0007095131],"category_scores_gemma":[0.002483353,0.00023527165,0.00025102246,0.002142805,0.0008441591,0.00030103623,0.0005603972,0.0018137635,0.0038885341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010673832,0.0005008448,0.017449703,0.00040720843,0.00005538241,0.000410943,0.0003030249,0.0000026977013,0.9571145,0.00043845965,0.015313912,0.0069359103],"study_design_scores_gemma":[0.0017952971,0.004527844,0.0059408452,0.00012008885,0.000025645662,0.0000070841165,0.0003065301,0.00020330536,0.9407419,0.00006337882,0.04605998,0.00020813129],"about_ca_topic_score_codex":0.00044952516,"about_ca_topic_score_gemma":0.000021118713,"teacher_disagreement_score":0.09812315,"about_ca_system_score_codex":0.00018993286,"about_ca_system_score_gemma":0.0011548047,"threshold_uncertainty_score":0.996887},"labels":[],"label_agreement":null},{"id":"W3013944367","doi":"10.1016/j.antiviral.2020.104780","title":"Put a cork in it: Plugging the M2 viral ion channel to sink influenza","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Health Research","keywords":"Virology; Virus; Adamantane; Influenza A virus; Pandemic; Biology; Chemistry; Coronavirus disease 2019 (COVID-19); Medicine; Infectious disease (medical specialty)","score_opus":0.4645564701714462,"score_gpt":0.5617031123935495,"score_spread":0.09714664222210334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013944367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028873427,0.9779758,0.000005814044,0.0047367695,0.00017719957,0.005830883,0.000072102295,0.000091097136,0.010821602],"genre_scores_gemma":[0.0015360875,0.9919493,0.00004550319,0.0019256222,0.0012125954,0.0010720032,0.000035467678,0.00016468241,0.0020587277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903954,0.0018355984,0.0011476441,0.0012305368,0.0031129273,0.0022778783],"domain_scores_gemma":[0.99553585,0.002191764,0.00015646189,0.0011692521,0.0005994405,0.0003472089],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005497074,0.0007265996,0.0026956352,0.0017145567,0.00059830997,0.0002553558,0.0012763953,0.00048066047,0.000041861218],"category_scores_gemma":[0.008759424,0.00046188832,0.00062130304,0.0045186584,0.0006868811,0.00020217836,0.0025113665,0.0055241743,0.00428326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043253766,0.00014468809,0.00007573281,0.011160629,0.00032437875,0.0013024268,0.0016237249,7.419097e-7,0.000051353065,0.00027832258,0.02680396,0.9578015],"study_design_scores_gemma":[0.00068493217,0.0008426537,0.000116743766,0.019502733,0.00010386211,0.000025593663,0.00036145284,0.000053421194,0.00003717018,0.00008825533,0.9777897,0.0003935103],"about_ca_topic_score_codex":0.0006027949,"about_ca_topic_score_gemma":0.00014626997,"teacher_disagreement_score":0.957408,"about_ca_system_score_codex":0.0010254674,"about_ca_system_score_gemma":0.0020441506,"threshold_uncertainty_score":0.9997833},"labels":[],"label_agreement":null},{"id":"W3019419026","doi":"10.1016/j.antiviral.2020.104807","title":"Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Virology; Recombinant DNA; In vitro; Biology; Mutation; Virus; Genetics; Gene","score_opus":0.2550754146358055,"score_gpt":0.45181588539935874,"score_spread":0.19674047076355322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019419026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968334,0.00017331197,0.0000057905268,0.00125769,0.000019244639,0.0011760975,0.000046672543,0.000012686331,0.00047513456],"genre_scores_gemma":[0.99935955,0.000108619686,0.0001638423,0.0002352041,0.000021710333,0.000057134308,0.000013539104,0.000018565128,0.000021864515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747944,0.00043226953,0.00064947404,0.0003925747,0.0006398697,0.00040639256],"domain_scores_gemma":[0.9987309,0.000404853,0.000083536936,0.00021461389,0.0004542432,0.00011186017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016706339,0.00012987069,0.00051357254,0.0006485756,0.000051500123,0.000015741225,0.00014411146,0.00007912444,0.000006284903],"category_scores_gemma":[0.0040186015,0.00012333509,0.000043007734,0.0015945316,0.00033511507,0.00027193973,0.0003062424,0.0005001514,0.000010636403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033755794,0.00018776426,0.1587982,0.00040384813,0.000019300705,0.000028626782,0.0021104899,5.917178e-7,0.83315843,0.000025459403,0.000014922409,0.0018767572],"study_design_scores_gemma":[0.0010855749,0.00037942582,0.39254418,0.00021763195,0.000002768203,3.0001283e-7,0.00044627872,0.00015689137,0.60498804,0.000022773205,0.0000933472,0.0000627807],"about_ca_topic_score_codex":0.0012985277,"about_ca_topic_score_gemma":0.0000807318,"teacher_disagreement_score":0.23374596,"about_ca_system_score_codex":0.000104148305,"about_ca_system_score_gemma":0.0003671236,"threshold_uncertainty_score":0.5029459},"labels":[],"label_agreement":null},{"id":"W3022455442","doi":"10.1016/j.antiviral.2020.104816","title":"Mechanisms of HBV immune evasion","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Innate immune system; Acquired immune system; Immunology; Immunity; Immune system; Biology; Context (archaeology); Hepatitis B virus; Evasion (ethics); Virology; Virus","score_opus":0.3115883086993262,"score_gpt":0.5095569659367478,"score_spread":0.19796865723742163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022455442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001579292,0.986845,0.000039723433,0.00023247446,0.000113404596,0.0014066987,0.000050386745,0.000038966482,0.011257558],"genre_scores_gemma":[0.0034862556,0.99359286,0.00031294016,0.000016035943,0.00014124297,0.00009418209,0.00006448298,0.0000818334,0.0022101952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961237,0.0006141067,0.00072592706,0.00049729773,0.0014629957,0.0005760149],"domain_scores_gemma":[0.99814606,0.00057094515,0.00016487887,0.0005931563,0.00043297082,0.00009196674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015754141,0.00030503608,0.002618734,0.00047826002,0.00012586809,0.000017056782,0.00034507425,0.00030593996,0.00008033019],"category_scores_gemma":[0.0020203178,0.00022286849,0.00060225476,0.0011929389,0.00027306934,0.000052315118,0.0007334577,0.0013837573,0.0015662351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028938905,0.000085598804,0.000011072383,0.023887591,0.0002689944,0.0003088617,0.00005581694,3.8455902e-10,0.0006961784,0.001747491,0.002318065,0.97059137],"study_design_scores_gemma":[0.00023621548,0.00082153984,0.00005237434,0.024217546,0.00032403055,0.00001935934,0.000020624731,0.0000028238621,0.0011293618,0.0003937087,0.9726086,0.00017376406],"about_ca_topic_score_codex":0.0005403825,"about_ca_topic_score_gemma":0.000033187083,"teacher_disagreement_score":0.9704176,"about_ca_system_score_codex":0.00017010192,"about_ca_system_score_gemma":0.0009123849,"threshold_uncertainty_score":0.99921113},"labels":[],"label_agreement":null},{"id":"W3037030278","doi":"10.1016/j.antiviral.2020.104853","title":"Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"HBsAg; Hepatitis B virus; Virology; Biology; Immune system; Virus; Antibody; HBeAg; Immunology","score_opus":0.07151390067108727,"score_gpt":0.3604882220197021,"score_spread":0.28897432134861484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037030278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864765,0.000043353168,0.0000047716753,0.009000422,0.00005524789,0.00083193206,0.000013542798,0.000010570061,0.0035636928],"genre_scores_gemma":[0.99893355,0.00018256536,0.000008635225,0.0004795281,0.00009690455,0.000026482345,0.0000045157244,0.000016825898,0.00025098334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978736,0.0005783435,0.0002651688,0.00021168402,0.0007751521,0.00029606718],"domain_scores_gemma":[0.9986664,0.0007237712,0.00008070405,0.0003383347,0.00016405234,0.000026721982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007920207,0.00009738428,0.0003034063,0.000098122786,0.000091014226,0.000009065941,0.00021552297,0.000057635345,0.0000070831056],"category_scores_gemma":[0.003693657,0.00005456202,0.00008852818,0.00089410204,0.00034289103,0.000065684966,0.00024016724,0.00047717383,0.000040394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035505975,0.00011852951,0.08061292,0.00023106203,0.000025747971,0.000017865072,0.0010390461,4.110757e-8,0.9135599,0.00032896886,0.00031504795,0.0033957767],"study_design_scores_gemma":[0.00033126015,0.0003152521,0.34253412,0.00020741638,0.000006450691,2.2240715e-7,0.000034727058,0.00013604059,0.656183,0.000029452305,0.00019092472,0.000031133306],"about_ca_topic_score_codex":0.00037405294,"about_ca_topic_score_gemma":0.000044327113,"teacher_disagreement_score":0.26192123,"about_ca_system_score_codex":0.000033546545,"about_ca_system_score_gemma":0.00010279191,"threshold_uncertainty_score":0.44219193},"labels":[],"label_agreement":null},{"id":"W3041182781","doi":"10.1016/j.antiviral.2020.104859","title":"Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; International Development Research Centre; University of Alberta","keywords":"Zika virus; Virology; Sofosbuvir; Transmission (telecommunications); Medicine; Biology; Virus; Computer science","score_opus":0.031691202223836104,"score_gpt":0.3313672773429618,"score_spread":0.2996760751191257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041182781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929997,0.0008879095,0.0000467345,0.0029768606,0.000011834305,0.002032586,0.000021103262,0.000021236056,0.0010020365],"genre_scores_gemma":[0.9994676,0.00010765217,0.0000041734143,0.00016733377,0.000028487753,0.00014013701,0.000008470472,0.000019916792,0.000056244007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972968,0.00092025497,0.0002732132,0.00033923515,0.00072728976,0.00044321083],"domain_scores_gemma":[0.9986621,0.0008419169,0.000026491418,0.00017092872,0.00013820316,0.00016036494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011067857,0.00014593957,0.00052589906,0.0000974957,0.000095492,0.000030359875,0.00014134616,0.000121980825,0.000020828249],"category_scores_gemma":[0.001979788,0.00008992836,0.00015152538,0.00049869565,0.00045872747,0.00007637843,0.0000910969,0.00070719584,0.000016604861],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053930767,0.0012056545,0.041491654,0.0008397829,0.0008577096,0.0025084368,0.0033368932,0.0000027966355,0.7312136,0.00095135276,0.00035510087,0.1633062],"study_design_scores_gemma":[0.06882326,0.015219042,0.66476655,0.0012140841,0.0005225874,0.000034154997,0.001387047,0.09129948,0.15502623,0.0008009307,0.0002702511,0.00063636847],"about_ca_topic_score_codex":0.00033996903,"about_ca_topic_score_gemma":0.000036428817,"teacher_disagreement_score":0.6232749,"about_ca_system_score_codex":0.000048063688,"about_ca_system_score_gemma":0.00015544488,"threshold_uncertainty_score":0.36671722},"labels":[],"label_agreement":null},{"id":"W3048772446","doi":"10.1016/j.antiviral.2020.104903","title":"Viperin protein inhibits the replication of caprine parainfluenza virus type 3 (CPIV 3) by interaction with viral N protein","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"Postdoctoral Science Foundation of Jiangsu Province; National Natural Science Foundation of China; China Postdoctoral Science Foundation; Jiangsu Agricultural Science and Technology Innovation Fund","keywords":"Virology; Replication (statistics); Viral replication; Biology; Virus","score_opus":0.10710064305604855,"score_gpt":0.40899579909448636,"score_spread":0.3018951560384378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048772446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926,0.00021106699,0.000032778076,0.0073168026,0.000009021339,0.0016132933,0.000016208087,0.000042159052,0.0014986434],"genre_scores_gemma":[0.9981187,0.000021525473,0.000055934637,0.000510102,0.000094037074,0.00016697885,0.00003892803,0.000022755396,0.000971023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820673,0.00030757312,0.00024658203,0.0004124204,0.00051575777,0.0003109373],"domain_scores_gemma":[0.99900156,0.0000562292,0.000085610154,0.00047400483,0.00029415602,0.00008844776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005733065,0.00012999223,0.00021622049,0.00007235842,0.00014244845,0.000020524252,0.00017351804,0.00009216963,0.00005952438],"category_scores_gemma":[0.0009299156,0.000081251266,0.000050766834,0.0005525511,0.000390624,0.0001792617,0.00010621118,0.0006201621,0.0001747049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053114216,0.00021999502,0.0026737119,0.00012736573,0.00004716487,0.000017063106,0.00022283709,6.88319e-7,0.98451287,0.00049598125,0.0017999377,0.0045709955],"study_design_scores_gemma":[0.001018035,0.0039233337,0.015695395,0.00015959246,0.000023818415,0.000005602973,0.00018079783,0.00033848983,0.9708357,0.00011605242,0.0075962907,0.00010690245],"about_ca_topic_score_codex":0.00031650555,"about_ca_topic_score_gemma":0.000021554531,"teacher_disagreement_score":0.013677148,"about_ca_system_score_codex":0.000033750614,"about_ca_system_score_gemma":0.0001631365,"threshold_uncertainty_score":0.33133304},"labels":[],"label_agreement":null},{"id":"W3095531782","doi":"10.1016/j.antiviral.2020.104970","title":"Burden of influenza B virus infection and considerations for clinical management","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Department of Health and Aged Care, Australian Government; Roche","keywords":"Medicine; Epidemiology; Pandemic; Neuraminidase; Disease; Intensive care medicine; Disease burden; Virology; Virus; Clinical trial; Neuraminidase inhibitor; Disease management; Immunology; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.6702519866143979,"score_gpt":0.6349529966941866,"score_spread":0.0352989899202113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095531782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019763481,0.9900428,0.000022885099,0.00022522264,0.000076815326,0.004717926,0.00013010047,0.000035475765,0.0045511173],"genre_scores_gemma":[0.00020088883,0.9973574,0.00073042227,0.00008057107,0.00044497388,0.0005654414,0.000025229961,0.000054189393,0.0005408494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961102,0.0007488302,0.0010785232,0.000624039,0.00088792533,0.00055045565],"domain_scores_gemma":[0.9948482,0.0036341178,0.00018546528,0.0004383055,0.00075275137,0.00014118296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031833367,0.00028452097,0.0019433972,0.0006644849,0.00028151623,0.000063989726,0.00012080691,0.00031080237,0.000020710235],"category_scores_gemma":[0.0064962623,0.00022314003,0.00049155107,0.0006243872,0.00082195696,0.0000933775,0.0006407422,0.0012185018,0.00012566279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016260274,0.00011130678,0.0001767348,0.03831701,0.001243684,0.00008565888,0.000095523814,4.0534257e-8,0.000009059949,0.0019435781,0.013073538,0.94478124],"study_design_scores_gemma":[0.00095681817,0.0009366477,0.00016451019,0.005517743,0.0005762635,0.000011131118,0.000037239206,0.000018436473,0.000021229815,0.0004632307,0.99113816,0.0001586032],"about_ca_topic_score_codex":0.00021513976,"about_ca_topic_score_gemma":0.000021042262,"teacher_disagreement_score":0.9780646,"about_ca_system_score_codex":0.00011871646,"about_ca_system_score_gemma":0.00063314656,"threshold_uncertainty_score":0.90993863},"labels":[],"label_agreement":null},{"id":"W3107388860","doi":"10.1016/j.antiviral.2020.104972","title":"Host RNA quality control as a hepatitis B antiviral target","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Virology; RNA; Medicine; Biology; Genetics; Gene","score_opus":0.19952415320008277,"score_gpt":0.500807972834056,"score_spread":0.3012838196339732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107388860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025289383,0.95439667,0.000026680655,0.0014723467,0.00033039943,0.003582909,0.00081839855,0.0001962142,0.038923487],"genre_scores_gemma":[0.037122898,0.9553038,0.00019729738,0.00038178306,0.00083795894,0.00044735926,0.00028658644,0.00021435908,0.005207966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892634,0.0031568597,0.0014923116,0.0014817254,0.0028291028,0.0017765968],"domain_scores_gemma":[0.99494225,0.0023625577,0.0003687353,0.0011368312,0.00083108555,0.00035855162],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035333545,0.0008988925,0.0054066954,0.0007066778,0.00051538646,0.00018027278,0.00071570446,0.0006849867,0.00020136451],"category_scores_gemma":[0.007797271,0.00072555424,0.0013146763,0.0018817087,0.0009693803,0.0002344284,0.00076302,0.003610056,0.010589083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001881716,0.00030604447,0.0037849466,0.02403021,0.0013708647,0.0034883334,0.0002224466,1.0310087e-9,0.00013231691,0.0008390878,0.01823399,0.9474036],"study_design_scores_gemma":[0.0010664231,0.0010866172,0.0015233213,0.012630947,0.00047085996,0.000038507587,0.00002418376,0.000007389936,0.0000710356,0.00013550703,0.9823084,0.0006367918],"about_ca_topic_score_codex":0.006932858,"about_ca_topic_score_gemma":0.0007499228,"teacher_disagreement_score":0.96407443,"about_ca_system_score_codex":0.00061350456,"about_ca_system_score_gemma":0.0026903355,"threshold_uncertainty_score":0.99968004},"labels":[],"label_agreement":null},{"id":"W3128621058","doi":"10.1016/j.antiviral.2021.105034","title":"Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies","year":2021,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Antiviral therapy; Disease; Limiting; Medicine; Virology; Intensive care medicine; Virus; Outbreak; Immunology; Biology; Internal medicine","score_opus":0.2334401548311417,"score_gpt":0.5003849075069242,"score_spread":0.26694475267578255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128621058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005201579,0.99100393,0.0003110996,0.00005659507,0.00016595375,0.0015154071,0.00010083953,0.000022871021,0.0016217193],"genre_scores_gemma":[0.006426609,0.9897986,0.00022262683,0.000040017756,0.00052205444,0.0003740321,0.0008840904,0.00015009276,0.0015818957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578506,0.00068008824,0.00058033416,0.0011194147,0.00074092223,0.001094196],"domain_scores_gemma":[0.9982442,0.00014340346,0.00015389301,0.0006659705,0.0007007799,0.0000917355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021051841,0.0005312486,0.0009541005,0.00042149783,0.0007010201,0.00041556836,0.0005121197,0.00061176333,0.000015071284],"category_scores_gemma":[0.0001497638,0.00048809565,0.00032069953,0.0007530002,0.00039832576,0.000021730095,0.0006821458,0.00088920805,0.000020540627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014765507,0.00016640643,0.000032788023,0.002301243,0.00061585446,0.000011286991,0.000035956677,1.4101643e-7,0.028467087,0.00038728846,0.00048124915,0.96735305],"study_design_scores_gemma":[0.0005886814,0.0015753725,0.000013880152,0.0012429177,0.00008466338,0.000014577416,0.00007951013,0.0000024970159,0.01332548,0.00009564622,0.98244125,0.0005355454],"about_ca_topic_score_codex":0.000042381762,"about_ca_topic_score_gemma":0.00032300033,"teacher_disagreement_score":0.98196,"about_ca_system_score_codex":0.00011193739,"about_ca_system_score_gemma":0.0019552184,"threshold_uncertainty_score":0.99975705},"labels":[],"label_agreement":null},{"id":"W3130514573","doi":"10.1016/j.antiviral.2021.105046","title":"Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Infection and Immunity","keywords":"Foscarnet; Ganciclovir; DNA polymerase; Virology; Mutant; Biology; Human cytomegalovirus; Recombinant DNA; Herpes simplex virus; Molecular biology; DNA; Mutation; Virus; Genetics; Gene","score_opus":0.08317647964692601,"score_gpt":0.42198399510508827,"score_spread":0.33880751545816223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130514573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961666,0.00043920017,0.000015872336,0.00012696478,0.000028905186,0.00017224309,0.000029190709,0.0000067047445,0.0030143114],"genre_scores_gemma":[0.9977324,0.00062144373,0.000014531639,0.000003539945,0.000024047687,0.0000075676894,0.000033769666,0.000008486732,0.0015542051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895054,0.00014024485,0.00019601427,0.00018741246,0.00027812543,0.0002476838],"domain_scores_gemma":[0.99938375,0.00013751307,0.000033586213,0.00022159165,0.00016723515,0.00005634412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013033797,0.00008267607,0.00025785805,0.00026375876,0.00013423599,0.000007593536,0.000032769647,0.00007541489,0.00010842543],"category_scores_gemma":[0.00019283287,0.00006482861,0.00009323805,0.00051609875,0.00026868924,0.000060577295,0.00012941536,0.00017924215,0.0000072374505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050022814,0.0019046923,0.7207423,0.00009698509,0.00021798682,0.00047996282,0.0004225627,6.4389405e-7,0.25741944,0.0008043597,0.0003533813,0.017057471],"study_design_scores_gemma":[0.0020238885,0.0009320975,0.6638301,0.00021099606,0.000034111006,0.000075145595,0.000060933096,0.00006442362,0.33236706,0.00011777396,0.0002199014,0.000063544525],"about_ca_topic_score_codex":0.004661163,"about_ca_topic_score_gemma":0.00083620613,"teacher_disagreement_score":0.07494762,"about_ca_system_score_codex":0.00013215662,"about_ca_system_score_gemma":0.00029212836,"threshold_uncertainty_score":0.7046315},"labels":[],"label_agreement":null},{"id":"W3154943564","doi":"10.1016/j.antiviral.2021.105078","title":"A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Exoribonuclease; RNA-dependent RNA polymerase; Virology; Biology; Proofreading; Polymerase; RNA polymerase; Favipiravir; RNA; Genetics; Gene; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.08491855043424056,"score_gpt":0.4161720030832382,"score_spread":0.33125345264899764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154943564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97162557,0.0007781448,0.00035187087,0.0019402283,0.00016449956,0.0007045692,0.0000437838,0.000043454293,0.02434788],"genre_scores_gemma":[0.98905545,0.0000135209175,0.00019185594,0.0093469545,0.00027861746,0.000070034206,0.000013877381,0.00007259394,0.0009570634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99347526,0.0007381334,0.00054613483,0.000844406,0.0031296115,0.0012664536],"domain_scores_gemma":[0.9970357,0.0007790477,0.00006913425,0.0010635065,0.00094952754,0.00010308791],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025079218,0.0002894281,0.0005888317,0.000866253,0.00019156007,0.00013179467,0.00044774127,0.0002186558,0.000028576702],"category_scores_gemma":[0.0017501414,0.0002530085,0.0003113714,0.0021813994,0.00034072754,0.00019278549,0.00056478864,0.0011104933,0.0006421335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009616392,0.0009583626,0.015589387,0.00029828202,0.000063920816,0.0016197539,0.00025834623,3.09575e-7,0.9659555,0.00009994644,0.0076064784,0.0065880925],"study_design_scores_gemma":[0.0022076762,0.0007573446,0.001536219,0.00027421414,0.000026635487,0.000010630805,0.00038881923,0.00020307009,0.98522717,0.00006769926,0.009060077,0.0002404177],"about_ca_topic_score_codex":0.0021124175,"about_ca_topic_score_gemma":0.00030722388,"teacher_disagreement_score":0.023390817,"about_ca_system_score_codex":0.00027485625,"about_ca_system_score_gemma":0.0028186855,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W3165190372","doi":"10.1016/j.antiviral.2021.105103","title":"Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy","year":2021,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; National Institutes of Health","keywords":"Lytic cycle; Epigenetics; Chromatin; Biology; Histone; Virus latency; Gene silencing; Epigenetic therapy; Cell biology; Genetics; Viral replication; Computational biology; Virus; DNA methylation; Gene; Gene expression","score_opus":0.1237211014503995,"score_gpt":0.4490785500216084,"score_spread":0.3253574485712089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165190372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03419983,0.9601473,0.000036659385,0.000050198752,0.00016487623,0.0019638103,0.00006887117,0.00003238243,0.003336067],"genre_scores_gemma":[0.25706622,0.7408021,0.00012490088,0.0000062520894,0.000116641255,0.00012556055,0.00076863717,0.000057763533,0.0009318782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957448,0.00126188,0.0008621541,0.0005921546,0.000953884,0.00058509066],"domain_scores_gemma":[0.9986735,0.00023101951,0.00018213675,0.00051352225,0.00032819845,0.00007165235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011870313,0.00035973423,0.001675593,0.0010990127,0.000113042544,0.000043620243,0.00014598534,0.00051429536,0.00030867115],"category_scores_gemma":[0.0002495964,0.00029029688,0.0005737968,0.0019395092,0.00022370504,0.00012973143,0.000052152063,0.00087887316,0.0002974628],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077403005,0.0009899347,0.00023848366,0.002909613,0.00032454234,0.00028473802,0.00009563524,2.6045706e-7,0.0030145594,0.00006613985,0.00013137535,0.9918673],"study_design_scores_gemma":[0.0046701985,0.0022372294,0.0061240764,0.027724853,0.00046871186,0.0001220535,0.00009489801,0.00017117313,0.00780931,0.0003346436,0.9495928,0.0006500184],"about_ca_topic_score_codex":0.000607977,"about_ca_topic_score_gemma":0.000035280813,"teacher_disagreement_score":0.9912173,"about_ca_system_score_codex":0.0002575538,"about_ca_system_score_gemma":0.0011802043,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W3176968497","doi":"10.1016/j.antiviral.2021.105123","title":"Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Public Health Agency of Canada; St. Paul's Hospital; University of British Columbia","funders":"Merck Canada; Faculty of Medicine, Prince of Songkla University; University of British Columbia","keywords":"Minion; Sanger sequencing; Ion semiconductor sequencing; DNA sequencing; Genotyping; Virology; Biology; Nanopore sequencing; Computational biology; Genetics; Genotype; DNA; Gene","score_opus":0.2735702276180468,"score_gpt":0.45701563234995074,"score_spread":0.18344540473190396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176968497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640215,0.0023713405,0.000296109,0.002317824,0.0002277062,0.0010392587,0.00006387158,0.000053992342,0.0072277654],"genre_scores_gemma":[0.99034697,0.0015087347,0.0020515507,0.00060727383,0.0011177959,0.00015441354,0.0001036131,0.00007319485,0.004036451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99430025,0.001281704,0.0009423728,0.0010718914,0.0010099428,0.0013938292],"domain_scores_gemma":[0.9964601,0.0011764697,0.000093918105,0.0007361843,0.0013502392,0.00018313368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0073461495,0.0002496488,0.0007580209,0.0007007672,0.00045931948,0.0002113678,0.00027117974,0.00044235788,0.00006469234],"category_scores_gemma":[0.0039969166,0.00025043485,0.00025539668,0.0019493282,0.00042821412,0.00045853332,0.00026520682,0.0017284356,0.00024696926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018566988,0.00038822615,0.03016614,0.00028805993,0.00009043703,0.001375916,0.00027792796,0.0000012270731,0.9340197,0.0033668599,0.005502973,0.022665877],"study_design_scores_gemma":[0.012738055,0.0019516415,0.109638155,0.0007643334,0.00008253766,0.000052561212,0.001380807,0.013251618,0.6080163,0.0017577684,0.24923287,0.0011333734],"about_ca_topic_score_codex":0.0002274627,"about_ca_topic_score_gemma":0.0051481863,"teacher_disagreement_score":0.32600337,"about_ca_system_score_codex":0.00058795256,"about_ca_system_score_gemma":0.0027305537,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W3212269280","doi":"10.1016/j.antiviral.2021.105206","title":"Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Monoclonal antibody; Virology; Antigenicity; Neutralization; Antibody; Neutralizing antibody; Virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Biology; Vaccination; Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Immunology; Infectious disease (medical specialty)","score_opus":0.16186344511486248,"score_gpt":0.4262860896056333,"score_spread":0.2644226444907708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212269280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941534,0.0002623928,0.000121289384,0.00049142336,0.000049978265,0.00026527452,0.000008722535,0.000026964135,0.004620566],"genre_scores_gemma":[0.99666566,0.000093896895,0.001250274,0.0016334492,0.00009452203,0.000019158744,0.00002638126,0.000026493433,0.00019018934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747,0.00019613771,0.00034834552,0.0004337808,0.0009789998,0.00057272357],"domain_scores_gemma":[0.99877644,0.00017075997,0.000049251863,0.0002919401,0.0006877191,0.000023922144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011523389,0.00014749114,0.0003477361,0.00037378081,0.00019433246,0.00008189135,0.00013201825,0.0001209168,0.0000037058574],"category_scores_gemma":[0.00033460866,0.00013450281,0.00006227552,0.0007496602,0.0002750648,0.00020135657,0.0003100687,0.00043589313,0.000054756812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019957185,0.00018010668,0.03572587,0.00030952413,0.0000766506,0.0005167485,0.0007199915,1.7952418e-9,0.9453617,0.0011608179,0.000075886004,0.01567318],"study_design_scores_gemma":[0.0006384845,0.00010514652,0.07252772,0.0002054398,0.00000998615,0.00006257064,0.00019208391,0.00011463331,0.90299535,0.00009345901,0.022942007,0.00011311687],"about_ca_topic_score_codex":0.000101745056,"about_ca_topic_score_gemma":0.00004215142,"teacher_disagreement_score":0.042366296,"about_ca_system_score_codex":0.000068514506,"about_ca_system_score_gemma":0.0009177356,"threshold_uncertainty_score":0.5484866},"labels":[],"label_agreement":null},{"id":"W3216010712","doi":"10.1016/j.antiviral.2021.105209","title":"2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; National Infrastructure for Microbiological Resources; Chinese Academy of Medical Sciences; National Natural Science Foundation of China","keywords":"Virology; RNA polymerase; Exoribonuclease; RNA-dependent RNA polymerase; Thio-; Coronavirus; Biology; Virus; Viral replication; RNA; Medicine; Coronavirus disease 2019 (COVID-19); Gene; Chemistry; Disease; Biochemistry; Infectious disease (medical specialty)","score_opus":0.10424055489291661,"score_gpt":0.4223945402369167,"score_spread":0.3181539853440001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216010712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361744,0.0030470917,0.000068008514,0.002945288,0.00048142238,0.0009841695,0.000035287314,0.00020727135,0.05605707],"genre_scores_gemma":[0.98109096,0.00020653392,0.00016594368,0.013837321,0.0011842292,0.00013992738,0.00002838728,0.00016309167,0.0031835998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98936266,0.0011181758,0.000884058,0.001573447,0.004548391,0.002513246],"domain_scores_gemma":[0.99553376,0.00090934796,0.00011829127,0.001756185,0.0015111631,0.00017124975],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035214566,0.0005736916,0.0009716602,0.0010900621,0.0006587934,0.00047380978,0.00079713156,0.00050174195,0.0000801611],"category_scores_gemma":[0.002992754,0.0005230193,0.0005285206,0.0027938273,0.0008450554,0.0005292331,0.0011775035,0.0029116892,0.0030027314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084472675,0.00082884345,0.008995192,0.0002932989,0.00021976091,0.006110753,0.0005070037,4.6810747e-8,0.94150037,0.00055672077,0.01007155,0.03007174],"study_design_scores_gemma":[0.0032142731,0.0006857989,0.0012443286,0.00037136543,0.00004846727,0.00015965641,0.0011992152,0.00014594237,0.94314915,0.0004255685,0.04887617,0.00048006],"about_ca_topic_score_codex":0.0020063154,"about_ca_topic_score_gemma":0.00047103624,"teacher_disagreement_score":0.05287347,"about_ca_system_score_codex":0.0005703332,"about_ca_system_score_gemma":0.0030011984,"threshold_uncertainty_score":0.9997221},"labels":[],"label_agreement":null},{"id":"W3217351888","doi":"10.1016/j.antiviral.2021.105211","title":"Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"cccDNA; HBsAg; Virology; HBeAg; In vitro; Hepatitis B virus; In vivo; Viral replication; Biology; Molecular biology; Hepatitis B; Virus; Biochemistry","score_opus":0.18417890910065435,"score_gpt":0.46262113204812266,"score_spread":0.27844222294746834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217351888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645925,0.00010510017,0.000045721255,0.0015967729,0.000041057563,0.0007484815,0.00002990091,0.000017877577,0.0009558584],"genre_scores_gemma":[0.99805385,0.00020100437,0.00034549134,0.00004353431,0.000249343,0.00006723613,0.00014209082,0.000018664989,0.00087879563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976806,0.0004588393,0.00049950887,0.0003410018,0.0007544512,0.00026557888],"domain_scores_gemma":[0.9977515,0.00023138308,0.000147278,0.00063185,0.0011989592,0.00003907096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024337808,0.00008405366,0.00028597953,0.00008215481,0.00013831677,0.000014445798,0.00013419973,0.00009203457,0.000025971487],"category_scores_gemma":[0.005348546,0.000061291525,0.000071666254,0.00048048518,0.00036933916,0.0001493903,0.0001948283,0.0003934167,0.000018994304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000162392,0.00024183748,0.097100765,0.0001479441,0.000025945066,0.000009377572,0.00042885504,2.7422331e-8,0.8900319,0.00065325835,0.00021689791,0.010980814],"study_design_scores_gemma":[0.00029927856,0.0005203666,0.25209242,0.00020817597,0.000011413967,0.0000015988419,0.00011925952,0.00022749582,0.745576,0.00013500279,0.0007626002,0.00004635002],"about_ca_topic_score_codex":0.00027908405,"about_ca_topic_score_gemma":0.00008488622,"teacher_disagreement_score":0.15499167,"about_ca_system_score_codex":0.000034946803,"about_ca_system_score_gemma":0.0002879128,"threshold_uncertainty_score":0.6403096},"labels":[],"label_agreement":null},{"id":"W4200346724","doi":"10.1016/j.antiviral.2021.105229","title":"Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Immunogenicity; Adjuvant; Vaccination; Immunology; Immune system; Virology; Influenza vaccine; Virus; Biology; Influenza A virus; Medicine","score_opus":0.09122811490464562,"score_gpt":0.45445366300993256,"score_spread":0.36322554810528696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200346724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478173,0.0038222882,0.000013275766,0.00017119007,0.00006355955,0.00095205556,0.000008639459,0.000005365649,0.00018189003],"genre_scores_gemma":[0.9989402,0.0008206658,0.0000055013475,0.000035561246,0.000019055808,0.000045927143,0.0000017782972,0.000011405354,0.00011986253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972029,0.0008705677,0.0003696584,0.00026851255,0.000941915,0.00034649612],"domain_scores_gemma":[0.99821484,0.0009610855,0.00009981772,0.00030052627,0.0003941163,0.000029635643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013679372,0.00012642257,0.00035813,0.00014392186,0.0003153782,0.000039083854,0.00012622448,0.00008618888,0.0000028230045],"category_scores_gemma":[0.003921187,0.00007413537,0.000056438468,0.00049722195,0.00032295712,0.00008764742,0.00042256547,0.00082920666,0.0000014884203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059844455,0.0002166372,0.21368858,0.00042274327,0.00005371531,0.0000037889188,0.0012574163,7.602219e-7,0.774438,0.000023377692,0.00002980169,0.00926671],"study_design_scores_gemma":[0.00092257804,0.0002874471,0.49026117,0.00024165655,0.000008199123,0.0000013268683,0.00026752826,0.00013227934,0.5078054,0.000035865683,0.000005024642,0.000031501808],"about_ca_topic_score_codex":0.001511571,"about_ca_topic_score_gemma":0.0010449144,"teacher_disagreement_score":0.2765726,"about_ca_system_score_codex":0.00013065929,"about_ca_system_score_gemma":0.00007678453,"threshold_uncertainty_score":0.46943104},"labels":[],"label_agreement":null},{"id":"W4210245365","doi":"10.1016/j.antiviral.2022.105254","title":"5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Key Research and Development Program of China; Chinese Academy of Meteorological Sciences; Fundamental Research Funds for the Central Universities; Beijing Municipal Commission of Education; National Natural Science Foundation of China","keywords":"Virology; Biology; Coronavirus; RNA-dependent RNA polymerase; RNA polymerase; RNA; Genetics; Disease; Gene; Medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.14213532369573625,"score_gpt":0.42689788046419735,"score_spread":0.2847625567684611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210245365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91777986,0.00051518634,0.000011090431,0.002149651,0.00013159466,0.0008161154,0.00003353551,0.00013250492,0.07843047],"genre_scores_gemma":[0.9870898,0.00002435798,0.00007144061,0.011008988,0.00028758676,0.0004897988,0.000006705385,0.000089851725,0.00093142944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99264103,0.0010382214,0.0004235906,0.00085904,0.0034992925,0.0015388286],"domain_scores_gemma":[0.9973479,0.0011474476,0.0000528332,0.00095604436,0.00044429093,0.00005149438],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047779996,0.0002714101,0.0005251742,0.0011720835,0.0009540788,0.00013280858,0.00073729263,0.00013999692,0.000088760535],"category_scores_gemma":[0.00219766,0.0002534828,0.00027192401,0.0025605955,0.00047426618,0.00022378532,0.0014143338,0.0022191675,0.0016941641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009125493,0.00050697254,0.009430327,0.00011714792,0.00008513916,0.0009080898,0.00035160186,4.8730982e-8,0.9368797,0.0007237913,0.023183584,0.02690104],"study_design_scores_gemma":[0.0008212831,0.0006611656,0.0011892386,0.00006350346,0.000019697409,0.000071066424,0.00060044916,0.00024640787,0.8381047,0.00039205884,0.15761106,0.0002193583],"about_ca_topic_score_codex":0.0013022122,"about_ca_topic_score_gemma":0.000077589306,"teacher_disagreement_score":0.13442747,"about_ca_system_score_codex":0.0005661048,"about_ca_system_score_gemma":0.0010352188,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W4225331163","doi":"10.1016/j.antiviral.2022.105328","title":"In vitro activity of letermovir against human cytomegalovirus isolates with different drug susceptibility phenotypes","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Infection and Immunity; Canadian Institutes of Health Research; Merck Canada","keywords":"Human cytomegalovirus; Biology; Virology; Recombinant DNA; Polymerase; Sanger sequencing; DNA polymerase; Mutation; Virus; Genetics; DNA; Gene","score_opus":0.05244458202467387,"score_gpt":0.36691472865145586,"score_spread":0.31447014662678197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225331163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911544,0.0001810777,0.0000042782017,0.0008845528,0.000040011775,0.0011178924,0.000096288444,0.000038583556,0.006482963],"genre_scores_gemma":[0.99702686,0.000091809816,0.000029655748,0.0000890304,0.00009289409,0.00016082417,0.000041130614,0.000060386257,0.0024073862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946775,0.0010188062,0.00045261037,0.00078377343,0.0019433262,0.0011239727],"domain_scores_gemma":[0.9980806,0.00048916787,0.00010458094,0.000870026,0.00028812984,0.00016747057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026955297,0.00028840615,0.00078233756,0.0010687596,0.0005767887,0.000058812366,0.000500167,0.00008448865,0.000391001],"category_scores_gemma":[0.0001526976,0.00023065557,0.00018382086,0.0015201366,0.0007379615,0.0002746568,0.0008994397,0.0022938296,0.00003764789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076529663,0.001899771,0.04577151,0.00021615691,0.000078348865,0.00026084288,0.0007273097,0.0000030597002,0.93210596,0.00013911889,0.000620487,0.01052449],"study_design_scores_gemma":[0.0038214573,0.001988419,0.13302138,0.00007673483,0.0000152330185,0.000012060475,0.0006619602,0.00050275255,0.85640424,0.0003134826,0.0028420116,0.0003402451],"about_ca_topic_score_codex":0.00435254,"about_ca_topic_score_gemma":0.0014414462,"teacher_disagreement_score":0.08724987,"about_ca_system_score_codex":0.00066083827,"about_ca_system_score_gemma":0.00043446076,"threshold_uncertainty_score":0.99656755},"labels":[],"label_agreement":null},{"id":"W4251161773","doi":"10.1016/j.antiviral.2019.104610","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Epidemiology; Seroprevalence; Virology; Chikungunya; Virus; Natural history; Biology; Serology; Disease; Alphavirus; Medicine; Immunology; Antibody; Ecology; Internal medicine","score_opus":0.2324811269300088,"score_gpt":0.4959641093547184,"score_spread":0.2634829824247096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251161773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010532081,0.97970265,0.000024512117,0.00041435543,0.00032145734,0.0030657374,0.0010320775,0.00006069347,0.004846425],"genre_scores_gemma":[0.028551329,0.9619435,0.000015033323,0.00010426848,0.00081187685,0.00021968,0.0024284748,0.00007497748,0.005850839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99281526,0.0015611632,0.0016486669,0.0014737796,0.0013147796,0.0011863381],"domain_scores_gemma":[0.99514896,0.00185874,0.0006283721,0.0016087539,0.00041188276,0.0003432702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049290103,0.0006626939,0.0036982559,0.00031410024,0.00019133936,0.000065952496,0.00043937963,0.00083682634,0.00015217034],"category_scores_gemma":[0.005777,0.0004506636,0.0010704201,0.00070718525,0.0005699254,0.000105666106,0.0004680099,0.0019009117,0.00040312647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009179825,0.00075845275,0.0034405303,0.018589094,0.0006387413,0.0016247655,0.000011819605,1.434999e-7,0.000084523235,0.0036955317,0.030340241,0.9398982],"study_design_scores_gemma":[0.00082191784,0.0013635183,0.0062159766,0.012396342,0.00092081656,0.00017478058,0.000016044072,0.00003227899,0.000048948852,0.0001571371,0.97742563,0.0004265973],"about_ca_topic_score_codex":0.00045560472,"about_ca_topic_score_gemma":0.000026279824,"teacher_disagreement_score":0.9470854,"about_ca_system_score_codex":0.0002557789,"about_ca_system_score_gemma":0.0008436944,"threshold_uncertainty_score":0.9997945},"labels":[],"label_agreement":null},{"id":"W4298148582","doi":"10.1016/j.antiviral.2022.105427","title":"Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Dolutegravir; Integrase; Elvitegravir; Raltegravir; Virology; Integrase inhibitor; Rilpivirine; Drug resistance; Pharmacology; Human immunodeficiency virus (HIV); Genotype; Medicine; Drug; Biology; Viral load; Genetics; Antiretroviral therapy; Gene","score_opus":0.040519588999534624,"score_gpt":0.33569647352513765,"score_spread":0.29517688452560303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298148582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811396,0.00067704276,0.00008642937,0.011814906,0.00008508682,0.0009056745,0.00011143398,0.00002041261,0.0051594116],"genre_scores_gemma":[0.9212635,0.000075353375,0.00013342407,0.0000670895,0.000052768064,0.00013187513,0.00006162866,0.00002078007,0.07819356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977189,0.00028229313,0.0002575765,0.00029129733,0.0010297904,0.00042018783],"domain_scores_gemma":[0.9991478,0.00025212538,0.00001532193,0.0003379077,0.00016458238,0.00008226563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011871231,0.00013032353,0.0002450685,0.00025334998,0.0003967509,0.000019361885,0.00022463223,0.00003787018,0.00023309691],"category_scores_gemma":[0.00011670818,0.000083961364,0.00009744498,0.00093431957,0.00015692902,0.00004357217,0.000113433845,0.00064809615,0.00023376626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017199669,0.0037857045,0.2389496,0.0005921974,0.0014356152,0.0019465518,0.047759034,0.000030004405,0.1651841,0.012618491,0.44925532,0.061243728],"study_design_scores_gemma":[0.010337545,0.0028068672,0.11640526,0.00070746994,0.0003321308,0.000049829912,0.022141099,0.00018121758,0.3116108,0.001145279,0.53345996,0.00082256424],"about_ca_topic_score_codex":0.00005818055,"about_ca_topic_score_gemma":0.00022422771,"teacher_disagreement_score":0.1464267,"about_ca_system_score_codex":0.00014503102,"about_ca_system_score_gemma":0.000317997,"threshold_uncertainty_score":0.34238452},"labels":[],"label_agreement":null},{"id":"W4311089805","doi":"10.1016/j.antiviral.2022.105484","title":"Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Université de Sherbrooke; Simon Fraser University; University of British Columbia","funders":"Mitacs; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Bafilomycin; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Vero cell; EC50; Monoclonal antibody; Cell culture; Chemistry; Microbiology; In vitro; Coronavirus disease 2019 (COVID-19); Biology; Virus; Medicine; Biochemistry; Antibody; Immunology; Infectious disease (medical specialty); Disease","score_opus":0.21066745483164154,"score_gpt":0.45967938277607084,"score_spread":0.2490119279444293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926713,0.0013229749,0.00014608003,0.0028236196,0.00023506771,0.0014573473,0.000034294993,0.000042008927,0.0012672789],"genre_scores_gemma":[0.9923635,0.00002811739,0.0005219283,0.005667995,0.00023397396,0.00026801013,0.000020675227,0.000057335972,0.0008384321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960085,0.0003406034,0.0003713391,0.00057844835,0.0017658179,0.0009352591],"domain_scores_gemma":[0.9978901,0.00064478925,0.00007226346,0.0005822356,0.00080671237,0.0000038926805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024595538,0.00018954198,0.000411655,0.0005516497,0.00041653184,0.00007607804,0.00053154957,0.00007493061,1.9185066e-7],"category_scores_gemma":[0.00082880934,0.00016143272,0.00016552671,0.0015469971,0.00039962822,0.00026772643,0.0006225447,0.0010837099,0.00002578195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014343231,0.00024678797,0.003468053,0.00042644146,0.00012567369,0.00005312321,0.00039575994,5.451671e-9,0.9789035,0.0018817151,0.001648775,0.0114158485],"study_design_scores_gemma":[0.0012649376,0.00087605393,0.0018410288,0.00006875435,0.000020159638,0.000018857176,0.00059705623,0.000300147,0.9757851,0.0007853926,0.018264597,0.00017793845],"about_ca_topic_score_codex":0.00024717147,"about_ca_topic_score_gemma":0.000038644775,"teacher_disagreement_score":0.016615821,"about_ca_system_score_codex":0.00031912455,"about_ca_system_score_gemma":0.001702644,"threshold_uncertainty_score":0.6583035},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4361281962","doi":"10.1016/j.antiviral.2023.105577","title":"Corrigendum to “Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics” “Antiviral Research 209 (2023)/105484”","year":2023,"lang":"en","type":"erratum","venue":"Antiviral Research","topic":"Phytochemistry and Biological Activities","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Université de Sherbrooke; Simon Fraser University; University of British Columbia","funders":"National Institutes of Health; Sealy and Smith Foundation; Gillson Longenbaugh Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation","keywords":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); Lead (geology); 2019-20 coronavirus outbreak; Natural (archaeology); Medicine; Biology; Infectious disease (medical specialty); Internal medicine; Disease","score_opus":0.3318802516409663,"score_gpt":0.4201467638412243,"score_spread":0.088266512200258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361281962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594434,0.001909505,0.0000050145795,0.00795462,0.013149627,0.0034664944,0.0017037471,0.00020758384,0.012159989],"genre_scores_gemma":[0.71910214,0.0009125968,0.00007100918,0.000219959,0.0033221554,0.00031484084,0.0011516697,0.000014437317,0.27489117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9919935,0.0009791345,0.0007317679,0.0017531812,0.0021166655,0.0024257533],"domain_scores_gemma":[0.99544656,0.0019216465,0.00022578941,0.00038862022,0.0019859793,0.000031411106],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0043860553,0.0006277799,0.0010485598,0.00023985795,0.0009426487,0.0004858662,0.0021518369,0.0010013384,0.0000018183035],"category_scores_gemma":[0.0019776495,0.00027415535,0.00040394487,0.0035675976,0.0011051701,0.0004624038,0.0015391652,0.0031913614,0.00026551003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032562471,0.0001290069,0.000027297037,0.0002554787,0.000070808666,0.000016620963,0.000040027448,2.1396904e-9,0.6035523,0.00013024647,0.37971342,0.015739214],"study_design_scores_gemma":[0.00013940613,0.001335082,0.0021672267,0.00057891454,0.000014575513,0.000002033311,0.0005757249,0.000017417045,0.8489807,0.0021205482,0.14343895,0.00062942854],"about_ca_topic_score_codex":0.0007998946,"about_ca_topic_score_gemma":0.0010683214,"teacher_disagreement_score":0.2627312,"about_ca_system_score_codex":0.00024004659,"about_ca_system_score_gemma":0.00052399223,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W4382396744","doi":"10.1016/j.antiviral.2023.105660","title":"Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Discontinuation; Capsid; Hepatitis B virus; Medicine; Combination therapy; Viral load; Hepatitis B; Virology; Internal medicine; Gastroenterology; Virus","score_opus":0.10915616196660032,"score_gpt":0.4383497965040562,"score_spread":0.32919363453745587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382396744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966002,0.00008645092,0.000003387861,0.00077655737,0.000019439067,0.0017187832,0.00010132431,0.0000393989,0.000654467],"genre_scores_gemma":[0.99885243,0.00023834356,0.000004537234,0.00007420563,0.000051428662,0.0002641828,0.00008540973,0.000028345912,0.00040111854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953393,0.0010730464,0.0004031268,0.00047086648,0.0019565,0.00075721333],"domain_scores_gemma":[0.99788266,0.00068843714,0.00009445729,0.0007798609,0.0005027192,0.00005184481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023131086,0.00021328116,0.00060124474,0.0009248514,0.0003264428,0.000049660266,0.0004467991,0.00006544497,0.000019313913],"category_scores_gemma":[0.00058285485,0.00011106539,0.000133156,0.0070975935,0.0005017454,0.00015617817,0.00021017948,0.0006049765,0.00007950944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000233987,0.0012742819,0.98380333,0.000035140238,0.0009235906,0.00034323678,0.0035892876,0.000013690467,0.0045226915,0.00003287542,0.001155545,0.00407237],"study_design_scores_gemma":[0.0025437481,0.004543297,0.9826388,0.00007025888,0.00040517704,8.611925e-7,0.0009671112,0.0063057267,0.0022671467,0.000008273168,0.00012835744,0.00012125066],"about_ca_topic_score_codex":0.041859075,"about_ca_topic_score_gemma":0.06291306,"teacher_disagreement_score":0.021053983,"about_ca_system_score_codex":0.00027830264,"about_ca_system_score_gemma":0.00025828517,"threshold_uncertainty_score":0.9645213},"labels":[],"label_agreement":null},{"id":"W4385189431","doi":"10.1016/j.antiviral.2023.105680","title":"The hepatic GABAergic system promotes liver macrophage M2 polarization and mediates HBV replication in mice","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Shandong First Medical University; Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Hepatitis B virus; Viral replication; HBsAg; GABAergic; Transfection; Biology; Virology; Immunology; Cancer research; Chemistry; Virus; Receptor; Medicine; Internal medicine; Cell culture","score_opus":0.03898125543924413,"score_gpt":0.3605482639271823,"score_spread":0.3215670084879382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385189431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876214,0.0012505007,0.000004747697,0.00890032,0.000041513,0.0010467389,0.0000075168355,0.00007132925,0.0010558886],"genre_scores_gemma":[0.98381436,0.0011655035,0.000011379855,0.000018789468,0.0000935169,0.00017549522,0.000042461692,0.000026325035,0.014652189],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99738026,0.00042400436,0.00025262043,0.0004248103,0.00091295084,0.0006053298],"domain_scores_gemma":[0.9988447,0.00023284694,0.000036708436,0.00044955808,0.0003446341,0.00009155989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042874683,0.00010275734,0.00017236764,0.00040502672,0.0003730727,0.00013956243,0.00017359818,0.000100106845,0.0000058859837],"category_scores_gemma":[0.0016300625,0.000069937974,0.000039387913,0.0017330049,0.00029462684,0.00011651813,0.0002162861,0.00051233143,0.00019722278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039534032,0.00018559083,0.11840601,0.0019054981,0.000048890957,0.0006583052,0.0016341105,5.932492e-7,0.7384194,0.005812913,0.01640542,0.116127886],"study_design_scores_gemma":[0.00091484707,0.0004668243,0.91466695,0.0003611612,0.000012792939,0.000035048604,0.0017087611,0.024757486,0.053827066,0.00023182176,0.0028704226,0.00014683553],"about_ca_topic_score_codex":0.00096640334,"about_ca_topic_score_gemma":0.00015183233,"teacher_disagreement_score":0.7962609,"about_ca_system_score_codex":0.0001489252,"about_ca_system_score_gemma":0.00018166669,"threshold_uncertainty_score":0.28694114},"labels":[],"label_agreement":null},{"id":"W4387358847","doi":"10.1016/j.antiviral.2023.105730","title":"Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; Queen's University; Banting Research Foundation","keywords":"Cyclophilin A; Biology; Virology; Gene; Coronavirus; Cell culture; Cyclophilin; Gene expression; Cell biology; Coronavirus disease 2019 (COVID-19); Molecular biology; Genetics; Medicine; Pathology","score_opus":0.06718686528676804,"score_gpt":0.38283595623790806,"score_spread":0.31564909095114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387358847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984308,0.00011904235,0.00019775018,0.000046255922,0.000113962684,0.0006128761,0.0004051723,0.000016625008,0.00005753565],"genre_scores_gemma":[0.998393,0.00055480836,0.000045373006,0.0000074443296,0.00013057404,0.000055357446,0.0005113662,0.000027073442,0.00027502817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978286,0.0003516844,0.00056310464,0.00041427094,0.0005010245,0.0003413245],"domain_scores_gemma":[0.99890167,0.000082044404,0.00020430872,0.00029747246,0.0004678818,0.000046605837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012114329,0.00015194407,0.0002827696,0.00048917293,0.00007757706,0.000009450641,0.00013942116,0.00023772083,0.000004747418],"category_scores_gemma":[0.00074996316,0.00014681095,0.00008817312,0.0011725392,0.00014292843,0.0000226532,0.00025065782,0.00023434544,0.0000063542084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019496669,0.00038801806,0.018984389,0.00020006849,0.00001651559,0.000010001094,0.000051680803,0.00007125284,0.9772797,0.000016193448,0.00046124085,0.0005712452],"study_design_scores_gemma":[0.0013991909,0.0011874184,0.032662522,0.00020129244,0.00001115626,5.2852516e-7,0.00004310709,0.00010211905,0.9641637,0.0000732399,0.000035074892,0.00012060723],"about_ca_topic_score_codex":0.0006810646,"about_ca_topic_score_gemma":0.000071342314,"teacher_disagreement_score":0.013678135,"about_ca_system_score_codex":0.000053212563,"about_ca_system_score_gemma":0.00014244957,"threshold_uncertainty_score":0.5986777},"labels":[],"label_agreement":null},{"id":"W4387747110","doi":"10.1016/j.antiviral.2023.105736","title":"ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Biology; Virology; ASK1; Virus; Viral replication; Protein kinase R; Kinase; Vaccinia; Activator (genetics); Protein kinase A; Interferon; Cell biology; Mitogen-activated protein kinase kinase; Receptor; Biochemistry","score_opus":0.11998237690830317,"score_gpt":0.41046820339299284,"score_spread":0.2904858264846897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387747110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453133,0.0002375254,0.000012001775,0.0005660917,0.00058107055,0.00041085112,0.00008034131,0.00014171434,0.0034390641],"genre_scores_gemma":[0.9937152,0.0004602032,0.000009472303,0.0000466706,0.00008067175,0.000033787142,0.00014519875,0.000036991918,0.005471801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964229,0.0012532684,0.000510721,0.0006643596,0.00028016831,0.00086860644],"domain_scores_gemma":[0.99800336,0.0004068881,0.00019463808,0.0008341807,0.0005441796,0.000016770671],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028018546,0.0002248509,0.0004197577,0.0008314825,0.0005810768,0.000057535683,0.00063938374,0.00033832426,0.00008012233],"category_scores_gemma":[0.0016751713,0.00020511309,0.00017199025,0.0014353531,0.00060213916,0.00035492503,0.0011016992,0.0008174706,0.0035449003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000982451,0.00013097117,0.009102858,0.00004391004,0.0001303127,0.000015802267,0.0007846194,3.7698464e-7,0.9486999,0.00045650883,0.02672683,0.012925495],"study_design_scores_gemma":[0.00082837394,0.00034089928,0.04332833,0.0001586089,0.00001892732,0.0000051819698,0.0023903032,0.000021053862,0.9413109,0.00015882603,0.011228233,0.00021039546],"about_ca_topic_score_codex":0.00089625106,"about_ca_topic_score_gemma":0.000044232343,"teacher_disagreement_score":0.03422547,"about_ca_system_score_codex":0.00008071171,"about_ca_system_score_gemma":0.00018845063,"threshold_uncertainty_score":0.99723095},"labels":[],"label_agreement":null},{"id":"W4388968728","doi":"10.1016/j.antiviral.2023.105758","title":"A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Saint Vincent University; Saint Mary's University; University of Saskatchewan; Dalhousie University","funders":"","keywords":"Proteases; Protease; Polyproteins; Viral replication; Biology; Coronavirus; Biochemistry; Virology; Enzyme; Virus; Coronavirus disease 2019 (COVID-19)","score_opus":0.14375048098441648,"score_gpt":0.4499879883160517,"score_spread":0.30623750733163524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388968728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414594,0.00013294064,0.00026302174,0.002253097,0.00005511964,0.0024321836,0.000026458481,0.0003730977,0.010318142],"genre_scores_gemma":[0.9929799,0.000023916105,0.000119920995,0.004511382,0.0004064241,0.0006802805,0.00011121526,0.00007816926,0.0010888226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99473745,0.00046864577,0.0004683509,0.0010115966,0.0021296125,0.0011843733],"domain_scores_gemma":[0.99735445,0.0003799406,0.000087227556,0.0010628046,0.0010261807,0.00008941696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003148118,0.00026933762,0.00038828483,0.000996571,0.00042997173,0.00011976759,0.00025774038,0.00025089047,0.000018860068],"category_scores_gemma":[0.002497605,0.00024276036,0.0001517303,0.003274066,0.00054797344,0.0004324852,0.0004384019,0.0012579077,0.004283199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012981272,0.000328104,0.013973864,0.00019601421,0.000048367347,0.00034574894,0.0005563609,8.909992e-8,0.9266452,0.00064057985,0.0041235043,0.05184401],"study_design_scores_gemma":[0.002254148,0.0011364378,0.035366204,0.00024868603,0.000016099013,0.000036419366,0.00021877956,0.0016588647,0.93766904,0.003088727,0.018045675,0.00026091898],"about_ca_topic_score_codex":0.0008621418,"about_ca_topic_score_gemma":0.000047580823,"teacher_disagreement_score":0.05158309,"about_ca_system_score_codex":0.0003573559,"about_ca_system_score_gemma":0.0006938579,"threshold_uncertainty_score":0.9964921},"labels":[],"label_agreement":null},{"id":"W4390145972","doi":"10.1016/j.antiviral.2023.105787","title":"Pralatrexate inhibited the replication of varicella zoster virus and vesicular stomatitis virus: An old dog with new tricks","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Natural Science Foundation of China","keywords":"Varicella zoster virus; Viral replication; Vesicular stomatitis virus; Virus; Virology; In vitro; In vivo; Biology; Antiviral drug; Mechanism of action; Biochemistry","score_opus":0.07582295121733769,"score_gpt":0.40132375678653737,"score_spread":0.3255008055691997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390145972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951351,0.00009269343,0.000049302933,0.0008112629,0.000016620408,0.00068055803,0.00001353541,0.00006448816,0.003136381],"genre_scores_gemma":[0.99515295,0.00047421412,0.00009259259,0.00008135281,0.000059269478,0.00004248924,0.00004299561,0.00002491378,0.004029194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984487,0.00018951597,0.00019553282,0.00035891938,0.0005036351,0.00030364326],"domain_scores_gemma":[0.998817,0.00019890383,0.00005794526,0.0006709984,0.00016493967,0.00009020875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096234254,0.0001115824,0.00019115325,0.0003055657,0.00020212976,0.000052068855,0.00007948685,0.00007761315,0.000029802783],"category_scores_gemma":[0.00013788787,0.0000664271,0.000037421843,0.0014872281,0.00017661508,0.00016134359,0.00007768933,0.00026356982,0.00013077621],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006705401,0.0009630177,0.18784525,0.00017950601,0.000542389,0.000320118,0.0023553146,0.00000318188,0.15802439,0.0009076582,0.008101805,0.6400868],"study_design_scores_gemma":[0.0034936927,0.0028453253,0.67139405,0.00029006743,0.00016149,0.00006600299,0.00035115873,0.0010579416,0.29873285,0.00064464274,0.02074616,0.00021660073],"about_ca_topic_score_codex":0.004982069,"about_ca_topic_score_gemma":0.00028227776,"teacher_disagreement_score":0.6398702,"about_ca_system_score_codex":0.000039272898,"about_ca_system_score_gemma":0.00013228232,"threshold_uncertainty_score":0.7531432},"labels":[],"label_agreement":null},{"id":"W4391022518","doi":"10.1016/j.antiviral.2024.105815","title":"An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; National Institute of Mental Health; National Health and Medical Research Council; National Institutes of Health","keywords":"Nasal administration; Small interfering RNA; Gene silencing; RNA interference; Virology; Biology; Immunology; Medicine; RNA; Gene; Genetics","score_opus":0.08624937850393366,"score_gpt":0.4367229983958779,"score_spread":0.35047361989194425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391022518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896811,0.0011353928,0.00007357407,0.0017927516,0.00008778601,0.0011849282,0.000008040741,0.000117379466,0.0059190155],"genre_scores_gemma":[0.99629897,0.0001811833,0.000049308885,0.0030221208,0.00024457028,0.0001129524,0.0000074583445,0.000046910674,0.00003654012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954981,0.0010790135,0.0003687479,0.0007935488,0.0014035392,0.0008570245],"domain_scores_gemma":[0.9976412,0.0012226382,0.000024809164,0.0006606715,0.0004097441,0.000040916828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004042123,0.00023199586,0.0003275703,0.000674875,0.00025466323,0.0006082687,0.00034131214,0.00022393043,0.00000399272],"category_scores_gemma":[0.0015499415,0.00016159206,0.00010220831,0.0016378114,0.00063294254,0.0006006036,0.00009871886,0.0018171559,0.000086193635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010755355,0.0003744032,0.095470496,0.000616006,0.00007027349,0.0015602958,0.0011077767,6.961873e-8,0.8855789,0.000833843,0.00112139,0.01219106],"study_design_scores_gemma":[0.0015097782,0.0019788907,0.13038012,0.0004683959,0.000052309457,0.00021979687,0.0003806558,0.0046668467,0.85349596,0.0012317452,0.005309828,0.00030568722],"about_ca_topic_score_codex":0.007724464,"about_ca_topic_score_gemma":0.001936446,"teacher_disagreement_score":0.034909636,"about_ca_system_score_codex":0.00017010164,"about_ca_system_score_gemma":0.0008384811,"threshold_uncertainty_score":0.9988832},"labels":[],"label_agreement":null},{"id":"W4391056045","doi":"10.1016/j.antiviral.2024.105811","title":"Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Stimulator of interferon genes; Sting; Interferon; Signal transduction; Gene knockdown; Biology; IRF3; Cell biology; Interferon regulatory factors; Interferon type I; TANK-binding kinase 1; Viral replication; Virus; Virology; Receptor; Innate immune system; Gene; MAPK/ERK pathway; Biochemistry","score_opus":0.08233381906551915,"score_gpt":0.39395751064259904,"score_spread":0.3116236915770799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391056045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993915,0.0027884168,0.0021016386,0.00032253232,0.0003520513,0.0002778073,0.000015556912,0.00009249647,0.0041103316],"genre_scores_gemma":[0.99390507,0.00016600458,0.0000316073,0.000016605625,0.00004484726,0.000028774934,0.000060452996,0.000024529252,0.005722137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997975,0.00067779166,0.000367864,0.0004271164,0.00013614775,0.0004161068],"domain_scores_gemma":[0.99814713,0.0010723972,0.00005742901,0.00043725048,0.0002756317,0.000010168235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018238109,0.00013044165,0.00020756107,0.00041372346,0.00017593453,0.00006508789,0.00030936484,0.00017601796,0.00029301917],"category_scores_gemma":[0.0007523366,0.00011265763,0.00008780485,0.0003586233,0.00028442804,0.0002801374,0.00020635442,0.00066275755,0.0008211452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000591134,0.00006613124,0.00020314055,0.00011520323,0.00009312265,0.0000048159795,0.000475197,0.0000010224504,0.95596516,0.0013204134,0.0014458806,0.0397188],"study_design_scores_gemma":[0.00020395087,0.00047444625,0.00049006153,0.00037936086,0.000009723175,0.000015946976,0.00037324373,0.00010337627,0.99193215,0.00028196888,0.0056316643,0.000104100865],"about_ca_topic_score_codex":0.00029882786,"about_ca_topic_score_gemma":0.0000059263675,"teacher_disagreement_score":0.0396147,"about_ca_system_score_codex":0.00007838575,"about_ca_system_score_gemma":0.00012294076,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W4393195508","doi":"10.1016/j.antiviral.2024.105869","title":"Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Simon Fraser University; Université de Sherbrooke; University of British Columbia","funders":"GeneTex; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University of British Columbia","keywords":"Host (biology); Chemistry; Virology; Mechanism of action; TMPRSS2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Action (physics); Microbiology; Coronavirus disease 2019 (COVID-19); Biology; Biochemistry; Medicine; Genetics; Physics; Pathology","score_opus":0.09663143742622812,"score_gpt":0.40928353614016016,"score_spread":0.31265209871393207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393195508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888511,0.000929744,0.000042255306,0.0007553409,0.00024364032,0.0010231434,0.000031583695,0.0002095457,0.007913675],"genre_scores_gemma":[0.9986752,0.000090883055,0.00005211235,0.0004311501,0.00027261727,0.00004747642,0.0000028347163,0.00008995653,0.000337758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955297,0.00073225435,0.0003652189,0.0008837346,0.0015326465,0.000956428],"domain_scores_gemma":[0.99754703,0.0011193196,0.00010043158,0.0006993467,0.0004950101,0.00003888126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002190934,0.00034287016,0.0006338566,0.0006815678,0.00042946282,0.0002694536,0.00031102568,0.0002483618,0.0000029942455],"category_scores_gemma":[0.0011674002,0.00022604389,0.00018107006,0.0022790884,0.0009763705,0.0005284584,0.00042165155,0.0015430845,0.00006155147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000849568,0.0002116318,0.019244822,0.0008794989,0.0001821241,0.00022967279,0.0002846762,3.328683e-8,0.9574688,0.000053650005,0.0006701936,0.019925307],"study_design_scores_gemma":[0.0008086897,0.00062556966,0.021714088,0.0011544293,0.00006784782,0.00003665839,0.00016530322,0.0010131367,0.9628602,0.000030082185,0.011286312,0.00023768438],"about_ca_topic_score_codex":0.0016280978,"about_ca_topic_score_gemma":0.00026603643,"teacher_disagreement_score":0.019687623,"about_ca_system_score_codex":0.00024970362,"about_ca_system_score_gemma":0.0008877155,"threshold_uncertainty_score":0.9217802},"labels":[],"label_agreement":null},{"id":"W4393346747","doi":"10.1016/j.antiviral.2024.105877","title":"Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute on Aging; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Georgia State University","keywords":"Virology; Vaccination; Heterologous; Influenza vaccine; Ectodomain; Biology; Neuraminidase; Virus; Population; Hemagglutination assay; Immunology; Titer; Medicine; Receptor; Genetics","score_opus":0.12293599411864774,"score_gpt":0.4235850161126214,"score_spread":0.30064902199397364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393346747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567616,0.0022872018,0.000036025704,0.00036281545,0.000026909982,0.0014656287,0.000047683287,0.00005196762,0.000045589997],"genre_scores_gemma":[0.99838036,0.0006754337,0.0003302221,0.00023082728,0.00003909111,0.00019960832,0.000011468904,0.000034596866,0.00009840916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99737847,0.0004719612,0.00035074804,0.00052391394,0.0006456009,0.000629317],"domain_scores_gemma":[0.99894863,0.00047717692,0.00004805299,0.00020007735,0.0002282649,0.00009777155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001525259,0.00020168528,0.0003459223,0.000457636,0.00018290649,0.00009460669,0.00008291202,0.00009989121,0.000008336305],"category_scores_gemma":[0.00063490163,0.00015347928,0.000035407196,0.00078058423,0.000498498,0.00035279998,0.00022110376,0.0007399336,0.000012133582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004260099,0.00023938395,0.118396096,0.0006770158,0.00013173628,0.000420207,0.0012645894,0.0000025527254,0.84936744,0.000024216362,0.00010527499,0.0251114],"study_design_scores_gemma":[0.006016327,0.0045169056,0.55018216,0.00040994826,0.000045922723,0.000055725697,0.0009068323,0.00777946,0.4295093,0.00005771597,0.00029923316,0.00022046905],"about_ca_topic_score_codex":0.0014350585,"about_ca_topic_score_gemma":0.0022807994,"teacher_disagreement_score":0.43178606,"about_ca_system_score_codex":0.00009917444,"about_ca_system_score_gemma":0.00016682653,"threshold_uncertainty_score":0.62587035},"labels":[],"label_agreement":null},{"id":"W4395685088","doi":"10.1016/j.antiviral.2024.105893","title":"Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections","year":2024,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Schwartz/Reisman Emergency Medicine Institute; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal antibody; Medicine; Antibody; Immunology; Virology; Hepatitis B virus; Hepatitis B; Antigen; Virus","score_opus":0.20371630802164337,"score_gpt":0.5213370371599079,"score_spread":0.3176207291382645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395685088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018000136,0.99256337,0.000031698986,0.00071422715,0.00040351506,0.0036223563,0.00067734433,0.000048715552,0.00013873783],"genre_scores_gemma":[0.0064837183,0.99159193,0.000057420897,0.000029158311,0.00056210835,0.0004137396,0.000118195654,0.00007075256,0.00067296793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962362,0.0010714704,0.0006593807,0.0005459904,0.00087797997,0.0006089706],"domain_scores_gemma":[0.9970014,0.0013551331,0.00012597741,0.000638054,0.00070966023,0.00016978632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010129805,0.00041347602,0.0019651894,0.000975904,0.00025649532,0.00007951934,0.00017610405,0.00025305373,0.000035899888],"category_scores_gemma":[0.0019558684,0.00025885474,0.00041654723,0.0015327417,0.00042327613,0.0000934197,0.00040936196,0.0019740472,0.00020790655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010951085,0.0007025462,0.0006606304,0.04357867,0.0007189572,0.00016649847,0.0001816504,3.4361175e-8,0.000053193045,0.00015965168,0.012558996,0.94110966],"study_design_scores_gemma":[0.00035568475,0.001195685,0.00065255765,0.030563949,0.0010956201,0.000013987055,0.000027220649,0.000010041304,0.000034890807,0.0000102686845,0.96582097,0.00021911439],"about_ca_topic_score_codex":0.0011805163,"about_ca_topic_score_gemma":0.00072873855,"teacher_disagreement_score":0.953262,"about_ca_system_score_codex":0.00024012798,"about_ca_system_score_gemma":0.0016902989,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W4401324553","doi":"10.1016/j.antiviral.2024.105979","title":"Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infection","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Ministry of Education; CHEO Research Institute","keywords":"Vaccination; Virology; Virus; Medicine; Antibody; Immunology; Immunization; Antibody titer; Influenza A virus; Antigen; Titer","score_opus":0.09475089796329865,"score_gpt":0.4613536525207302,"score_spread":0.3666027545574315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401324553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864162,0.0030686613,0.00010107864,0.001546262,0.00032771358,0.0014366327,0.00005146696,0.00023457802,0.006817378],"genre_scores_gemma":[0.98871,0.0014311862,0.00011228942,0.0006028882,0.0007082646,0.00021569798,0.000016968866,0.000077070195,0.008125657],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99505967,0.00038490916,0.0004435996,0.0007693788,0.0020494128,0.0012930167],"domain_scores_gemma":[0.99790555,0.00034225007,0.000025805766,0.0005387382,0.00087129575,0.00031633436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022112518,0.0002904527,0.00042245485,0.0011965252,0.0004979561,0.00034238165,0.00023709395,0.00017361825,0.00036224432],"category_scores_gemma":[0.0024603503,0.00023900071,0.00022914378,0.0018496603,0.00015395027,0.0004905812,0.0008795194,0.001387088,0.003180336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035747564,0.0007182285,0.016279243,0.0013335629,0.0010702739,0.0036868171,0.0032489,0.00009584972,0.7829146,0.0008934393,0.08570491,0.10047946],"study_design_scores_gemma":[0.0036400342,0.009095587,0.15016311,0.004021528,0.00033373418,0.00024512317,0.0010735019,0.006857713,0.38254043,0.0016754816,0.4389218,0.0014319295],"about_ca_topic_score_codex":0.005028282,"about_ca_topic_score_gemma":0.0005200944,"teacher_disagreement_score":0.4003741,"about_ca_system_score_codex":0.0005121854,"about_ca_system_score_gemma":0.00077788066,"threshold_uncertainty_score":0.9975958},"labels":[],"label_agreement":null},{"id":"W4401355252","doi":"10.1016/j.antiviral.2024.105976","title":"Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Diverse Scientific Research Studies","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; Clinical and Translational Science Institute, Boston University; Clinical and Translational Science Institute, University of Pittsburgh; National Cancer Institute; National Institutes of Health; Massachusetts Consortium on Pathogen Readiness; Boston University","keywords":"Coronavirus; Virology; Virus; Viral replication; Biology; eIF4A; Translation (biology); Medicine; Coronavirus disease 2019 (COVID-19); Gene; Biochemistry","score_opus":0.20925698202647447,"score_gpt":0.4840355234944932,"score_spread":0.2747785414680187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401355252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98122674,0.0007672808,0.000050552106,0.002185424,0.00024860818,0.0023452165,0.00025664995,0.00008307979,0.012836418],"genre_scores_gemma":[0.996938,0.0005160566,0.00016759352,0.000012746326,0.000095444484,0.00045246308,0.000020365162,0.000045150526,0.0017521811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9927702,0.0018890687,0.0012446247,0.0009024168,0.0022096778,0.000984041],"domain_scores_gemma":[0.9947971,0.0019858913,0.00042829895,0.0010721827,0.0016625565,0.00005396554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069928025,0.00024888603,0.00067845674,0.0008779618,0.00052429386,0.000038356182,0.00047742494,0.00027980126,0.00004479519],"category_scores_gemma":[0.005395837,0.00020022267,0.00025107834,0.0020804047,0.0014285487,0.000671831,0.00086646836,0.0010881767,0.00028689415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026351507,0.0002977265,0.0024225137,0.004208008,0.00013802778,0.000024422452,0.003049974,0.0000011188147,0.9624446,0.010314735,0.01185635,0.0049790135],"study_design_scores_gemma":[0.000257922,0.00029096517,0.0022570966,0.006359052,0.000030708525,6.60319e-7,0.0060431734,0.0004454176,0.9771543,0.0048287082,0.0021676433,0.00016431825],"about_ca_topic_score_codex":0.0020020588,"about_ca_topic_score_gemma":0.00013757528,"teacher_disagreement_score":0.01571123,"about_ca_system_score_codex":0.00029868673,"about_ca_system_score_gemma":0.0006217897,"threshold_uncertainty_score":0.8164844},"labels":[],"label_agreement":null},{"id":"W4402314510","doi":"10.1016/j.antiviral.2024.105995","title":"Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada); Public Health Agency of Canada","funders":"Public Health Agency of Canada","keywords":"Monkeypox; Cidofovir; Outbreak; Virology; Clade; Pandemic; Transmission (telecommunications); Smallpox; Disease; Virus; Biology; Medicine; Infectious disease (medical specialty); Vaccination; Vaccinia; Coronavirus disease 2019 (COVID-19); Gene; Phylogenetics","score_opus":0.05016156535997781,"score_gpt":0.3652086948991522,"score_spread":0.3150471295391744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402314510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646265,0.02235549,0.000011201061,0.0005682968,0.00018887996,0.00045060174,0.00014652041,0.00009951671,0.011553016],"genre_scores_gemma":[0.9776418,0.007839942,0.00002029234,0.000024946725,0.0000762615,0.000036016685,0.0000714007,0.000034162244,0.014255157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734086,0.00051957567,0.00033663015,0.00058982347,0.0001715062,0.0010415878],"domain_scores_gemma":[0.99830943,0.0010561413,0.000031258427,0.00041365187,0.0001250983,0.00006440223],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006233109,0.00024261783,0.00038926725,0.0005694169,0.00046232526,0.00007908001,0.00033353892,0.0002840207,0.00013116073],"category_scores_gemma":[0.00031784768,0.0001837531,0.00015949001,0.0005588947,0.0010518184,0.0002648117,0.00051328936,0.00076868484,0.0012271071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040385293,0.00025791788,0.00051975565,0.000057188226,0.00027597332,0.0000894799,0.00068785297,2.6235656e-7,0.8120523,0.0014349862,0.0027078644,0.18151258],"study_design_scores_gemma":[0.0016519536,0.0020915642,0.0070471163,0.00014038495,0.000024585728,0.000037652408,0.00018217144,0.0001184565,0.81258905,0.00039486508,0.17548506,0.00023712295],"about_ca_topic_score_codex":0.0014716362,"about_ca_topic_score_gemma":0.00013261005,"teacher_disagreement_score":0.18127546,"about_ca_system_score_codex":0.00011091036,"about_ca_system_score_gemma":0.00031709607,"threshold_uncertainty_score":0.9995506},"labels":[],"label_agreement":null},{"id":"W4402758970","doi":"10.1016/j.antiviral.2024.106010","title":"Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Capsid; Virology; Virus; Hepatitis B virus; Medicine; Biology","score_opus":0.1261666485360752,"score_gpt":0.45854313196582813,"score_spread":0.3323764834297529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402758970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424046,0.000739331,0.00010673861,0.001115175,0.00043896932,0.00080362044,0.00015519762,0.000107829306,0.0022926494],"genre_scores_gemma":[0.9800256,0.017939992,0.0002062317,0.00019404563,0.000530288,0.000036739955,0.00007680334,0.000060656734,0.00092966715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958362,0.0006480779,0.0009748177,0.0007592574,0.0011291249,0.0006525086],"domain_scores_gemma":[0.99794155,0.000878138,0.000090531285,0.00044168,0.0004883407,0.00015974347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029997546,0.0002480705,0.00076933997,0.00040412068,0.00016939068,0.00010463012,0.00016034632,0.00028349826,0.00001575341],"category_scores_gemma":[0.0020700083,0.0002044975,0.00024971645,0.0006598714,0.00079863786,0.0003330698,0.00039804776,0.001027121,0.00021596263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000221499,0.000369234,0.62247866,0.00038151012,0.00023079521,0.0003885637,0.00020549448,2.4756416e-8,0.28098312,0.00035236782,0.0011243477,0.09326437],"study_design_scores_gemma":[0.00072319806,0.0013810617,0.95521224,0.0008397584,0.000079648125,0.000011099103,0.000018611601,0.0049210778,0.03303513,0.000074082665,0.0035024271,0.00020165021],"about_ca_topic_score_codex":0.0020793176,"about_ca_topic_score_gemma":0.00086253305,"teacher_disagreement_score":0.3327336,"about_ca_system_score_codex":0.00009549544,"about_ca_system_score_gemma":0.00041551905,"threshold_uncertainty_score":0.8339166},"labels":[],"label_agreement":null},{"id":"W4402910425","doi":"10.1016/j.antiviral.2024.106015","title":"Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health~Holland; Aids Fonds; National Institutes of Health; amfAR, The Foundation for AIDS Research","keywords":"Effector; Human immunodeficiency virus (HIV); Antibody; Virology; Antibody-dependent cell-mediated cytotoxicity; Immunology; Computational biology; Biology; Monoclonal antibody","score_opus":0.07181583889299027,"score_gpt":0.43451503544276354,"score_spread":0.3626991965497733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402910425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98384094,0.0013481925,0.0027453927,0.0022890978,0.00056274014,0.0006811908,0.0002454289,0.00012680219,0.008160202],"genre_scores_gemma":[0.9871877,0.000082119055,0.00028457626,0.000021611573,0.00065370963,0.000047837162,0.0002819976,0.000043796852,0.011396664],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967396,0.00011954641,0.00039802515,0.0005267423,0.0014400459,0.00077600003],"domain_scores_gemma":[0.9981947,0.000794366,0.00002116001,0.0003268507,0.0004521039,0.00021081022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010245818,0.00021961707,0.0004830856,0.00089870807,0.00018994814,0.00017878771,0.0001884049,0.00012685065,0.00029270913],"category_scores_gemma":[0.00029605586,0.00017356637,0.00022124109,0.001437553,0.00023328954,0.0002588629,0.00024422893,0.0010765763,0.0037293257],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057673454,0.00026502315,0.022366835,0.0012893182,0.00024386492,0.00012657336,0.00022079713,0.000072750285,0.9325271,0.0033299087,0.032495953,0.006485143],"study_design_scores_gemma":[0.0014301033,0.006731056,0.49976194,0.0020433778,0.00013944262,0.00009047003,0.0019136845,0.029415559,0.30472985,0.00016896176,0.15282035,0.00075520633],"about_ca_topic_score_codex":0.00024953185,"about_ca_topic_score_gemma":0.000013773741,"teacher_disagreement_score":0.62779725,"about_ca_system_score_codex":0.00008286198,"about_ca_system_score_gemma":0.00050145003,"threshold_uncertainty_score":0.9970464},"labels":[],"label_agreement":null},{"id":"W4402943571","doi":"10.1016/j.antiviral.2024.106016","title":"Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Virology; Drug resistance; Mutation; Antiviral drug; Drug; Biology; Computational biology; Genetics; Virus; Pharmacology; Gene","score_opus":0.11011392141884757,"score_gpt":0.432911242165294,"score_spread":0.3227973207464464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402943571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92569757,0.0121679995,0.00015618757,0.0063837115,0.00045097942,0.0014277009,0.000245769,0.00041439084,0.053055685],"genre_scores_gemma":[0.943527,0.0022348638,0.00051661726,0.00026549675,0.00060439913,0.0000863028,0.00018417265,0.00010266489,0.052478522],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445754,0.0005369775,0.00047068758,0.0010226236,0.0022454103,0.0012667766],"domain_scores_gemma":[0.9972824,0.00090721145,0.00003530519,0.0007969614,0.0007584105,0.00021970157],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019001055,0.00032050064,0.00049481465,0.001093858,0.00047803577,0.0004956791,0.00036584277,0.00015243438,0.00033129146],"category_scores_gemma":[0.00039194472,0.0002748606,0.00023204951,0.002277354,0.0007477957,0.00075012905,0.00038363528,0.0018613698,0.0046932898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030651365,0.0006818828,0.002427109,0.003739414,0.00044894853,0.012201106,0.0018516406,3.957558e-7,0.4010162,0.014771551,0.45022535,0.10957127],"study_design_scores_gemma":[0.0013989509,0.00026675194,0.004084656,0.0014030163,0.000052675783,0.00006035032,0.0008265022,0.0014844281,0.13538356,0.0012829396,0.8532994,0.00045681736],"about_ca_topic_score_codex":0.00077112747,"about_ca_topic_score_gemma":0.0004292441,"teacher_disagreement_score":0.403074,"about_ca_system_score_codex":0.00027414036,"about_ca_system_score_gemma":0.00082523486,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W4404564887","doi":"10.1016/j.antiviral.2024.106038","title":"Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus; Coronavirus Infections; Betacoronavirus; Biology; Medicine","score_opus":0.18140645004224987,"score_gpt":0.4345981075462438,"score_spread":0.2531916575039939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964937,0.0002669504,0.0004209308,0.00069510785,0.0000664448,0.00082877005,0.000051911,0.00007916604,0.0010970248],"genre_scores_gemma":[0.9986012,0.0000989991,0.0000789544,0.0007942127,0.00021744451,0.000071178314,0.000013957721,0.000037811966,0.00008621856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971722,0.00018662344,0.00024883295,0.0006487191,0.0010957094,0.0006479289],"domain_scores_gemma":[0.9989459,0.00029058717,0.000039411454,0.0003421637,0.00034820987,0.000033760494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013117491,0.00020882615,0.0003979489,0.000468116,0.00012358588,0.000120881115,0.00016509311,0.00021030524,0.0000024519172],"category_scores_gemma":[0.00029322205,0.00013986471,0.000087283835,0.0010084437,0.0006908376,0.00028269857,0.00027236916,0.00087273464,0.000073410345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015977601,0.0004017422,0.016978651,0.00033551958,0.00007529905,0.00022062464,0.00014884464,1.8285752e-9,0.9109853,0.00029967452,0.000050596744,0.06890602],"study_design_scores_gemma":[0.0008827466,0.0017517783,0.10723777,0.0003397626,0.00001626061,0.0000498825,0.000042158517,0.0005158785,0.8826077,0.00004997647,0.0063656303,0.00014045509],"about_ca_topic_score_codex":0.0005095224,"about_ca_topic_score_gemma":0.00002850742,"teacher_disagreement_score":0.09025912,"about_ca_system_score_codex":0.00012022973,"about_ca_system_score_gemma":0.0005094874,"threshold_uncertainty_score":0.5703517},"labels":[],"label_agreement":null},{"id":"W4405596769","doi":"10.1016/j.antiviral.2024.106061","title":"HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Nucleic acid; Kinetics; RNA; Chemistry; Virology; Medicine; Biochemistry; Gene","score_opus":0.0889990070505941,"score_gpt":0.37468070897946293,"score_spread":0.2856817019288688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405596769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97586435,0.004582406,0.00004568163,0.0060465904,0.0003981954,0.00043334762,0.000045983732,0.00021476949,0.012368658],"genre_scores_gemma":[0.99073106,0.0014365686,0.000061884704,0.00020670662,0.00069932756,0.00006946617,0.000023412895,0.00006623484,0.006705309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970946,0.00017070015,0.00023148983,0.00045375247,0.001324502,0.0007249662],"domain_scores_gemma":[0.99910545,0.0002177756,0.00001672155,0.00032731492,0.00022037677,0.00011234104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059490587,0.00018824953,0.00024835276,0.00045235935,0.00027561156,0.000097107775,0.00013365278,0.000120995865,0.0008483805],"category_scores_gemma":[0.00022285322,0.00015278756,0.00014038151,0.00084666285,0.00033807705,0.00014102609,0.00012667332,0.00083544094,0.00067590387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084966485,0.0003620754,0.07994938,0.0005883781,0.00042682124,0.0010847589,0.0011293531,0.0000014563392,0.83040595,0.0002826478,0.03731658,0.04760294],"study_design_scores_gemma":[0.0020558762,0.001452456,0.4565666,0.000756783,0.000041600535,0.000026314345,0.0004021431,0.0025659276,0.5083689,0.00010007358,0.027351268,0.00031205558],"about_ca_topic_score_codex":0.00018905856,"about_ca_topic_score_gemma":0.00007066767,"teacher_disagreement_score":0.37661722,"about_ca_system_score_codex":0.00016881782,"about_ca_system_score_gemma":0.00031935214,"threshold_uncertainty_score":0.92891717},"labels":[],"label_agreement":null},{"id":"W4407382229","doi":"10.1016/j.antiviral.2025.106104","title":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft","keywords":"Amantadine; Virology; Antiviral drug; Drug resistance; Drug; Medicine; Pharmacology; Virus; Biology; Microbiology","score_opus":0.2674005673238715,"score_gpt":0.517625843708419,"score_spread":0.2502252763845475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407382229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390585,0.001470624,0.00034102902,0.0022281208,0.000039608723,0.0025568379,0.000044828244,0.00005117654,0.009361908],"genre_scores_gemma":[0.9948758,0.00010096306,0.0018439967,0.0011408202,0.00004015668,0.00024247944,0.000008480426,0.000033324402,0.0017140189],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99365926,0.0010958781,0.0005728132,0.00078188453,0.0030333423,0.00085684203],"domain_scores_gemma":[0.9950671,0.0015214749,0.00011864454,0.0006805245,0.0024717536,0.00014049123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008890044,0.00028781904,0.00076752977,0.0011246115,0.0003236368,0.00009155396,0.0002833308,0.00014384197,0.000020945554],"category_scores_gemma":[0.005455199,0.00022235616,0.000103413215,0.0018325264,0.0010367243,0.00023825161,0.00039750172,0.00080120657,0.00003357155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03318524,0.0014199737,0.598847,0.0021490292,0.0011732541,0.00020020064,0.001732255,0.00002427402,0.2992569,0.010248409,0.019355386,0.03240811],"study_design_scores_gemma":[0.0124984225,0.0018435968,0.24941103,0.003685818,0.0002880425,0.0000019800964,0.0009293477,0.0015843143,0.7209299,0.0029357618,0.0054485984,0.0004431937],"about_ca_topic_score_codex":0.00036282436,"about_ca_topic_score_gemma":0.0014377284,"teacher_disagreement_score":0.421673,"about_ca_system_score_codex":0.00021024028,"about_ca_system_score_gemma":0.0011841491,"threshold_uncertainty_score":0.9067421},"labels":[],"label_agreement":null},{"id":"W4408907087","doi":"10.1016/j.antiviral.2025.106151","title":"Tenofovir alafenamide promotes weight gain and impairs fatty acid metabolism-related signaling pathways in visceral fat tissue compared to tenofovir disoproxil fumarate","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Tenofovir alafenamide; Tenofovir; Pharmacology; Metabolism; Fatty acid metabolism; Medicine; Chemistry; Endocrinology; Human immunodeficiency virus (HIV); Virology; Viral load; Antiretroviral therapy","score_opus":0.04103409760759242,"score_gpt":0.3564029374775032,"score_spread":0.31536883986991077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408907087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801309,0.006156006,0.00031633873,0.0045333486,0.00019624521,0.0023595071,0.000039057955,0.00014138182,0.006127177],"genre_scores_gemma":[0.9908981,0.00046831707,0.0011592518,0.00032607038,0.00019208378,0.0001576796,0.000075185,0.00006907543,0.006654266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995073,0.00068161637,0.00079235114,0.001018838,0.0009399751,0.0014941791],"domain_scores_gemma":[0.9982266,0.00031707285,0.00008439078,0.00065430236,0.00037008277,0.00034756967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022687363,0.00046379544,0.0011119131,0.0013387487,0.000371968,0.00014620904,0.0003810252,0.0003002698,0.00007031201],"category_scores_gemma":[0.0007600721,0.00037878889,0.00012630135,0.0023031377,0.00042197754,0.00035619343,0.000544338,0.0012842958,0.00025142642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007531639,0.00040731445,0.014612674,0.00023936393,0.00018125902,0.00050192914,0.002149362,0.0000049068494,0.938078,0.0038765238,0.001482542,0.037712976],"study_design_scores_gemma":[0.005363183,0.00062323426,0.15078175,0.0010214633,0.00018004888,0.00003374066,0.001066979,0.0015023159,0.8235639,0.005014356,0.0101915095,0.00065751333],"about_ca_topic_score_codex":0.00090473186,"about_ca_topic_score_gemma":0.00020088127,"teacher_disagreement_score":0.13616909,"about_ca_system_score_codex":0.00014069038,"about_ca_system_score_gemma":0.0004087067,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W4409973699","doi":"10.1016/j.antiviral.2025.106184","title":"Chemical arsenal for helicase Hunters: Striking the toughest targets in antiviral research","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education; Foundation for the National Institutes of Health","keywords":"Helicase; Virology; Biology; Computational biology; Genetics; Gene; RNA","score_opus":0.18112455032403105,"score_gpt":0.5172940450822192,"score_spread":0.33616949475818814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409973699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503193,0.0007315711,0.00035412313,0.03244512,0.0001464071,0.0022426401,0.00004895333,0.000043553482,0.013668359],"genre_scores_gemma":[0.99422014,0.00047795288,0.0005747635,0.00057607295,0.0004492959,0.00043567806,0.00006906707,0.000034930017,0.0031621202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99293447,0.0017289656,0.0006376175,0.00084700953,0.001239289,0.0026126357],"domain_scores_gemma":[0.9963401,0.0019255225,0.000041876352,0.00072358234,0.0008130728,0.0001558221],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011433389,0.00023778496,0.00062109454,0.0011333962,0.00048734713,0.00014344552,0.0007296839,0.00025492746,0.00002606775],"category_scores_gemma":[0.011022211,0.00017207184,0.00024709018,0.0019030271,0.001571004,0.00021115063,0.0008033068,0.002862423,0.000085567175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009494479,0.0011728831,0.067096256,0.0006563736,0.00019784622,0.0011094402,0.0004035776,9.548115e-7,0.66302574,0.006847704,0.15745082,0.09254391],"study_design_scores_gemma":[0.027016435,0.010144467,0.1553273,0.006191519,0.000082655955,0.00027122904,0.011776731,0.0147994505,0.52809274,0.020649396,0.22441074,0.0012373195],"about_ca_topic_score_codex":0.00044164693,"about_ca_topic_score_gemma":0.0003010857,"teacher_disagreement_score":0.13493301,"about_ca_system_score_codex":0.00037883106,"about_ca_system_score_gemma":0.00062023604,"threshold_uncertainty_score":0.999438},"labels":[],"label_agreement":null},{"id":"W4411125619","doi":"10.1016/j.antiviral.2025.106211","title":"Marburg and Kasokero viruses elicit differential antiviral innate immune control by their natural reservoir bat, the Egyptian rousette (Rousettus aegyptiacus)","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"Defense Threat Reduction Agency; Centers for Disease Control and Prevention; University of Georgia","keywords":"Biology; Virology; Filoviridae; Innate immune system; Viral replication; Interferon; Virus; Immunology; Marburg virus; Viremia; Immune system; Viral disease; Ebola virus; Paramyxoviridae","score_opus":0.029558243995364518,"score_gpt":0.356492189541267,"score_spread":0.3269339455459025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411125619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117167,0.002581377,0.0001666236,0.009560961,0.00047641832,0.0012369489,0.00015381031,0.00016261447,0.004489555],"genre_scores_gemma":[0.98867446,0.0009172097,0.000014526885,0.0012422072,0.00029187428,0.00010497342,0.00006268014,0.00006564121,0.008626444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99565554,0.0008901764,0.0006002481,0.00076009,0.0008315744,0.0012623508],"domain_scores_gemma":[0.99763083,0.0008292367,0.00010432653,0.00090392306,0.00041415932,0.00011751586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015425986,0.00046753333,0.0007442004,0.0005967346,0.0011396159,0.00038491777,0.00050394126,0.00027925926,0.0000626065],"category_scores_gemma":[0.0005989655,0.0002902357,0.0002954244,0.0013536485,0.0011092004,0.00037369877,0.00054184056,0.0021479852,0.00008285875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002820166,0.0007210031,0.09809389,0.00022809103,0.0011029498,0.00012220716,0.00039627982,0.0000011905207,0.7677053,0.0018466174,0.10419186,0.022770442],"study_design_scores_gemma":[0.015957912,0.0030284387,0.49454674,0.0011995871,0.0005285078,0.00009485577,0.0011917753,0.009127885,0.3207847,0.0016470606,0.15038916,0.0015034061],"about_ca_topic_score_codex":0.0016019505,"about_ca_topic_score_gemma":0.00027348322,"teacher_disagreement_score":0.44692063,"about_ca_system_score_codex":0.00014777738,"about_ca_system_score_gemma":0.0002061457,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W4413270284","doi":"10.1016/j.antiviral.2025.106260","title":"Optimization of the monoclonal antibody 3E1 through W32I mutation enhances antiviral efficacy against influenza virus subtypes H1N1 and H3N2","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Department of Science and Technology of Jilin Province; National Natural Science Foundation of China","keywords":"Hemagglutinin (influenza); Monoclonal antibody; Virology; Influenza A virus; Virus; Mutant; In vivo; Antibody; Biology; Chemistry; Immunology; Gene; Biochemistry","score_opus":0.09963536486003413,"score_gpt":0.4710256397204209,"score_spread":0.3713902748603868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787155,0.0022137396,0.00041735783,0.0009755594,0.0001154362,0.0011114851,0.000026686143,0.000045134395,0.0163791],"genre_scores_gemma":[0.9950319,0.0023006434,0.0010153666,0.00044783548,0.00009615489,0.000038138158,0.00002562189,0.000025728401,0.0010186253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963892,0.00056078285,0.0005178226,0.00052088755,0.0013104008,0.00070088456],"domain_scores_gemma":[0.9975254,0.0008703858,0.0001230085,0.0005002067,0.00093547505,0.000045525627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014547464,0.00024304673,0.00047829677,0.00042053935,0.0006173611,0.000094480965,0.0003312177,0.00016585627,0.000011785315],"category_scores_gemma":[0.002400125,0.00017125018,0.00013871453,0.0016986948,0.0014354946,0.00045104587,0.0005856403,0.00077053794,0.000024443862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034765333,0.0009630948,0.09653188,0.0010458531,0.0007730347,0.00008543404,0.0032142317,0.0004801967,0.85513276,0.005975778,0.0031200266,0.029201193],"study_design_scores_gemma":[0.0035792887,0.000618566,0.23802397,0.00089890446,0.000084422965,0.00000412019,0.0010795804,0.0048028934,0.7462939,0.0005939522,0.0037350028,0.00028539132],"about_ca_topic_score_codex":0.0003586124,"about_ca_topic_score_gemma":0.000057285146,"teacher_disagreement_score":0.14149208,"about_ca_system_score_codex":0.0001105158,"about_ca_system_score_gemma":0.0005258618,"threshold_uncertainty_score":0.69833803},"labels":[],"label_agreement":null},{"id":"W4414555588","doi":"10.1016/j.antiviral.2025.106284","title":"Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Public Health Agency of Canada; University of Ottawa; Health Canada","funders":"Health Canada; Government of Canada","keywords":"Hemagglutinin (influenza); Influenza vaccine; Peptide vaccine; Immune system; Context (archaeology); Antibody; Immunity; Vaccination","score_opus":0.1849438717008265,"score_gpt":0.4615874212466871,"score_spread":0.2766435495458606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414555588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830978,0.005730801,0.000018665447,0.0009895465,0.000050327457,0.00086218596,0.000014259949,0.000044957433,0.009191442],"genre_scores_gemma":[0.99760234,0.0010926957,0.00006539001,0.0006242616,0.000088284934,0.000056737004,0.000003057551,0.000022998982,0.00044423022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627745,0.00079872896,0.0005677699,0.0003984207,0.0011075429,0.00085009134],"domain_scores_gemma":[0.9960702,0.002326277,0.00009447246,0.00061315,0.00081437174,0.000081528815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041178497,0.00023175967,0.0005570175,0.00064183195,0.00072722894,0.00008972948,0.00043661302,0.00013749662,0.00000969707],"category_scores_gemma":[0.0029575836,0.0001519788,0.00009909663,0.0016737002,0.0010098708,0.00022593068,0.0011674875,0.001572719,0.00001948058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029869045,0.0004782824,0.5317769,0.0013763709,0.0007715956,0.00010558481,0.0021623229,0.0000016990897,0.30784473,0.0029103379,0.002638917,0.14694637],"study_design_scores_gemma":[0.004597636,0.0011515188,0.8130014,0.0017999047,0.00007882325,0.000008628215,0.005274874,0.000258957,0.16882306,0.0004198773,0.004313207,0.0002721158],"about_ca_topic_score_codex":0.00095712126,"about_ca_topic_score_gemma":0.0002822173,"teacher_disagreement_score":0.2812245,"about_ca_system_score_codex":0.00009705413,"about_ca_system_score_gemma":0.0003615721,"threshold_uncertainty_score":0.6832769},"labels":[],"label_agreement":null},{"id":"W4416248423","doi":"10.1016/j.antiviral.2026.106463","title":"Drug Combination Treatment as a Strategy for Inhibiting Human Adenovirus Replication","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Drug; Antiviral drug; Viral replication; Replication (statistics); Combination therapy; Toxicity","score_opus":0.08563366477006425,"score_gpt":0.4557436435268426,"score_spread":0.37010997875677837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416248423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364556,0.0004676642,0.00011636213,0.00083342695,0.000024160805,0.0010519554,0.00001674526,0.000019016597,0.013825098],"genre_scores_gemma":[0.97907984,0.00019223394,0.00003641364,0.00007366783,0.00011413696,0.00042124922,0.00031784558,0.000023440558,0.019741151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811715,0.00029809645,0.00020936494,0.00059029204,0.00031120182,0.00047389528],"domain_scores_gemma":[0.99881136,0.000087302105,0.00004052533,0.00059500325,0.00042511337,0.000040675663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507897,0.00013011486,0.00012873368,0.00023167652,0.00046241612,0.000099245095,0.00026445923,0.00011473315,0.000008456602],"category_scores_gemma":[0.00028629636,0.00012558451,0.00009060178,0.00035452785,0.00015112742,0.000008832053,0.00011833478,0.00015270269,0.0000370658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009092956,0.00021911254,0.00046413852,0.000026696804,0.00005215334,0.0000017746794,0.000040124003,0.000002994752,0.92883754,0.0034573136,0.0022568966,0.063731976],"study_design_scores_gemma":[0.0013461243,0.004470624,0.00037922512,0.00002403683,0.0000057252696,6.830471e-7,0.00018809999,0.00011681806,0.98402345,0.0037562873,0.005578968,0.00010998094],"about_ca_topic_score_codex":0.00024509948,"about_ca_topic_score_gemma":0.00048695394,"teacher_disagreement_score":0.063622,"about_ca_system_score_codex":0.00011817891,"about_ca_system_score_gemma":0.00037984637,"threshold_uncertainty_score":0.51211876},"labels":[],"label_agreement":null}]}